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I. Abstract (English) 
This Thesis aims at the development of two novel families of inorganic phosphate cements 
with suitable characteristics for clinical applications in hard tissue regeneration or replacement. It 
is organized in two distinct parts.  
The first part focuses at the development of silicon-doped α-tricalcium phosphate and the 
subsequent preparation of a silicon-doped calcium phosphate cement for bone regeneration 
applications. For this purpose, silicon-doped α-tricalcium phosphate was synthesized by sintering a 
calcium-deficient hydroxyapatite at 1250°C with different amounts of silicon oxide. The high 
temperature polymorph α-tricalcium phosphate was stabilized by the presence of silicon, which 
inhibited reversion of the β−α transformation, whereas in the Si-free α-tricalcium phosphate 
completely reverted to the β-polymorph. It was observed that the presence of Si did not alter the 
β–α transformation temperature. Both the Si-doped α-tricalcium phosphate and its Si-free 
counterpart were used as reactants in the formulation of calcium phosphate cements. While Si-
doped α-tricalcium phosphate showed faster hydrolysis to calcium deficient hydroxyapatite, the 
composition, morphology and mechanical properties of both cements were similar upon 
completion of the reaction. When the samples were immersed in simulated body fluid, the Si-
doped cement exhibited a faster deposition of an apatite layer on its surface than its Si-free 
counterpart, suggesting an enhanced bioactivity of the doped-cement. An in vitro cell culture 
study, in which osteoblast-like cells were exposed to a medium modified by the materials, showed 
a delay in cell proliferation and a stimulation of cell differentiation, the differentiation being more 
marked for the Si-containing cement. These results were attributed to the Ca depletion from the 
medium by both cements and to the continuous Si release detected for the Si-containing cement.  
The second part of this Thesis is focused on the development of a new family of inorganic 
phosphate-based cements for biomedical applications, namely magnesium phosphate cements. 
The magnesium phosphate cements have been extensively used in civil engineering due to their 
fast setting, early strength acquisition and adhesive properties, properties that can be also of use 
for biomedical applications. However, there are some aspects that should be improved before they 
can be used in the human body, namely their high exothermic setting reaction and the release of 
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potentially harmful ammonium ions. Therefore, a new family of magnesium phosphate cements 
was explored as candidate biomaterials for hard tissue applications. These cements were prepared 
by mixing magnesium oxide with either sodium dihydrogen phosphate, ammonium dihydrogen 
phosphate or an equimolar mixture of both. The exothermia and the setting kinetics of the new 
cement formulations were tailored. The ammonium-containing magnesium phosphate cements 
resulted in struvite as the major reaction product, whereas the magnesium phosphate cement 
prepared with sodium dihydrogen phosphate resulted in an amorphous product. The magnesium 
phosphate cements studied showed an early compressive strength substantially higher than that of 
conventional apatitic calcium phosphate cements. Moreover, they showed antimicrobial 
properties against bacteria present in dental infections, which were attributed to the synergistic 
effect of a high osmolarity and high pH of the cement extracts. These properties make magnesium 
phosphate cements good candidates for endodontic applications. It is with this latter point in mind 
that some of the most relevant physico-chemical properties were further optimized and 
characterized. Particularly, their radiopacity was enhanced by the addition of bismuth oxide. The 
sealing efficiency of the magnesium phosphate cements and their adhesion to dentin were shown 
to be comparable or even higher than those presented by other inorganic cements used for 
endodontic treatments.   
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Resum (Catalan) 
 Aquesta Tesi té com a objectiu el desenvolupament de dues noves famílies de ciments 
inorgànics de base fosfat amb propietats adequades per a aplicacions clíniques en regeneració o 
substitució de teixits durs. La Tesi està organitzada en dues parts. 
La primera part està centrada en el desenvolupament de fosfat tricàlcic α dopat amb silici i 
la subseqüent preparació de ciments de fosfat de calci dopats amb silici. Per a aquest objectiu, es 
va obtenir fosfat tricàlcic α dopat amb silici mitjançant la sinterització d’una hidroxiapatita 
deficient en calci amb diferents quantitats d’òxid de silici a 1250°C. La presència de silici va 
estabilitzar el polimorf d’alta temperatura (fosfat tricàlcic α), inhibint-se la reversió de la 
transformació β−α, mentre que el fosfat tricàlcic α sense silici va revertir completament a polimorf 
β. La presència de silici no va alterar la temperatura de la transformació β−α. Tant el fosfat tricàlcic 
α dopat amb silici com el seu homòleg sense silici van ser utilitzats com a reactius en la formulació 
de ciments de fosfat de calci. Si bé el fosfat tricàlcic α dopat amb silici va mostrar en les fases 
inicials una hidròlisi més ràpida a hidroxiapatita deficient en calci, un cop completada la reacció, la 
composició, morfologia i propietats mecàniques d’ambdós ciments van ser similars. L’estudi de 
bioactivitat mitjançant la immersió de les mostres en fluid corporal simulat va donar com a resultat 
la formació d’una capa d’apatita a la superfície del ciment dopat amb silici, més ràpida que al seu 
homòleg sense silici, fet que va suggerir una bioactivitat millorada del ciment dopat. L’estudi in 
vitro, en el qual cèl·lules osteoblàstiques es van exposar a un medi de cultiu que havia estat 
prèviament en contacte amb els ciments estudiats, va mostrar un retràs en la proliferació cel·lular i 
un estímul de la diferenciació cel·lular, aquest últim més marcat pel ciment que contenia silici. 
Aquests resultats es van atribuir a la reducció de calci en els medis en els quals estaven introduïts 
els ciments i a l’alliberament continu d’ions silici per part del ciment que en contenia. 
La segona part d’aquesta Tesi està centrada en el desenvolupament d’una nova família de 
ciments inorgànics per a aplicacions mèdiques, els anomenats ciments de fosfat de magnesi. 
Aquests ciments s’han utilitzat extensament en enginyeria civil degut a la seva presa ràpida, 
elevades propietats mecàniques a temps curts i adhesivitat, propietats que poden ser de gran 
utilitat en aplicacions biomèdiques. No obstant, hi ha alguns aspectes que s’haurien de millorar 
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abans de poder utilitzar aquests ciments en el cos humà, com l’exotèrmia de reacció de presa o la 
possible alliberació d’ions amoni. Amb aquesta finalitat es planteja el desenvolupament d’una nova 
família de ciments de fosfat de magnesi amb possibles aplicacions clíniques. Aquests ciments es 
van preparar mitjançant la combinació d’òxid de magnesi amb dihidrogen fosfat de sodi, 
dihidrogen fosfat d’amoni o una barreja equimolar d’ambdós. L’exotèrmia i la cinètica de presa de 
les noves formulacions de ciment es van ajustar per tal de complir els requeriments clínics. Els 
ciments que contenien amoni van donar com a producte majoritari de reacció estruvita, mentre 
que els preparats amb dihidrogen fosfat de sodi van donar lloc a un producte amorf. Els ciments 
desenvolupats van presentar una resistència a la compressió superior als ciments apatítics de 
fosfat de calci, especialment a temps curts, i van mostrar propietats antimicrobianes contra 
bactèries presents en infeccions dentals. Aquestes propietats converteixen aquests ciments en 
bons candidats per aplicacions endodòntiques. Tenint en compte aquest últim punt, es va millorar 
la radiopacitat dels ciments i es va avaluar la capacitat de segellat dels ciments de fosfat de 
magnesi i la seva adhesió a la dentina, propietats que van resultar comparables o fins i tot 
superiors a les que presenten altres ciments inorgànics utilitzats en tractaments endodòntics.  
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Resumen (Spanish) 
 Esta Tesis tiene como objetivo el desarrollo de dos nuevas familias de cementos 
inorgánicos de base fosfato con propiedades adecuadas para aplicaciones clínicas en regeneración 
o sustitución de tejidos duros. La Tesis está organizada en dos partes. 
La primera parte está centrada en el desarrollo de fosfato tricálcico α dopado con silicio y 
la subsecuente preparación de cementos de fosfato de calcio dopados con silicio. Para este 
objetivo, se preparó fosfato tricálcico α dopado con silicio mediante la sinterización de una 
hidroxiapatita deficiente en calcio con distintas cantidades de óxido de silicio a 1250°C. La 
presencia de silicio resultó en la estabilización del polimorfo de alta temperatura (fosfato tricálcico 
α), inhibiéndose la reversión de la transformación β−α, mientras que el fosfato tricálcico α sin 
silicio revertió completamente al polimorfo β. La presencia de silicio no alteró la temperatura de 
transformación β−α. Tanto el fosfato tricálcico α dopado con silicio como su homólogo sin silicio se 
utilizaron como reactivos en la formulación de cementos de fosfato de calcio. Si bien el fosfato 
tricálcico α dopado con silicio mostró una hidrólisis más rápida a hidroxiapatita deficiente en 
calcio, una vez completada la reacción, la composición, morfología y propiedades mecánicas de los 
dos cementos fueron similares. El estudio de bioactividad mediante inmersión en fluido corporal 
simulado mostró la formación de una capa de apatita en la superficie del cemento dopado con 
silicio, más rápida que en su homólogo sin silicio, lo que sugirió una mejora de la bioactividad del 
cemento dopado. El estudio in vitro, en el cual células osteoblásticas se expusieron a un medio de 
cultivo que había estado previamente en contacto con los cementos estudiados, mostró un retraso 
en la proliferación celular y un estímulo de la diferenciación celular, éste último más marcado en el 
cemento que contenía silicio. Estos resultados se atribuyeron a la reducción de calcio del medio de 
cultivo que había estado en contacto con los cementos y a la continua liberación de iones silicio 
por parte del cemento que contenía este elemento.  
La segunda parte de esta Tesis está centrada en el desarrollo de una nueva familia de 
cementos inorgánicos para aplicaciones médicas, los cementos de fosfato de magnesio. Estos 
cementos se han utilizado extensamente en ingeniería civil, debido a su rápido fraguado, sus 
elevadas propiedades mecánicas a tiempos cortos y su adhesividad, propiedades que pueden ser 
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de gran utilizad en aplicaciones biomédicas. No obstante, hay algunos aspectos que requieren una 
mejora antes de utilizar estos cementos en el cuerpo humano, tales como su alta exotermia de 
reacción o la posible liberación de iones amonio. Con esta finalidad se plantea el desarrollo de  una 
nueva familia de cementos de fosfato de magnesio para aplicaciones clínicas. Estos cementos se 
prepararon mediante la combinación de óxido de magnesio con dihidrógeno fosfato de sodio, 
dihidrógeno fosfato de amonio o una mezcla equimolar de ambos. La exotermia y la cinética de 
reacción de las nuevas formulaciones de cemento se ajustaron para cumplir con los requerimientos 
clínicos. Los cementos de fosfato de magnesio que contenían amonio resultaron en estruvita como 
producto mayoritario de la reacción, mientras que los preparados con dihidrógeno fosfato de sodio 
dieron lugar a un producto amorfo. Los cementos estudiados presentaron una resistencia a la 
compresión superior a los cementos apatíticos de fosfato de calcio, especialmente a tiempos 
cortos, y mostraron propiedades antimicrobianas contra bacterias presentes en infecciones 
dentales. Estas propiedades convierten a los cementos de fosfato de magnesio en buenos 
candidatos para aplicaciones endodónticas. Teniendo en cuenta este último punto, se optimizó la 
radiopacidad de los cementos, y se evaluó la capacidad de sellado de los cementos de fosfato de 
magnesio y su adhesión a la dentina, propiedades que resultaron ser comparables o incluso 
superiores a las que presentan otros cementos inorgánicos utilizados en tratamientos 
endodónticos. 
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IV. Motivation, objectives and structure of this Thesis 
Motivation 
The motivation of this Thesis is originated by two different health problems. The first issue 
of focus is the prevalence of diseases or disorders and the large number of fractures occurring in 
an ageing population, which has increased the need for bone substitutes able to replace areas of 
bone that are too large to heal by themselves. The use of synthetic bioactive materials can 
overcome the limitations of the conventional treatments (i.e. autografts and allografts) [1].  
Calcium phosphate cements (CPCs) are well-known for their excellent bioactivity and 
osteoconductivity owed to their similarity to the mineral phase of the bone [2]. The cements can 
be introduced into a bone defect by minimal invasive techniques and they can be used as drug 
delivery systems. However, the CPCs also have some drawbacks, such as slow resorption, poor 
mechanical properties [3] and lack of macroporosity [4]. Considerable efforts have been devoted to 
combine the intrinsic bone regeneration potential of CPCs with their ability to incorporate drugs, 
active molecules or specific ions for different therapeutic needs [3]. Silicon, specifically, is very 
important during the growth of bone and cartilage at early stages and also during bone 
remodelation [5].  
The aim of the first part of this Thesis is to develop α-tricalcium phosphate doped with 
silicon, which will be used as the reactant of silicon-doped calcium phosphate cements for bone 
regeneration, with the expectation that these cements will have enhanced osteogenic properties 
than their silicon-free counterparts due to the presence of silicon.  
 
The second issue of focus is the common damage of the hard tissues protecting the dental 
pulp (i.e. enamel and dentin) due to trauma or dental caries. This situation gives advantage to the 
oral microorganisms to infect the dental pulp, threatening the health of the whole tooth and even 
causing serious health problems to the individual if the infection is not eradicated. Depending on 
the grade of injury, the endodontic treatments aim either at the closure of the damaged hard 
tissue or at the removal of the diseased part of the pulp or at the removal of the entire pulp. If the 
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entire pulp is removed, the root canal has to be filled with a tightly sealing and antimicrobial 
material that prevents reinfection. However, there is still not a single material that fulfills all the 
requirements demanded by this application and therefore the root canal is usually obturated with 
the combination of two or more materials. 
Magnesium phosphate cements (MPCs), which have been used in civil engineering for their 
fast setting and adhesive properties [6–8], were envisaged as a novel family of inorganic cements 
that could overcome the low mechanical properties of the calcium phosphate cements. Moreover, 
the chemical composition of this system allowed predicting their antimicrobial potential. Despite 
the unique benefits provided by these systems, only recently they have been proposed for clinical 
applications, specifically for bone regeneration [9–11]. At the best of our knowledge, the MPCs 
have not yet been suggested for endodontic applications. 
The second part of the Thesis aims at the development of a novel system of antimicrobial 
MPCs tailored for clinical applications. This family of cements has been pointed out as promising 
candidates for endodontic applications, in which an infection of the root canal has to be battled.  
 
Objectives 
The main objectives of this Thesis are the following: 
 
1. To develop a Si-doped calcium phosphate cement, using as a main reactant a Si-stabilized α-TCP, 
and to study the role of Si on the stabilization and hydrolysis reaction of this compound, as well as 
in the cell response to the Si-doped calcium phosphate cement. 
 
2. To develop and characterize a new family of magnesium phosphate cements for clinical uses and 
to optimize their properties for endodontic applications. 
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Structure 
This Thesis has been organized in two differentiated parts. The first part aims at the 
development of silicon-doped calcium phosphate cements for bone regeneration applications, and 
arises from the desire to improve the intrinsic bone regeneration potential of CPCs. The second 
part of this Thesis aims at the development of magnesium phosphate cements with high early 
compressive strength and tailored properties for clinical applications, which are envisaged to 
eradicate or prevent a localized infection.  
Even though both Si-doped calcium phosphate cements and magnesium phosphate 
cements have several points in common, such as being inorganic phosphate cements intended to 
be used in clinical applications, their specific applications are different. Therefore, in order to 
facilitate the reading, this Thesis has been organized in two parts, each of them containing its own 
theoretical framework Chapter. This Thesis will conclude with a final Chapter in which the most 
relevant results will be recapitulated. Figure 1 shows the structure of this Thesis. 
 
Figure 1. Structure of this Thesis.  
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1.1 Social context encouraging the development of novel biomaterials 
Spanish population is aging since life expectancy in this country has increased almost 
linearly since the World War II [1]. As consequence of the increase of life expectancy, the bone 
fracture risks have increased as well. For instance, in Spain, a total of 318 new cases of hip fracture 
were recorded in 1988, and 490 in 2002. This represents an increase of 54% in the absolute 
number of hip fractures for the 14-year period (3.9% per year). [2]. The incidence of hip fractures 
have been reported to be more frequent in women compared to men [2], since a 26.1% of women 
who are 50 years old or older suffer from osteoporosis [3]. Figure 1.1 shows that the incidence of 
hip fracture starts increasing exponentially with age for people older than 65 years. In 2006 it was 
estimated that the 25,000 bone fractures that occur in Spain each year result in direct costs of 
more than €126 million and indirect costs of about €420 million [4]. 
 
Figure 1.1. Overall age-specific incidence of hip fracture in Cantabria, Spain (from [2]). 
 
Current medical treatments for severe bone injuries are problematic and may yield poor 
results [5]. Therefore, it is crucial to have a deep understanding of the bone from the biological 
point of view, in order to be able to perform a successful research focused on looking for new 
strategies to heal bone fractures. 
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1.2 Bone 
1.2.1 Bone as a hierarchically organized tissue 
Bone is a composite tissue with great stiffness and strength that constitute the skeleton. 
Bones have several functions: they are designed to protect vital organs of the body (e.g. skull or 
thorax), provide the frame for locomotion of the musculoskeletal system and withstand 
physiological load without breaking. Additionally, bone is a reservoir for many essential minerals, 
such as calcium and phosphate, and plays an important role in the regulation of ion concentration 
in extracellular matrix. Bone marrow contains mesenchymal stem cells (MSCs) and hematopoietic 
cells. MSC are multipotent stem cells that can differentiate into a variety of cell types, including: 
osteoblasts (bone cells), chondrocytes (cartilage cells), myocyte (muscle cell) and adipocytes (fat 
cells) [6] [5] [7]. 
Bone is a highly organized tissue that is hierarchically arranged at the macro- (tissue level), 
at the micro- (cellular), and at the nano-scale (molecular) [8].  
1.2.1.1 Classification of bones (macroscopical organization) 
The bones can be organized according to their shape, which is genetically programmed in 
order to attain a certain function. Four kinds of bones can be mentioned regarding their shape: 
long, short, flat and irregular bones. Long bones are those in which length exceeds width, having a 
cylindrical shape with thicker end portions, e.g. femur or humerus; short bones have the three 
dimensions similar, being cubelike, e.g. carpals of wrist; flat bones are thin and flattened, with light 
curvature, e.g. parietal bone of skull or ribs; irregular bones are those with complicated shapes, 
e.g. pelvis or vertebrae [7] (Figure 1.2). 
Theoretical framework 11 
 
 
Figure 1.2. Classification of bones on the basis of their shape (from [7]). 
 
The gross structure of a long bone is shown in Figure 1.3 a. The diaphysis makes up most of 
the bone’s length and is composed of compact bone. The diaphysis is covered and protected by a 
ﬁbrous connective tissue membrane, the periosteum. Hundreds of connective tissue ﬁbers, called 
Sharpey’s ﬁbers, secure the periosteum to the underlying bone (Figure 1.3 c). The epiphyses are 
the ends of the long bone. Each epiphysis consists of a thin layer of compact bone enclosing an 
area filled with spongy bone. Articular cartilage, instead of a periosteum, covers its external 
surface.  
Bone tissue has two major forms: the cortical or compact bone, and the cancellous, 
trabecular or spongy one. The bone tissue called cortical or compact is dense and forms most of 
the outer shell of a whole bone, which has variable thickness [9]. The cancellous bone forms a 
complex three-dimensional scaffold composed of short struts of bone material called trabeculae, 
being thus a porous material. [8]. The cortical bone embraces the trabecular one like a hull to 
protect the delicate trabecular scaffold from impact [8]. While cortical bone has four times the 
density of trabecular bone, its metabolic turnover is eight times lower [8]. The location of these 
bone types in a long bone is illustrated in Figure 1.3 b. 
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Figure 1.3. The structure of a long bone, a) anterior view with longitudinal section cuts away at the 
proximal end; b) pie-shaped, three-dimensional view of spongy bone and compact bone of the 
epiphysis; c) cross section of the shaft (diaphysis) (from [7]).  
 
1.2.1.2 Bone structural organization (microscopical organization) 
At the microscopic or cellular level, the organic and mineral phases are arranged into two 
forms of bone tissue: woven or primary bone, and lamellar bone.  
The woven bone is typically found in both cortical and cancellous bone of young growing 
animals and also in adults after a bone injury. During normal maturation woven bone is gradually 
replaced by lamellar bone, so that in man, for example, there is normally no woven bone present 
after the age of 14–16 years [9]. Woven bone is an isotropic tissue with coarse collagen fibers 
which are randomly oriented [8]. The ratio of mineral to collagen in woven bone varies 
enormously, and hyper-mineralization is often observed. The woven bone can be understood as a 
temporary scaffold that bears a complete structure, and that precedes the lamellar bone [9]. 
The lamellar bone is formed from woven bone during the remodelling process. It is highly 
anisotropic and stress oriented, i.e. the tissue organization adapts and depends on the applied 
forces [8], and the mineral to collagen ratio is fixed. As shown in Figure 1.4, the lamellar bone 
consists of a number of concentrically arranged laminae, called osteons or Haversian system. 
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Osteons have a central lumen containing a blood vessel and also accommodate small vessels, 
arterioles and capillaries for microcirculation. While the blood vessels in the osteonal canal 
transport blood generally along the long axis of a long bone, it is the Volkmann canals that contain 
the blood vessels that transport blood generally perpendicular to the long axis of a long bone, 
connecting different osteonal systems, and also connecting to the outside of the bone [7] [9]. The 
mature bone cells, osteocytes, are found in tiny cavities within the matrix called lacunae, which 
are arranged in the lamellae around the Haversian canals. Tiny canals, canaliculi, radiate outward 
from the central canals to all lacunae, connecting all the bone cells to the nutrient supply.  
 
Figure 1.4. Microscopic structure of the compact bone. Diagram of a pie-shaped segment of compact 
bone (from [7]).  
 
1.2.1.3 Bone composition (nanoscopical organization) 
In general terms, bone tissue is a composite material made by ∼ 50-60 wt% of an inorganic 
phase, ∼ 30-40 wt% of an organic one, and up to 10 wt% of water [5] [10]. The inorganic phase is 
comprised by calcium orthophosphate crystals, precisely non-stoichiometric hydroxyapatites (Ca10-
x
(HPO4)x(PO4)6-x(OH)2-x, 0 < x < 1), in the form of small plates of 2–3 nm thick and tens of 
nanometers in length and width [5]. The nanometric size and poor crystallinity of the natural 
apatites, combined with their non-stoichiometric composition and inner crystalline disorder [11], 
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provide the material with a higher solubility than mineral apatites. The organic phase consists 
mostly of collagenous proteins [5] [10] that align into triple helices that bundle into fibrils (1.5–3.5 
nm diameter), which then bundle into collagen fibers (50–70 nm diameter).  
Collagen builds up the bone matrix that is mechanically reinforced with apatitic nano-
crystals [8] through a mechanism known as biomineralization. During this process, osteoblasts use 
the inorganic ions in body fluids (supersaturated in calcium phosphates, although their 
spontaneous precipitation is prevented by a buffering effect of the body) in order to produce 
hydroxyapatite that is afterwards incorporated at specific sites onto the collagen fibers, forming a 
complex-large-scale inorganic-organic composites [12]. Figure 1.5 shows that bone is formed by a 
systematic combination of hydroxyapatite crystals and collagen. 
 
Figure 1.5. Geometry of the nanostructure of bone, showing several hierarchical features from atomic 
scale to microscale (from [13]). 
 
1.2.2 Bone cells 
The bones of vertebrates can be considered as ‘‘living biominerals’’ since there are cells 
inside them under permanent activity [11]. Bone cells are responsible for bone formation, 
resorption and repair, as well as for mineral homeostasis. The different sources of bone cells are 
mesenchymal stem cells (MSC) and hematopoietic progenitors cells [8]. 
 There are five kinds of bone cells: osteoprogenitor, osteoblasts, osteoclasts, osteocytes and 
bone-lining cells. The cells are located upon the cellular interface, which includes the vasculature, 
the osteonal canals and the Volkmann canals, as well as the endosteum and 
periosteum [9]. The function of each cell type is briefly explained below 
and location in the bone of each bone cell type are schematically shown in Figure 1.6. 
 Osteoprogenitor cells: The pre
pre-osteoclasts give rise to bone
 Osteoblasts: Bone-forming cells, whose function is to synthesize and to secrete unmineralized 
collagenous bone matrix, the osteoid. They also participate in the calcification of bone, as 
regulate the flux of calcium and phosphate in and out of the bone.
  Osteoclasts: Responsible for bone resorption. The osteoclasts are giant cells whose diameter 
ranges from 20 to over 100 µm and may contain from 2 to 50 nuclei; 
  Osteocytes: Derive from osteoblasts that stayed behind as the mineralization front advances 
and, consequently, they become encased in the mineral matrix.
extensively interconnected by the cell processes of the osteocytes, forming a connec
network important in signal transduction of mechanical stimuli;
 Bone-lining cells: They are believed to be derived from osteoblasts and/or osteoblasts precursors 
that have ceased their activity or differentiation and flattened out on bone su
Figure 1.6. Schema of osteoblasts, osteocyte and osteoclasts (from 
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1.2.3 Mechanical properties of bone 
Although bones are relatively light in weight [7], they have outstanding mechanical 
properties and are able to withstand repeated high impacts and compressive forces throughout 
the life-span of the organism. In fact, bone has a tensile strength similar to that of cast iron, but it 
is thrice lighter and ten times more flexible. The hierarchical features responsible for outstanding 
fracture resistance range from the nano- to the macro-scale are complex, and thus it is a challenge 
to replicate them in synthetic materials [8]. 
The mineral compound imparts hardness and stiffness, while the organic one increases the 
bone’s toughness and resilience [8]. Collagen fibers are capable to dissipate energy, imparting 
tensile properties to bone [5] since the stresses are transferred in a zigzag manner [15]. 
The strength of cortical and trabecular bone to compressive and tensile forces, as well as 
its elastic modulus, is shown in Table 1.1. 
Table 1.1. Compressive and tensile strength, and elastic modulus of both cortical and trabecular bone 
(data extracted from [16]). 
 Cortical bone Trabecular bone 
Compressive strength (MPa) 100 – 230 2 – 12 
Bending strength (MPa) 50 – 150 - 
Young’s Modulus (GPa) 7 – 30 0.05 – 0.5 
 
1.2.4 Bones evolve lifelong. Tips to maintain them healthy 
Most people reach their “peak bone mass” (maximal density and strength) in their 20s. 
After the peak bone mass is reached, bone density remains stable during adulthood, and then 
begins to decline. The bone density reached by each person depends essentially on the diet and on 
the physical exercise performed. Diet includes sufficient calcium intake and exposure to sunlight, 
which is necessary for production of vitamin D in the skin, this vitamin allows the absorption of 
calcium from food. Physical exercise maintains bones healthy since bones deteriorate if they are 
not used, just as muscles do. Bones need a variety of brief, frequent loads every day (e.g. walking 
and climbing stairs) to maintain their strength, and bones need to be loaded a bit more than usual 
(exercise) to improve their strength. Bones respond when they are “stressed,” in other words, 
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when they are forced to bear more weight than they are used to. This can be achieved by “weight 
bearing” or impact exercises such as walking, running, lifting weights, jumping, or dancing [17]. 
1.2.5 Bone remodeling 
 Bone has a high complexity that can be reflected for its continuous removal and 
replacement throughout life. The skeleton of an individual is replaced several times during all his 
life by means of bone remodeling; this is, by resorbing the old bones and building them up again. 
This is a stochastic process that serves to continually rejuvenate the bone mineral, to remove bone 
matrix that is micro- or macroscopically damaged or has been functionally suboptimal, and to 
optimize bone architecture in response to functional loading. At a fundamental level, the removal 
and replacement of the extracellular matrix is necessary to establish and maintain bone mass and 
architecture [6].  
The bone remodeling unit (BRU) describes the sequential activities of osteoclasts and 
osteoblasts that are spatially and temporally coupled to ensure that the removal of mineralized 
matrix is replaced by an equivalent quantity of new bone. Thus, over innumerable remodeling 
cycles, the collective activities of individual BRUs ensure that an organism’s bone mass remains in 
constant balance and its skeletal architecture remains relatively unchanged [6]. However, 
dysfunction of either process may lead to excessive bone formation (osteopetrosis, osteosclerosis) 
or bone degradation (osteoporosis) [8]. 
The BRUs is a coordinated activity, commonly separated into four distinct phases: 
activation, resorption, reversal, and formation. The BRUs cycle starts with the activation of a 
resting bone surface in response to a stimulus. Groups of osteoclasts are recruited to the 
resorption site, and dissolve and resorb the mineralized bone matrix until a small piece of bone 
matrix is removed. As the osteoclastic activity subsides, a resorption cavity is formed, called 
Howship’s lacuna. The resorptive tunnel excavated by the osteoclasts is eventually filled in by 
osteoblastic bone formation, producing a mature lamellar structure [6]. Figure 1.7 shows the 
stages conforming bone remodeling. 
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Figure 1.7. Representation of the life cycle stages of the bone remodeling process on a cortical bone 
surface. (from [6]). 
 
1.2.6 Bone fractures 
Despite their remarkable strength, bones are susceptible to fractures all their life. During 
youth, most fractures result from exceptional trauma that twists or smashes the bones. These 
fractures usually occur while practicing sports or in automobile accidents. In old age, bones have a 
lower mineral density and fractures occur more often due to their weakness [7]. Figure 1.8 shows a 
schema in which the different clinical procedures, which are described below, to heal a bone 
fracture depending on its size are indicated. 
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Figure 1.8. Schema of the strategies for bone healing after a minor fracture or a fracture causing 
delayed union or non-union is produced in the bone. 
 
1.2.6.1 Spontaneous healing of bone fractures 
When a minor fracture of a bone is produced, the fracture is treated by reduction, which is 
the realignment of the broken bone ends. In a closed reduction, the bone ends are coaxed back 
into their normal position by the physician’s hands. In an open reduction (broken bone ends 
penetrate through the skin), surgery is performed and the bone ends are secured together with 
pins or wires (made of Fe, Co or Ti alloys). After the broken bone is reduced, it is immobilized by a 
cast or traction to allow the healing process to begin.  
The healing time for a simple fracture is 6 to 8 weeks, but it is much longer for large bones 
and for the bones of elderly people because of their poorer circulation [7]. Injury initiates a 
cascade of healing events that recapitulate some of the steps of embryonic bone formation, which 
are described in biological stages involving inflammation, repair and remodeling (Figure 1.9) [5] [7]:  
1. Blood vessels are ruptured when the bone breaks, resulting in the formation of a blood-filled 
swelling called hematoma. Bone cells deprived of nutrition die. 
20 Chapter 1 
 
2. New capillaries grow into the clotted blood at the site of the damage, and phagocytes dispose of 
dead tissue. As this goes on, connective tissue cells form a mass of repair tissue, the fibrocartilage 
callus, which acts to “splint” the broken bone, closing the gap. 
3. As more osteoblasts and osteoclasts migrate into the area and multiply, fibrocartilage is 
gradually replaced by a callus made of spongy bone, the bony callus. 
4. Over the next few months, the bony callus is remodeled in response to the mechanical stresses 
placed on it, so that it forms a strong permanent “patch” at the fracture site. 
 
Figure 1.9. Stages in the healing of a bone fracture (from [7]). 
 
1.2.6.2 Non-spontaneous healing of bone fractures 
Although bone has its own ability to repair, the ability decreases with age and it can be also 
reduced by diseases or other factors. Moreover, spontaneous healing is limited to small bone 
defects [18]. The situation when bony bridging is delayed or does not occur is called delayed union 
or non-union, respectively. The risk for non-unions can be greatly reduced if the defect (produced 
by the excision of bone tumor, other bone diseases or in cases of bone loss in accidents) is filled 
with a graft to which new bone can bond. The bone void fillers reduce the distance in the defect to 
be bridged [8] [18].  
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Bone grafting consists on filling the missing bone with a material that allows rapid bone 
regeneration and reconstruction of bone loss. Therefore, bone grafts have to comply with the 
following properties [19]:  
i) to provide structural support/strength (immediate and static);  
ii) to be osteoconductive (provide scaffolding for ingrowth of new bone);  
iii) to be osteoinductive (stimulate new bone production in bone-forming cells);  
iv) to favor osteogenesis (process of direct bone formation).  
The bone graft sources can be natural (bone grafts), synthetic (biomaterials) or a mixture 
of a synthetic material supplemented with biological factors (treatment known as tissue 
engineering). 
1.2.6.2.1 Natural bone grafts 
Several natural bone grafts can be the choice in clinics for bone repair: autograft, allograft 
and xenograft, as schematically represented in Figure 1.10 [18] [19] [8] [20] [5].  
 
Figure 1.10. Schema of the three main sources of natural bone grafts. 
 
 Autograft: the bone used is procured from the patient himself. It has no problems of 
biocompatibility or immunoresponse, and contains osteogenic cells and osteoinductive growth 
factors from the patient (such as bone morphogenetic proteins, BMPs). It is still regarded as the 
“golden standard”, in other words, it is the most-used bone graft. The common problems related 
with this technique are the increase of operative time (double operation), blood loss, 
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postoperative pain, length of hospital stay, and cost. Moreover, the technique can only be used for 
the repair of small bone defects, since there are limited sites where bone can be harvested without 
loss of function. Other drawbacks presented by natural bone grafts are their lower effectiveness in 
irregularly shaped defects and their too fast resorption.  
 Allograft (unprocessed): the bone used is provided by dead donors. The allografts have 
osteogenic cells and osteoinductive growth factors. Possible decrease of the osteogenic capacity 
due to an immunologic rejection, the limited supply of allografts and the risk of diseases 
transmission can be mentioned as main drawbacks. 
 Allograft (demineralized bone matrix, DBM): the bone used is provided by dead donors but the 
risk of disease transmission is decreased by demineralizing the bone matrix. However, this 
treatment reduces the osteogenic capacity since not all growth factors and osteoinductive proteins 
survive the processing of the material. 
 Xenograft: the bone is extracted from other species. The main drawback is the risk of 
immunologic rejection and transmission of diseases. 
To date, the only graft having real osteogenic properties is the autograft. Achieving optimal 
bone regeneration with another graft would require the incorporation of growth factors that 
would produce an adequate local environment for cells to regenerate bone [19] [18]. The 
shortcomings of bone grafts together with the surgeon’s desire for new bone grafting tools and 
their potential marketability has provided the stimulus to scientists for developing innovative and 
effective synthetic products over the last decade [19] [18] [20]. 
1.2.6.2.2 Synthetic bone grafts (biomaterials) and tissue engineering 
a) Biomaterials 
The first documented use of synthetic bone grafts, commonly known as biomaterials for 
bone regeneration, was reported in 1892 by van Meekeran, who treated large-bone defects with 
calcium sulfate.  
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The general requirements for ideal bone grafts are as follows:  
i. Macroporosity (interconnected pores > 100 μm). Porous calcium phosphates provide mechanical 
fixation in addition to providing sites on the surface that allow chemical bonding between 
biomaterials and bone [21] and, moreover, permit the cell colonization [22]. Macroporosity in solid 
biomaterials is intentionally introduced by: (i) addition of various porogens (crystals or particles of 
either volatile or soluble substances) [23]; (ii) sintering spherical particles to generate porous 
three-dimensional bioceramics [24]; (iii) foaming methods [25].  
ii. To fill effectively bone defects. In order to permit growth of new bone into bone defects, a 
suitable material should fill the defects. Otherwise, ingrowth of fibrous tissue might prevent bone 
formation within the defects. 
iii. Biodegradation rate comparable to the formation of bone tissue. A biomaterial should be 
progressively resorbed by both active (resorption by osteoclasts) and passive (dissolution) 
mechanisms. In parallel, new bone should replace the space left by the newly resorbed 
biomaterial. The total substitution of the biomaterial by new bone formation should take between 
few months and about two years.  
iv. Sufficient mechanical stability. The mechanical stability of a material is one of the 
characteristics that will determine its application. A biomaterial for bone regeneration should offer 
a superior compressive resistance than that of a cancellous bone graft, while remaining resorbable 
for the ingrowth of bone and vasculature to enable their remodelation into new bone over time 
[20].  
b) Tissue engineering 
 Recently, since the knowledge regarding biomaterials has broadened, the 
interdisciplinarity between materials science and biology has been determined to be crucial [26]. 
Lately, grafts and implants that do not only mimic the body, but actually encourage the organism 
to “colonize” the foreign material itself have been proposed [27]. 
In the past decade, tissue engineering has emerged as a promising approach to 
orthopaedic repair. Utilizing a combination of cells, growth factors and/or biomaterials, the 
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principles of tissue engineering have been readily applied to the formation of a variety of 
connective tissues such as bone, cartilage, ligament or tendon, both in vitro and in vivo [28]. 
 For the success of a tissue engineering treatment, the interaction between 
osteoconductive, osteoinductive and osteogenic elements is required. The osteoconductive 
scaffold is in charge of supporting bone growth at the same time that provides mechanical support, 
sites for cell attachment, vascular ingrowth, and a delivery vehicle for implanted growth factors 
and cells; osteogenic components include cells capable of bone production such as 
osteoprogenitor cells or differentiated osteoblasts; and osteoinductive factors include bioactive 
chemicals that induce recruitment, differentiation and proliferation of the proper cell types at an 
injury [5].  
A key factor for the healing success of non-unions is the use of MSCs in cell-based 
strategies. The MSCs are promising tools for regenerative therapy due to their proliferation 
capabilities and their ability to build new tissue in a defect. However, due to the limited quantity of 
MSCs in the bone marrow (less than 0.001%), progenitor cells have to be extracted from the bone 
marrow of a patient, expanded in vitro and, finally, seeded onto a carrier for implantation into a 
defect (Figure 1.11) [5]. 
 
Figure 1.11. Cell transplantation: osteogenic cells may be isolated from the iliac crest, expanded in cell 
culture, seeded onto a scaffold and implanted into a defect (from [5]). 
  
Theoretical framework 25 
 
1.2.6.2.3 Pros and cons of natural grafts, biomaterials and tissue engineering 
The advantages and drawbacks of the natural bone grafting techniques (autograft, allograft 
and xenograft) and those that use synthetic materials (biomaterials and tissue engineering) are 
summarized in Table 1.2. Tissue engineering is envisaged as the treatment that will produce better 
results and which might be worthy even though its high complexity. 
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Table 1.2. Advantages and drawbacks brought by natural bone grafting techniques such as autograft, allograft and xenograft and by synthetic bone grafts as biomaterials 
and tissue engineering strategy (from [18] [19] [8] [20] [5]).  
  
Natural/synthetic 
bone graft 
Bone graft source Advantages Drawbacks 
Natural bone 
Autografts 
(bone from the own patient) 
“golden standard” 
 Provides support/strength 
 Biocompatibility 
 No immune response 
 Contains osteogenic cells and osteoinductive growth 
factors 
 Stimulates bone regeneration 
 Increase of time endowed in surgery (double surgery) 
 Blood loss 
 Postoperative pain 
 Length of hospital stay 
 Cost 
Allografts 
(from a dead human donor) 
 Provide support/strength 
 Osteogenic cells and osteoinductive growth factors 
 Osteogenic capacity may decrease due to an immunologic 
rejection 
 Limited supply of allograft 
 Risk of disease transmission 
Allografts 
(from a dead human donor) 
with demineralized bone 
matrix (DBM) 
 Provide support/strength 
 Risk of disease transmission decreases by a processing of 
the material 
 Osteogenic capacity is reduced due to the material 
processing 
Xenografts 
(from other species) 
 Provide support/strength 
 Osteogenic cells and osteoinductive growth factors 
 Risk of immunologic rejection 
 Risk of  diseases transmission 
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Natural/synthetic 
bone graft 
Bone graft source Advantages Drawbacks 
Synthetic material 
Biomaterials 
 Provide support/strength 
 No risk of rejection 
 No risk of diseases transmission 
 Biocompatibility 
 Does not contain osteogenic cells or osteoinductive growth 
factors 
 Osteogenesis, osteoconduction and osteoinduction depend 
on material characteristics 
 Resorption depends on the chemical and physical properties 
of material 
Tissue engineering 
 Provide support/strength 
 No risk of rejection 
 No risk of diseases transmission 
 Biocompatibility 
 Osteogenic cells and osteoinductive growth factors 
 Complex, long and expensive preparation: it requires to 
expand cells of patient and to grow them in the scaffold 
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The tissue engineering has been envisaged as a promising method to enhance bone 
regeneration, even though the strategy to carry out the process is very complex and the overall 
route is slow. The first step to guarantee a successful tissue engineering process is linked with the 
development of a biocompatible material with an ideal architecture and good chemical, physical, 
osteoconductive and osteoinductive properties. Therefore, from now on attention will be focused 
in the biomaterials.  
 
1.3 Biomaterials for bone regeneration 
 Biomaterials emerged as an alternative strategy for the treatment of severe bone loss or 
fracture. Since antiquity, humans have used natural materials such as metals, polymers, glass or 
ceramics, to replace a part of their body that has been damaged [29]. The “biomaterial” term was 
defined for the first time in 1987, and since then its description has been considerably modified. In 
1999, a “biomaterial” was defined as “a material intended to interface with biological systems to 
evaluate, treat, augment or replace any tissue, organ or function of the body” [30]. A recent 
definition makes the concept more precise “substance that has been engineered to take a form 
which, alone or as part of a complex system, is used to direct, by control of interactions with 
components of living systems, the course of any therapeutic or diagnostic procedure, in human or 
veterinary medicine” [31]. 
 Biomaterials are classically classified in function of their chemical nature (subdivisions 
indicated in parenthesis) [31]: 
i) Metallic: based on metallic bonds (pure metals and alloys); 
ii) Ceramic: based on ionic bonds (glasses, glass-ceramics, ceramics and carbons); 
iii) Polymeric: based on covalent bonds (thermosets, thermoplastics, elastomers and textiles); 
iv) Hybrids or composites (combinations of ceramics and polymers). 
Table 1.3 shows materials used nowadays as biomaterials and their respective applications. 
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Table 1.3. Classification of the materials in function of their chemical nature and their applications 
(modified from [32]). 
MATERIALS 
Ceramic Metallic Polymeric Composites Natural 
Alumina (Al2O3) 
Zirconia (ZrO2) 
Calcium 
phosphates 
Calcium sulfates 
Bio-glass 
Bio-ceramics 
Carbon 
Ti and Ti alloys 
Cr-Co alloys 
Stainless steels 
Au 
Pt 
Ag 
Nylon 
Silicone 
Polyesters 
Polytetrafluoroethylene 
(PTFE) 
Polystyrene (PS) 
Polymethacrylate methyl 
(PMMA) 
Carbon-carbon 
Resin 
Epoxy-graphite 
 
Collagen 
Chitosan 
APLICATIONS 
 Components of 
joint prosthesis 
 Coatings of 
metallic implants 
 Bone grafts 
 
 Joint prosthesis 
 Osteosynthesis 
devices 
 Dental implants 
 Orthodontic 
material 
 Sutures 
 Vascular prosthesis 
 Components of joint 
prosthesis 
 Drug release devices 
 Heart valves 
 Root canal fillers 
 Dental 
restoration 
materials 
 Artificial skin 
 Heart valves 
 Vascular 
prosthesis 
 
  The materials have been further classified as bioinert or bioactive according to 
their interaction with the host tissue [33]. The materials that have a minimal biological response 
from the physiological environment are known as bioinert and their function is simply to substitute 
a lost part of the body (1st generation). Bioactive materials, unlike bioinerts, are those that 
produce a positive interaction with the host tissue. The bioactive materials can be also classified as 
non-resorbable (2nd generation) or resorbable. Those bioactive materials that are as well resorbed 
with time (3rd generation) allow the regeneration of the tissue. 
 
1.4 Calcium orthophosphates for bone substitution and regeneration 
By definition, all calcium orthophosphates consist of three major chemical elements: 
calcium (oxidation state +2), phosphorus (oxidation state +5) and oxygen (reduction state -2), as a 
part of orthophosphate anions [34]. Calcium orthophosphates have been studied as bone repair 
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materials for the last 80 years [35]. One of the most used calcium phosphate is hydroxyapatite, 
Ca10(PO4)6(OH)2, since it is the most similar material to the mineral component of bones [11], in 
terms of chemical composition and crystalline structure. The hydroxyapatite is well accepted for 
the host bone and enhances bone regeneration, thus exhibiting the required properties for a 
biomaterial such as biocompatibility, bioactivity and osteoconductivity [11]. 
The calcium orthophosphates are usually classified by their Ca/P ratio since it is known that 
the lower the Ca/P ratio, the larger the acidity and solubility of the compound [11]. Table 1.4 
shows a list of known calcium phosphates, including their standard abbreviations and their major 
properties. 
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Table 1.4. Properties of the biologically relevant calcium orthophosphates (modified from [36]).  
Ca/P ionic 
ratio 
Compound Chemical formula 
Solubility at 
25°C 
(-log K
s
) 
pH stability 
range in 
aqueous 
solution at 
25°C 
0.5 
Monocalcium phosphate 
monohydrate (MCPM) 
Ca(H2PO4)2·H2O 1.14 0.0-2.0 
0.5 
Monocalcium phosphate 
anhydrous (MCPA) 
Ca(H2PO4)2 1.14 
b 
1.0 
Dicalcium phosphate dihydrate 
(DCPD), brushite 
CaHPO4·2H2O 6.59 2.20-6.0 
1.0 
Dicalcium phosphate anhydrous 
(DCPA), monetite 
CaHPO4 6.90 
b 
1.33 Octacalcium phosphate (OCP) Ca8(HPO4)2(PO4)4·5H2O 96.6 5.5-7.0 
1.5 α-Tricalcium phosphate (α-TCP) α-Ca3(PO4)2 25.5 
a 
1.5 β-Tricalcium phosphate (β-TCP) β-Ca3(PO4)2 28.9 
b
 
a 
1.2-2.2 
Amorphous calcium phosphate 
(ACP) 
CaxHy(PO4)z·nH2O; 
n = 3-4.5; 15-20% H2O 
25.7 ± 0.1 (pH = 
7.40); 29.9 ± 
0.1 (pH = 6.00); 
32.7 ± 0.1 (pH = 
5.28) 
∼ 5-12 
c
 
1.5-1.67 
Calcium deficient hydroxyapatite 
(CDHA)
d
 
Ca10-x(HPO4)x(PO4)6-x(OH)2-x 
(0 < x < 1) 
e
 
∼ 85.1 6.5-9.5 
1.67 Hydroxyapatite (HA) Ca10(PO4)6(OH)2 116.8 9.5-12 
1.67 Fluroapatite (FA) Ca10(PO4)6F2 120.0 7-12 
2.0 
Tetracalcium phosphate (TTCP), 
hilgentockite 
Ca4(PO4)2 38-44 
a 
 
a
 These compounds cannot be precipitated in aqueous solutions 
b
 Stable at temperatures above 100°C 
c
 Always metastable 
d
 CDHA can be named as precipitated HA 
e
 In the case x = 1 (Ca/P = 1.5), the chemical formula of CDHA is Ca9(HPO4)(PO4)5(OH)  
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Each calcium phosphate has a different solubility in an aqueous system, and the solubility 
of each calcium phosphate depends on the pH of the solution, as shown in Figure 1.12. In the 
solubility diagram a negative slope is observed at the acidic pH range, indicating that the solubility 
increases as the pH decreases, and a positive slope at the basic pH range, showing that the 
solubility increases as the pH increases. The diagram shows that for a given pH value, any salt 
whose isotherm lies below another will be relatively less soluble and thus more stable. Down to a 
pH of 4.2, HA is the least soluble calcium phosphate salt [36].  
 
Figure 1.12. Solubility isotherms of different calcium phosphate salts in equilibrium with their solutions 
at 37°C in a representation of log [Ca] versus pH (from [36], redrawn by [37]).  
 
Some calcium orthophosphates can be obtained by precipitation from an aqueous solution 
at low temperature (e.g. CDHA and brushite), while others can only be obtained at high 
temperature (e.g. α-TCP, HA, TTCP) [38], through a sintering process. 
Sintering is of great importance to produce a variety of bioceramics with the required 
properties [34]. Several processes occur during sintering of calcium orthophosphates. Firstly, 
moisture, carbonates and all volatile chemicals remaining from the synthesis stage are removed as 
gaseous products. The removal of these gases facilitates the production of dense materials during 
sintering. Afterwards, there is an increase in crystal size and a decrease in the specific surface area. 
Finally, there is the chemical decomposition of all acidic orthophosphates, which transform into 
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other phosphates (e.g. 2 HPO4
2- → P2O7
4- + H2O). Besides, sintering causes toughening of the 
ceramics [39]. The sintering process, together with the intrinsic solubility of the material, will also 
determine the stability under physiological conditions.  
One of the most commonly used orthocalcium phosphate is hydroxyapatite. Although this 
compound can be prepared by several techniques, which can be divided into solid-state reactions 
and wet methods, pure hydroxyapatite (HA, Ca5(PO4)3(OH) can be only obtained by a sintering 
process. This is the reason why it can never be found in biological systems. Nevertheless, due to 
the chemical similarities to bone and teeth mineral, HA has been widely used as a coating on 
orthopedics (e.g. hip joint prosthesis) and dental implants. HA has been also implanted as a solid 
block or as HA particles in a bone defect [34].  
1.4.3 Characteristics of calcium orthophosphates 
Calcium orthophosphates fall into the categories of bioactive and/or bioresorbable 
materials [16]. Both the chemical and physical properties (crystallinity, porosity, etc.) of calcium 
phosphates will determine their level of bioactivity and bioresorbability.  
Bioactive calcium phosphates are able to form a layer of biological apatite before 
interfacing directly with the hard tissue, resulting in the formation of a direct chemical bond with 
bone and providing good mechanical stabilization. Bioceramics made of dense HA are good 
examples of bioactive materials. Depending on the chemical and physical properties of the calcium 
phosphate, it can be bioresorbable, allowing a newly formed tissue to grow into any surface 
irregularities [40]. Porous scaffolds made of BCP (i.e. α or β-TCP + HA) [41] or bone grafts made of 
CDHA, TCP and/or ACP appear to be examples of bioresorbable materials [34].  
The excellent biocompatibility and bioactivity that exhibit some calcium orthophosphates 
when used as biomaterials for hard tissues substitution has been associated to their similarity with 
the inorganic phases of biomineralized tissues. Indeed, calcium phosphate biomaterials should 
mimic the natural apatites, thus consisting on apatite crystals of nanometric dimensions, low 
crystallinity and non-stoichiometric composition [42]. 
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1.4.4 Forms of calcium orthophosphates 
Bioceramics of calcium orthophosphates are available in several physical forms: particles, 
blocks (dense or porous), injectable compositions, self-setting cements, coatings on metal 
implants, composites with polymers, etc. [43]. Figure 1.13 shows several calcium orthophosphates 
prepared in different forms. 
 
Figure 1.13. Examples of calcium phosphate-based bone substitution materials (from [10]). 
 
The mechanical properties of a ceramic are dependent on its form, shape and size. As 
expected, a macroporous calcium phosphate has a much lower mechanical properties than a dense 
material. However, in general, even dense calcium orthophosphate bioceramics possess poor 
mechanical properties. For this reason, the medical applications of calcium orthophosphates are 
currently focused on the production of non-load-bearing implants, such as pieces for middle ear 
surgery, bone defect filling material for oral or orthopedic surgery, or as coatings of dental 
implants and metallic prosthesis [11] [44]. 
The need of biomaterials for minimally invasive surgery has induced a larger development 
of self-setting bone cements, commonly known as calcium phosphate cements (CPCs) [36] [45] [46] 
[47] [48] [49]. 
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1.5 Calcium phosphate cements (CPCs) 
CPCs were discovered by LeGeros [50], and Brown and Chow [51] in the early 1980s. They 
demonstrated the formation of hydroxyapatite in a monolithic form at room or body temperature 
by means of a cementitious reaction. The CPCs are prepared by mixing one or more calcium 
phosphate powders with an aqueous solution. The mixture consists on a cement paste that can be 
injected into the bone defect, where it adapts perfectly to the cavity. The cement sets in situ 
through a dissolution-precipitation reaction. During this continuous process, the calcium 
phosphates are partially dissolved within the aqueous medium and they subsequently precipitate 
into the most insoluble calcium phosphate phase, with the hardening of the paste due to the 
entanglement of the formed crystals. Within minutes the cement paste has transformed into a 
solid body with mechanical properties (Figure 1.14).  
 
Figure 1.14. Rationale of calcium phosphate cements (from [38]). 
 
1.5.1 Chemistry of CPCs 
The CPCs are usually divided into two groups: the apatite CPC and the brushite CPC. The 
formation of a cement type or another depends upon the Ca/P ratio of the reactants and also upon 
the pH value of the cement paste. The cementious reaction results into precipitated 
hydroxyapatite (PHA or CDHA) when the pH > 4.2, and into brushite (DCPD) when the pH < 4.2 
[38]. 
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1.5.1.1 Apatite CPCs 
The CPCs that lead to the formation of calcium deficient hydroxyapatite (CDHA) can be 
divided in three groups, taking into account the number and type of calcium phosphate used in the 
powder mixture [52]. 
(i) A single calcium phosphate. α-TCP is hydrolyzed in an aqueous solution, giving place to CDHA 
(Reaction 1.1) [53] [54] [55] [56] [57] [58] [59]. 
Reaction 1.1.   3 α-Ca3(PO4)2 + H2O → Ca9(HPO4)(PO4)5(OH) 
(ii) One acidic and other alkaline calcium phosphate, which set following an acid-base reaction. 
TTCP usually acts as an alkaline compound, and can be combined with one or more calcium 
phosphates with lower Ca/P ratio to obtain CDHA (Reaction 1.2 and 1.3), without the formation of 
acids or bases as by-products [51]. 
Reaction 1.2.  Ca4(PO4)2O + CaHPO4 → Ca5(PO4)3(OH)  
Reaction 1.3.  Ca4(PO4)2O + CaHPO4·2 H2O → Ca5(PO4)3(OH) + 2 H2O  
(iii) Calcium phosphates and other salts. A mixture of calcium phosphates with a Ca/P ratio lower 
than that of CDHA are used (α-TCP and MCPM), together with CaCO3 as an additional source of 
calcium ions [60]. 
1.5.1.2 Brushite CPC 
Brushite CPCs are acidic and metastable under physiological solutions [61]. Thus, they 
resorb much faster than apatite CPCs. Brushite CPCs are obtained as a result of an acid-base 
reaction (Reaction 1.4) [62]. 
Reaction 1.4.  β-Ca3(PO4)2 + Ca(H2PO4)2·H2O + 7 H2O → 4 CaHPO4·2H2O 
1.5.2 Processing parameters 
 The properties of a cement system such as its setting time, cohesion, viscosity, injectability, 
bioactivity, porosity and resorption, among others, depend on several processing parameters, 
which can be tailored to adjust them to a specific clinical application. On one hand, the powder 
Theoretical framework 37 
 
characteristics depend on its chemistry, the incorporation of additives such as seeds or accelerants, 
and the particle size distribution of the powder. On the other hand, the addition of additives to the 
liquid phase and its pH also has a significant influence on the cement properties. Also, while mixing 
the powder with the liquid, the porosity can be modified by the liquid to powder ratio or the 
mixing protocol. Finally, environmental factors such as temperature, humidity or pH can also have 
an effect on the resulting solid body. Figure 1.15 shows the processing parameters influencing the 
properties of CPCs for each factor involved in their preparation. 
 
Figure 1.15. Processing parameters that affect the properties of a calcium phosphate cement (modified 
from [38]). 
 
1.5.3 Setting and hardening of CPCs 
CPCs must set slowly enough to provide sufficient time to the surgeon to perform 
implantation, but fast enough to prevent delaying the operation. Ideally, good mechanical 
properties should be reached within minutes after initial setting. The setting time of cements is 
commonly measured with Gillmore or Vicat needle methods. The purpose of both methods is to 
examine visually the surface of cement samples to decide whether the cement has already set, i.e. 
if no mark can be seen on the surface after indentation [63].  
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Gillmore needles have been used with success to measure the initial setting time (tI) and 
final setting time (tF) of calcium orthophosphate cements. A light and thick needle is used to 
measure the tI, while a heavy and thin needle for the tF. In clinics, the cement paste should be 
implanted before tI and the wound could be closed after time tF. The cement should not be 
deformed between tI and tF because in that stage of the setting process any deformation could 
induce cracks [49]. The cohesion time (tC), which is the time that a cement requires to no longer 
disintegrate when immersed in an aqueous solution [64], must be at least 1 min before tI, so that a 
clinician has at least 1 min to mold and apply the material. The paste has to be introduced into the 
bone cavity after tC and before tI [64]. Figure 1.16 schematically shows the mentioned parameters. 
 
Figure 1.16. A diagram of the setting parameters relevant for a calcium orthophosphate cement. tC 
stands for cohesion time, tI stands for initial setting time, and tF stands for final setting time (modified 
from [49]). 
 
For dental applications, tI must be close to 3 min, whereas for orthopedic applications it 
must be close to 8 min. However, if time tF becomes greater than 15 min, in no case it will be 
tolerable for the clinicians [49] [64].  
1.5.4 Advantages of CPCs 
The CPCs have several advantages in comparison with the use of calcium phosphate ceramics 
[38] [35].  
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On one hand, physico-chemical properties such as i) ability to self-setting in vivo, ii) ease of 
preparation and handling; iii) moldeability, allowing a perfect adaptation to the implant site; iv) 
injectability, allowing the implantation by a minimally invasive surgical technique; and v) good 
osteoconductivity and occasional osteoinductivity can be mentioned as technical advantages.  
On the other hand, several biological properties of CPCs can be pointed as advantageous, such 
as i) excellent biocompatibility and bioactivity; ii) resorption and replacement by newly formed 
bone after a period of time (osteotransductivity); and iii) chemical and physical similarity of the 
end-product to bone in the case of apatite cements, resulting in high bioactivity. 
Other advantages shown by CPCs are: i) possibility to use them as carriers of antibiotics, anti-
inflammatory drugs or growth factors, since the setting reaction takes place at low temperature; ii) 
no toxicity; and iii) low cost. 
1.5.5 Drawbacks of CPCs 
However, CPCs also present some problems. The main concerns of clinicians in respect to CPCs 
are the following [65]: 
i) In vivo biodegradation of many formulations is slower than the growth rate of a newly forming 
bone; 
ii) Mechanical weakness: limited use due to potential collapse of material. Metal supports are 
required for load-bearing areas; 
iii) They can be washed out from surgical defect if excess of blood; 
iv) Lack of macroporosity, especially interconnected pores, which prevents bone ingrowth. 
Moreover, the cements only degrade from the outside to the inside. 
 The mentioned drawbacks have stimulated the scientific community to continue studying 
the CPCs in order to improve some of their limitations.  
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1.6 Tricalcium phosphate (TCP) 
In this section, emphasis is done to α-tricalcium phosphate since it is the reactant of 
apatite CPCs that will be used in the Thesis. 
The chemistry of calcium phosphates is generally complex, and the phases with 
stoichiometry Ca3(PO4)2 provide no exception [66]. The tricalcium phosphate (TCP, Ca3(PO4)2 is 
constituted by 3 CaO (coded as C in the diagram phase) and 1 P2O5 (coded as P in the diagram 
phase), being therefore found as C3P at 75% CaO – 25% P2O5 in the diagram phase (Figure 1.17). 
The TCP is a high temperature phase that exists under three crystallographic forms, α, α’ and β. 
The β-TCP can only be prepared at temperatures above 800°C by thermal decomposition of CDHA 
or by solid-state interaction of acidic calcium orthophosphates [34]. The transition temperature 
from β-TCP to α-TCP is found at around 1125°C [67]. The α-TCP is thermodynamically stable 
between 1120 and 1470°C [68] in the absence of impurities, but it is metastable at room 
temperature. The α’-TCP, stable above 1430°C, is unable to survive quenching to room 
temperature [67]. Figure 1.17 shows the occurrence of these phases in the high temperature CaO-
P2O5 phase diagram. 
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Figure 1.17. Equilibrium diagram for the system CaO-P2O5 with melting points and inversion 
temperatures, C = CaO, P = P2O5 (from [67]).  
 
There is a general knowledge that α-TCP is an allotropic form unstable at low 
temperatures, since the β-α transformation reverts when cooling down to its transition 
temperature [10]. Therefore, α-TCP is usually prepared by heating a calcium phosphate mixture 
with a Ca/P ratio of 1.5 above ∼ 1125 °C [67], retaining the α-phase by quenching above its 
transformation temperature, in order to prevent the reverse transformation. The quenching 
process entails certain drawbacks that are mainly the thermal shock that suffer both the material 
and the furnace.  
1.6.1 The crystal structure of α-TCP 
α-TCP crystallizes in a monoclinic space group P21/a, with cell parameters a = 12.887 ± 2, b 
= 27.280 ± 4, c = 15.219 ± 2 Å and β = 126.20 ± 1° at 25°C. The calculated density for Z = 24 was of 
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2.863 g/cm3 [69]. A prominent subcell exists with b’’ = b/3 [69]. Moreover, a pseudoorthorhombic 
cell with a’ = 15.22, b’ = 20.71, c’ = 9.11 Å has been reported on ASTM card 9-348 and can be 
derived from the monoclinic cell by taking a’ ∼ c, b’ ∼ 2a cos (β-90°) and c’ ∼ b/3. Precession 
photographs and the intensity data show that the Laue symmetry of the subcell is 2/m [66]. 
The structure of α-TCP consists of calcium and phosphate ions arranged in columns along 
[001]. Both the pseudocell translation and the 21 axis are along b, giving a pseudounique slice of 
b/6 for α-Ca3(PO4)2. Each cation column is surrounded by six cation-anion columns and each 
cation-anion column by alternate cation-cation and cation-anion columns [66]. Figure 1.18 shows 
two representations of the crystalline structure of the α-TCP. 
 
Figure 1.18. a) α-TCP unit cell projected on the (a, b) plane. (from [70]); and b) crystal structure of α-
TCP projected along the a-axis; A, Ca column; B, Ca-PO4 column; numerals 1-6 along the left side 
denote the six possible cutting positions for making surface models [71]. Tetrahedra represent PO4 
groups, and balls (blue (a) or green (b)) denote Ca atoms. 
 
The fabrication process of the α-TCP allows the incorporation of different ions in its lattice 
depending on the composition of the starting materials [38]. Interestingly, the relative stability of 
the α and β-polymorphs is highly affected by the presence of some impurities [72]. Thus, whereas 
Mg is known as an element that stabilizes the β-phase [66] [72] [73] [74], Si is known to stabilize 
the α-form [66] [68] [75] [76] [77].  
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1.6.2 Si-stabilized α-TCP (Si-α-TCP) 
The Ca2SiO4-Ca3(PO4)2 binary system was first studied at the end of XIX century when 
silicocarnotite was described as a component of slag (by-product of smelting ore) [78].  
Nurse et al. [75], and afterwards Fix et al. [68] and Barnes et al. [76] studied the phase 
equilibrium diagram for the binary system Ca2SiO4-Ca3(PO4)2 and indicated that a new α-form 
containing silicon was stabilized down to low temperatures. The Ca2SiO4-Ca3(PO4)2 binary system 
was first studied by means of X-ray diffraction using a high-temperature stage by Nurse et al. [75]. 
In order to be as close as possible to the equilibrium, the X-ray analysis was pursued through 
successively higher temperatures, heating the reactants at 1550°C for 20 h and then annealing the 
end-product at 500°C for 70 h. Nurse et al. determined from heating curves that in the system 
Ca2SiO4-Ca3(PO4)2 a 2.8 wt% of Ca2SiO4 stabilized the α-form after the standard thermal process. 
Otherwise, if no Si was present in the phase, the β-TCP was the stable phase in these conditions.  
The system was also studied by Fix et al. by holding the phases at every high-temperature 
for 21 days during synthesis and afterwards keeping the temperature for several hours for X-ray 
analysis [68]. The diagram of Fix et al. is shown in Figure 1.19.  
 
Figure 1.19. The system Ca2SiO4-Ca3(PO4)2. α: nagelschmidtite, α-Ca2SiO4; α’: α’-Ca2SiO4; A: A-phase, 2 
Ca2SiO4·Ca3(PO4)2; S: silicocarnotite, Ca2SiO4·Ca3(PO4)2; α: α- Ca3(PO4)2 (from [68]).  
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 Si is believed to be introduced into the TCP structure exchanging PO4
3- for SiO4
4- groups. 
This substitution is non-isoelectronic, it means that the extra negative charge introduced by SiO4
4- 
must be compensated by means of some mechanism [79]. The α-TCP lattice has to compensate 
the charge produced when Si4+ replaces P5+ either by the formation of O2- vacancies or by the 
presence of Ca2+ in excess [80]. However, it is important to mention that the oxygen-deficient and 
the calcium-rich Si-α-TCP mechanisms are extreme cases. In fact, Si-α-TCP may contain both 
oxygen vacancies and Ca in excess to compensate the Si dopants [80].  
1.6.3 α-TCP as a reactant of apatitic cements 
α-TCP has a lower density and a higher free energy of formation compared to the low 
temperature β-polymorph [66], and is therefore more reactive and soluble, which makes it a much 
more efficient reactant for CPC. Upon contact with water, α-TCP hydrolyses to calcium deficient 
hydroxyapatite (CDHA), as shown in Reaction 1.5 [58]. CDHA is the compound precipitated as α-
TCP dissolution progresses because, at physiological pH (7.2–7.4), it is the most stable of all calcium 
orthophosphates [37]. 
Reaction 1.5.  3 α-Ca3(PO4)2 + H2O → Ca9(HPO4)(PO4)5(OH)  
In general, calcium-deficient hydroxyapatite (CDHA) exist in a wide range of compositions 
(Ca10-x(HPO4)x(PO4)6-x(OH)2-x (0 < x < 1)) and is poorly crystalline [34]. Unsubstituted CDHAs (i.e. 
containing ions of Ca2+, PO4
3-, HPO4
2- and OH- only) do not exist in biological systems [34]. Several 
substitutions exist in bone mineral, in particular, carbonate ions are found at a concentration up to 
8 wt%, and elements such as Na, Mg, K, Sr, Zn, Ba, Cu, Al, Fe, F, Cl and Si occur at trace (< 1 wt%) 
levels [67]. The main inorganic part of human normal and pathological calcifications are 
constituted by ion substituted CDHA, where the following substitutions occur: Na+, K+, Mg2+, Sr2+ 
for Ca2+; CO3
2- for PO4
3- or HPO4
2-; F-, Cl-, CO3
2- for OH-, plus some water forms biological apatite. 
Therefore, ion substituted CDHA is a very promising compound for industrial manufacturing of 
artificial bone substitutes [34]. 
Scientists have focused many efforts in tailoring the ionic substitutions of synthetic apatites 
with the aim to improve their biological properties [42] [77] [81] [82] [83]. Per se, the ionic 
substitutions in apatites produce many modifications of bulk composition, crystal size, 
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morphology, surface composition, physico-chemical properties (zeta potential, surface energy, 
solubility) and materials properties (microstructure, texture, porosity). Therefore, it is difficult to 
determine which factors are involved in the biological behavior of the modified material [77]. 
 
1.7 Therapeutic ions for bone repair 
It is well known that the presence of certain elements can facilitate the bone regeneration 
when released during the resorption of the material [11]. Until 20 years ago, gold was one of the 
most commonly used disease-modifying anti-rheumatic drugs and today it is still the subject of 
active research [84]. Other substances under several stages of acceptance and research include 
strontium as an anti-osteoporotic agent, vanadate as an anti-diabetic and bismuth as an anti-ulcer 
therapy. Also, most people apply daily fluoride or fluoro-phosphates to their teeth in order to 
combat caries. However, it is always important to keep the words of Paracelsus in mind: 
“Everything is poisonous and nothing is non-toxic, only the dose makes something not poisonous” 
[85]. The toxicity of inorganics depends on the species, dose and duration.  
Single inorganic ions such as calcium (Ca) [86] [87], phosphorous (P) [88], silicon (Si) [89] 
[90] [91] [92], magnesium (Mg) [93] [94] [95], strontium (Sr) [96], zinc (Zn) [97] [98] [99], copper 
(Cu) [100] [101] [102] [103], manganese (Mn) [104], boron (B) [105] [106], vanadium (V) [107] and 
cobalt (Co) [108] are known to be involved in the bone metabolism, playing a physiological role in 
angiogenesis, growth and mineralization of bone tissues [109]. These effects make metal ions 
attractive for use as therapeutic agents in the fields of hard tissue engineering [84]. In fact, recent 
literature shows that these ions have attracted remarkable interest related with their possible use 
in the preparation of calcium phosphate-based biomaterials [42] [85] [109]. Table 1.5 revises the 
ions present in the hard tissues, which can be incorporated into calcium phosphate-based 
biomaterials in order to take advantage of their therapeutic effect. 
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Table 1.5. Effect to bone formation or bone remodeling of selected metallic ions when they are present in human bone metabolism in their normal 
concentration range, in a deficient concentration or in a concentration higher than the normal one. Compendium of published studies. 
 Biological response in vitro/in vivo 
Element Normal concentration Deficient concentration Excessive concentration 
Calcium 
 Favors osteoblast proliferation, differentiation and extracellular matrix (ECM) 
mineralization [86] 
 Activates Ca-sensing receptors in osteoblast cells, and increases expression of 
growth factors, e.g. IGF-I or IGF-II [87] 
 Stimulates osteoclast activity [87] 
 Stimulates osteoblast activity 
[87] 
Phosphorus 
 Stimulates expression of matrix gla protein (MGP) a key regulator in bone 
formation [88] 
 Stimulates osteoclastic resorption 
and osteoblastic differentiation [110] 
 Induces apoptosis of 
osteoblasts in vitro [111] 
Silicon 
 Essential for metabolic processes, formation and calcification of bone tissue 
[89] [90] 
 Dietary intake of Si increases bone mineral density [92] 
 Aqueous Si induces precipitation of HA [112] 
 Si(OH)4 stimulates collagen I formation and osteoblastic differentiation [91] 
 Causes problems in bone quality if 
present in a deficient concentration 
during early-bone formation stage 
[113] 
 Improves bioactivity [42] 
Magnesium 
 Stimulates the beginning of the calcification process [114] [115] 
 Increases bone cell adhesion and stability (probably due to interactions with 
integrins) [95] 
 Affects bone healing [116] 
 Good tissue tolerance during 
degradation of Mg-biomaterial 
[85] 
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 Biological response in vitro/in vivo 
Element Normal concentration Deficient concentration Excessive concentration 
Strontium 
 Improves the vertebral bone density and stimulates bone formation in rats 
(doses 0.19–0.34%) [117] [118]. Used for osteoporosis treatment [119] 
 
 Defects in bone mineralization 
(doses > 0.4%) [117] [118] 
Zinc 
 Shows anti-inflammatory effect and stimulates bone formation in vitro by 
activation of protein synthesis in osteoblasts [98] 
 Increases ATPase activity, regulates transcription of osteoblastic 
differentiation genes, e.g. collagen I, ALP, osteopontin and osteocalcin [99] 
 Decreases bone density [98] 
 Inhibits osteoclast 
differentiation and promotes 
osteoblast activity [120] 
Copper 
 Favors angiogenesis of human endothelial cells [100] 
 Promotes synergetic stimulating effects on angiogenesis when associated 
with angiogenic growth factor FGF-2 [101] 
 Stimulates proliferation of human endothelial cells [102] 
 Induces differentiation of mesenchymal cells towards the osteogenic lineage 
[103] 
 Is life threatening, causing 
cardiovascular deformities culminating 
in rupture [85] 
 
Manganese  Influences regulation of bone remodeling [104] 
 Reduces organic matrix synthesis and 
retards endochondral osteogenesis, 
increases possibility of bone 
abnormalities and decreases bone 
thickness or length [104] 
 Inhibitor of loss of bone mass 
after ovariectomy [121] 
Boron 
 Stimulates RNA synthesis in fibroblast cells [106] 
 Dietary boron stimulates bone formation [105] 
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1.8 Development of Si-containing calcium phosphates  
1.8.1 Si as a therapeutic ion 
The presence of Si in mammalian systems is quite variable. Si is present at a level of ∼ 1 
ppm in the serum, 2-10 ppm in the liver, kidney, lungs and muscles, 100 ppm in the bones and 
ligaments and 200-600 ppm in cartilages and other connective tissues [122]. Si is found in levels of 
200-550 ppm in extracellular matrix compounds [122], implying a role for Si in these compounds. It 
has been hypothesized that Si acts as a biological cross-linking agent that contributes to the 
architecture and resilience of connective tissues [122].  
The importance of Si for the health of the body, especially the growth of bone and cartilage 
at early stages, is nowadays a fact [77]. The role of Si as an essential element for birds, 
mammalians and probably other organisms was discovered in the 1970s through the studies of 
Carliste [89] [113] [123], Schwarz [124] and Seaborne [125]. In Carliste’s studies, chicks were fed 
with Si-deficiency food and it was proved that the development of a healthy skeleton was linked to 
Si. The Si deficient animals showed lower levels of collagen, with no significant difference in the 
level of non-collagenous proteins [123]. The Si deficiency was also linked to deformities in the skull 
and teeth of rats [124]. In contrast, the Si supplemented to the diet of rats caused an increase of 
33.8% of the growth rate compared to the Si deficient animals [124].  
The effects of the dietary Si have also been recently evaluated with humans, analyzing the 
bone mineral density in hips of men and premenopausal women. Bone mineral density was 
reported to increase up to a 10% when the Si intake levels were high (> 40 mg Si/day), in 
comparison to lower ones (< 14 mg Si/day) [92].  
1.8.2 Effect of Si on the chemistry and microstructure of α-TCP and CDHA  
The Si that is introduced into α-TCP (Si-α-TCP) or into HA (Si-HA) is expected to modify the 
behavior of the material with its surrounding environment. However, there are still controversies 
regarding whether Si ions are the veritable reason of a positive biological response (active 
mechanism), or the presence of Si in the structure of the material causes chemical or 
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topographical changes at the surface that eventually lead to a change of the biological response 
(passive mechanism) [79] [126].  
Concerning the passive mechanism, it is well known that Si modifies the chemistry and the 
microstructure of both Si-α-TCP and Si-HA. The incorporation of Si into HA has been more studied 
than the incorporation in α-TCP. Some changes that Si can induce to HA are indicated below. 
i) decrease of the grain size [127] [81] [128] [129], increasing the triple point junctions per area and 
thus increasing the dissolution at the surface [130]; 
ii) modification of the surface topography [126], which can affect the cellular behavior [131]; 
iii) increase of the amorphous phase [127]; 
iv) increase of the electronegative surface (for Si-α-TCP and Si-HA) [77]; 
v) change of the protein conformation at the material surface [132].  
1.8.3 Preparation of Si-doped α-TCP and Si-doped HA  
The studies based on Si-doped calcium phosphate-based materials can be mainly divided in 
two groups, regarding the material that was evaluated: the Si-substituted HA (Si-HA) and the Si-
substituted α-tricalcium phosphate (Si-α-TCP). Both materials have been the focus of many 
research efforts [77] [126].  
The synthesis of both Si-α-TCP and Si-HA usually consists in a two-steps process. Firstly, a 
precursor is precipitated by wet chemical methods and, secondly, Si is incorporated into the 
crystalline structure of a calcium phosphate end-product through a thermal treatment [77] [42]. 
This process have been generally performed using Si as an organic compounds such as tetra ethyl 
or propyl ortho-silicate (TEOS or TPOS), silicon (IV) acetate (Si(COOCH3)4) [133] [134] [135] [128] 
[136] [127] or some form of nano-particulate silica; and the calcium phosphate used has been 
obtained by precipitation to have a nanocrystalline HA [80] [137] [138] [139] [129]. 
Even though the preparation of Si-α-TCP has been the aim of several studies, several works 
have shown that the α-phase is contaminated with other subproducts, namely HA, β-TCP or an 
amorphous phase [80] [137] [138] [140] [141]. 
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1.8.4 Preparation of Si-doped CPC  
Although there are several articles regarding the stabilization of the α-phase of TCP by Si 
doping and, undoubtedly, there are hundreds of papers and patents in the calcium phosphate 
cements (CPC) field, there are few works in which Si-doped CPCs (Si-CPC) are developed.  
In 2006, Camiré et al. prepared Si-doped CPC from Si-α-TCP. In vitro tests with SBF resulted 
in the formation of a thicker apatite layer on the surface of a CPC containing 1 wt% Si in 
comparison with its Si-free counterpart. It should be highlighted, however, that the effect of Si on 
the stabilization of the α-phase could not be verified, since the α-TCP was stabilized by quenching 
the calcium phosphate in air from 1325°C [142].  
In 2009, Motisuke et al. reported the preparation of a Si-CPC using Si-α-TCP [143]. 
However, since the reactivity of Si-α-TCP was low, the paper discussed different strategies to 
improve it. In 2011, Su et al. prepared Si-apatite cements with powder mixtures of tetracalcium 
phosphate, dicalcium phosphate anhydrous and 5 wt% sodium silicate [144]. Comparing with the 
analogous material free of Si, the results indicated a shorter setting time, higher compressive 
strength and higher degradability in Tris-HCl in the case of Si-CPC. The same material was modified 
by Cao et al. for the incorporation of macroporosity [145]. Similarly, Zhao et al. also showed 
improved results when calcium silicate (CS) was included to a CPC (CS/CPC) [146].  
1.8.5 Assessment of the effect of Si on the performance of calcium 
phosphates 
1.8.5.1 Predicting in vivo bioactivity in simulated body fluid (SBF) 
The concept of bioactivity was employed for the first time in 1969 to designate a property 
of some bioceramics used for implant applications. A bioactive material was described as “one that 
elicits a specific biological response at the interface of the material, which results in the formation 
of a bond between the tissue and the material” [147]. In other words, a bioactive material creates 
an environment compatible with osteogenesis (bone growth), the mineralizing interface 
developing as a natural bonding junction between the living material (bone) and the non-living one 
(biomaterial) [148].  
Theoretical framework 51 
 
Not all materials can bond to living bone and each bioactive material has a different 
mechanism, time dependence, strength and thickness of the bonding zone. The rate of 
development of the interfacial bond can be referred as the level of bioactivity [148]. The 
bioactivity of a material is an important factor for the success of a bone implant, and many 
researchers have been interested in correlating the level of bioactivity in vitro with the real 
bioactivity capacity that would have the material when implanted into the body. The possibility to 
test the bioactivity of a material in vitro allows reducing remarkably the duration of the in vivo 
experiments and the number of animals used [149] and, in second place, saving a lot of time and 
money.  
In 1991, Kokubo et al. proposed that an essential requirement for a biomaterial to bond to 
a living bone was the previous formation of bone-like apatite on the biomaterial’s surface when 
implanted in the body [150]. In their study, it was proved that the formation of this apatite layer in 
vivo could be reproduced in a simulated body fluid (SBF), a synthetic medium that contains ion 
concentrations nearly equal to those of human plasma [150]. Other studies have also correlated 
the ability to form apatite on the surface of different materials in SBF with the in vivo bone 
bioactivity of a material, being observed the same trend (HA < A-W < Bioglass) in both situations 
[151]. 
 SBF has experienced some improvements in its formulation since 1990, when the original 
SBF was proposed by Kokubo et al. [152]. The original SBF lacked SO4
2-
 ions that are contained in 
human blood plasma. Thus, the SBF was corrected by Kokubo et al. one year later [150] and, since 
then many researchers have been using the corrected-SBF (c-SBF), usually known simply as “SBF”. 
A detailed recipe to prepare SBF was reported in 1995 by Cho et al. [153]. In 2003, Oyane et al. 
prepared a revised SBF (r-SBF): the Cl
-
 ion concentration was decreased and the HCO3
-
 ion 
concentration was increased with the aim to get closer to the human blood plasma [154]. 
However, the calcium carbonate of the r-SBF had a strong tendency to precipitate. In 2004, 
Takadama et al. proposed a newly improved SBF (n-SBF) in which the Cl
-
 ion concentration was 
decreased to the level of human blood plasma [155]. A study compared the n-SBF with the c-SBF 
and it was shown that they did not differ in stability and reproducibility [155]. Hitherto, the c-SBF 
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(or simply SBF) has been the most commonly used medium to evaluate the bioactivity in vitro in 
the scientific community.  
Studies evaluating the Z-potential of the surface of a hydroxyapatite immersed in SBF have 
increased the knowledge of the formation of the apatite layer. Kim et al. proposed several steps 
that lead to the formation of the apatite layer [156], as explained below. 
The iso-electric point of HA in water is between 5 and 7 [157] [67], lower than the pH of 
the SBF, 7.4. Therefore, HA immersed in SBF presents negative surface charge by exposing hydroxyl 
and phosphate units in its crystal structure (Figure 1.20 a) [157]. The HA surface uses this negative 
charge to interact specifically with the positive calcium ions in the fluid, which subsequently attract 
phosphate groups, forming a Ca-rich ACP. The Ca ions are accumulated, which makes the Ca-rich 
ACP to acquire and to increase its positive charge. The Ca-rich ACP on the HA therefore interacts 
specifically with the negative phosphate ions in the fluid to form a Ca-poor ACP (rich in phosphate 
groups). This type of Ca-poor ACP has been observed as a precursor, which eventually crystallizes 
into bonelike apatite on various bioactive ceramics [158] [159] [160] [161]. The solubility of 
apatites in water is lower than that of any other calcium phosphate [36], and therefore the Ca-poor 
ACP in SBF could be thermodynamically stabilized by transforming into a crystal phase of apatite. 
Once formed in SBF, which is a medium supersaturated with respect to the apatite [162], the 
apatite grows spontaneously consuming the calcium and phosphate ions, and incorporating minor 
ions such as sodium, magnesium and carbonate. Thereby, a mineral bone-like regarding both its 
compositional and structural features is developed. The mechanism by which apatite is deposited 
on the HA is schematically shown in Figure 1.20 b. 
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Figure 1.20. a) Schematic presentations of the origin of negative charge on the HA surface; b) process 
of bone-like apatite formation thereon in SBF (modified from [156]). 
 
1.8.5.2 Influence of Si on in vitro cell behavior 
In vitro cell studies are usually performed to predict the response that a material will have 
when implanted into the body. There are different strategies aimed at assessing the cell response 
to biomaterials: direct or indirect methods, as schematically shown in Figure 1.21. A direct method 
implies seeding the cells on the surface of the material, which can be a dense sample (Figure 1.21 
a) or a porous scaffold (Figure 1.21 b). Indirect methods consist on evaluating the cell response in 
presence but not in direct contact with the material, either in the form of suspended particles 
(Figure 1.21 c) or bulk material (Figure 1.21 d). The cells medium can also be modified in situ by 
soaking into it a membrane (commercially named as insert or transwell) that contains the material 
(Figure 1.21 e). Another option is to put the cells in contact with an extract, a medium previously 
modified by the material (Figure 1.21 f).  
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Figure 1.21. Different methods for analyzing the cellular response to degradable biomaterials (modified 
from [109]). 
 
 Every cell culture method evaluates differently the cell response, since the stimulatory 
factors are not the same. In the direct methods
the material (density, porosity, crystallinity, chemistry, surface area, roughness, surfac
chemistry, topography and hardness/stiffne
The indirect methods only evaluate the effect that the ion release/uptake from the m
the cell behavior. Figure 1.22 shows a schematic overview of a few biological responses 
the ions released by a material. 
, the cells are affected by the surface properties of 
ss) and also by the ionic modification of the medium. 
aterial
 
e charge, 
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caused by 
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Figure 1.22. Overview of biological responses to ionic dissolution products of bioactive glasses 
(modified from [109]). 
 
There are many studies evaluating the effect of Si on the material bioactivity and cell 
behavior, although the results are somehow controversial. However, there is a good number of 
works showing that Si released into the medium enhances osteoblast proliferation, differentiation 
and collagen production. Table 1.6 briefly summarizes some of the studies performed, including 
the Si concentration ([Si]) and the outcomes of each work. 
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Table 1.6. Effect of Si on in vitro cell behavior. Compendium of literature studies. 
Materials used in the study, cells, incubation time [Si] in medium Cells behavior References 
 Study: Cells supplemented with orthosilicic acid 
 Cells: Human osteoblasts-like cells 
0 to 50 µM (0-1.4 
ppm Si) 
Physiological concentrations of soluble Si increase osteogenesis by: 
 Stimulating collagen type I synthesis 
 Promoting osteoblasts differentiation 
[91] 
 Study: Human osteoblast supplemented with aqueous Si 
 Cells: Human osteoblasts 
 Incubation time: 48 h 
0.1-100 ppm 
Dose-dependent increase in osteoblast proliferation and cell differentiation 
through up-regulation of transforming growth factor beta (TGF-β) 
[163] 
 Study: Cells treated with dissolution products of Bioglass 
45S5 (45 wt% SiO2) 
 Cells: Human osteoblasts (isolated from the trabecular 
bone of femoral heads) 
 Incubation time: 48 h 
16.5 ± 3.5 ppm Osteogenesis and collagen synthesis is stimulated [164] 
 Study: Cells treated with ionic products of Bioglass (BG60S) 
 Cells: Osteoblasts derived from rat calvaria 
 Incubation time: 72 h 
∼ 40 ppm 
Cell proliferation, differentiation, collagen segregation and cell viability is 
increased. It is speculated that Si might be the main cause 
[165] 
 Study: Cultures dosed with aqueous Si derived from Si-TCP 
 Cells: Rat osteoblast 
0-100 ppm Dose-dependent effect of Si [166] 
 Study: Cells cultured on dense Si-HA (1.97 wt% Si) 
 Cell type: MG-63 osteoblast-like cells 
 Incubation times: 0, 3, 6, 24 h 
0.02 wt% Cell proliferation is enhanced in Si-HA in comparison with HA [136] 
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Materials used in the study, cells, incubation time [Si] in medium Cells behavior References 
 Study: Cells cultured in Si-HA 
 Cells: Human osteosarcoma cells (HOC) 
- 
 Si-HA is biocompatible and non-cytotoxic 
 Metabolic activity of cells cultured in direct contact is higher for Si-HA than 
for HA 
[167] 
 Study: Cells cultured over Si-HA (1-2 mol TEOS/1 mol HA) 
 Cells: Human osteosarcoma cells (HOC) 
 Incubation time: 1, 2, 3 and 7 days 
Not measured Stimulation of cell proliferation [79] 
 Study: Cells seeded on surfaces of Si-HA coatings 
 Cells: Primary human osteoblast-like cells (HOB) 
 Incubation time: 2, 4, 7 days 
Not measured 
 Good attachment of cells to HA and Si-HA, ECM formation 
 Level of mineral deposits is higher on Si-HA coatings than on HA 
 Higher cell growth, well-organised cytoskeletal architecture and enhanced 
biomineralisation were achieved on Si-HA 
[168] 
 Study: Cells were seeded on disks of Si-HA (0.8 wt % Si ) 
 Cell type: Human osteoblast cells 
 Incubation time: From 1 to 27 days 
Not measured Higher cell number and ALP production when compared with HA [169] 
 Study: Cells in contact with Si-HA (1.5 wt% Si) 
 Cell type: Peripheral blood mononuclear cells (PBMC) and 
monocytes expressing the CD14 antigen 
Not measured 
 Si-HA allows differentiation of PBMC into mature osteoclasts 
 A higher osteoclastic resorption activity was observed for Si-HA 
[170] 
 Study: Cells in contact with Si-CPC (5 wt% sodium silicate)  
 Cell type: MG-63 
Not measured  Si-CPC promoted cell proliferation and differentiation [144] 
 Study: Calcium silicate (15wt%) was included to a CPC  
 Cell type: MC3T3-E1 and HUVEC cells 
 Incubation time: 1, 3 and 7 days 
20-70 ppm 
 Excellent biocompatibility and improved cell attachment, proliferation and 
differentiation of cells  
[146] 
 1.8.5.3 Influence of Si on the in vivo biological response  
Several studies claim that calcium phosphate based-materials doped with Si enhanced 
biological properties in vivo in comparison with their stoichiometric counterparts [79]. For 
instance, Patel et al. implanted granules of pure HA and Si-substituted HA in a rabbit model and 
observed an increase of bone ingrowth and bone-implant coverage [171]. This enhanced biological 
response was associated to an unknown mechanism that produced up-regulation in osteoblast cell 
metabolism, as reported by several works (Table 1.6). Similarly, Hing et al. showed that bone 
ingrowth was increased when 0.8 wt% Si was incorporated into the HA lattice of porous scaffolds 
[172].  
Very few studies have been performed with in vivo studies using Si-CPC. Camiré et al. 
implanted Si-CPC in tibiae of rabbit model and observed that this material enhanced mesenchymal 
cell differentiation and increased osteoblast activity compared to CPC [142]. Cao et al. developed a 
macroporous Si-CPC and the scaffolds exhibited good biocompatibility, degradation and 
osteogenesis in vivo [145]. 
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2.1 Introduction 
The interest of doping α-TCP with silicon (Si) is twofold. On one hand, Si can stabilize the α-
phase at low temperatures, facilitating the fabrication process. Otherwise high-temperature 
thermal treatments are required and, in many cases, quenching has to be performed to avoid the 
reversion of the reconstructive β→α transformation. On the other hand, Si has a specific metabolic 
role connected to the bone growth, and it has attracted the interest of many scientists who 
considered that the incorporation of Si into calcium phosphate-based biomaterials was a promising 
way of improving the bioactivity [1], as well as the osteogenic potential of these materials. 
  
2.2 Objectives 
The main aim of this Chapter is to obtain a Si-stabilized α-TCP. In order to fulfill this 
purpose, the specific objectives of this Chapter are the following: 
1. To develop a new method to stabilize α-TCP by Si doping. 
2. To assess the effect of Si on the stabilization of the α-TCP phase and on the reversion of β→α 
transformation.  
3. To evaluate the effect of impurities and specific surface area of the starting powders on the Si-
stabilization of the α-phase. 
4. To determine the effect of different amounts of Si on the stabilization of the α-phase.  
5. To physico-chemically characterize the Si-α-TCP in terms of crystalline and amorphous phases, 
FTIR, lattice parameters and β→α transition temperature, comparing the results with an undoped 
α-TCP (control).  
Figure 2.1 shows a schema of the procedure proposed to obtain Si-stabilized α-TCP (Si-α-
TCP) and its Si-free counterpart (α-TCP), as well as the characterizations performed in this Chapter. 
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Figure 2.1. Schema of the studies performed in 
 
2.3 Materials and methods
2.3.1 Reactants 
The effect of the addition 
commercial hydroxyapatites (HA) were evaluated as potential
n. 1.02196.1000; calcined at 1000°C for 4 h)
in an aqueous dispersion (SiO2, Cab-O
The ratio in which the HA and the SiO
complementary rationales: i) the Si-
assumed to be stoichiometric, Ca5(PO
were mixed in a SiO2/HA molar ratio of 0.32.
this ratio were also used to evaluate the effect of
influence of Si, samples were also prepared with 0 wt% Si
and the Si wt% for each SiO2/HA molar ratio
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of Si on the stability of the α-TCP was investigated. 
 starting reactants: HA1 (
 and HA2 (CalbioChem, ref n. 391948). A colloidal silica 
-Sperse® 1030K) was used as Si source. 
2 were mixed was calculated using two 
α-TCP required a Ca/(P+Si) ratio of 1.50, and ii) the 
4)3(OH). To fulfill the two established criteria, the reactants 
 In addition to this SiO2/HA molar ratio, half 
 different amounts of Si. In order to evaluate the 
. Table 2.1 shows the SiO2/(SiO
, and the amount added of each reactant. 
 
Two 
Merck, ref. 
HA was 
and twice 
2+HA) wt% 
 Table 2.1. SiO2/HA ratios used in this study, shown as SiO
reactants needed in each case.
SiO2/HA 
(molar ratio) 
SiO2/(SiO
(wt%)
0 0 
0.16 1.88
0.32 3.69
0.48 5.43
 
2.3.2 Preparation of Si-doped 
HA and SiO2 were mixed at different SiO
5.43, which correspond to 0, 0.88, 1.72 and 2.54 wt
procedure was as follows. Twenty
The colloidal SiO2 was previously sonicated with 30 ml
of water of 20 ml was added to the reactants
slurry was milled in a planetary ball mill (Fritsch Pulverisette 6) using 3 agate balls (
350 rpm for 30 min. Finally, the mixture was dried for 24 h in a furnace at 110
powder was sintered at 1250°C for 2 h, with a heating and cooling rate of 5
was performed. The sample that resulted in higher amount of Si
further characterization and was coded as 
the obtaining of Si-α-TCP. 
Figure 2.2. Flow chart of the preparation of Si
Undoped α-TCP was prepared
treatment (since no Si was added)
treatment resulting in a higher amount of 
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2/(SiO2+HA) wt% and Si wt%, and amount of 
 
2+HA) 
 
Si (wt%) 
Weight 
HA (g) 
Weight SiO2 
dispersion (g) 
Weight 
SiO
0 
20 
0 
 0.88 6.4 
 1.72 12.8 
 2.54 19.1 
α-TCP (Si-α-TCP) 
2/(HA+SiO2) weight ratios, namely 0, 1.88, 3.69 and 
% Si, respectively, as detailed in Table 2.1
 g of HA were mixed with the needed amount of 
 of distilled water for 5 min. An extra amount 
 mixture in order to improve its homogeneity. The 
°
°C/min. No quenching 
-stabilized α-TCP was selected for 
Si-α-TCP. Figure 2.2 summarizes the steps followed 
-α-TCP. 
 as control. The α-phase was stabilized through a thermal 
 followed by a quench. In order to determine the 
α-phase, the HA2 (which resulted to be Ca
 81 
2 (g) 
0 
1.92 
3.84 
5.73 
. The 
SiO2 (Table 2.1). 
φ = 30 mm), at 
C. The resultant 
for 
 
thermal 
-deficient) was 
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sintered at different temperatures (1250, 1400 and 1450°C) for 2 h, with a heating rate of 5°C/min, 
and the sample was quenched in air to retain the α-phase at room temperature. Moreover, a 
thermal treatment at 1250°C slowly cooling down the temperature was performed in order to 
determine the influence of the fast cooling in the stabilization of the α-phase.  
2.3.3 Physico-chemical characterization of the reactants  
The chemical composition of the two HAs was measured in triplicate by inductively 
coupled plasma (ICP). Ca, P, Na, K, Si and Fe were analyzed by ICP-optical emission spectrometry 
(ICP-OES, Perkin Elmer Optima 3200 RL), and Mg, Al, Sr, Mn and Zn by ICP-mass spectrometry (ICP-
MS, Perkin Elmer Elan 6000). Each HA was dissolved in an acidic aqueous solution (2% HCl) in a 
concentration of 750 ppm.  
The specific surface area (SSA) of the reactants was analyzed in duplicate by N2 adsorption 
(Micromeritics ASAP 2020) following the Brunauer–Emmett–Teller method (BET) theory. In the 
case of SiO2, the dispersion was previously dehydrated and manually crushed.  
The morphology of the commercial HAs was observed with a Scanning Electron Microscope 
(SEM, JEOL JSM 6400). The samples were mounted on a carbon fiber stuck on a copper foil and 
their conductance was increased creating a link with silver colloidal suspension between the 
sample and the carbon layer. The morphology of the colloidal SiO2 was observed in a Transmission 
Electron Microscope (TEM, JEOL 1200 EX-II). The samples were prepared by diluting the colloidal 
dispersion with water, sonicating it for 5 min and, finally, disposing a drop on a cupper grate.  
The phase composition of the reactants was assessed by high resolution X-ray powder 
diffraction (XRD, PANalytical, X’Pert PRO Alpha-1). The XRD measurements were done by scanning 
in Bragg Brentano geometry using a copper Kα radiation. The experimental conditions were: 2θ 
scan step 0.020° between 4-100°, counting time 150 s per point, voltage 45 kV and intensity 40 
mA. The diffraction patterns were compared to the Joint Committee on Powder Diffraction 
Standards for HA (JCPDS #9-432), tridymite (JCPDS #42-1401) and β-cristobalite (JCPDS #82-0512) 
[2].  
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2.3.4 Physico-chemical characterization of Si-α-TCP 
2.3.4.1 Phase quantification by X-ray diffraction 
The phase composition of the sintered doped and undoped α-TCP was assessed by high 
resolution X-ray powder diffraction (XRD, PANalytical, X’Pert PRO Alpha-1). The same experimental 
conditions that were described in section 2.3.3 were used, including the structural model for α-TCP 
(JCPDS #9-348) [2]. Rietveld refinements were carried out with three different samples of each 
formulation in order to quantify the phases present. For this purpose the Inorganic Crystal 
Structure Database (ICSD) was used, including structural models for α-TCP (ICSD #923), β-TCP (ICSD 
#6191), HA (ICSD #151414) and β-cristobalite (ICSD #75483) [3]. Quality fits for phase 
quantification were obtained by refining the instrument displacement, scale factors and lattice 
parameters using a Thompson-Cox-Hastinge pseudo Voight*Axial divergence, FWHM/shape 
parameters, preferred orientation and background. The Rietveld refinements were performed 
using the software package FullProf Suite [4]. XRD spectra analyzed with Rietveld refinement were 
also used to calculate the lattice parameters of the main phase of each sample. 
The presence of an amorphous phase was evaluated by the external standard method, 
adding a known amount of a zinc oxide standard (ZnO, Panreac ref n. 141786-1210) to the Si-α-TCP 
(prepared with 2.54 wt% Si) and to the α-TCP. Rietveld refinement was performed, including the 
structural model for ZnO (ICSD #26170) [3]. 
2.3.4.2 Phase transition temperatures (differential thermal analysis) 
Differential thermal analysis (DTA, Netzsch STA-409) was performed at a heating rate of 
5°C/min step from room temperature to 1300°C and an air flow of 80 ml/min. The samples 
(approximately 60 mg) were placed in Al2O3 crucibles and Al2O3 powders were used as standard. 
Four series were analyzed, namely the HA used as main reactant, the SiO2/HA mixture with 2.54 
wt% Si, and the sintered doped (2.54 wt% Si) and undoped α-TCP powders.  
2.3.4.3 FTIR analysis 
Fourier Transform Infrared spectra (FTIR) from 400 to 4000 cm-1 were obtained using an 
ABB FTLA 2000 spectrometer. A few milligrams of powder was mixed with KBr in a 3.33 wt% ratio, 
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in order to obtain semi-quantitative results. The mixture was pressed in a 6 mm diameter die at 5 t 
for 1 min to produce uniform and translucent discs for analysis.  
2.3.5. Statistical analysis of the results 
A Student’s t-test was used to determine the statistically significant differences between 
the mean values of the different experimental groups. A difference between groups was 
considered to be significant at p < 0.05. 
 
2.4 Results 
2.4.1 Physico-chemical characterization of the reactants 
2.4.1.1 Hydroxyapatite 
The elemental composition data for the HA1 and HA2, measured by ICP, is shown in Table 
2.2, and the Ca/P and the (Ca+Na)/P atomic ratio for HA1 and HA2 are shown in Table 2.3. On one 
hand, the HA1 had a high content of Mg (more than 2,500 ppm) and also had impurities such as 
Na, Sr, Al, Fe, Si and Mn in the order of hundreds of ppm. The Ca/P ratio of HA1 was close to 1.67, 
indicating that it was a nearly stoichiometric HA. On the other hand, HA2 had a concentration of 
Mg ions lower than 10 ppm and a remarkably high Na content (more than 16,000 ppm), which was 
consistent with its low Ca/P atomic ratio (1.43 ± 0.72), since Na ions could substitute Ca ones in the 
apatite crystal structure [5]. Thus, the HA2 was non-stoichiometric.  
  
 Table 2.2. Elemental compositional data 
OES, and Mg, Al, Sr, Mn and Zn by ICP
 Ca (wt %) P (wt %) 
HA1 55.0±8.2 25.9±3.8 
HA2 51.7 ± 13.2 27.9 ± 6.8 
   
 Fe (ppm) K (ppm) 
HA1 212.6±9.6 0.0±0.0 
HA2 23.3±7.8 127±41.5 
 
Table 2.3. Atomic ratio of Ca/P and 
 Ca/P atomic 
HA1 1.64 ± 0.48
HA2 1.43 ± 0.72
 
HA1 and HA2 were characterized in terms of XRD. 
hydroxyapatite (Figure 2.3), indicati
crystalline phases. The wide peaks 
contrast to the high crystallinity ascribed to the sharp peaks of HA1
Figure 2.3. X-ray spectra of HA1 and HA2. The theoretical positions of the hydroxyapatite
indicated. A.U. stands for arbitrary units.
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of HA1 and HA2. Ca, P, Na, K, Si and Fe were measured by ICP
-MS.   
Na (ppm) Mg (ppm) Sr (ppm) 
300.6±103.3 2534.0±67.6 166.9±6.5 
1.67·10
4±1.01·103 9.8±0.9 49.1±0.7 
   
Si (ppm) Mn (ppm) Zn (ppm) 
372.2±16.5 90.2±1.6 8.0±3.0 
3.1±0.3 0.4±0.1 180.2±88.0
(Ca+Na)/P, and SSA of both HA1 and HA2.  
ratio (Ca+Na)/P atomic ratio SSA (m
2
/g) 
 1.65 ± 0.98 4.3 ± 0.2 
 1.51 ± 0.85 71.1 ± 0.6 
All peaks correspond
ng that the reactants did not have any impurity of other 
of HA2 indicated that this reactant was poorly crystalline, in 
. 
 
 85 
-
Al (ppm) 
221.0±10.2 
5.7±2.6 
 
 
 
  
ed to 
 
 peaks are 
86 Chapter 2 
 
HA2 was also characterized by FTIR. The spectrum showed the expected bands for this 
compound (Figure 2.4) [6]. The experimental values for HA2 were compared with the theoretical 
ones, as displayed in Table 2.4.  
 
Figure 2.4. FTIR of HA2. A.U. stands for arbitrary units. 
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Table 2.4. Band assignments for HA2. Some abbreviations were used: sh: shoulder; s: strong band; w: 
weak; wd: wide.  
Band assignment 
Experimental 
values (cm
-1
) 
Frequency (cm
-1
) 
according to 
literature 
References 
HA2 
OH stretching 3571 (w) 3572 (w) [6] 
OH water-adsorbed deformation 3430 (wd) 3400 [6] 
OH water-adsorbed bending 
CO3
2- 
1636 (m) 
1625 
1648 
[6] 
[7] 
PO4
3-
, ν3 
1095 (sh) 
1030 (s) 
1085 (sh) 
∼ 1035 (vs) 
[6] 
[6] 
PO4
3-, ν1 961 (w) 965 (w) [6] 
P-O(H), deformation of HPO4
2-
, v5 
CO3
2-
 
857 (w) 
870 (w) 
875 
[6] 
[7], [8] 
OH, libration - 632 (sh, vw) [6] 
PO4
3-, ν4 
601 (m) 
560 (m) 
605 (m) 
565 (m) 
[6] 
[6] 
PO4
3-
, ν2 466 (w) ∼ 462 (sh) [9] 
 
The high SSA of HA2 (Table 2.3) was associated to the presence of nanometric crystals 
covering the surface of its rhomboedrical particles of 1-75 µm in size (Figure 2.5). 
 
Figure 2.5. Morphology of HA2 observed by SEM: a) particles of powder; b) surface of the particles.  
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2.4.1.2 SiO2 
The dispersion of SiO2 was composed of spherical nanoparticles with a size be
200 nm (Figure 2.6) and a surface area of 74.5 ± 6.4 m
Figure 2.6. Morphology of the colloidal SiO
 
The X-ray diffraction spectrum
around 70° (Figure 2.7 a). The spectrum 
which was associated to its small particle size. However, 
h, the SiO2 transformed into crystalline compounds
cristobalite (Figure 2.7 b). 
Figure 2.7. X-ray spectra of colloidal 
for 2 h. A.U. stands for arbitrary units.
tween 20 and 
2
/g. 
 
2 observed by TEM. 
 of the colloidal SiO2 showed wide bands centered a
indicated that the compound had a poor crystallinity, 
after a thermal treatment at 1250
, mainly tridymite and a low amount of β
SiO2: a) raw material, and b) after a thermal treatment at 1250
  
t 22° and 
°C for 2 
-
 
°C 
 The FTIR spectra of the 
h, is shown in Figure 2.8. As it can be observed, the thermal treatment slightly modified the bands 
shape and caused a small shift to
Figure 2.8. FTIR spectra of SiO
stands for arbitrary units.  
 
Table 2.5 indicates the bands assignation by comparing the experimental values with those 
reported in literature. 
Table 2.5. Band assignments for SiO
weak; wd: wide. 
Band assignment 
OH water-adsorbed deformation 
O = C = O, carbonates 
O-Si-O, cristobalite 
O-Si-O, bending, cristobalite 
O-Si-O, bending, cristobalite 
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SiO2 of both the raw material and after sintering it
 them.  
2: a) raw material; b) after thermal treatment at 1250°C for 2 h. A.U.
2. Some abbreviations are used: sh: shoulder; s: strong 
Experimental values (cm
-1
) 
Frequency (cm
-1
) 
according to literature 
3440 (wd) 3400 
1630 (w) 1643 
1080, 1110 (s) 1080 
810 (m) 800 
470 (s) 481 
 89 
 at 1250°C for 2 
 
 
band; w: 
References 
[6] 
[7] 
[10] 
[10] 
[10] 
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2.4.2 Preparation of Si-stabilized α-TCP 
2.4.2.1 Effect of the hydroxyapatite used as a starting reactant 
Figure 2.9 shows the amount of crystalline phases (quantified by XRD) formed when 
hydroxyapatite (HA1 or HA2) was mixed with 1.72 wt% SiO2, followed by sintering at 1250°C and 
cooling down slowly inside the furnace. The crystalline phases formed when no Si (0 wt%) was 
added are also indicated. Interestingly, the phases formed when no Si was added depended on the 
HA used. While HA1 remained untransformed, HA2 decomposed mainly into β-TCP, remaining only 
about 10 wt% of the initial compound. However, both HA1 and HA2 were partly stabilized into α-
TCP when 1.72 wt% Si was added. On one hand, HA1 transformed in a mixture of α-TCP, β-TCP and 
HA, with a small quantity of β-cristobalite as subproduct. On the other hand, HA2 resulted in α-TCP 
as a majority phase, with β-TCP and β-cristobalite as subproducts.  
 
Figure 2.9. Distribution of the crystalline phases formed mixing HA with 0 or 1.72 wt% Si, subsequently 
sintering at 1250°C and cooling down slowly inside the furnace. Two HAs were used: a) HA1 and b) HA2. 
Error bars indicate standard deviation, n = 3. * indicates statistically significant differences.  
 
 When 1.72 wt% Si was added, a higher amount of Si-α-TCP was obtained when using HA2 as 
initial reactant. This result was in accordance with the fact that the HA2 had a lower amount of Mg 
impurities, element known to be a β-stabilizer [11] [12]. Therefore, the HA2 was selected and, 
from now on, it will be coded as HA.  
2.4.2.2 Effect of the amount of Si added 
Figure 2.10 shows the effect of different amounts of Si (0, 0.88, 1.72 and 2.54 wt% Si) on 
the stabilization of the α-TCP phase after sintering the SiO2/HA mixture at 1250°C for 2 h, and 
Development and characterization of Si-doped α-tricalcium phosphate 91 
 
subsequent slow cooling inside the furnace. The quantification of the crystalline phases was done 
including α-TCP, β-TCP, HA and β-cristobalite. The sample that did not contain Si (0 wt% Si) resulted 
in 1.0 ± 0.1 wt% α-TCP, 89.8 ± 0.3 wt% β-TCP and 9.2 ± 0.3 wt% HA. In contrast, the samples 
prepared with Si contained α-TCP as the main phase, with decreasing amounts of β-TCP when the 
amounts of added SiO2 increased. The sample with 2.54 wt% Si resulted in a nearly single-phase α-
TCP, namely 94.4 ± 1.8 wt% α-TCP, 2.2 ± 0.8 wt% β-TCP, 0.2 ± 0.1 wt% HA and 3.2 ± 1.0 wt% β-
cristobalite, according to the Rietveld refinement. Thereby, this was the sample selected for 
further characterization, and was coded as Si-α-TCP. 
 
Figure 2.10. Crystalline phase composition as function of the Si wt%. The samples were sintered at 
1250°C for 2h and cooled down in the furnace. Error bars indicate standard deviation, n = 3. The 
amount of α-TCP, β-TCP and HA showed statistically significant differences between 0 Si wt% and the 
other amounts of Si; the amount of β-TCP also showed statistically significant differences between 
both 0.88 and 1.72 wt% and 2.54 wt%; the amount of β-cristobalite showed statistically significant 
differences between 0 Si wt% and both 1.72 and 2.54 wt%.  
 
Figure 2.11 shows a representative Rietveld profile analysis assuming the presence of α-
TCP, β-TCP, HA and β-cristobalite for the Si-α-TCP.  
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Figure 2.11. XRD pattern of HA mixed with 2.54 wt% Si sintered at 1250°C for 2 h and cooled down in 
the furnace, refined using the Rietveld method. The vertical lines mark the positions of the calculated 
Bragg peaks of the phases included in the refinement, which from top to bottom were β-TCP, α-TCP, 
HA and β-cristobalite.  
 
 The amount of Si selected for the continuation of the study was 2.54 wt%. 
2.4.3 Preparation of undoped α-TCP 
As previously observed, when HA2 (without any addition of Si) was sintered, cooling down 
the sample slowly inside the furnace, the phase stabilized was β-TCP (Figure 2.9 b). This indicated 
that the initial HA, which in fact was a CDHA (Ca/P = 1.43 ± 0.72), was transformed into TCP during 
the thermal treatment. However, the α-phase was only stabilized if Si was added (Figure 2.10). This 
result showed that the HA did not retain the α-TCP polymorph upon slow cooling down.  
An alternative procedure to stabilize the α-phase without the addition of any external 
compound is quenching the sample in air right after the thermal treatment. Therefore, HA was 
submitted to several thermal treatments that included the quenching of the sample in order to 
find out which of them resulted in a higher amount of α-phase. Figure 2.12 confirms that the α-
phase was only stabilized if the sample was quenched after the heating process, otherwise being 
formed β-TCP. As higher was the maximum heating temperature, the amount of HA decomposed 
and transformed into TCP was increased. Thus, a Si-free α-TCP (coded as α-TCP) was prepared by 
heating the HA at 1450°C for 2 h, followed by quenching the sample in air. 
 Figure 2.12. Crystalline phases resulting of 
“Without TT” stands for “without thermal treatment”, 
quenching is indicated as “+Q”. Every thermal treatment lasted for 2 h. 
deviation, n = 2. * indicates statistically
 
 The conditions selected in order to prepare both
Figure 2.13. 
Figure 2.13. Flow charts in which the methodology followed to prepare Si
treatment applied to prepared 
phosphate source selected. 
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2.4.4 Characterization of Si-α-TCP and α-TCP 
2.4.4.1 Phase transition temperatures  
The effect of SiO2 addition in the phase transition temperatures was analyzed by 
differential thermal analysis (DTA). The curves obtained for the HA powder, the SiO2/HA mixture 
prepared with 2.54 wt% Si, the Si-α-TCP and the α-TCP are shown in Figure 2.14. The heating 
curves for the SiO2/HA mixture and the HA were similar (Figure 2.14 a and b). Two endothermic 
peaks, attributed to the loss of surface-bound water and to the loss of lattice water were 
respectively observed around 90°C and 510°C [13]. An exothermic peak indicated the HA 
transformation into β-TCP at 713°C, which in turn transformed into the α-form through an 
endothermic reaction upon subsequent heating, at 1148°C. When the HA sample was cooled 
down, an exothermic peak corresponding to the reverse transformation of α to β-TCP was 
observed at 996°C (Figure 2.14 b). Interestingly, this peak did not appear in the SiO2/HA mixture 
(Figure 2.14 a), indicating that the α-phase was stabilized down to room temperature. When the α-
TCP was heated up (Figure 2.14 d), an exothermic peak at 684°C was attributed to the 
transformation into β-TCP, whereas in the Si-α-TCP (Figure 2.14 c) only a diffuse band appeared 
around 750°C. The β to α endothermic transformation was produced upon subsequent heating, 
around 1150°C in both samples. During the cooling process, the α-TCP showed the expected 
exothermic peak corresponding to the α to β transformation at 978°C, whereas this transformation 
was not detected in the Si-α-TCP.  
 Figure 2.14. DTA analysis of reactants and products:
no thermal treatment, b) HA,
 
2.4.4.2 Lattice parameters 
The evaluation of the lattice
XRD spectra by the Rietveld method
(p > 0.05), as indicated in Table 
experimental α-phases than for the 
slightly shorter. 
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 c) Si-α-TCP, and d) α-TCP.  
 parameters of both Si-α-TCP and α-TCP, calculated from the 
, showed no statistically significant differences between them
2.6. However, the b and β parameters were larger for the 
α-TCP reported in literature [14], and the c 
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parameter was 
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Table 2.6. Lattice parameters obtained by Rietveld refinement method of Si-α-TCP and undoped α-
TCP. The data indicate mean ± standard deviation, n= 3. 
 a (Å) b (Å) c (Å) β (°) 
Si-α-TCP 12.9002 ± 0.001 27.3796 ± 0.002 15.1977 ± 0.001 126.4328 ± (0.004 
α-TCP 12.8999 ± 0.0089 27.3789 ± 0.0143 15.2009 ± 0.0183 126.4368 ± 0.0384 
α-TCP, reported 
in literature [14] 
12.887 ± 0.002 27.280 ± 0.004 15.219 ± 0.002 126.20 ± 0.001 
 
2.4.4.3 Amorphous phase 
An external standard was added to the sample and the amorphous phase was quantified 
from the XRD spectra by the Rietveld method. The amount of amorphous phase was 13.8 ± 0.3 
wt% for Si-α-TCP and 11.2 ± 0.2 wt% for α-TCP.  
2.4.4.4 FTIR analysis 
The FTIR spectra of α-TCP and of Si-stabilized α-TCP prepared with different Si wt%, are 
shown in Figure 2.15.  
 
Figure 2.15. FTIR spectra of Si-α-TCP prepared with SiO2/HA mixtures with 0.88, 1.72 and 2.54 wt% of 
Si, subsequently sintered at 1250°C for 2 h and cooled down slowly. The α-TCP spectra is also showed. 
A.U. stands for arbitrary units. 
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The wavenumbers of the α-TCP bands were in accordance with those reported in the 
literature [8], as displayed in Table 2.7. When the amount of added SiO2 increased, the wide bands 
corresponding to ν3 stretching (969-1155 cm
-1) and ν4 bending (540-640 cm
-1) decreased their 
intensity and got narrower. This trend was associated to the increasing content of α-TCP. The 
bands located at 480, 798 and 1196 cm-1, that slightly increased their intensity with the amount of 
SiO2 added, were assigned to the O-Si-O vibration of β-cristobalite [10] [15]. In the sample with 
2.54 wt% Si, a small sharp band was detected at 668 cm-1. This band was also detected in a 
previous study on attenuated total reflection infrared spectroscopy of Si-stabilized tricalcium 
phosphate [16] and it can be attributed to the formation of Si2O7
6- groups within the α-TCP 
structure [16] [17].  
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Table 2.7. Band assignments for α-TCP and Si-α-TCP. Some abbreviations were used: sh: shoulder; s: 
strong band; w: weak; wd: wide.  
Band assignment 
Experimental values (cm
-1
) Frequency (cm
-1
) 
according to literature 
References 
α-TCP Si-α-TCP  
PO4
3-
, ν3 stretching 
969-1155 (wd, s) 974-1144 (wd, s) 950-1100 (wd) [8] 
- - 1136 (sh) [8] 
- - 1100 (sh) [8] 
1076 (sh) 1079 (sh) 1078 (sh) [8] 
1055 (sh) 1048 (sh) 1045 (s) [8] 
1011 (sh) 1018 (sh) 1010 (sh) [8] 
- - 990 (sh) [8] 
PO4
3-, ν1 stretching 960 (sh) 960 (sh) 960 (s) [8] 
(PO4
3-
) ν4 bending 
540-640 (wd) 543-632 (wd) ∼ 550-600 (wd) [8] 
- - 609 [8] 
598 (sh) - 595 [8] 
586 (sh) 586 (sh) 583 [8] 
565 (sh) 565 (sh) 562 [8] 
PO4
3-, ν2 470 (w) 472 (w) 462 (w) [8] 
O-Si-O, bending, 
cristobalite 
- 480 (w) 481 [10] 
Si2O7
6-
, bridging - 668 (w) 668 [16] 
O-Si-O, bending, 
cristobalite 
- 798 (w) 800 [10] 
O-Si-O, cristobalite - 1196 (w) 1192 [15] 
 
2.5 Discussion 
α-TCP, which is a widely used compound for the preparation of apatitic cements, was 
stabilized by a simple process that consisted in mixing hydroxyapatite (HA) with silicon oxide (SiO2), 
subsequently sintering the mixture and cooling it down slowly inside the furnace. A straight 
advantage of this process is that the α-phase is obtained without performing any quench after the 
thermal treatment, which simplifies substantially the production of the α-TCP.  
Sayer et al. [18] [19] [20] [21] prepared Si-α-TCP following several steps. They precipitated 
hydroxyapatite via a basic precipitation reaction in an ammoniated aqueous mixture and, 
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afterwards, added the Si source either as an organic compound or as SiO2. Subsequently, the sols 
were sprayed using a spray dryer and, finally, thermal treatments were performed, which aimed 
both at the removal of water and NO2 associated with the precursor reactants and at the 
incorporation of Si to the crystalline structure of the calcium phosphate. The main differences 
between the strategy followed by Sayer et al. and the methodology explained in this Chapter are: i) 
the reactants used, in our case being inorganic commercial compounds, and ii) the procedure to 
mix these reactants, in this work, was done by ball milling, including some water to improve their 
homogenization. The methodology followed in this work resulted in a nearly single phase Si-α-TCP 
with a high reproducibility, which was ascribed to the simplicity and the low number of steps of the 
overall process.  
Another work aiming at the Si-stabilization of α-TCP that followed a similar methodology 
was published by Li et al. [22]. In fact, Li et al. also mixed a commercial HA with SiO2 using a ball 
mill. However, their mixture contained 10 wt% of SiO2 (almost 5 wt% Si) and it was milled for 24 h; 
subsequently, the mixture was sintered at 1200°C to stabilize the α-phase. Li et al. reported that 
more than 24 wt% HA remained and that an amorphous phase was formed, which increased by 
adding higher quantities of SiO2. 
2.5.1 Factors influencing on the Si-stabilization of α-TCP 
The effectiveness to stabilize α-TCP with Si was evaluated with two HAs and adding 
different amounts of Si.  
2.5.1.1 Calcium phosphate source (HA) 
It is well known that the relative stability of the different TCP polymorphs is strongly 
influenced by the presence of some impurities. For instance, Mg has been shown to increase the 
β→α transformation temperature, acting in practice as a beta-stabilizer [23] [11] [12]. On the other 
hand, it has been proved that Si stabilizes the alpha phase down to low temperatures [24] [25] [26] 
[27].  
Two commercial HAs were used in this work, which differed in their impurities content 
(Table 2.2), their Ca/P ratio (Table 2.3), their SSA (Table 2.3) and their crystallinity (Figure 2.3). The 
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HA1, which was nearly stoichiometric, had impurities of betagen elements such as Na, Mg, Sr, Al 
and Fe. Mg, which is an ion known to stabilize the β-phase even in low concentrations [23] [11] 
[28] [12] [29], was the betagen element found in a higher amount (thousands of ppm). The 
elemental composition of the HA2 was very different, with less than 10 ppm of Mg, and less than 
50 ppm of other betagen impurities such as Sr, Fe and Al. In contrast, HA2 had a low Ca/P ratio, 
indication that the HA was deficient in Ca, which was associated to the high concentration of Na 
ions occupying Ca sites [5]. The (Ca+Na)/P ratio of HA2 was 1.51 (calculated from the elemental 
composition resulting from the ICP-OES analysis).  
The two HAs had very different SSA (Table 2.3). The low SSA of HA1 was due to the 
calcination performed to this compound, which increased its crystallinity as indicated by the sharp 
peaks of the XRD spectrum (Figure 2.3). In contrast, the HA2 had a very high SSA, due to the 
nanometric crystals covering its particles (Figure 2.5), which were the reason for the poor 
crystallinity of the compound, as observed by the wide peaks of the XRD spectrum.  
When the HAs (without Si) were submitted at 1250°C, cooling down the samples inside the 
furnace, different results were observed. While HA1 remained stable, HA2 was decomposed 
mainly into β-TCP (Figure 2.9). The different thermostability of the HAs was associated to their 
distinct Ca/P ratio. Therefore, the nearly stoichiometric HA1 had a high thermostability, while the 
non-stoichiometric HA2 was not thermostable.  
The initial studies were performed adding Si to the two HAs in order to evaluate the 
stabilization of the α-TCP after sintering the mixture and cooling it down slowly. It is interesting to 
note that, in these conditions, HA1 was decomposed into α-TCP, β-TCP and HA when 1.72 wt% Si 
was added (Figure 2.9). In contrast, HA2 resulted in about 90 wt% α-TCP by adding Si. The higher 
stability of α-TCP when using HA2 was associated to two different factors: i) the lower amount of 
betagenic impurities, such as Mg (less than 10 ppm), Sr, Fe and Al [23] of HA2, and ii) the higher 
SSA of HA2, which enhanced an intimate contact between the HA and the SiO2. However, it was 
not possible to ascribe the stability of the α-phase to only one of these properties. Thus, the 
calcium deficient hydroxyapatite (HA2) was selected to synthesize Si-doped α-TCP.  
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2.5.1.2 Amount of Si 
According to DTA (Figure 2.14) and to XRD (Figure 2.9 and 2.10), when no Si was added to 
HA2, the α-TCP phase that was formed over 1148°C was not retained upon slow cooling and it 
completely reverted to β-TCP, in spite of the low Mg concentration. Unlike what was reported in 
other studies [11] [12], it was necessary to quench the samples to obtain α-TCP. This behavior 
could be attributed to the high amount of Na impurities in the HA, which have also been reported 
to increase the stability of the β polymorph [30]. 
The minimum amount of Si necessary to effectively stabilize the α-phase is still not clear, 
since it depends on many factors, namely the Ca/(P+Si) ratio of the system, the method of 
introducing Si and the sintering conditions [27]. In the current work, it was observed that although 
0.88 wt% Si was enough to produce 89.7 ± 1.1 wt% Si-α-TCP, an excess of Si (up to 2.54 wt% Si) 
increased the amount of stabilized α-TCP, together with residual β-cristobalite (Figure 2.10).  
It is interesting to note that β-cristobalite is not the stable allotropic form of silicon oxide at 
1250°C. In fact, the stable phase at this temperature was tridymite, which is the one that was 
obtained when sintering the colloidal SiO2 dispersion at 1250°C in absence of hydroxyapatite 
(Figure 2.7 b). However, the presence of both Ca and Na are known to decrease the tridymite→β-
cristobalite phase transformation temperature from 1470°C to lower values [31].  
2.5.2 Characterization of Si-α-TCP and α-TCP 
After the initial studies, the HA2, a calcium deficient hydroxyapatite that did not retain the 
α-phase at room temperature (Figure 2.10 and 2.14), and had low amounts of betagen elements 
(Table 2.2), was used as initial reactant. The sample containing 2.54 wt% Si, which was the one 
producing the highest amount of α-phase, was coded as Si-α-TCP. 
The addition of SiO2 to HA stabilized and retained the α-phase upon slow cooling, as 
assessed by XRD and DTA (Figures 2.10 and 2.14). The α→β retransformation did not take place 
when cooling down the Si-doped samples (Figure 2.14 a and c), in contrast to what happened in 
the Si-free samples, that showed this phase reversion (Figure 2.14 b and d). However, although 
some studies reported a reduction of the β→α transformation temperature with Si addition [24] 
102 Chapter 2 
 
[25] [26] [27], in our case, very similar β→α transformation temperatures (1148-1150°C) were 
observed for both, the Si-free and the Si-containing samples. It is interesting to note that without 
the addition of Si, nearly pure α-TCP was produced only if the HA was heated up to 1450°C and 
quenched afterwards in order to stabilize the α-phase (Figure 2.12).  
In addition to the crystalline phases, 13.8 ± 0.3 wt% and 11.2 ± 0.2 wt% of an amorphous 
phase was detected in Si-α-TCP and α-TCP, respectively. The existence of an amorphous phase in 
coexistence with Si-stabilized α-TCP has been previously associated with the formation of a non-
crystalline Ca-Si-P-O phase and was directly related with the presence of Si in excess [19] [22]. 
However, the fact that an amorphous phase was also detected in the non-doped TCP would rather 
suggest the formation of a glassy phase in the system CaO-Na2O-P2O5 [32]. The amorphous phase 
was expected to remain preferentially in the grain boundaries of the crystalline phase, as 
determined by Li et al. in SEM micrographs [22].  
The α-TCP obtained had larger b and β parameters than the theoretical one, reported by 
Mathew [14], as shown in Table 2.6. The enlargement of the α-TCP lattice was associated to the 
lattice distortions produced by the presence of other ionic substitutions like Na. However, no 
statistically significant changes were detected in the lattice parameters of the Si-stabilized α-TCP 
(Table 2.6), unlike previous works that indicate the enlargement of the unit cell volume with Si 
incorporation [19] [21]. In fact, in the current study, the preexisting lattice distortions caused by Na 
ions may mask the effect of Si substitution in the modification of lattice parameters. 
Finally, the comparison of the FTIR spectra of Si-containing and Si-free samples confirmed 
the presence of β-cristobalite in the Si-containing samples (Figure 2.15). Moreover, in addition to 
the β-cristobalite-related bands at 480, 668 and 798 cm-1, a band at 668 cm-1 was also found in the 
sample with highest Si content, which was previously detected in Si-stabilized TCP and adscribed to 
Si2O7
6- groups [16]. Ab initio calculations performed by Yin et al. suggested that Si2O7
6- species 
could be formed within the Si-α-TCP structure after the incorporation and fusion of SiO4
4- groups 
into the crystal lattice, through an oxygen-vacancy formation mechanism [17]. The incorporation of 
Si into the crystal lattice did not affect the position of the bands associated with phosphate group 
vibrations. This was in accordance with the close vibration energies of both Si-O and P-O bonds, 
since Si and P have a similar dipolar movement and atomic weight [18].  
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2.6 Conclusions 
The conclusions that can be extracted from this Chapter are the following: 
1. A new method to stabilize α-tricalcium phosphate with silicon was developed and optimized. 
The high temperature polymorph α-tricalcium phosphate was stabilized by the presence of silicon, 
which inhibited the reversion of the β→α transformation. This was achieved by the addition of 
2.54 wt% colloidal silicon oxide to a calcium deficient hydroxyapatite and subsequent sintering at 
1250°C for 2 h, followed by slow cooling. In the Si-free sample α-tricalcium phosphate completely 
reverted to the β-polymorph.  
2. The addition of Si did not modify the β→α transformation temperature, which took place 
between 1148 and 1150°C regardless the presence of Si. 
3. The Si-stabilization of the α-phase was enhanced using a calcium deficient hydroxyapatite that 
contained a low amount of Mg impurities and had a high SSA.  
4. Fourier Transform Infrared analysis suggested the formation of Si2O7
6- groups within the α-TCP 
structure, following an oxygen-vacancy formation mechanism. 
5. No significant modifications in the lattice parameters were detected in the Si-α-TCP, probably 
because the crystal lattice was already distorted by a high quantity of Na ions present in the 
starting reactants. 
6. Both Si-α-TCP and α-TCP contained about 10 wt% amorphous phase, which was attributed to the 
formation of a non-crystalline Ca-Na-P-O phase due to the high amount of Na impurities in the HA.  
7. The Si in excess was transformed into β-cristobalite during the thermal treatment, instead of 
tridymite, probably due to the presence of both Ca and Na in the HA, decreasing the tridymite→β-
cristobalite phase transformation temperature to lower values. 
 
104 Chapter 2 
 
2.7 Acknowledgements 
This work is a continuation of part of the studies performed by Carolina Mochales during 
her Thesis, and thus was initiated with her help and following her previous experience. The most 
important characterization technique to evaluate the stabilization of the α-phase was the XRD, 
performed in the Serveis Cientifico-Tècnics of the University of Barcelona. The XRD spectra were 
quantified by Rietveld refinements, with the invaluable help of Xavier Alcobé, who provided many 
hours of his time to teach me how to use this valuable tool. I would like to specially mention 
Salvador Martínez, professor in the Geology Faculty of the University of Barcelona, who was always 
very kind and helped me to use his DTA equipment. I should also mention Maite Garcia-Valles and 
Glòria Àvila for their help with some of the equipment used in their laboratories. Finally, I would 
like to sincerely appreciate the work performed by Clémence Le Van as part of her final year 
project. 
  
Development and characterization of Si-doped α-tricalcium phosphate 105 
 
2.8 References 
[1] Boanini E, Gazzano M, Bigi A. Ionic substitutions in calcium phosphates synthesized at low 
temperature. Acta Biomaterialia 2010; 6: 1882–1894. 
[2] Joint Committee for Powder Diffraction Studies (JCPDS). International Center for Diffraction 
Data and American Society for Testing Materials. Powder diffraction file (Inorganic and Organic). 
Swarthmore (USA), 1991. 
[3] Inorganic Crystal Structure Database (ICSD). Institut Laue-Langevin (ILL), Grenoble, France. 
[4] Rodríguez-Carvajal J. Fullprof.2k Software. CEA-CNRS; 2007. 
[5] Lin FH, Liao CJ, Chen KS, Sun JS. Preparation of high-temperature stabilized beta-tricalcium 
phosphate by heating deficient hydroxyapatite with Na4P2O7 x 10H2O addition. Biomaterials 1998; 
19: 1101-1107. 
[6] Ginebra MP, Fernández E, De Maeyer EAP, Verbeeck RMH, Boltong MG, Ginebra J, Driessens 
FCM, Planell JA. Setting reaction and hardening of an apatitic calcium phosphate cement. Journal 
of Dental Research 1997; 76: 905–912. 
[7] Gibson IR, Best SM, Bonfield W. Chemical characterization of silicon-substituted hydroxyapatite. 
Journal of Biomedical Materials Research 1999; 44: 422-428. 
[8] Radin S, Ducheyne P, The effect of calcium phosphate ceramic composition and structure on in 
vitro behavior, II: precipitation. Journal of Biomedical Materials Research 1993; 27: 25–34. 
[9] Berry EE. The structure and composition of some calcium deficient apatites. Journal of Inorganic 
and Nuclear Chemistry 1967; 29: 317-327. 
[10] Mollah M, Promreuk S, Schennach R, Cocke D, Guler R. Cristobalite formation from thermal 
treatment of Texas lignite fly ash. Fuel 1999; 78: 1277–1282. 
[11] Enderle R, Götz-Neunhoeffer F, Göbbels M, Müller FA, Greil P. Influence of magnesium doping 
on the phase transformation temperature of beta-TCP ceramics examined by Rietveld refinement. 
Biomaterials 2005; 26: 3379–3384. 
106 Chapter 2 
 
[12] Carrodeguas RG, De Aza AH, Turrillas X, Pena P, De Aza S. New Approach to the β→α 
polymorphic transformation in magnesium-substituted tricalcium phosphate and its practical 
implications. Journal of the American Ceramic Society 2008; 91: 1281–1286. 
[13] Elliott JC. Structure and chemistry of the apatites and other calcium orthophosphates. 
Amsterdam: Elsevier, 1994. 
[14] Mathew M, Schroeder W, Dickens B, Brown W. The crystal structure of α-Ca3(PO4)2. Acta 
Crystallographica B: Structural Science 1977; 33: 1325–1333. 
[15] Simon I, McMahon H. Study of the structure of quartz, cristobalite, and vitreous silica by 
reflection in Infrared. The Journal of Chemical Physics 1956; 21: 23–30. 
[16] Dunfield D, Sayer M, Shurvell HF. Total attenuated reflection infrared analysis of silicon-
stabilized tri-calcium phosphate. The Journal of Physical Chemistry B 2005; 109: 19579-19583. 
[17] Yin X, Stott MJ. Theoretical insights into bone grafting silicon-stabilized alpha-tricalcium 
phosphate. The Journal of Chemical Physics 2005; 122: 024709-1–9. 
[18] Langstaff SD, Sayer M, Smith TJN, Pugh SM, Hesp SA, Thompson WT. Resorbable bioceramics 
based on stabilized calcium phosphates, part I: rational design, sample preparation and material 
characterization. Biomaterials 1999; 20: 1727–1741. 
[19] Sayer M, Stratilatov AD, Reid J, Calderin L, Stott MJ, Yin X, MacKenzie M, Smith TJN, Hendry JA, 
Langstaff SD. Structure and composition of silicon-stabilized tricalcium phosphate. Biomaterials 
2003; 24: 369–382. 
[20] Pietak AM, Reid JW, Sayer M, Dunfield D, Smith TJN. Phase formation and evolution in the 
silicon substituted tricalcium phosphate/apatite system. Biomaterials 2005; 26: 2887–2897. 
[21] Reid JW, Tuck L, Sayer M, Fargo K, Hendry JA. Synthesis and characterization of single-phase 
silicon-substituted alpha-tricalcium phosphate. Biomaterials 2006; 27: 2916–2925. 
[22] Li XW, Yasuda HY, Umakoshi Y. Bioactive ceramic composites sintered from hydroxyapatite 
and silica at 1,200°C: preparation, microstructures and in vitro bone-like layer growth. Journal of 
Materials Science: Materials in Medicine 2006; 17: 573–581. 
Development and characterization of Si-doped α-tricalcium phosphate 107 
 
[23] Ando J. Tricalcium phosphate and its variation. Bulletin of the Chemical Society of Japan 1958; 
31: 196–201. 
[24] Fix W, Heymann H, Heinke R. Subsolidus relations in the system 2CaO·SiO2·3CaO·P2O5. Journal 
of the American Ceramic Society 1969; 52: 346–347. 
[25] Nurse RW, Welch J, Gutt W. High-temperature phase equilibria in the system dicalcium 
silicate-tricalcium phosphate. Journal of the Chemical Society 1959; 220: 1077–1083. 
[26] Barnes MW, Klimkiewicz M, Brown PW. Hydratation in the system Ca2SiO4-Ca3(PO4)2 at 90
oC. 
Journal of the American Ceramic Society 1992; 75: 1423–1429. 
[27] Pietak AM, Reid JW, Stott MJ, Sayer M. Silicon substitution in the calcium phosphate 
bioceramics. Biomaterials 2007; 28: 4023–4032. 
[28] Reid JW, Fargo K, Hendry JA, Sayer M. The influence of trace magnesium content on the phase 
composition of silicon-stabilized calcium phosphate powders. Materials Letters 2007; 61: 3851–
3854. 
[29] Motisuke M, García Carrodeguas R, Zavaglia CAC. Mg-free precursors for the synthesis of pure 
phase Si-doped α-Ca3(PO4)2. Key Engineering Materials 2008; 361–363: 199–202. 
[30] Matsumoto N, Yoshida K, Hashimoto K, Toda Y. Thermal stability of β-tricalcium phosphate 
doped with monovalent metal ions. Materials Research Bulletin 2009; 44: 1889–1894. 
[31] Ning CQ, Greish Y, El-Ghannam A. Crystallization behavior of silica-calcium phosphate 
biocomposites: XRD and FTIR studies. Journal of Materials Science: Materials in Medicine 2004; 15: 
1227-1235. 
[32] Navarro ME, Ginebra MP, Clement J, Martinez S, Avila G, Planell JA. Physicochemical 
degradation of titania-stabilized soluble phosphate glasses for medical applications. Journal of the 
American Ceramic Society 2003; 86: 1345–1352. 
  
108 Chapter 2 
 
 
  
Development of silicon-doped calcium phosphate cement: study of its bioactivity and cell 
response 
109 
 
 
 
 
 
 
Chapter 3. 
Development of silicon-doped calcium phosphate 
cement: study of its bioactivity and cell response 
 
  
110 Chapter 3 
 
 
  
Development of silicon-doped calcium phosphate cement: study of its bioactivity and cell 
response 
111 
 
Table of contents 
3.1 Introduction ............................................................................................................................... 113 
3.2 Objectives .................................................................................................................................. 113 
3.3 Materials and methods .............................................................................................................. 114 
3.3.1 Preparation of Si-CPC and CPC ........................................................................................... 114 
3.3.2 Physico-chemical characterization of Si-CPC and CPC ........................................................ 115 
3.3.2.1 Setting time .................................................................................................................. 115 
3.3.2.2 Cohesion time .............................................................................................................. 116 
3.3.2.3 Compressive strength .................................................................................................. 116 
3.3.2.4 Crystalline phases ........................................................................................................ 116 
3.3.2.5 FTIR .............................................................................................................................. 117 
3.3.2.6 Morphology ................................................................................................................. 117 
3.3.2.7 Specific surface area .................................................................................................... 117 
3.3.3 Ion exchange of the samples in different media ................................................................ 117 
3.3.3.1 Experimental design .................................................................................................... 117 
3.3.3.2 Media of study ............................................................................................................. 118 
3.3.3.3 Quantification of the ion release ................................................................................. 119 
3.3.4 In vitro bioactivity study of Si-CPC and CPC ........................................................................ 119 
3.3.4.1 Experimental design .................................................................................................... 119 
3.3.4.2 Preparation of SBF ....................................................................................................... 120 
3.3.4.3 Characterization of the bioactivity .............................................................................. 121 
3.3.4.3.1 Crystalline phases (X-ray diffraction) .................................................................... 121 
3.3.4.3.2 Crystallinity of the surface layer (glancing angle-X-ray diffraction) ..................... 122 
3.3.4.3.3 Morphology (Scanning electron microscopy, SEM) .............................................. 122 
3.3.4.3.4 Elemental analysis (energy dispersive spectroscopy, EDS) .................................. 123 
3.3.5 Cell culture study ................................................................................................................ 123 
3.3.6 Statistical analysis of the results ......................................................................................... 126 
3.4 Results ........................................................................................................................................ 126 
3.4.1 Physico-chemical characterization of Si-CPC and CPC ........................................................ 126 
3.4.2 Ion exchange of the Si-CPC and CPC ................................................................................... 130 
3.4.2.1 Ion concentration of pristine media ............................................................................ 130 
3.4.2.2 Ion exchange in H2O ..................................................................................................... 131 
3.4.2.3 Ion exchange in SBF ..................................................................................................... 131 
112 Chapter 3 
 
3.4.3 Bioactivity study of the CPCs ............................................................................................... 132 
3.4.3.1 Phase composition (X-ray diffraction) .......................................................................... 132 
3.4.3.2 Crystallinity of the apatite layer (glancing angle-X ray diffraction) .............................. 133 
3.4.3.3 Morphology .................................................................................................................. 134 
3.4.3.4 Elemental analysis (energy dispersive spectroscopy, EDS) .......................................... 138 
3.4.4 Cell culture study ................................................................................................................. 138 
3.5 Discussion ................................................................................................................................... 140 
3.5.1 Physico-chemical characterization of CPC and Si-CPC ........................................................ 140 
3.5.2 Ion exchange in different media .......................................................................................... 141 
3.5.3 Bioactivity study of the CPCs ............................................................................................... 144 
3.5.4 Cell culture study ................................................................................................................. 147 
3.6 Conclusions ................................................................................................................................. 149 
3.7 Acknowledgements .................................................................................................................... 150 
3.8 References .................................................................................................................................. 151 
 
 
Development of silicon-doped calcium phosphate cement: study of its bioactivity and cell 
response 
113 
 
3.1 Introduction 
This Chapter proposes the preparation of a Si-doped calcium phosphate cement (Si-CPC), 
using as main reactant the Si-α-TCP developed in Chapter 2. The aim to dope CPCs with Si is to 
improve some biological properties of the cement, such as its bioactivity and the cell response to 
the material [1], which are of high interest for medical applications. However, whether the 
biological improvements are associated to the Si itself or to the modifications that this ion causes 
to the physical properties of the material is still unclear [2]. Therefore, special attention will be 
paid to discern, when possible, between both factors.  
 
3.2 Objectives 
The main aim of this Chapter is to develop and to characterize a Si-doped calcium 
phosphate cement (Si-CPC). The specific objectives of this Chapter are the following: 
1. To develop a Si-doped calcium phosphate cement (Si-CPC) with suitable characteristics for 
clinical applications, using alpha-tricalcium phosphate doped with silicon (Si-α-TCP) as reactant. 
2. To characterize the Si-CPC in terms of chemical, physical and mechanical properties. 
3. To evaluate the bioactivity of Si-CPC using Kokubo’s method. 
4. To evaluate the ion exchange of Si-CPC with two different immersion media. 
5. To assess the cell response to the Si-CPC in terms of cell proliferation and differentiation. 
In order to assess the role of Si in the mentioned studies, a Si-free CPC was included as a 
control in all tests. Figure 3.1 summarizes schematically the studies evaluated in this Chapter. 
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Figure 3.1. Schema of the studies evaluated
of Ca, P and Si, respectively. 
 
3.3 Materials and methods
3.3.1 Preparation of Si-CPC and CPC
The reactant used to prepare 
α-TCP developed in Chapter 2. Analogously,
counterpart, namely CPC, which was used as 
SiO2/HA mixture containing 2.54 wt% Si, sintered at 1250
furnace. α-TCP was prepared by heating the
stabilize the α-phase.  
Fifty g of bulk material of α
Pulverisette 6) with 6 agate balls (φ = 30 mm), at 350 rpm for 30 min. 
size distribution of both powders. The SSA of the
± 0.12 m2/g for Si-α-TCP and 2.55 ± 0.23 m
 in Chapter 3. [Ca], [P] and [Si] stands for the concentration 
 
 
the Si-doped calcium phosphate cement (Si-CPC) 
 α-TCP was the reactant used to prepare the Si
a control. Briefly, Si-α-TCP was prepared
°C and cooled down slowly inside the 
 HA at 1450°C for 2 h, followed by quenching
-TCP or Si-α-TCP were milled in a planetary ball mill (Fritsch 
Figure 3.2 shows t
 milled powders, analyzed in duplicate,
2
/g for α-TCP.  
 
was the Si-
-free 
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 in air to 
he particle 
 were 2.64 
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Figure 3.2. Particle size distribution of milled Si-α-TCP and α-TCP. 
 
The cements were prepared by mixing the powder phase with distilled water in a liquid to 
powder ratio of 0.32 ml/g. Therein, the cement obtained with the Si-α-TCP powder was coded as 
Si-CPC and the cement obtained from α-TCP was coded as CPC (Figure 3.3). 
 
Figure 3.3. Schema of the preparation of Si-CPC and CPC. The codes used for the TCP reactants and the 
cements are indicated. 
3.3.2 Physico-chemical characterization of Si-CPC and CPC 
3.3.2.1 Setting time 
The setting times of Si-CPC and CPC were measured in triplicate using the Gillmore 
needles, following the regulation ASTM-C266-89 [3]. The Gillmore needles is a device made of two 
solid elongated cylinders with a weight on the top of each of them. The “needle” that indicates the 
initial setting time (tI) has a larger diameter and a lower weight, thus exerts a lower pressure than 
the “needle” used to evaluate the final setting time (tF), which has a smaller diameter and a higher 
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weight. The standard values of diameter, weight and pressure for both needles are shown in Table 
3.1. 
Table 3.1. Standard values of the Gillmore needles [3]. 
 Weight (g) Diameter (mm) Pressure (MPa) 
Needle for initial setting time 113.4 ± 0.5 2.12 ± 0.05 0.3 
Needle for final setting time 453.6 ± 0.5 1.06 ± 0.05 5 
 
3.3.2.2 Cohesion time 
The cohesion of CPC pastes was evaluated by virtual inspection after introducing the paste 
in water at 37°C, as explained by Fernández et al. (method 1) [4]. The procedure consists of 
introducing the fresh cement in a plastic surface and then soaking it in distilled water. The 
cohesion time is the period of time from the moment when the liquid and powder are mixed (time 
zero) until the cement suffers no disintegration when soaked.  
3.3.2.3 Compressive strength 
Cement cylinders (6 mm diameter, 12 mm height) were prepared by filling Teflon 
cylindrical moulds and immersing them in Ringer’s solution at 37°C for 8 h, 1 day and 7 days.  
The compressive strength evolution with time was measured in wet conditions in a 
Universal testing machine (Adamel Lhomargy DY 32/34) equipped with a load cell of 10 kN at a 
crosshead speed of 1 mm/min. Eight specimens of 6 mm diameter and 12 mm height were tested 
at each time point. After performing this test, the setting reaction of the specimens was stopped 
by introducing them in acetone for 1 h and, subsequently, they were dried at 110°C overnight.  
3.3.2.4 Crystalline phases 
The phase composition at different reaction times was assessed by high resolution X-ray 
powder diffraction (XRD, PANalytical, X’Pert PRO Alpha-1). Measurements of XRD were done by 
scanning in Bragg Brentano geometry using a copper Kα radiation. The experimental conditions 
were: 2θ scan step 0.020° between 4-100°, counting time 150 s per point, voltage 45 kV and 
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intensity 40 mA. The diffraction patterns were compared with those of the Joint Committee on 
Powder Diffraction Standards for α-TCP (JCPDS #9-348), β-TCP (JCPDS #9-169), HA (JCPDS #9-432), 
and β-cristobalite (JCPDS #89-3607) [5]. Rietveld refinements were carried out in triplicate in order 
to quantify the phases present. For this purpose the Inorganic Crystal Structure Database (ICSD) 
was used, including structural models for α-TCP (ICSD #923), β-TCP (ICSD #6191), HA (ICSD 
#151414) and β-cristobalite (ICSD #75483) [6]. Quality fits for phase quantification were obtained 
by refining the instrument displacement, scale factors and lattice parameters using a Thompson-
Cox-Hastinge pseudo Voight*Axial divergence, FWHM/shape parameters, preferred orientation 
and background. The Rietveld refinements were performed using the software package FullProf 
Suite [7].  
3.3.2.5 FTIR 
Fourier Transform Infrared spectra (FTIR) from 400 to 4000 cm
-1
 were obtained using an 
ABB FTLA 2000 spectrometer. A few milligrams of crunched cement were mixed with KBr in a 3.33 
wt% ratio, in order to obtain semi-quantitative results. The mixture was pressed in a 6 mm 
diameter die at 5 t for 1 min to produce uniform and translucent disks for analysis.  
3.3.2.6 Morphology 
The microstructure of the cements was observed in fractured surfaces by scanning electron 
microscopy (SEM, JEOL JSM 6400). For this purpose, the specimens were previously coated with 
gold to improve their electrical conductivity. 
3.3.2.7 Specific surface area  
The specific surface area (SSA) of the set cements was analyzed by N2 adsorption 
(Micromeritics ASAP 2020) following the Brunauer–Emmett–Teller method (BET theory). 
3.3.3 Ion exchange of the samples in different media 
3.3.3.1 Experimental design 
Si-CPC and CPC disks of 15 mm diameter and 2.5 mm height were prepared using Teflon 
molds. The cement disks were set in distilled water at 37°C for 48 h, in order to guarantee an 
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almost complete transformation to CDHA. The setting reaction was stopped by immersing the 
cement disks in acetone for 1 h and, finally, the disks were dried at 110°C overnight. The hardened 
disks were sterilized by gamma radiation at 25 kGy. 
Another set of samples was prepared in order to determine whether the Si ions released 
came from the colloidal SiO2 in excess or from the Si ions incorporated into the crystalline structure 
of Si-CPC. These samples consisted of a mixture of SiO2/HA with 2.54 wt% Si, and distilled water 
was added in 40 w/v % to improve homogeneity. No thermal treatment was performed. The slurry 
was dried at 110°C for 3 h and, afterwards, the powder was pressed in a 9 mm diameter die at 5 t 
for 1 min to produce disks of 4 mm height for analysis. The samples were coded as SiO2/HA.  
The ion exchange of Si-CPC and CPC was evaluated in two different media: distilled water 
(H2O) and simulated body fluid (SBF). The ion exchange of SiO2/HA was evaluated only in distilled 
H2O. The study was performed by soaking the disks with media in a 24-well plate, having a 
surface/volume ratio equal to 3 cm
2
/ml. The mentioned ratio was selected because it is commonly 
used for the preparation of extracts to evaluate the cytotoxicity of ceramics through an indirect 
method [8]. The amount of medium added was 1.0 ml to the Si-CPC and CPC disks, and 0.5 ml to 
the SiO2/HA ones. 
After different time periods, 6 h, 3, 7, 14 and 21 days for the CPCs, and 6 h, 3 days and 7 
days for the SiO2/HA, the media were collected for further analysis and pristine medium was added 
to all the samples. The assay was performed with 8 replicates for each sample. The media of each 
group of samples were collected together in order to have enough volume to quantify the ionic 
concentration.  
3.3.3.2 Media of study 
As mentioned previously, the study was performed with two different media, free of 
proteins and cells. The media were selected for the reasons indicated below.  
 Distilled water (H2O) was used as plain medium, which should allow the maximum solubilization 
of the material.  
Development of silicon
 
 Simulated body fluid (SBF) was used since it has a similar 
physiological plasma. Moreover, t
which was performed with this medium
With the aim to decrease the chances of bacteria
penicillin/streptomycin solution 
possibility of adding sodium azide (NaN
toxicity of this compound [9].  
3.3.3.3 Quantification of the ion release
The Ca, P and Si concentration
by inductively coupled plasma-optical emission
RL). Previous to the quantification of the
filter of polycarbonate membrane 
(Figure 3.4) in order to exclude 
0.01 µm, as shown in Chapter 2
detect the dissolved species. Finally, 1
precipitation of any metallic ion.
Figure 3.4. Syringe, filter holder and filters 
SiO2 after soaking the samples.
3.3.4 In vitro bioactivity study 
3.3.4.1 Experimental design 
The bioactivity of the CPC
samples into a simulated body fluid (SBF)
-doped calcium phosphate cement: study of its bioactivity and cell 
ionic concentration to the 
his assay provided complementary data to the bioactivity study
. 
l contamination in the solutions,
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 in the media, from now on [Ca], [P] and [Si]
 spectrometry (ICP-OES, Perkin Elmer Optima 3200 
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% HNO3 was added to each solution in order to avoid the 
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material in vitro. A new apatite layer should be deposited on the surface of the material in case of 
a positive response.  
Cement disks (15 mm diameter and 2.5 mm height) were prepared and were set for 48 h in 
Ringer’s solution, in order to guarantee an almost complete transformation to CDHA. Since it is 
known that SBF gets easily contaminated, the CPCs disks were sterilized by gamma radiation at 25 
kGy. 
The cement disks were soaked in 50 ml of SBF solution (surface/volume ratio of 10 
mm
2
/ml), as indicated in the guidelines of the bioactivity study in vitro established by Kokubo et al. 
[10]. The disks soaked in SBF were stored in a plastic container at 37°C (Figure 3.5) and the SBF 
solution was refreshed twice a week. The changes of media were performed in a fume hood 
previously sterilized with ethanol and UV light for 15 min. The same face of the disk was kept 
facing up during the study, in order to afterwards observe the microstructure of this surface. At 
different time periods, 7, 14, 28 and 56 days, the specimens were taken out from SBF and gently 
washed with distilled H2O. Finally, the specimens were dried at 120°C over 3 h. One disk of Si-CPC 
and one of CPC were evaluated at every time point. 
 
Figure 3.5. Experimental set-up for the in vitro bioactivity study.  
3.3.4.2 Preparation of SBF 
The preparation of SBF requires having all the recipients and instruments totally clean to 
avoid bacterial contamination and also to remove any residual particles that could induce the 
precipitation of the salts present in the SBF. Thus, the first step was to wash carefully all recipients 
and instruments to use in the following order: 1) solution of HCl 1M, 2) neutral soap and 3) distilled 
water.  
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The reactants (Table 3.2) were dissolved in a plastic jar with 800 ml of distilled water at 
37°C. In order to avoid precipitation, each reactant was added after complete dissolution of the 
previous one, following the order indicated in Table 3.2. The pH of the solution, still at 37°C, was 
set to 7.40 with HCl 1 M. Finally, the solution was diluted to 1 L in a volumetric flask.  
The SBF was stored at 4°C. Before its use, the SBF was filtered with a 0.22 µm pore size 
membrane (Millipore, GP Express
TM
 Plus, ref. n. SCGPU01RE) and 1 v/v% of a commercial 
penicillin/streptomycin solution (Gibco ref. n. 15140-122) was added, even though the SBF 
protocol [10] does not contemplate the addition of any compound to avoid the contamination. 
Table 3.2. Reactants used for the preparation of SBF. TRIS stands for tris-hydroxymethyl 
aminomethane ((HOCH2)3CNH2). 
Order Compound Amount (g or ml) Purity 
Commercial brand name, 
ref. n. 
1 NaCl 8.036 ≥ 99.5 Sigma, S9625 
2 NaHCO3 0.352 ≥ 99.5 Sigma, S6297 
3 KCl 0.225 ≥ 99.5 Fluka, 60130 
4 K2HPO4·3H2O 0.230 ≥ 99.0 Sigma, P5504 
5 MgCl2·6H2O 0.311 ≥ 99.0 Sigma-Aldrich, M0250 
6 HCl 1.0 M 40 37 % Panreac, 131020 
7 CaCl2 0.293 ≥ 96.0 Sigma-Aldrich, C4901 
8 Na2SO4 0.072 ≥ 99.0 Sigma, S6547 
9 TRIS 6.063 ≥ 99.9 Panreac, 131940 
 HCl 1.0 M 
Amount needed to 
adjust the pH 
37 % Panreac, 131020 
 
3.3.4.3 Characterization of the bioactivity 
3.3.4.3.1 Crystalline phases (X-ray diffraction) 
Si-CPC and CPC, unsoaked and soaked in SBF for 56 days, were ground and evaluated by X-
ray powder diffraction (XRD, Panalytical, X’Pert PRO Alpha-1), using the same experimental 
conditions that were described in Section 3.3.2.  
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3.3.4.3.2 Crystallinity of the surface layer (glancing angle-X-ray diffraction) 
With the aim to evaluate the composition of the apatite layer deposited on the surface of 
the cement, the disks immersed in SBF for 28 days were analyzed by glancing angle-X-ray 
diffraction (glancing angle-XRD, Bruker D8 Advance). Glancing angle-XRD allows reducing the 
penetration of X-rays into the specimen, therefore recording the diffraction pattern of thin layers 
with minimum contribution from substrate, which could overshadow the signal of the layer [11]. 
This is achieved by reducing the angle of incidence in comparison with the Bragg-Brentano 
geometry, also known as θ-2θ geometry (Figure 3.6 a). Hence, Grazing Incidence Angle Asymmetric 
Bragg (GIAB) geometry was used to perform the glancing angle-XRD (Figure 3.6 b). 
 
Figure 3.6. Schematic diagrams of three diffraction geometries: a) Bragg-Brentano or θ-2θ geometry; b) 
Grazing Incidence Angle Asymmetric Bragg (GIAB) geometry (modified from [11]). 
 
The experimental conditions were: 2θ scan step 0.020° between 30° and 34°, counting 
time 8 s per point, voltage 40 kV and intensity 40 mA. The goniometer radius was 217.5°. 
3.3.4.3.3 Morphology (Scanning electron microscopy, SEM) 
The CPC disks that were immersed in SBF for 0, 7, 14, 28 and 56 days were observed with 
scanning electron microscope (SEM, JEOL JSM 6400). The presence of an apatitic layer was 
observed from two different visual perspectives: a) the surface and b) the transversal fracture. The 
transversal fracture allowed observing the morphological differences between the original CDHA 
and the apatite deposited on its surface. To carry out the morphological observations, a 
transversally fractured disk was mounted on a carbon fiber stuck on a copper foil (Figure 3.7). 
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Figure 3.7. Preparation of the disk for the observation of the apatite layer (deposited on the surface of 
the CDHA). Both images taken with SEM are so marked: image A corresponds to the surface of the 
apatite layer and image B shows the transversal fracture, with the apatite layer growing on the surface 
of the set cement (CDHA).  
 
3.3.4.3.4 Elemental analysis (energy dispersive spectroscopy, EDS) 
The elemental composition of the Si-CPC, unsoaked or after being immersed in SBF for 28 
days, was semi-quantitatively analyzed by energy dispersive spectroscopy (EDS). The fundaments 
of the EDS technique rely on the fact that each element has a unique atomic structure, which 
releases a characteristic X-ray when hit by a high-energy beam of charged particles such as 
electrons. The transversally fractured sample (image B of Figure 3.7) was embedded inside a 
polyacrilic resin and it was slightly polished to obtain a smooth surface that would cause a minimal 
dispersion of the radiation. 
In the case of disks soaked in SBF, the elemental analysis was performed on two different 
areas: on the surface and on the core of the disk (0.5 mm far from the surface). The Ca/P, 
(Ca+Na)/P and (Ca+Na)/(P+Si) atomic ratios were determined, since the calcium phosphate source 
used for the preparation of α-TCP (CPC reactant) had a high Na concentration (Table 2.2). Three 
different spots were analyzed in each area.  
3.3.5 Cell culture study 
Human osteoblast-like Saos-2 (ATCC-HTB85) cells were used as cell model. The cells were 
maintained in cell culture flasks in an incubator with humidified atmosphere of 5% CO2 in air at 
37°C. McCoys medium (Sigma, ref. n. M8403) supplemented with 0.75% of L-glutamine (Gibco, ref. 
n. 25030), 1% penicillin/streptomycin (Gibco, ref. n. 15140), 2% of sodium pyruvate (Gibco, ref. n. 
11360) and 15% of fetal bovine serum (Gibco, ref. n. 10270-106) was used. The culture medium 
was exchanged every second day. Upon confluence, cells were detached with a minimum amount 
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of trypsin-EDTA (Gibco, ref. n. 12605
after 10 min. The cells were then re-cultured or used for the experiments.
The cell culture study was performed with an indirect method in order to assess the effect 
of the ionic exchange between the cements and the culture medium. This method allows 
discriminating the ion-exchange eff
(roughness, Z-potential, topography, 
were prepared with Si-α-TCP or α-TCP. After 7 days of immersion in Ringer’s solution at 37
hardened disks were sterilized by gamma irradia
sterile disks were introduced into a 24
Scientific, Nunc, ref. n. 137052) with 0.4 
exchange. Both disks and inserts were preconditioned for 24 h by introducing 1.5 m
per well. After preconditioning them
the insert with 1 ml of medium. Cells were also 
material, as control series. Figure 3.
medium was exchanged every second day. 
3 replicates in each experiment. 
Figure 3.8. Schema of the experimental set
 
At each medium exchange and at the end of the culturing period, samples were collected 
from the medium to determine [P] and [Si] 
spectrometry (ICP-OES). [Ca] and pH were measured by means of a selective electrode (Ilyte: Ca
K
+
, Na
+
, pH, Instrumentation Laboratory). 
-028) that was inactivated with complete McCoys medium 
 
ects from the effect of the cements’ surface properties 
etc.). Cement disks (15 mm diameter and 2.5 mm height) 
tion at 25 KGy to ensure complete reaction
-well plate and cell culture polycarbonate inserts (Thermo 
µm pores were placed over them to allow the 
l 
, the medium was removed and 25,000 cells were seeded in 
cultured in inserts placed in wells containing no 
8 schematically shows the set-up of the assay. The culture 
Each cell culture experiment was performed twice, with 
 
-up of the in vitro study. 
by using inductively coupled plasma-optical emission
 
°C, the 
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ionic 
of medium 
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Cell proliferation and cell differentiation were evaluated at 6 h and at 3, 7, 14 and 21 days. 
At each time point, the inserts were rinsed twice with PBS to remove non-attached cells. The 
attached cells were lysed three times via freezing at -80°C and thawing at room temperature. The 
lysates were centrifuged at 1500 rpm for 10 min. 
Cell proliferation was analyzed using a LDH Kit (Roche, ref n. 1644793), an indirect method 
to measure the number of alive cells before lysing. The LDH assay allows measuring the lactate 
dehydrogenase (LDH), a stable cytoplasmic enzyme that is released after plasma membrane 
rupture. LDH reduces yellow tetrazolium salt into a red formazan component, indicator of the 
enzymatic activity (Reaction 3.1). The reaction was incubated protected from light for 10 min and 
afterwards it was stopped with HCl 1 M. Finally, the LDH activity was determined 
spectrophotometrically in a plate reader (Power WaveX, Bio-Tek Instruments, USA; 490 nm). A 
calibration curve with decreasing concentrations of cells was created to express results as cell 
number. 
 
Reaction 3.1. Reaction to measure alive cells through the indirect reaction of lactate dehydrogenase 
(LDH), a cytoplasmatic enzyme, with a calorimetric reactant. 
 
Alkaline phosphatase activity, an early marker of osteoblast differentiation that is 
expressed just before matrix mineralization begins [12], was measured using a colorimetric 
method based on the conversion of p-nitrophenyl phosphate to p-nitrophenol in the presence of 
alkaline phosphatase (ALP). ALP is a hydrolase enzyme responsible for removing phosphate groups 
from many types of molecules, process known as dephosphorylation (Reaction 3.2). The lysates 
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obtained in the previous section, which contained an unknown amount of ALP, were mixed with a 
phosphatase substrate solution (p-nitrophenyl phosphate, Sigma, ref n. P5994) and 2-amino-2-
methyl-1-propanol buffer (AMP, Sigma Diagnostics Inc., ref n. A9226). The AMP is an alkaline 
buffer that was added because the ALP enzyme is more effective in an alkaline medium. The 
mixture was incubated protected from light for 25 min. The reaction was stopped with NaOH 1 M 
and the production of p-nitrophenol was determined spectrophotometrically in a plate reader 
(Power WaveX, Bio-Tek Instruments, USA; 490 nm) by measuring the absorbance at 405 nm. The 
values were calibrated to a standard curve prepared from known concentrations of p-nitrophenol 
(Sigma, ref n. N7660). The ALP activity was shown as the p-nitrophenol concentration normalized 
to both the number of cells and the reaction time. 
 
Reaction 3.2. Colorimetric reaction for the measurement of the ALP activity. 
 
3.3.6 Statistical analysis of the results 
A Student’s t-test was used to determine the statistically significant differences between 
the mean values of the different experimental groups. A difference between groups was 
considered to be significant at p < 0.05. 
 
3.4 Results 
3.4.1 Physico-chemical characterization of Si-CPC and CPC 
The initial setting time of Si-CPC was 8-9 min and its cohesion time was 6-8 min. The initial 
setting and cohesion times of undoped CPC were slightly longer, around 10-11 min and 8-10 min, 
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respectively. The setting and cohesion times were within the ranges established for clinical 
applications [13]. 
Figure 3.9 shows the evolution of the crystalline phases determined by X-ray diffraction 
and quantified by the Rietveld method. Both Si-α-TCP and α-TCP were hydrolyzed into CDHA, 
although Si-α-TCP reacted statistically significantly faster (p < 0.05), since after 8 h a 61 wt% of 
CDHA was already detected, compared to a 39 wt% for the α-TCP.  
 
Figure 3.9. Phase composition of: a) Si-CPC and b) CPC, immersed in Ringer’s solution for 0, 8, 24 and 
168 h (7 days). Quantified by the Rietveld method, including models for α-TCP (), β-TCP (), CDHA 
() and β-Cristobalite ().  Error bars indicate standard deviation, n = 3. 
 
The evolution of the compressive strength of both cements followed the progress of the 
setting reaction, as reported in Figure 3.10. Statistically significant differences (p < 0.05) were only 
found at 8 h of reaction, being the compressive strength of the Si-CPC higher than that of the 
undoped CPC.  
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Figure 3.10. Compressive strength of the set cements after 8, 24 and 168 h (7 days) of immersion in 
Ringer’s solution. Error bars indicate standard deviation, n = 8. * indicates statistically significant 
differences. 
 
The setting reaction was also followed by FTIR (Figure 3.11 a). The evolution of the bands 
was consistent with the hydrolysis of the α-TCP to a precipitated HA, as previously reported [14] 
[15], and it is summarized in Table 3.3. The absorption bands at 962 cm
-1
 (ν1 of PO4), 1035 and 
1091 cm
-1
 (ν3 of PO4), and 563 and 603 cm
-1
 (ν4 of PO4), typical for apatite, become more 
pronounced with increasing reaction time. The bands located at 480, 798 and 1196 cm
-1
 were 
assigned to the O-Si-O vibration of β-cristobalite [16] [17]. Moreover, a small sharp band detected 
at 668 cm
-1
 was also observed in a previous study on attenuated total reflection infrared 
spectroscopy of Si-stabilized TCP [18], and it was attributed to the formation of Si2O7
6-
 groups 
within the crystalline structure [18] [19].  
When comparing the set cements (Si-CPC and CPC) after complete reaction (Figure 3.11 b), 
it was assessed that the additional bands detected in the Si-CPC coincided to those previously 
observed in the Si-α-TCP (Figure 3.11 a, at 0 h). However, interestingly, whereas the bands at 480, 
798 and 1196 cm
-1
, which were assigned to β-cristobalite, had the same intensity in the Si-CPC 
reacted for 7 days than in the Si-α-TCP (0 h), the band at 668 cm
-1
 was much smaller in the set Si-
CPC. 
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Figure 3.11. a) IR spectra of Si-α-TCP cement powder (0h) and the corresponding Si-CPC immersed in Ringer’s solution 
for 8 h, 1 day and 7 days; b) Comparison of Si-CPC and CPC, immersed in Ringer’s solution for 7 days. The bands indicated 
below the spectra are assigned to phosphate vibrations and the bands showed above are associated to O-Si-O vibrations. 
A.U. stands for arbitrary units. 
 
Table 3.3. Band assignments for the CPC and the Si-CPC reacted for 7 days. Some abbreviations were 
used: sh: shoulder; s: strong band; vs: very strong band; m: medium band; w: weak band. 
Band assignment 
Experimental values (cm
-1
) Frequency (cm
-1
) according 
to literature for CDHA 
References 
CPC 7 days Si-CPC 7 days 
PO4
3-
, ν3 
1096 (sh) 
1039 (s) 
1091 (sh) 
1035 (s) 
1085 (sh) 
∼ 1035 (vs) 
[15] 
[15] 
PO4
3-
, ν1 965 (w) 962 (w) 965 (w) [15] 
P-O(H), deformation of 
HPO4
2-
, v5 
858 (w) 862 (w) 870 (w) [15] 
OH, libration - - 632 (sh, vw) [15] 
PO4
3-
, ν4 
603 (m) 
565 (m) 
603 (m) 
563 (m) 
605 (m) 
565 (m) 
[15] 
[15] 
PO4
3-
, ν2 472 (w) 472 (w) ∼ 462 (sh) [14] 
O-Si-O, bending, 
cristobalite 
- 480 (w) 481 [16] 
Si2O7, bridging - 668 (w) 668 [18] 
O-Si-O, bending, 
cristobalite 
- 798 (w) 800 [16] 
O-Si-O, cristobalite - 1196 (w) 1192 [17] 
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Figure 3.12 shows the microstructure of the Si
reaction. Both of them were formed by a network of needle
samples was 21.4 ± 1.1 and 21.6 ± 0.9 m
Figure 3.12. Microstructure of fracture surfaces 
solution for 24 h: a) Si-CPC; b) CPC. 
 
3.4.2 Ion exchange of the Si-
First of all, it should be emphasized that the medium was refreshed at every time point. 
This means that any change observed on the ionic concentration of the medium from one time 
point to the next one was consequence of the ionic release or uptake b
medium.  
3.4.2.1 Ion concentration of pristine 
The theoretical and the experimental 
ICP-OES, are shown in Table 3.4. 
Table 3.4. Theoretical and experimental 
distilled H2O and SBF. The experimental values (indicated as “Exp.”) were 
concentrations under the detection limit are 
 [Ca] (mM)
 Theoretical 
Distilled H2O 0 
SBF 2.5 
 
-doped and undoped cements af
-like entangled crystals. The SSA of
2
/g for the Si-doped and the undoped CPC, respectively.
of the cements, which were immersed in Ringer’s 
CPC and CPC 
y the material to/f
media 
[Ca], [P] and [Si] of each pristine media, quantified by 
[Ca], [P] and [Si] of the media used for the ion exchange study, 
quantified by ICP-OES
shown as “< DL”. 
 [P] (mM) [Si] (mM) 
Exp. Theoretical Exp. Theoretical Exp.
< DL 0 < DL 0 < DL
2.31 1 0.98 0 < DL
ter 24 h of 
 the 
 
 
rom the 
. The 
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3.4.2.2 Ion exchange in H2O 
Figure 3.13 shows the [Ca], [P] and [Si] of the distilled H2O containing Si-CPC, CPC and 
SiO2/HA disks. The three samples released small amounts of Ca ions along the study, increasing the 
[Ca] of the medium from 0 to about 0.06 mM. P ions were also released, producing a concentration 
between 5 and 11 mM in both Si-CPC and CPC, and 2-4 times higher in the case of SiO2/HA. Finally, 
both SiO2/HA and Si-CPC released similar amounts of Si ions, producing concentration between 1.5 
and 2.5 mM. 
 
Figure 3.13. Evolution of the ionic concentration of distilled H2O containing Si-CPC, CPC and SiO2/HA 
(SiO2/HA was only measured for 7 days): a) [Ca], b) [P], c) [Si]. A dashed line shows the ionic 
concentration of pristine distilled H2O. 
 
3.4.2.3 Ion exchange in SBF 
In the case of soaking the disks in SBF, the scenario changed significantly, as shown in 
Figure 3.14. The [Ca] in SBF dropped from 2.31 to 0.25 mM after 3 days, probably uptaken by the 
CPC disks. After this time, the [Ca] decreased less at every time, showing that although the CPC 
disks kept uptaking Ca ions while refreshing the medium, they did so in a lower amount. Regarding 
the [P], the cements released this ion during the whole period of study. After only 6 h, the [P] of 
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SBF medium was 3-4 times higher than that of pristine SBF. However, this concentration decreased 
linearly with time, indicating that the samples released a lower amount of P with time. The Si-CPC 
released Si to the SBF medium during the whole study, producing a [Si] close to 2 mM. 
 
Figure 3.14. Evolution of the ionic concentration of SBF medium containing Si-CPC and CPC: a) [Ca], b) 
[P], c) [Si]. A dashed line shows the ionic concentration of pristine SBF. 
 
3.4.3 Bioactivity study of the CPCs 
3.4.3.1 Phase composition (X-ray diffraction) 
Figure 3.15 shows XRD spectra of Si-CPC and CPC disks (both set in Ringer’s for 48 h), prior 
and after immersion in SBF (0 h and 56 days, respectively). Prior to immersion in SBF, the cements 
were mainly composed by CDHA. No significant differences were detected between CPC and Si-
CPC, and neither due to their immersion in SBF.  
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Figure 3.15. X-ray spectra of 
Si-CPC and b) CPC, or soaked in SBF for 56 days: c) Si
 
3.4.3.2 Crystallinity of the apatite
In order to assess if an apatitic layer
immersed in SBF, glancing angle
SBF solution for 28 days are compared
in Figure 3.16. The spectra of both 
32.3 and 32.9°, which corresponded to 
and 300, respectively. In contrast, the 
peaks at the same positions, the peaks
3.16 a). The CPC showed similar spectra prior and after immersion in SBF, 
width although they were slightly 
-doped calcium phosphate cement: study of its bioactivity and cell 
cement disks (set in Ringer’s solution for 48 h), before soaking
-CPC and d) CPC. 
 layer (glancing angle-X ray diffraction) 
 was deposited on the surface of the
-XRD was performed. The spectra of Si-CPC and CPC 
 with that of the corresponding unsoaked samples
Si-CPC and CPC unsoaked in SBF showed broad peaks at 31.8, 
the highest intensity peaks of HA with Miller index
spectra of Si-CPC soaked in SBF showed much 
 being barely differentiated due to their wideness 
with bands of
less intense after being soaked in SBF (Figure 3.16 
response 
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 in SBF: a) 
 cement disks 
disks soaked in 
, as shown 
 211, 112 
less intense 
(Figure 
 similar 
b).  
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Figure 3.16. Glancing angle-XRD spectra of the set cements, which were unsoaked or soaked in SBF for 
28 days: a) Si-CPC and b) CPC. 
 
3.4.3.3 Morphology 
The morphologies of the cement disks soaked in SBF for different time periods are shown 
in Figure 3.17 for Si-CPC and in Figure 3.18 for CPC, respectively. The morphology of both Si-CPC 
and CPC unsoaked in SBF was homogeneous, consisting of rosette-like networks made by 
nanometric crystals (Figure 3.17 b and 3.18 b).  
Regarding Si-CPC soaked in SBF (Figure 3.17), the deposition of a new apatite layer was 
clearly observed after 14 days. The apatite layer was deposited over the rosette-like agglomerates. 
The transversal fracture showed that the layer was dense and about 3-5 µm thick (Figure 3.17 e). 
After 28 days, the apatite layer was thicker, about ∼ 20 µm (Figure 3.17 g), and had a smooth 
texture that covered the entire surface (Figure 3.17 h). Similar morphologies were observed after 
56 days (Figure 3.17 I and j).  
Regarding CPC soaked in SBF (Figure 3.18), the deposition of an apatite layer on the surface 
of CPC was not observed as clearly as in the Si-CPC. After 14 days, some particles were observed on 
the surface of CPC (Figure 3.18 e), although their aspect was not the one expected for the 
formation of an apatite layer. Moreover, no evident sign of an apatite layer could be distinguished 
on the surface of CPC soaked in SBF for 28 days (Figure 3.18 g and h) and 56 days (Figure 3.18 l and 
j).  
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Although preventions were taken to avoid contamination, most of the SBF containing the 
cement disks were contaminated after 28 days, turning into a brown media with a strong smelling. 
The lacunas left by bacteria were also observed in some SEM images, as elongated dark embedded 
flecks (Figure 3.17 h and j).  
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Figure 3.17. Morphology of Si-CPC soaked in SBF for: a, b) 0 h; c, d) 7 days; e, f) 14 days; g, h) 28 days; i, 
j) 56 days. The transversal fracture face is shown on the left image and the surface of the disk is shown 
on the right one.  
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Figure 3.18. Morphology of CPC
56 days. The transversal fracture face is shown on the left image and the surface of the disk is shown 
on the right one.  
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3.4.3.4 Elemental analysis (energy dispersive spectroscopy, EDS) 
The elemental analysis was only performed with Si-CPC, since this was the formulation in 
which a new apatite layer was clearly observed on its surface. Table 3.5 shows the elemental 
composition of Si-CPC, unsoaked and soaked in SBF for 28 days, including the Ca/P, (Ca+Na)/P and 
(Ca+Na)/(P+Si) ratio. Two different areas of the soaked Si-CPC samples were analyzed: the surface 
and the cement core (0.5 mm far from the apatite layer).  
Table 3.5. Elemental analysis by EDS (semi-quantitative results) of set Si-CPC, before soaking in SBF and 
soaked in SBF for 28 days. The soaked Si-CPC was analyzed on the surface and on the cement core (0.5 
mm apart from the deposited apatite). The atomic % and the calculated atomic ratios are shown. The 
standard deviations are indicated in parenthesis. 
Treatment  
Analyzed 
area 
Atomic (%) Atomic ratios (calculated) 
Ca Na P Si Ca/P (Ca+Na)/P (Ca+Na)/(P+Si) 
Before soaking 
in SBF 
Core 
53,43 
(0,55) 
2,18 
(0,43) 
38,82 
(0,33) 
5,57 
(0,35) 
1.38 
(0.06) 
1.43 
(0.24) 
1.25 
(0.31) 
Soaked in SBF 
for 28 days 
Core 
53,31 
(0,10) 
2,33 
(0,04) 
38,89 
(0,40) 
5,47 
(0,54) 
1.37 
(0.03) 
1.43 
(0.06) 
1.25 
(0.58) 
Surface 
50,29 
(0,91) 
1,40 
(0,18) 
34,02 
(1,23) 
14,29 
(2,32) 
1.46 
(0.05) 
1.50 
(0.21) 
1.11 
(0.76) 
 
It is worth noting that the core area of Si-CPCs, soaked or unsoaked in SBF, resulted in 
similar elemental compositions, as determined by the atomic ratios. In contrast, the surface of the 
Si-CPC soaked in SBF had a higher Ca/P ratio and lower (Ca+Na)/(P+Si) ratio than the unsoaked Si-
CPC.  
3.4.4 Cell culture study 
Figure 3.19 a represents the proliferation rate of Saos-2 cells grown in the inserts in 
presence of Si-CPC, CPC or control medium. The cells in contact with the medium containing either 
Si-CPC or CPC had a marked delay on cell proliferation. No statistically significant differences were 
observed between the Si-doped and the undoped CPC. 
The ALP activity of the cells reached a maximum value at day 14 in all series and it was 
statistically significantly increased (p < 0.05) in the cells cultured in presence of Si-CPC or CPC, as 
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displayed in Figure 3.19 b. The values detected were similar for the cells in presence of both 
cements, except at day 14, when the ALP activity was statistically significantly higher (p < 0.05) for 
the cells in presence of Si-CPC as compared to CPC.  
 
Figure 3.19. a) Cell proliferation measured by quantifying the LDH of lysed cells, for cells in contact with 
a medium containing Si-CPC or CPC, or in contact with control medium; b) Cell differentiation 
measured as [p-nitrophenol]/(cell number*reaction time), for cells in contact with a medium 
containing Si-CPC or CPC, or in contact with control medium. Errors bars indicate standard deviation, n 
= 3. * indicates statistically significant differences. 
 
In parallel, the [Ca], [P] and [Si] and the pH in the media were quantified. The initial [Ca] in 
the control medium was 0.8 mM and decreased continuously with time, reaching a minimum value 
of 0.5 mM after 14 days (Figure 3.20 a). In presence of Si-CPC or CPC, [Ca] decreased sharply after 
only 6 h and remained low throughout all the study, between 0.05 and 0.1 mM, even though the 
medium was refreshed every second day. The [P] in the control medium decreased slightly during 
the culture period (Figure 3.20 b). In presence of Si-CPC or CPC, [P] showed an increase in the initial 
stages followed by a decrease, although the concentration was higher than in the control medium 
at all time-points. As expected, Si was detected only in presence of Si-CPC, with a concentration 
close to 1.5 mM during the whole culturing period (Figure 3.20 c). Finally, the pH of the control 
medium ranged between 7.7 and 7.4 (Figure 3.20 d). The pH was acidified at the initial stages in 
presence of Si-CPC, and subsequently evolved to more alkaline values. The same trend was 
observed for the CPC, although a higher dispersion of the measurements was found.  
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Figure 3.20. [Ca], [P], [Si] and pH in the medium in contact with Si-CPC or CPC and in the control 
medium at different times during the cell culture study. [P] and [Si] were measured by means of ICP-
OES, and [Ca] and pH by means of a selective electrode: a) [Ca]; b) [P]; c) [Si]; d) pH. The dotted lines 
correspond to the initial values in the culture medium. 
 
3.5 Discussion 
3.5.1 Physico-chemical characterization of CPC and Si-CPC 
Si-CPC had an appropriate handling time for clinical use. This means that, when used in 
clinics, the cement would set slowly enough to provide the surgeon with sufficient time to perform 
implantation, but at the same time would be fast enough to avoid delaying the operation [13].  
The setting of both Si-CPC and CPC pastes was produced by a dissolution-precipitation 
mechanism that led the α-TCP hydrolysis to CDHA crystals (Figure 3.9 and 3.12). The setting 
kinetics of Si-CPC was shown to be faster than that of CPC, as revealed by a slightly shorter setting 
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and cohesion times, and a faster transformation to CDHA (Figure 3.9), specifically after 8 h. In fact, 
Si-CPC also led to slightly higher early strength development than CPC (Figure 3.10). The higher 
reactivity of the Si-doped CPC, also reported by Camiré et al. [20], could be a consequence of the 
higher solubility of the Si-α-TCP, caused by the lower stability of the doped crystalline structure 
[21]. The hydrolysis of both CPCs was almost complete after 24 h, as observed by XRD (Figure 3.9) 
and FTIR (Figure 3.11), and their morphology (Figure 3.12), SSA and mechanical properties (Figure 
3.10) were similar.  
No evidence was found that Si was incorporated into the precipitated HA produced by the 
setting reaction, which is in agreement with other reported works [22]. None of the bands 
associated to silicate incorporation into HA, e.g. at 888 or 890 [23] [24], 756 [24] and 504 [23] cm
-1
, 
were detected in the FTIR spectra of Si-CPC (Figure 3.11). In fact, some authors claim that Si ions 
can only be introduced into the hydroxyapatite crystal lattice under high temperature conditions, 
which favor diffusion processes [25].  
In Si-CPC, three bands detected by FTIR (1196, 798 and 480 cm
-1
), which were stable with 
the reaction time (Figure 3.11 a), were attributed to β-cristobalite. However, the band attributed 
to Si2O7
6-
 groups (668 cm
-1
) decreased with time (Figure 3.11 a), being much smaller in the Si-CPC 
set for 7 days than in the Si-α-TCP (0 h). This would agree with the assignment of this band to 
Si2O7
6-
 groups incorporated in the α-TCP structure (Figure 2.15), which would disappear upon TCP 
dissolution.  
3.5.2 Ion exchange in different media 
The ionic exchange produced between a solid compound (solute) and a medium (solvent) 
are regulated by a dynamic equilibrium known as solubility equilibrium. The relationship 
established between the solute and the solvent consists in the migration of individual ions or 
molecules between them. When equilibrium is reached, the rates of dissolution and precipitation 
are equal to one another and the solvent is said to be saturated. The concentration of the solute 
dissolved in a saturated solution indicates its solubility. In this study, the solutes were Si-CPC, CPC 
and SiO2/HA disks, and the solvents were distilled H2O and SBF. For Si-CPC and CPC, the study was 
carried out with the two solvents for 21 days, and the behavior of SiO2/HA was evaluated only with 
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distilled H2O for 1 week. The evolution of [Ca], [P] and [Si] was followed at different time points, 
the solvent being also refreshed at each interval. Another experimental factor that should be taken 
into account is that the media (modified by the materials) were filtered prior to their analysis in 
order to ensure that the atomic concentration observed only came from dissolved species. 
When soaking Si-CPC or CPC disks in distilled H2O, the disks were slightly dissolved and Ca 
and P ions were released to the medium. However, interestingly, the two samples produced a 
significantly higher [P] (around 5-10 mM) than [Ca] (around 0-0.15 mM) during the 21 days of the 
study (Figure 3.13), indication that the P ions were released in a greater amount than the Ca ones. 
This result indicated that the dissolution of the materials was incongruent, in other words, they 
modified the solvent (distilled H2O) so that its molecular composition did not match that of the 
solute (Si-CPC or CPC). Therefore, although it would be expected that in distilled H2O (solvent free 
of ions) the CDHA would maintain the same Ca/P ratio than the precursor of the cement (Si-α-TCP 
or α-TCP), i.e. Ca/P = 1.5, the ions released to the solvent indicated that the surface of the CPC 
disks might slowly increase their Ca/P ratio. The incongruent dissolution of the CPCs could be 
associated with the atomic reorganization of the superficial CDHA, which trended to form a more 
stoichiometric hydroxyapatite, thermodynamically more stable. In other words, the CDHA, which is 
a solid solution, would evolve from Ca10-x(HPO4)x(PO4)6-x(OH)2-x with a x value of 1 
(Ca9(HPO4)(PO4)5(OH)) to a x value closer to 0 (Reaction 3.3).  
Reaction 3.3.   
3 α-Ca3(PO4)2 + H2O  →  Ca9(HPO4)(PO4)5(OH)  → → →  Ca10-x(HPO4)x(PO4)6-x(OH)2-x (0 < x < 1) 
     Ca/P = 1.5          Ca/P = 1.5         Ca/P > 1.5 
 
Regarding the dissolution of SiO2/HA when immersed in distilled H2O, it produced a [Ca] of 
the same order than that produced by the CPCs. However, SiO2/HA released a significantly higher 
amount of P ions than the CPCs, the SiO2/HA producing a [P] of 22-48 mM and the CPCs of 5-10 
mM. This fact could be related to the higher SSA of the HA (about 71 m
2
/g), increasing its 
dissolution in comparison with the CPCs, which SSA was close to 21 m
2
/g.  
Moreover, regarding to the release of Si ions, both SiO2/HA and Si-CPC immersed in 
distilled H2O released a similar amount of this ion, increasing the [Si] from 0 to around 2 mM. The 
Ca
2+
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Si ions detected when SiO2/HA was soaked in distilled H2O could only come from a partial 
dissolution of SiO2. However, the Si ions released by Si-CPC could either come from a partial 
dissolution of β-cristobalite (SiO2 in excess that transformed during the thermal treatment applied 
to prepare Si-α-TCP) or from the release of Si ions incorporated into the crystal lattice of CDHA. It 
was indeed not possible to ascribe the release of Si to a unique source since the SiO2/HA control 
contained SiO2 whereas the Si-CPC contained the Si in excess as β-cristobalite. 
A different scenario was observed when the CPC disks were soaked in SBF in comparison 
with that in distilled H2O. In SBF, the initial [Ca] (2.31 mM) was significantly decreased at each time 
due to the uptake of Ca ions by the CPC disks, even though the medium was refreshed twice per 
week. However, after 3.5 days, the trend of [Ca] followed a positive slope, indicating that the CPC 
disks uptake a lower amount of Ca each time. Regarding the [P], the cements released P ions 
during the 21 days of the study. For the first 14 days, a negative slope indicated that the CPCs 
released a lower amount of P ions each time, and at 21 days the concentration remained 
approximately constant. The trends observed for [Ca] and [P] indicated that, after 21 days, the 
cements were closer to reach equilibrium with SBF. Finally, a [Si] around 1-2 mM was found at 
each time of study, indication that the β-cristobalite was slowly dissolved, as previously discussed.  
When comparing the dissolution of Si-CPC with that of CPC, no significant differences were 
observed in the [Ca] and [P] in both distilled H2O and SBF. Therefore, it was assumed that both CPC 
formulations had a similar solubility in the mentioned media. The fact that both CPC formulations 
had a similar solubility was an additional indication that, in Si-CPC, Si was not incorporated in the 
crystalline structure of CDHA, since it has been reported that the incorporation of SiO4
4-
 increases 
the number of defects [1], decreasing the stability of its crystalline system [20] [21] [26]. Thus, in 
Si-CPC, Si would initially be in the form of β-cristobalite and, after immersion in SBF, it would be 
also included in the newly formed apatite layer, which contained the Si, Ca and P ions of the media, 
as determined by a chemical analysis (Table 3.5). The chemical analysis also showed that, after 28 
days of immersion in SBF, the apatite layer had a higher Ca/P ratio and a higher amount of Si than 
the core area of Si-CPC. This result indicated again that the superficial CDHA was reorganized to 
form a CDHA more close to a stoichiometric HA.  
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A complete understanding of the underlying mechanisms of this ionic exchange would 
require monitoring all the ionic species in the immersion media, which is beyond the scope of this 
work. The ionic exchange can involve different situations in the material: substitution in the crystal 
lattice, on the crystal surface or in the hydration shell, or precipitation of different compounds. In 
any case, electroneutrality of the material must be preserved. In a previous study on ion reactivity 
of CDHA in standard culture media [27] it was shown that ionic substitution occurred between 
phosphate and carbonate, the latter one being incorporated in the apatite lattice and the former 
being released. However, with respect to the calcium uptake there is no clear explanation on the 
underlying mechanism. In another work on a similar CPC, it was hypothesized that the calcium 
uptake responded to a reorganization of the CDHA to a more stoichiometric HA, reducing its 
calcium deficiency [28], although no experimental evidence was provided.  
3.5.3 Bioactivity study of the CPCs 
 The bioactivity study was evaluated by soaking Si-CPC and CPC disks in SBF for different 
intervals of time. The core area of Si-CPC and CPC shown to be similar by XRD (Figure 3.15), 
regardless of the immersion in SBF, since the apatite layer only modified the surface of the 
material. The microstructure of the surface fracture of the Si-CPC and CPC disks exhibited rosette-
like agglomerates made by nanometric crystals prior SBF immersion (Figure 3.17 b and 3.18 b), 
whereas a new dense and smooth apatite layer covered the surface after immersion in SBF (Figure 
3.17 e, f, g and h). In contrast, the microstructure of CPC disks soaked in SBF did not clearly reveal a 
new apatite layer on their surface (Figure 3.18). Glancing angle-XRD verified these results. On one 
hand, the formation of a poorly crystalline apatite on the surface of Si-CPC was corroborated 
(Figure 3.16 a), since the soaked Si-CPC had a glancing angle-XRD spectrum with broader peaks 
(indication of poorer crystallinity) than the unsoaked sample. On the other hand, the presence of a 
new apatite layer on the surface of CPC disks could not be elucidated by glancing angle-XRD, which 
showed peaks with similar width for both unsoaked and soaked samples (Figure 3.16 b).  
 The chemical analysis was only performed for Si-CPC disks, which were the samples that 
clearly exhibited the formation of a new apatite layer. The chemical composition of the core area 
of Si-CPC was the same regardless of the immersion in SBF (Table 3.5), because the SBF only 
modified the material’s surface. Interestingly, the chemical analysis on the surface of Si-CPC disks 
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showed that the amount of Si ions present in the newly deposited apatite layer was about three 
times higher than that in the core area (Table 3.5). This result suggested that the Si ions released 
by Si-CPC were precipitated together with the Ca and P present in the medium, producing a layer 
of apatite containing the Ca, P and Si that was thermodynamically more stable. In fact, after 
immersion in SBF, the Ca/P ratio on the surface of the Si-CPC was also higher than that of the core 
area (Table 3.5), indication that the new apatite layer was constituted by CDHA more close to the 
stoichiometric one than that of the core area. 
It is known that when a bioactive material is immersed in a physiological medium such as 
SBF, a chain of reactions are triggered. The evolution of this process has been well defined by 
materials containing SiO2 such as Bioglass (24.5% Na2O – 45%SiO2 – 24.5% CaO – 6% P2O5) [29]. 
Firstly, there is an interaction between the material and the medium (either distilled H2O or SBF), 
including the following steps: 1) formation of SiOH bonds; 2) polycondensation of Si-O-Si; 3) 
adsorption of amorphous Ca-PO4-CO3 phases; and 4) crystallization of a hydroxy carbonate apatite. 
Secondly, the material interacts with the tissue, adsorbing biological moieties and, afterwards, 
interacting with osteoblasts that create and crystallize the extracellular matrix [29]. Since the 
chemical composition of Si-CPC is very different than that of Bioglass, the interaction between the 
material and the medium would be different, but the interaction between the material and the 
tissue would probably follow a similar pattern.  
The Si present in HA can promote the biomimetic precipitation by a combination of several 
factors: i) increasing the solubility of the materials via creation of defects in the lattice [1] [20] [21] 
[26], ii) creating a more electronegative surface due to the substitution of SiO4
4-
 for PO4
3-
 [30], and 
iii) generating smaller grains size [31] [32] [33] [34] with more triple point junctions per unit area, 
which facilitates increased dissolution at the surface [35]. In the current work, since Si-CPC had a 
similar solubility in SBF than CPC, the fact that a newly apatite layer was more evidently observed 
on the surface of Si-CPC disks than that of CPC disks was associated to the presence of SiO4
4-
 
groups on the surface of Si-CPC, increasing the electronegative charge of the material [30] [36]. 
Thus, preferential sites for nucleation would be provided and a higher adsorption of positive Ca 
ions would occur, resulting in a positive layer that attracts the phosphate groups, leading to the 
formation of the apatite layer [23] [37]. These explanations are schematically shown in Figure 3.21.  
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Figure 3.21. Comparative schema of the bioactivity kinetics for CPC and Si-CPC immersed in SBF 
solution. 
 
As previously indicated, the deposition of the new apatite layer was not clearly observed 
on the surface of CPC samples. This fact was a surprising outcome of this study, since CDHA is well-
known as a bioactive material [29]. However, under the conditions of the study, the apatite layer 
could have been deposited at longer time. Various bioactive materials can stimulate the formation 
of an apatite layer at different times, with diverse thickness and also by different mechanisms [29]. 
Regarding the different time at which the apatite layer can be observed, for instance, Kim et al. 
showed that the apatite forming ability of a Na2O-CaO-SiO2 glass varied largely with the 
composition of the material, from 0.5 to longer than 28 days [38]. Similarly, Balas et al. showed 
that after 6 weeks the Si-HA was more efficiently covered by an apatite layer than HA, which was 
associated with its higher efficiency trapping Ca ions from the solution [39]. Another in vitro study 
showed that HA maintained the same morphology after being immersed in SBF for 5 weeks, while 
Si-HA was clearly covered by an apatite layer that had a different morphology than the substrate 
[25]. Other works have also indicated that Si-substituted HA has a markedly enhanced in vitro 
apatite formation in SBF [23] [40]. 
Nevertheless, it is important to point out that the use of SBF to evaluate the bioactivity in 
vitro has recently been questioned [2]. Three main problems can be ascribed to this method. The 
first problem is that, although many improvements have been performed, none of the developed 
SBFs exactly simulates the composition of human blood serum, since the SBF i) has absence of 
proteins, which are known to play an essential role in controlling apatite nucleation [41] [42]; ii) 
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contains TRIS to buffer SBF solutions; and iii) the carbonate content is not controlled, although 
carbonates act as pH buffer in serum [43]. The second problem of SBF is that it is a highly 
supersaturated solution with respect to the apatite [44], which entails that i) special care has to be 
taken to prepare SBF with no precipitation [10], and ii) apatite can precipitate on any material 
surface with time (induction time), making it difficult to discern on the bioactive capacity of the 
material [2]. The third important limitation of testing the bioactivity of a material with SBF is that, 
in some cases, the method can lead not only to false positive but also to false negative results [52].  
3.5.4 Cell culture study 
Another objective of the study was to correlate the cell response with the ion exchange 
between the CPC formulations and the culture medium. For this reason the cells were cultured in 
inserts in presence of Si-CPC and CPC. The evolution of [Ca], [P], [Si] and pH in the culture medium 
surrounding the cells was monitored. The medium in presence of CPC and Si-CPC had very low [Ca] 
(Figure 3.20 a), suggesting a continuous Ca uptake by the cements, and a [P] higher than the 
control medium (Figure 3.20 b), in agreement with other works [45] [28] [46]. Si was detected only 
in the medium in contact with Si-CPC, at a concentration of approximately 1.5 mM (Figure 3.20 c). 
These results revealed that ion exchange between the CPC and the culture medium was taking 
place.  
As shown in the present data, cell behavior was strongly affected by the shifts in ionic 
concentrations of the culture media. The proliferation pattern was very similar for the cells in 
presence of the two cements, being significantly delayed in comparison with the cells in the control 
medium (Figure 3.19 a). A similar delay in cell proliferation was reported in previous studies where 
osteoblastic-like cells were cultured in direct contact [45] [28] [46] [47] or in extracts of 
hydroxyapatite cements [46] [28]. Hempel et al. [28] verified that the low [Ca] and high [PO4] in the 
culture media in presence of the CPC resulted in cell necrosis. Although it is clear that any 
modification of the pH as well as of the [Ca] and [PO4] lead to a reduced proliferation, it is difficult 
to ascribe this effect to a specific ion. Several works have addressed the influence of [Ca] on the 
regulation of essential osteoblastic functions [48] [49]. However, only a few have evaluated the 
effect of lowering [Ca] in osteoblastic cells, which in fact appear to be opposite of those of 
elevating [Ca]. Thus, Dvorak et al. showed that lowering [Ca] to 0.5 mM decreased fetal rat 
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calvarial cell proliferation [48], and Shie et al. [50] reported a lack of osteoblastic MG63 cell 
proliferation in low [Ca] medium (0-0.35 mM). Farley et al. [51] showed that a decrease of [Ca] 
from 2 to 0.2 mM reduced Saos-2 cell proliferation. It is interesting to note that the Si found in the 
culture medium in presence of the Si-CPC did not produce any difference in cell proliferation 
compared with those cultured in presence of CPC, contrary to the results obtained in previous 
studies [52] [50] that reported an enhanced cell proliferation in presence of aqueous Si. 
Moreover, the cells in presence of both CPC and Si-CPC showed a statistically significant 
increase of the ALP activity compared with the control medium (p < 0.05), although the kinetics 
was not affected (Figure 3.19 b). It is again difficult to ascribe this behavior to the concentration 
shift of a specific ion, especially if it is considered that the sensitivity to the ionic concentration 
depends on cell-type. In general it is accepted that elevations in [Ca] enhances osteoblastic 
differentiation [48] [49]. However, the role of [P] can be even more significant [53]. In fact, the 
results of our work are in good agreement with those reported by Farley et al. [51], who analyzed 
the effect of extracellular [Ca] and [P] on ALP activity and release in Saos-2 cells. They reported 
that the amount of ALP activity was directly dependent on [P] (medium containing 1.8 mM Ca and 
a [P] between 0.25-2.0 mM) and inversely dependent, although to a lower extent, on [Ca] (medium 
containing 1.0 mM P, and a [Ca] between 0.25-2.0 mM). These results are consistent with the 
increased ALP activity detected in our study in presence of the CPC, where [P] was increased and 
[Ca] was reduced. Enhanced cell differentiation was also reported in osteoblastic [46] and in 
human bone marrow osteoprogenitor cells [47] cultured on the surface of apatitic CPC, although in 
these studies, in addition to ionic concentrations, surface-related effects could also play a role.   
Interestingly, the Si-containing CPC elicited a statistically significantly higher (p < 0.05) ALP 
activity at 14 days (Figure 3.19 b), when the maximum activity was reached. This result is in 
accordance with other studies that reported a favorable effect of Si-releasing compounds on the 
differentiation of osteoblastic-like cells [54]. Similarly, an enhanced ALP activity was found in rMSC 
cultured in contact or in presence of a bioactive glass, where [Si] levels in the culture medium were 
similar to those of the present study [55]. Lower [Si] were also shown to result in enhanced 
differentiation of the osteoblastic-like MG-63 cell line when soluble Si was added in the culture 
medium, in the form of orthosilicic acid [56]. In all these reported studies, as in the present work, 
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the enhanced cell differentiation cannot be attributed to a direct interaction of the cells with the 
materials, but to the Si released to the culture medium by the materials. However, the mechanism 
through which Si improves the bioactivity and the cellular response of a material is still unknown 
[52]. 
It is quite difficult to predict any in vivo response from these results, since it is not even 
possible to say that the same trend would have been observed if a direct method would have been 
used to perform the in vitro study. If cells would have been cultured on the surface of the material, 
the cell behavior would have been determined by both the ions released to the medium and the 
surface properties of the material. Moreover, the Si-CPC, which is expected to have a more 
electronegative charge than CPC, is foreseen to interact in a different way with proteins than CPC 
[57]. This could lead to differences in the interaction with integrins, consecutively triggering 
specific signals that may regulate many cellular functions such as cell attachment, proliferation and 
differentiation, or even mobility and shape [57]. 
 
3.6 Conclusions 
This Chapter deals with the preparation of Si-doped CPC, using α-TCP doped with Si as a 
reactant. CPC prepared from undoped α-TCP was used as control. Si-CPC and CPC were 
characterized in terms of physico-chemical properties, ion exchange with two media, bioactive 
properties and cell behavior. The most outstanding conclusions extracted from this work are 
indicated below. 
1. The Si-stabilized α-TCP was suitable for the fabrication of a cement (Si-CPC), with setting and 
cohesion times adequate for clinical applications. Si-stabilized α-tricalcium phosphate was 
completely hydrolyzed to a calcium deficient hydroxyapatite, showing a faster reaction kinetics 
than its Si-free counterpart, as proved by its shorter setting and cohesion times, as well as its 
higher earlier compressive strength. Upon complete reaction the crystalline phases, morphology 
and mechanical properties of both cements were similar. 
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2. The in vitro bioactivity of the CPC was enhanced by the addition of Si. The formation of an 
apatite layer when immersed in SBF was accelerated by in the Si-containing CPC as compared to 
the conventional CPC. This apatite layer formed had a higher Ca/P ratio and a higher Si content 
than the core material. 
3. An in vitro study with osteoblast-like cells showed that the cell proliferation was decreased and 
the cell differentiation enhanced due to the modification of the ionic concentration of the medium 
by the cements. This was mainly ascribed to the strong decrease in [Ca], since both CPC and Si-CPC 
uptake Ca ions. Si-CPC further enhanced the ALP activity of the cells, which could be related to the 
release of Si ions. 
 
3.7 Acknowledgements 
I would like to mention some people that have collaborated on the development of this 
study. First of all, Clémence Le Van and Yassine Maazouz, who worked day after day with the Si-
doped CPC for a few months as a part of their master Thesis. Their work and ideas were an 
inestimable help. 
Since many techniques were carried out during the study, I would like to appreciate the time 
and help that I borrowed from some of the technicians involved. José María Manero and Renée 
Villascusa (SEM), Nestor Veglio (glancing angle-XRD), Antoni Padró (ICP). A special mention should 
be given to Xavier Alcobé who is always ready to help in the XRD facilities of SCT-UB. Other people 
working in the SCT-UB facilities, in units such as FTIR and EDS, also gave me interesting pieces of 
advice which I would like to thank them for. 
  
Development of silicon-doped calcium phosphate cement: study of its bioactivity and cell 
response 
151 
 
3.8 References 
[1] Boanini E, Gazzano M, Bigi A. Ionic substitutions in calcium phosphates synthesized at low 
temperature. Acta Biomaterialia 2010; 6: 1882–1894. 
[2] Bohner M, Lemaitre J. Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009; 
30: 2175–2179. 
[3] ASTM International C266-03. Standard test method for time of setting of hydraulic-cement 
paste by Gillmore needles.  
[4] Fernández E, Boltong MG, Ginebra MP, Driessens FCM, Bermúdez O, Planell JA. Development of 
a method to measure the period of swelling of calcium phosphate cements. Journal of Materials 
Science Letters 1996; 15: 1004–1005. 
[5] Joint Committee for Powder Diffraction Studies (JCPDS). International Center for Diffraction 
Data and American Society for Testing Materials. Powder diffraction file (Inorganic and Organic). 
Swarthmore (USA), 1991. 
[6] Inorganic Crystal Structure Database (ICSD). Institut Laue-Langevin (ILL), Grenoble, France. 
[7] Rodríguez-Carvajal J. Fullprof.2k Software. CEA-CNRS; 2007. 
[8] Norma Española ISO No. 10993-12:1997. Biological evaluation of medical devices, part 12: 
simple preparation and reference materials, 1997; pp. 1–19. 
[9] Russo I, Del Mese P, Viretto M, Doronzo G, Mattiello L, Trovati M, Anfossi G. Sodium azide, a 
bacteriostatic preservative contained in commercially available laboratory reagent, influences the 
responses of human platelets via the cGMP/PKG/VASP pathway. Clinical Biochemistry 2008; 41: 
343–349. 
[10] Kokubo T, Takadama H. How useful is SBF in predicting in vivo bone bioactivity? History 2006; 
27: 2907–2915. 
[11] Friedbacher G, Bubert H (editors). Surface and thin film analysis. Weinheim: Wiley-VCH, 2010. 
152 Chapter 3 
 
[12] Aubin J, Liu F. The osteoblast lineage. In: Principles of bone biology. Bilezikian J, Raisz L, Rodan 
G (editors). San Diego: Academic Press, 1996; pp. 51–67. 
[13] Dorozhkin SV. Calcium orthophosphate cements and concretes. Materials 2009; 2: 221–291. 
[14] Berry EE. The structure and composition of some calcium deficient apatites. Journal of 
Inorganic and Nuclear Chemistry 1967; 29: 317–327. 
[15] Ginebra MP, Fernández E, De Maeyer EAP, Verbeeck RMH, Boltong MG, Ginebra J, Driessens 
FCM, Planell JA. Setting reaction and hardening of an apatitic calcium phosphate cement. Journal 
of Dental Research 1997; 76: 905–912. 
[16] Mollah M, Promreuk S, Schennach R, Cocke D, Guler R. Cristobalite formation from thermal 
treatment of Texas lignite fly ash. Fuel 1999; 78: 1277–1282. 
[17] Simon I, McMahon H. Study of the structure of quartz, cristobalite, and vitreous silica by 
reflection in Infrared. The Journal of Chemical Physics 1956; 21: 23–30. 
[18] Dunfield D, Sayer M, Shurvell HF. Total attenuated reflection infrared analysis of silicon-
stabilized tricalcium phosphate. The Journal of Physical Chemistry B 2005; 109: 19579–19583. 
[19] Yin X, Stott MJ. Theoretical insights into bone grafting silicon-stabilized alpha-tricalcium 
phosphate. The Journal of Chemical Physics 2005; 122: 024709-1–9. 
[20] Camiré CL, Saint-Jean SJ, Mochales C, Nevsten P, Wang JS, Lidgren L, McCarthy I, Ginebra MP. 
Material characterization and in vivo behavior of silicon substituted alpha-tricalcium phosphate 
cement. Journal of Biomedical Materials Research B 2006; 76: 424–431. 
[21] Sprio S, Tampieri A, Landi E, Sandri M, Martorana S, Celotti G, Logroscino G. Physico-chemical 
properties and solubility behaviour of multi-substituted hydroxyapatite powders containing silicon. 
Materials Science and Engineering C 2008; 28: 179–187. 
[22] Tuck L, Astala R, Reid JW, Sayer M, Stott MJ. Dissolution and re-crystallization processes in 
multiphase silicon stabilized tricalcium phosphate. Journal of Material Science: Material Medicine 
2008; 19: 917–927. 
Development of silicon-doped calcium phosphate cement: study of its bioactivity and cell 
response 
153 
 
[23] Botelho CM, Lopes MA, Gibson IR, Best SM, Santos JD. Structural analysis of Si-substituted 
hydroxyapatite: zeta potential and X-ray photoelectron spectroscopy. Journal of Material Science: 
Material Medicine 2002; 13: 1123–1127. 
[24] Leventouri T, Bunaciu CE, Perdikatsis V. Neutron powder diffraction studies of silicon-
substituted hydroxyapatite. Biomaterials 2003; 24: 4205–4211. 
[25] Vallet-Regí M, Arcos D. Silicon substituted hydroxyapatites: a method to upgrade calcium 
phosphate based implants. Journal of Materials Chemistry 2005; 15: 1509–1516. 
[26] Porter AE, Patel N, Skepper J, Best SM, Bonfield W. Comparison of in vivo dissolution processes 
in hydroxyapatite and silicon-substituted hydroxyapatite bioceramics. Biomaterials 2003; 24: 
4609–4620. 
[27] Gustavsson J, Ginebra MP, Engel E, Planell JA. Ion reactivity of calcium-deficient 
hydroxyapatite in standard cell culture media. Acta Biomaterialia 2011; 7: 4242–4252. 
[28] Hempel U, Reinstorf A, Poppe M, Fischer U, Gelinsky M, Pompe W, Wenzel KW. Proliferation 
and differentiation of osteoblasts on Biocement D modified with collagen type I and citric acid. 
Journal of Biomedical Materials Research B 2004; 71: 130–143. 
[29] Cao W, Hench LL. Bioactive materials. Ceramics International 1996; 8842: 493–507. 
[30] Pietak AM, Reid JW, Stott MJ, Sayer M. Silicon substitution in the calcium phosphate 
bioceramics. Biomaterials 2007; 28: 4023–4032. 
[31] Arcos D, Rodríguez-Carvajal J, Vallet-Regí M, Silicon incorporation in hydroxylapatite obtained 
by controlled crystallization. Chemistry of Materials 2004; 16: 2300–2308. 
[32] Porter AE, Patel N, Skepper JN, Best SM, Bonfield W. Effect of sintered silicate-substituted 
hydroxyapatite on remodelling processes at the bone-implant interface. Biomaterials 2004; 25: 
3303–3314. 
[33] Gibson I, Best SM, Bonfield W. Effect of silicon substitution on the sintering and 
microstructure of hydroxyapatite. Journal of the American Ceramic Society 2002; 85: 2771–2777. 
154 Chapter 3 
 
[34] Li XW, Yasuda HY, Umakoshi Y. Bioactive ceramic composites sintered from hydroxyapatite 
and silica at 1,200°C: preparation, microstructures and in vitro bone-like layer growth. Journal of 
Materials Science: Materials in Medicine 2006; 17: 573–581. 
[35] Porter AE, Best SM, Bonfield W. Ultrastructural comparison of hydroxyapatite and silicon-
substituted hydroxyapatite for biomedical applications. Journal of Biomedical Materials Research A 
2004; 68: 133–141. 
[36] Thian ES, Huang J, Best SM, Barber ZH, Brooks RA, Rushton N, Bonfield W. The response of 
osteoblasts to nanocrystalline silicon-substituted hydroxyapatite thin films. Biomaterials 2006; 27: 
2692–2698. 
[37] Himeno T, Kim HM, Kaneko H, Kawashita M, Kokubo T, Nakamura T. Surface structural 
changes of sintered hydroxyapatite in terms of surface charge. In: Proceedings of the International 
Symposium on Ceramics in Medicine, Bioceramics 15. Besim Ben-Nissan D, Walsh W (editors). 
Uetikon- Zuerich: Trans Tech Inc, 2003; pp. 457–460. 
[38] Kim HM, Miyaji F, Kokubo T, Ohtsuki C, Nakamura T. Bioactivity of Na2O-CaO-SiO2 glasses. 
Journal of the American Ceramic Society 1995; 78: 2405–2411.  
[39] Balas F, Pérez-Pariente J, Vallet-Regí M. In vitro bioactivity of silicon-substituted 
hydroxyapatites. Journal of Biomedical Materials Research A 2003; 66: 364–375. 
[40] Gibson I, Huang J, Best SM, Bonfield W. Enhanced in vitro cell activity and surface apatite layer 
formation on novel silicon- substituted hydroxyapatites. Bioceramics 1999; 12: 191–194. 
[41] Juhasz J, Best SM, Auffret A, Bonfield W. Biological control of apatite growth in simulated body 
fluid and human blood serum. Journal of Materials Science: Materials in Medicine 2008; 19: 1823–
1829. 
[42] Garnett J, Dieppe P. The effects of serum and human albumin on calcium hydroxyapatite 
crystal growth. Biochemical Journal 1990; 266: 863–868. 
[43] Teitelbaum S. Bone resorption by osteoclasts. Science 2000; 289: 1504–1508. 
Development of silicon-doped calcium phosphate cement: study of its bioactivity and cell 
response 
155 
 
[44] Neuman WF, Neuman MW. The chemical dynamics of bone mineral. Chicago: The University 
of Chicago Press, 1958; p. 34. 
[45] Knabe C, Driessens FCM, Planell JA, Gildenhaar R, Berger G, Reif D, Fitzner R, Radlanski RJ, 
Gross U. Evaluation of calcium phosphates and experimental calcium phosphate bone cements 
using osteogenic cultures. Journal of Biomedical Materials Research 2000; 52: 498–508. 
[46] Engel E, del Valle S, Aparicio C, Altankov G, Asin L, Planell JA, Ginebra MP. Discerning the role 
of topography and ion exchange in cell response of bioactive tissue engineering scaffolds. Tissue 
Engineering A 2008; 14: 1341–1351. 
[47] Oreffo ROC, Driessens FCM, Planell JA, Triffitt JT. Growth and differentiation of human bone 
marrow osteoprogenitors on novel calcium phosphate cements. Biomaterials 1998; 19: 1845–
1854. 
[48] Dvorak MM, Siddiqua A, Ward DT, Carter DH, Dallas SL, Nemeth EF, Riccardi R. Physiological 
changes in extracellular calcium concentration directly control osteoblast function in the absence 
of calciotropic hormones. Proceedings of the National Academy of Science 2004; 101: 5140–5145. 
[49] Maeno S, Niki Y, Matsumoto H, Morioka H, Yatabe T, Funayama A, Toyama Y, Taguchi T, 
Tanaka J. The effect of calcium ion concentration on osteoblast viability, proliferation and 
differentiation in monolayer and 3D culture. Biomaterials 2005; 26: 4847–4855. 
[50] Shie MY, Ding SJ, Changa HC. The role of silicon in osteoblast-like cell proliferation and 
apoptosis. Acta Biomaterialia 2011; 7: 2604–2614. 
[51] Farley JR, Hall SL, Tanner MA, Wergedal JE. Specific activity of skeletal alkaline phosphatase in 
human osteoblast-line cells regulated by phosphate, phosphate esters, and phosphate analogs and 
release of alkaline phosphatase activity inversely regulated by calcium. Journal of Bone and 
Mineral Research 1994; 9: 497–508. 
[52] Botelho CM, Brooks RA, Best SM, Lopes MA, Santos JD, Rushton N. Human osteoblast 
response to silicon-substituted hydroxyapatite. Journal of Biomedical Materials Research A 2006; 
79: 723–730. 
156 Chapter 3 
 
[53] Beck GR. Inorganic phosphate as a signaling molecule in osteoblast differentiation. Journal of 
Cellular Biochemistry 2003; 90: 234–243. 
[54] Keeting PE, Oursler MJ, Wiegand KE, Bonde SK, Spelsberg TC, Riggs BL. Zeolite A increases 
proliferation, differentiation, and transforming growth factor β production in normal adult human 
osteoblast-like cells in vitro. Journal of Bone and Mineral Research 1992; 7: 1281–1289. 
[55] Radin S, Reilly G, Bhargave G, Leboy PS, Ducheyne P. Osteogenic effects of bioactive glass on 
bone marrow stromal cells. Journal of Biomedical Materials Research A 2005; 73: 21–29. 
[56] Reffitt DM, Ogston N, Jugdaohsingh R, Cheung HF, Evans BA, Thompson RP, Powell JJ, 
Hampson GN. Orthosilicic acid stimulates collagen type 1 synthesis and osteoblastic differentiation 
in human osteoblast-like cells in vitro. Bone 2003; 32: 127–135. 
[57] Thian ES, Huang J, Best SM, Barber ZH, Bonfield W. Silicon-substituted hydroxyapatite: the 
next generation of bioactive coatings. Materials Science and Engineering C 2007; 27: 251–256. 
  
Magnesium phosphate-based cements 157 
 
 
 
 
 
PART 2. 
Magnesium phosphate cements for           
endodontic applications 
 
 
 
 
 
 
“Man never made any material as resilient as the human spirit” 
Bern Williams 
  
158 Part 2 
 
  
Magnesium phosphate-based cements 159 
 
 
 
  
160 Part 2 
 
 
Theoretical framework 161 
 
 
 
 
 
 
Chapter 4. 
Theoretical framework 
 
 
  
162 Chapter 4  
 
  
Theoretical framework 163 
 
Table of contents 
4.1 Magnesium phosphate-based cements..................................................................................... 165 
4.1.1 Brief history ........................................................................................................................ 165 
4.1.2 Use in civil engineering ....................................................................................................... 167 
4.1.3 Chemistry of magnesium phosphate cements ................................................................... 169 
4.2 Mg-based compounds as biomaterials ...................................................................................... 171 
4.2.1 Calcium magnesium phosphate cements ........................................................................... 173 
4.2.2 Magnesium phosphate cements ........................................................................................ 179 
4.2.3 MPCs for endodontic applications ...................................................................................... 182 
4.3 Teeth .......................................................................................................................................... 182 
4.3.1 Materials that constitute the tooth .................................................................................... 183 
4.3.2 Embryology of the tooth ..................................................................................................... 184 
4.3.3 Dental pulp ......................................................................................................................... 187 
4.3.3.1 Anatomy of the pulp cavity .......................................................................................... 187 
4.3.3.2 Types of cells ................................................................................................................ 187 
4.3.3.3 Extracellular components, blood vessels and innervations ........................................ 188 
4.3.3.4 Functions ...................................................................................................................... 189 
4.3.3.5 Preservation of the apex .............................................................................................. 190 
4.3.3.6 Microorganisms found in an infected pulp .................................................................. 191 
4.4 Pulp therapies ............................................................................................................................ 192 
4.4.1 Root canal therapy .............................................................................................................. 195 
4.4.2 Timing of root canal obturations ........................................................................................ 196 
4.4.3 General requirements for root canal filling materials ........................................................ 197 
4.5 Properties required for root canal filling materials and assessment of these properties ......... 199 
4.5.1 Radiopacity ......................................................................................................................... 199 
4.5.2 Material stability ................................................................................................................. 202 
4.5.3 Dentin-cement bonding strength ....................................................................................... 204 
4.5.4 Sealing ability ...................................................................................................................... 204 
4.5.5 Biocompatibility .................................................................................................................. 209 
4.6 Materials commonly used to fill the root canals ....................................................................... 209 
4.6.1 Core obturating materials ................................................................................................... 210 
4.6.2 Sealers ................................................................................................................................. 211 
4.6.3 Gold standard for root canal filling ..................................................................................... 211 
164 Chapter 4  
 
4.7 Dough core obturating materials with intrinsic antimicrobial properties ................................. 211 
4.7.1 Calcium hydroxide ............................................................................................................... 212 
4.7.2 Mineral trioxide aggregate (MTA) ....................................................................................... 213 
4.8 References .................................................................................................................................. 215 
 
 
Theoretical framework 165 
 
4.1 Magnesium phosphate-based cements 
4.1.1 Brief history  
Magnesium-phosphate-based ceramics were discovered during 1939-1940 by Prosen [1,2] 
and Earnshaw [3] as investment materials for casting alloys. Several patents have been issued in 
Europe and in the United States on similar materials [4], in which magnesium oxide reacted with 
phosphoric acid or a source of phosphorous pentoxide, forming magnesium dihydrogen phosphate 
hydrated [Mg(H2PO4)2·nH2O] as a reaction product. However, the high solubility of the end-product 
motivated a modification of the reaction, and ammonium, sodium or potassium phosphate salts 
were used instead of phosphoric acid. 
Another modification that has suffered the initial MPC is the procedure to mix the 
reactants. Initially the MPC system was constituted by a phosphate compound in a liquid phase 
and magnesia in a powder phase, which had to be mixed prior to its application [5]. In 1974, they 
were developed as a two-components system, the powder product requiring only the addition of 
water prior to its application in situ, thus simplifying further the use of MPCs [6]. 
The number of publications (papers or patents) regarding magnesium phosphate cements 
from 1951 to 2011 was consulted on the Web of Knowledge1 (www.accesowok.fecyt.es/). Two 
different searches were done to determine, on one hand, the number of publications in 
magnesium phosphate cements used in non-clinical applications (coded as MPC) and, on the other 
hand, the number of publications regarding magnesium phosphate cements used in medical 
applications (coded as MPC-biomaterial). The topic entrances executed are indicated below. 
 MPC: “magnesium phosphate” cement NOT medicine, bone, clinics, biomaterials. 
 MPC-biomaterial: “magnesium phosphate” cement AND medicine, bone, clinics, biomaterials  
The search of MPC resulted in a total of 85 publications and it was reduced to 31 when the 
words related with clinics were included. The amount of publications regarding magnesium 
phosphate cements (MPCs) started to increase in the 1980s due to the use of this material for civil 
                                                            
1
 Study realized on 31
st
 of March 2012 
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engineering. Between 1980 and 2000, about 40% of the total publications on this topic were 
published and 49 entries out of 85 were found from 2000 to 2011 (58% out of total). In contrast, 
regarding the MPC as a biocement, there were only 3 publications until 2000. However, in the 
2000s decade, the interest about using MPC in clinical applications start increasing and 26 entries 
out of 28 (93% out of total) were found from 2000 to 2011. These data clearly indicated a very 
recent and increasing interest on this topic. Table 4.1 shows the number of publications per 
decade, including apart the publications of 2011. The accumulative percentage of the total 
publications for both MPC and MPC-biomaterial is plotted in Figure 4.1 in the period comprised 
between 1951 and 2011. 
Table 4.1. Number of publications found, including papers or patents, using as entry either 
“magnesium phosphate” cement + NOT medicine, bone, clinics or biomaterials (coded as MPC) or 
“magnesium phosphate” cement AND medicine, bone, clinics or biomaterials (coded as MPC-
biomaterial). Information extracted from the web of knowledge (www.accesowok.fecyt.es/) on 31
st
 of 
March 2012. 
Number of publications (papers or patents) 
Period of time MPC MPC-biomaterial 
1951-1960 0 0 
1961-1970 0 0 
1971-1980 1 0 
1981-1990 18 0 
1991-2000 17 3 
2001-2010 41 17 
2011 8 9 
Total 85 29 
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Figure 4.1. Accumulative percentage of publications (papers or patents) per decade, from 1951 to 
2011, using as entry either “magnesium phosphate” cement + NOT medicine, bone, clinics or 
biomaterials (coded as MPC) or “magnesium phosphate” cement AND medicine, bone, clinics or 
biomaterials (coded as MPC-biomaterial). Information extracted from the web of knowledge 
(www.accesowok.fecyt.es/) on 31
st
 of March 2012. 
 
4.1.2 Use in civil engineering 
 Several magnesium phosphate-based cements were developed to be used as structural 
materials during the second half of the last century. Specifically, MPCs were used to repair 
concrete in the United States in early 1970s and in early 1980 in the United Kingdom [7].  
The main advantages pointed out for the MPCs as concrete repair material are their quick 
setting and accelerated development of strength [8], their ease of application and their moderate 
cost. The fast early strength of MPC mortars made them suitable patching materials for concrete 
pavings, particularly where a minimum delay to traffic or any work disruption is of the utmost 
importance [7,9], as displayed in Figure 4.2. The MPC mortars have been used for patching and 
repair work of concrete in highways in cold regions, bridge decks, airport runways and industrial 
floors [7].  
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Figure 4.2. Thin bonded repair at joint of a motorway, in 1981. The traffic was opened 50 minutes after 
placing the cement (from [9]). 
 
Ten years after the initial utilization of MPC mortar in the United States, there was 
evidence of its good and long performance as concrete patching materials [7]. Other studies 
evaluating the durability of the hardened MPC mortar and concrete when exposed to the action of 
freezing and thawing, showed excellent results. The cement dimensions showed to be stable after 
setting, with just 0.02% of expansion, which did not cause any excessive or detrimental stress to 
the repair area. The permeability of the material was also reported to be low, with an absorption 
below than 1% after 28 days. A good bonding to the substrate was also reported [7,9,10].  
The reactants commonly used for the preparation of MPCs for patching were magnesia and 
ammonium hydrogen phosphate, blended with selected fine aggregates. When the powder was 
mixed with water, an exothermic reaction took place, producing mainly struvite (MgNH4PO4·6H2O) 
[7]. During the reaction, ammonia was released, which led to container corrosion and created an 
unpleasant environment odor, restricting its use to outdoor applications [11]. The material set in 
about 15 min at 20°C and after one hour its compressive strength was over 20 MPa. Its color and 
appearance were similar to that of ordinary Portland cement [7].  
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The fast setting and the exothermia of the magnesium phosphate cements has been 
tailored by adding retardants to the powder phase [12–14] and by calcining the MgO in order to 
decrease its reactivity [11,12,15]. 
4.1.3 Chemistry of magnesium phosphate cements 
The phosphate bonded cements are formed by the reaction of metal cations, generally an 
oxide (e.g. MgO or ZnO), with phosphate anions (either phosphoric acid or an acid phosphate) [16]. 
The first magnesium phosphate cement developed was formed by a reaction between magnesium 
oxide (MgO) and phosphoric acid (H3PO4), forming magnesium dihydrogen phosphate hydrated 
[Mg(H2PO4)2·nH2O] as a reaction product (Reaction 4.1). The main drawbacks of this reaction are 
two: i) the resulting product sets very rapidly, thus allowing very little working time, and ii) the 
Mg(H2PO4)2·nH2O formed is a water-soluble product. 
Reaction 4.1.  MgO + H3PO4 → Mg(H2PO4)2·nH2O 
Ceramics with very low solubility can be formed by replacing one or two hydrogens of 
phosphoric acid by cations, which will also replace the hydrogens of the end product. Salts such as 
ammonium mono- or dihydrogen phosphate ((NH4)2HPO4 or NH4H2PO4) [12,17], ammonium 
polyphosphate (NH4PO3)n [12], sodium polyphosphate ((NaPO3)n) [18] or potassium dihydrogen 
phosphate (KH2PO4) [19] provide the necessary additional cation. Then, when MgO reacts with one 
of these phosphate salts, the major products can be represented by the formula Mg(X2PO4)2·nH2O 
or MgXPO4·nH2O, where X is hydrogen (H), ammonium (NH4), sodium (Na) or potassium (K). The 
general reactions are displayed in Reaction 4.2 and 4.3 and the reaction products are listed in Table 
4.2. 
Reaction 4.2.   MgO + XH2PO4 + H2O → Mg(X2PO4)2·nH2O    X = H, NH4, Na, K 
Reaction 4.3.  MgO + X2HPO4 + H2O → MgXPO4·nH2O   X = H, NH4, Na, K 
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Table 4.2. Phases found in magnesium phosphate ceramics (from [16]). 
Formula Name Reference 
Mg(H2PO4)2·2H2O Magnesium dihydrogen phosphate [18] 
Mg(H2PO4)2·4H2O Magnesium dihydrogen phosphate [18] 
MgHPO4·3H2O Newberyite [20] 
MgHPO4·H2O; 
MgHPO4·2H2O 
Haysite [21] 
Mg(NH4·HPO4)2·4H2O Schertelite [8,22–24] 
MgNH4PO4·6 H2O Struvite [8,22–24] 
MgNH4PO4·H2O Dittmarite [8,22–24] 
MgK(PO4)2·6H2O Magnesium potassium phosphate [7] 
Mg3(PO4)2·4H2O Magnesium phosphate [12] 
 
Newberyite, struvite, magnesium potassium phosphate and magnesium phosphate are the 
most stable phases among the listed in Table 4.2 [16]. 
The phosphate bonded cements can be catalogued within the acid-base cements, because 
they are formed by a reaction between an acid and an alkaline compound [16]. The steps that form 
the acid-base cements have been summarized by Wilson et al. [25], Soudée et al. [26] and Wagh et 
al. [16,27]. The alkaline compounds that form acid-base cements (e.g. MgO) are sparsely soluble, in 
other words, they dissolve slowly and in a small fraction. On the other hand, acids (e.g. phosphate 
salt) are inherently soluble species. This implies that the acid solubilizes first, decreasing the pH 
and enhancing the dissolution of the bases, which occurs slowly. The dissolved species then react 
to form neutral complexes, which constitute a gel. When the gel crystallizes, a process that is 
inherently slow, it forms a solid in the form of a ceramic [16]. Coherent bonds can only be 
developed among precipitating particles that grow into crystalline structures and form a ceramic if 
the reaction rate is controlled properly. 
This mechanism of reaction produces a protective coating of less soluble products on the 
surface of the MgO particles, inhibiting the reaction between the core of individual MgO particles 
and the solubilized acid compounds. In most cases, saturation of the gel is accomplished even 
before all the basic material, namely MgO, is totally dissolved. The process is illustrated in Figure 
 4.3. The unreacted particles of MgO 
integrity of the ceramic since it resist
the matrix and improving the fracture toughness of the ceramic 
Figure 4.3. Pictorial representation of the formation of chemically bonded phosphate ceramic (from 
[16]). 
 
4.2 Mg-based compounds
Mg is known to be an important trace element in bone
concentration (generally between 
particular during the early stages of osteogenesis 
metabolism of bone by a combination of 
and mineral metabolism. It has been proved that Mg stimulates osteoblast proliferation 
the level of Mg increases at the beginning of the calcific
physiological values [30]. In contrast, 
adversely, causing cessation of bone growth, decreased osteoblastic and osteoclastic activity, 
osteopenia and bone fragility 
characterized by decreased bone mass
low amounts of Ca, Mg and vitamin D intakes 
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form a second phase that is good for the overall strength and 
s crack propagation within the ceramic, providing rigidity to 
[16].  
 as biomaterials 
s and teeth. Indeed, despite its low 
∼ 0.5 and 1.5 wt%), it plays a key role in bone metabolism
[28]. Mg influences both matrix and mineral 
hormone effects and other factors that regulate 
ation process, in comparison to the normal 
Mg depletion affects all stages of skeletal metabolism 
[31–33]. In fact, osteoporosis, a metabolic bone disorder 
, which increases bone fragility, has been associated with 
[34]. In conclusion, there is growing evidence that 
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Mg may be an important factor in the qualitative changes of the bone matrix that determine bone 
fragility [31,32,35].  
Given the relevant role of Mg in bone metabolism [28], many research teams have worked, 
on one hand, in developing metallic implants based on Mg and its alloys and, on the other hand, in 
the preparation of both calcium-phosphate materials doped with Mg and magnesium phosphate-
based materials.  
The preparation of metallic implants based on Mg and its alloys has been recently 
considered. These materials are investigated as lightweight, degradable, load bearing orthopedic 
implants, which would remain present in the body and maintain mechanical integrity over a time 
scale of 12–18 weeks while the bone tissue heals, eventually being replaced by natural tissue [36]. 
The main problem of this metal is that it can corrode too quickly, producing hydrogen gas. 
However, several possibilities exist to tailor the corrosion rate of Mg [37]. A Mg alloy has also 
proved to have antimicrobial properties against E. coli, P. aeruginosa and S. aureus due to both the 
release of Mg ions and the increase of pH [38]. 
Many efforts have been focused on doping calcium phosphates with Mg. According to 
literature, the replacement of calcium by magnesium in hydroxyapatite (HA) is limited. This is 
related to the large size difference between Mg and Ca ions (∼ 0.28 Å difference in radius 
according to the Pauling scale), which leads to strong distortions of the HA lattice and reduces its 
crystallinity [28]. These changes have a direct impact on the properties of Mg-HA, compared to its 
non-substituted analogous [39,40]: the solubility and biodegradability in physiological fluids is 
increased and the thermal conversion into β-tricalcium phosphate (β-TCP) is favored. The 
incorporation of Mg also plays an important role in the biological responses of bone cells. In vivo, 
Mg-doped HA has shown to enhance bioactivity and osteoconductivity with respect to free Mg-HA 
[29,39,41,42]. 
Magnesium phosphates may occur in physiological and pathological mineralized tissues 
[43,44]. Whitlockite (β-tricalcium magnesium phosphate) can be found in salivary gland stones, as 
well as in dental calculi [43], whilst struvite (MgNH4PO4·6H2O) and newberyite (MgHPO4·3H2O) are 
found in kidney stones [44]. Interestingly, these phases can be synthesized into materials showing 
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promising properties for hard tissue regeneration, as it will be explained in Section 4.2.2. 
Magnesium phosphates such as cattiite (Mg3(PO4)2·22H2O) and newberyite (MgHPO4·3H2O) have 
showed low cytotoxicity and demonstrated biocompatibility toward osteoblastic cells. Therefore, 
magnesium phosphate materials are expected to possess a similar bone regenerative capacity to 
their calcium phosphate counterparts and offer an interesting alternative for a hard tissue 
engineering scaffold [45].  
4.2.1 Calcium magnesium phosphate cements  
The development of new materials is stimulated by the rising expectations of customers, 
who demand new products and higher standards of goods and services [46]. The phosphate 
bonded cements are characterized to be quick-setting, hard materials and stable in a wide range of 
pH. Moreover, another great advantage of phosphate bonded ceramics for biomaterials or dental 
applications is the fact that their structure is mainly made by phosphate groups [16] that, together 
with calcium, are the main elements constituting the inorganic phase of hard tissues. 
 In 1993, Driessens et al. evaluated over 100 formulations of calcium orthophosphates 
combining calcium phosphates containing sodium, potassium, magnesium, zinc, carbonate or 
chloride [47]. One year later, Ginebra et al. focused in the preparation of magnesium-containing 
calcium phosphate cements, which showed successful setting times and compressive strength at 
the composition CaMg2(PO4)2·xH2O [48]. Moreover, this composition had an alkaline character 
during and after setting, indication that it could promote the precipitation of bone mineral from 
the body fluids [49]. 
In 1994, Driessens et al. reported three new formulations of calcium magnesium 
phosphate cements (CMPCs) that had appropriate setting time and compressive strength for 
clinical applications [50]. The end-product of the three formulations was CaMg2(PO4)2 and it was 
the result of mixing: i) MCPM + MgO; ii) DCPA + MgO + MgHPO4·3H2O; or iii) DCPD + MgO + 
MgHPO4·3H2O. As a continuation of this work, the same authors performed an in vivo study one 
year later [51], in which the CMPC prepared with DCPA + MgO + MgHPO4·3H2O (formulation ii) was 
tested. Initially, Mg(OH)2 was formed, although this phase was completely dissolved after 8 weeks, 
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being substituted by apatite. Even though that the use of CMPCs for bone regeneration was 
promising, no other papers were published until 10 years later. 
 In 2005, Driessens et al. prepared new formulations of CMPCs [52] using as reactants 
Mg3(PO4)2, MgHPO4·3H2O and different calcium phosphate reactants, such as PHA, CaHPO4, 
CaHPO4·H2O, β-TCP and α-TCP and a (NH4)2HPO4 solution as liquid phase. The studied CMPCs 
formulations had a high early strength, which was envisaged as the main advantage of Mg 
incorporation. Similarly, a patent by Zimmermann indicated that CMPCs could be prepared with 
different mixtures of calcium phosphates, magnesium phosphates and ammonium phosphates, 
and claimed that these cements could be used for bone regeneration since they are biologically 
degradable [53]. 
 In 2005, Lilley et al. incorporated Mg ions into brushite cements and found that the 
hydrolysis of brushite to hydroxyapatite was reduced with the presence of Mg [54]. A few years 
later, Klammert et al. indicated that the addition of Mg into brushite cements allowed to tailor 
their setting time and, moreover, enhanced cell proliferation and differentiation [55]. Klammert et 
al. [56] and Vomdran et al. [57] studied the effect of different Ca/P ratios when the CMPCs were 
prepared with reactants such as MgHPO4·3H2O, CaHPO4 and CaCO3, with ammonium phosphate 
dissolved in the liquid phase. They reported a fast setting time of the cement and improved 
biological results due to the presence of Mg. 
In 2006, Liu patented the formulations of CMPCs prepared with a combination of TTCP, 
DCPA and MgO, and ammonium phosphate was added either to the powder or liquid phase [58]. 
The-end products were HA and struvite. The main advantages claimed for the new formulation 
were its fast setting and high early compressive strength. Afterwards, these cement formulations 
were widely studied. In in vitro studies, good cell proliferation and differentiation was reported 
with set CMPCs prepared as dense [59,60] or as macroporous materials [61]. In in vivo studies, 
CMPCs exhibited not only good biocompatibility, biodegradability and osteoconductivity but also 
enhanced new bone formation [59].  
In 2009, Gbureck patented a formulation that comprised magnesium calcium phosphate, 
ammonium salt and water. This formulation was claimed for bone replacement as bone filler or as 
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bone glue, which could also act as carrier of pharmaceutical agents. The advantages highlighted for 
this formulation were its simplicity, defined setting time, good mechanical properties and 
improved resorbability. 
 On one hand, one of the advantages that has been claimed for the CMPCs is their fast 
degradation, which has been proved in in vitro studies by soaking set cements in both SBF [62] [59] 
and Tris-HCl media [60,61,63], and also in in vivo studies [59]. On the other hand, a common 
drawback of the CMPC formulations containing ammonium phosphate is the release of ammonium 
species that can produce necrosis of the surrounding tissues, as reported by Lu et al. [63] and Jia et 
al. [60]. Lu et al. suggested using a calcium dihydrogen phosphate instead of ammonium 
phosphate species.  
 Table 4.3 summarizes the reactants used for the preparation of different CMPC 
formulations and the resulting end-products, as well as the main properties attributed to the Mg 
addition. 
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Table 4.3. Compendium of literature study showing the reactants used to prepare calcium magnesium phosphate cements (CMPC) for biomedical applications, the formed 
end-products and the most outstanding properties of the materials. Some abbreviations are used. MCPM: monocalcium phosphate monohydrate; DCPA: dicalcium 
phosphate anhydrous (monetite), DCPD: dicalcium phosphate dehydrate (brushite); TCP: tricalcium phosphate; OCP: octacalcium phosphate; TTCP: tetracalcium phosphate; 
FA: fluorapatite; HA: apatite. 
Reactants 
End-product Most outstanding properties of the materials Refs. Ca (and P) 
source 
Mg-source P source 
Additives 
(retardants 
or not) 
i) MCPM 
ii) DCPA 
iii) DCPD 
i) MgO 
ii) MgO + MgHPO4·3H2O 
iii) MgO + MgHPO4·3H2O 
(NH4)2HPO4 - 
CaMg2(PO4)2 for the three 
formulations (after 1 day) 
Short setting times [50] 
DCP MgO + MgHPO4·3H2O - - 
Magnesium phosphate 
crystals (instead of the 
expected CaMg2(PO4)2) (after 
1 day) 
Injectable and good setting time 
Basic character that may promote bone mineral 
precipitation from the body fluids 
[48] 
DCPA MgO + MgHPO4·3H2O - - 
CDHA + Mg3(PO4)2·8H2O 
(after 8 weeks in vivo) 
Partially degraded in vivo [51] 
HA, CaHPO4, 
CaHPO4·H2O, β-
TCP and α-TCP 
Mg3(PO4)2, MgHPO4·3H2O (NH4)2HPO4 - Not evaluated High compressive strength [52] 
α/β-TCP, 
Na2HPO4, 
KH2PO4 
MgHPO4·3H2O, Mg3(PO4)2 
NH4
+
 in 
solution or 
salt 
 Not evaluated 
High biodegradability. Claimed for bone regeneration 
applications 
[53] 
Mg-HA:  [Mg(NO3)2·6H2O + Ca(NO3)2] 
+ H3PO4 
- - 
CDHA, monetite, brushite 
(after 16 h) 
The hydrolysis of brushite into hydroxyapatite was 
reduced due to the presence of Mg 
[54] 
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Ca (and P) source Mg-source P source 
Additives 
(retardants 
or not) 
End-products Most outstanding properties of the materials Refs. 
Mg-β-TCP: MgxCa(x-3)(PO4)2, 0 < x < 3 (prepared 
with Mg(OH)2 + MgHPO4·3H2O) 
+ MCPM 
- Citric acid 
Ca3Mg3(PO4)4 
(after 24 h) 
 Setting time was tailored 
 Promote the osteoblasts cells proliferation and 
differentiation 
[55] 
Ca(H2PO4)2·H2O Mg2.25Ca0.75(PO4)2 (NH4)2HPO4 - 
Newberite and brushite 
(after 7 days) 
 In vivo: higher resorption of CMPC than brushite, 
newberyite, struvite and hydroxyapatite 
[56] 
CaHPO4, CaCO3 
MgHPO4·3H2O, 
Mg(OH)2 
Different Mg/Ca 
ratios used: 1, 3, 
only-Mg 
(NH4)2HPO4 - 
Mg/Ca ratio = 1: 
Ca1.5Mg1.5(PO4)2, or mixtures 
with Mg3(PO4)2 for higher 
Mg/Ca ratios (after 24 h) 
 Fast setting and high early compressive strength 
 In vitro: cell proliferation: 3 > only-Mg > 1 
 In vitro: cell activity: only-Mg > 3 > 1 
[57] 
α or β-TCP, TTCP, OCP, 
CaHPO4·H2O, HA, FA 
MgO NH4H2PO4 
Borax 
(retardant) 
Not evaluated 
 End-products were HA and struvite 
 Fast setting and high early compressive strength 
[58] 
TTCP + DCPA MgO NH4H2PO4 - 
CDHA, TTCP, struvite and 
MgO (unreacted) (after 48 h) 
 Fast setting and high early compressive strength 
 Fast degradation in vitro (SBF) 
[62] 
TTCP + DCPA MgO NH4H2PO4 - 
CDHA, TTCP, struvite and 
MgO (unreacted) (after 24 h) 
 Fast setting and high early compressive strength 
 Fast degradation in vitro (SBF) 
 In vitro: good cell proliferation and differentiation 
 In vivo: good biocompatibility, biodegradability and 
osteoconductivity. Mg enhances new bone formation 
[59] 
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Ca (and P) source Mg-source P source 
Additives 
(retardants 
or not) 
End-products Most outstanding properties of the materials Refs. 
TTCP + DCPA MgO NH4H2PO4 
NaCl as 
porogen 
agent 
CDHA and struvite (after     
48 h) 
 Fast degradation in vitro (Tris-HCl) 
 In vitro: good cell proliferation and differentiation 
 In vivo: good biocompatibility, biodegradation and 
osteogenesis 
[61] 
Ca(H2PO4)2·H2O MgO 
NH4H2PO4 
not added 
to avoid 
NH3 release 
- 
Ca3(PO4)2 and Mg3(PO4)2 
(after 7 days) 
 Fast setting and high early compressive strength 
 Fast degradation in vitro (Tris-HCl) 
 In vitro: good cell proliferation and differentiation 
[60] 
Ca(H2PO4)2·H2O MgO 
NH4H2PO4 
not added 
to avoid 
NH3 release 
- CDHA (after 48 h) 
 Fast degradation in vitro (Tris-HCl) 
 Bioactivity in SBF: apatite layer formed at 7 days 
 In vitro: cell proliferation and enhanced 
differentiation (compared with Mg-free counterparts) 
[63] 
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4.2.2 Magnesium phosphate cements  
The MPCs for clinical applications have been mainly prepared with two different strategies. 
The first one uses farrangstonite (Mg3(PO4)2) and ammonium phosphate as reactants and, in some 
cases, struvite was also added [64–68]. The second strategy consists on mixing MgO with a 
phosphate salt [69,70]. The main end-products resulting include phases such as struvite 
(NH4H2PO4·6H2O) [65–68,70] and newberyite (MgHPO4·3H2O) [64–68] and, in some occasions, one 
of the reactants (Mg3(PO4)2 or MgO) remained unreacted. The reactants used for the preparation 
of different MPC formulations and the end-products formed, as well as the main properties 
attributed to the Mg addition, are summarized in Table 4.4. 
The MPCs were designed with the idea to be used in the cement form, in order to take 
advantage of their intrinsic properties (e.g. ease of preparation, moldeability, injectability, self-
setting in vivo, etc.). However, Klammert et al. and Vorndran et al. have recently proposed the use 
of MPCs for the preparation of scaffolds by a 3D powder printing method, preparing a layer of 
farringtonite powder (Mg3(PO4)2 and a binder solution of phosphate salts such as (NH4)2HPO4 and 
NH4H2PO4 [64,67]. 
In vitro studies performed by Klammert et al. [64] and Gloβart et al. [65] showed that 
MPCs are cytocompatible for both osteoblast and osteoclasts-like cells. Moreover, the MPCs 
extracts produced neither mutagenicity nor potential carcinogenicity and MPC implanted in vivo 
was not toxic [69]. MPCs have been used in in vivo for bone repair [59,71], and also for other 
applications such as tendon-bone fixation [72,73] and augmentation of bone-screw interfaces [74], 
since magnesium phosphate-based cements have better adhesion to bone than their calcium 
phosphate counterparts [73,75].  
Nevertheless, Jia et al. [60] and Lu et al. [63] suggested that ammonium phosphate 
reactants could compromise the biocompatibility of the material. Following this criterion, in this 
Thesis NaH2PO4 has been proposed as an alternative phosphate salt for the preparation of 
magnesium phosphate cements [70].  
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Table 4.4. Compendium of literature studies showing the reactants used to prepare MPC for biomedical applications, the end-products formed and the most outstanding 
properties of the materials.  
Reactants 
End-products 
 
Refs. 
Mg-source P source (others) 
Additives 
(retardants or 
not) 
Most outstanding properties of the materials 
Mg3(PO4)2 
Powder: (NH4)2HPO4 
Binder solution: NH4H2PO4 + 
(NH4)2HPO4 
- 
MgHPO4·3H2O + unreacted 
Mg3(PO4)2 
 In vitro: cell viability was reduced, up to 60%, in 
comparison with the cell plastic tissue (control) 
[64] 
Powder: Mg3(PO4)2 
Binder solution:  
i) 2 M K2HPO4 + 0.5M 
NH4)2HPO4; or ii) 20% H3PO4 
- 
i) MgKPO4·6H2O) (K-struvite); 
or ii) MgNH4PO4·6H2O) 
MgHPO4·3H2O) 
 K-Struvite long setting time, scaffolds do not 
maintain the structure 
 Both newberyite and struvite samples could be 
processed with good dimensional accuracy. 
[67] 
Powder: Mg3(PO4)2 
Powder: NH4H2PO4 
Liquid: pure (NH4)2HPO4 or 
with (NH4)2C6H6O7 
- 
Struvite + unreacted 
Mg3(PO4)2 
 Pastes can be injected only if (NH4)2C6H6O7 is added 
and a powder liquid ratio of 2.5 g/ml is used 
[68] 
Struvite + Mg3(PO4)2 NH4H2PO4, (NH4)2HPO4 - 
Struvite + unreacted 
Mg3(PO4)2 
 Struvite samples have a higher solubility than 
brushite, monetite and CDHA 
[65] 
Struvite + Mg3(PO4)2 (NH4)2HPO4 - 
Struvite + unreacted 
Mg3(PO4)2 
 In vitro: struvite had lower anchored molecule 
osteopontin and produced higher cellular growth and 
cell activity compared to brushite and CDHA 
[66] 
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Mg-source P source (others) 
Additives 
(retardants or 
not) 
End-products Main results associated to Mg Refs. 
MgO NH4H2PO4 
Retardant (not 
specified which 
one) 
Not evaluated 
 Extracts produced neither mutagenicity nor potential 
carcinogenicity 
 In vivo: no toxicity and good resorption 
[69] 
MgO 
i) NH4H2PO4 
ii) NaH2PO4 
iii) NH4H2PO4 + 
NaH2PO4 
Borax 
(retardant) 
i and iii) Struvite + schertelite 
+ unreacted MgO 
ii) Amorphous compound + 
unreacted MgO 
 Fast setting and high early compressive strength 
 Antibacterial properties 
 
[70] 
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4.2.3 MPCs for endodontic applications 
In this Thesis, novel MPCs containing magnesium oxide in excess have been developed. It 
was envisaged that the developed MPCs could have antimicrobial properties since the magnesium 
oxide is an alkaline compound that could provide the cements with an analogous effect to that of 
calcium oxide or other alkaline compounds [76–78].  
In this context, from now on, the theoretical framework reviews the main applications of 
cements with antimicrobial properties, which are usually applied in sites where an infection has to 
be prevented or battled. Even though antimicrobial cements are of great interest in orthopedics, 
this Thesis is focused to endodontic applications. Therefore, an introduction of the teeth, the root 
canal therapies and the root canal filling materials has been included. 
4.3 Teeth 
Teeth are dense structures found in the jaws of many vertebrates. The primary function of 
teeth is to tear and to chew food, while for carnivores they are also a weapon. Therefore, teeth 
have to withstand a range of physical and chemical processes, including compressive forces (up to 
∼ 700 N), abrasion and chemical attack due to acidic foods or products of bacterial metabolism. 
The roots of teeth are covered by the gums. The cutting edges of teeth are covered by an enamel 
layer of about 2 mm, which helps to prevent cavities on them [79].  
A tooth is divided in the crown and the root. The cervix is the junction between both parts. 
Figure 4.4 shows a schema of the morphological structure of a tooth [80]. 
 The crown can be divided in the anatomical and the clinical crown. The anatomical crown is that 
portion of the tooth encased in enamel and the clinical crown is the part of the crown exposed 
(visible) in the mouth. 
 The root is embedded in alveolar bone and is covered by cementum. The tooth may have 
between one and three roots, and the tip of each root is called apex. The apex of every root has a 
small opening (apical foramen) that allows the passage of blood vessels and nerves into the tooth. 
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 The cervix is a slight indentation that encircles the tooth and marks the junction of the crown 
with the root. The cementum joins the enamel at the cervix of the tooth and the point at which 
they join is called the cement-enamel junction. 
 
Figure 4.4. Anatomy of a tooth: crown, root and cervical line (from [80]). 
 
4.3.1 Materials that constitute the tooth 
Each tooth is built up with several materials: enamel, dentin, cementum and pulp, as 
displayed in Figure 4.5 [81]. The periodontium, the tissue that surrounds the teeth, is also included 
in this section. 
 
Figure 4.5. A schematic drawing of a tooth with its main parts indicated (from [82]). 
 
The composition of each tooth compound as well as its main function is indicated below. 
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 The enamel is the hardest tissue in the human body and consists of approximately 96% inorganic 
minerals, 1% organic materials and 3% water. This highly mineralized substance covers the entire 
anatomic crown of the tooth and protects the dentin. The inorganic compound is mainly apatite.  
 The dentin constitutes the largest portion of the tooth and it is more porous than enamel. 
Dentin, which consists of approximately 70% inorganic matter (calcium orthophosphate 
compounds) and 30% organic matter and water, is harder than bone but softer than enamel. 
Dentin is perforated by tubules that run between the cement-enamel junction and the pulp, 
through which pain stimuli are transmitted. The dentin can transform external stimuli into an 
appropriate message to cells and nerves in the pulp, which react to physiologic and pathologic 
stimuli due to the ability of the teeth of constant growth and repair [81,82]. 
 The dental pulp is a soft tissue of the tooth, with blood vessels and nerves that enter through the 
apical foramen. It is contained into the pulp chamber, which is located on the internal surface of 
the dentin walls [81].  
 The cementum is a calcified tissue (55% organic and 45% inorganic material) that covers the 
roots of the teeth in a thin layer, being an essential part of both the tooth and the periodontium. 
The main function of cementum is to anchor the teeth to the bony walls of the tooth sockets in the 
periodontium [81]. 
 The periodontium are the tissues that surround and support the tooth. Their main functions are 
to support, to protect and to provide nourishment to the teeth. The periodontium consists of 
cementum, alveolar process of the maxillae and mandible, periodontal ligament and gingival [81].  
4.3.2 Embryology of the tooth  
The in vivo formation and development of a tooth is a very complex biological process, by 
which the teeth grow and erupt into the mouth after they are formed from embryonic cells. The 
materials forming the human teeth –enamel, dentin and cementum– must be all developed during 
the appropriate stages of fetal development [79]. Recent data confirmed the need to incorporate 
an extra amount of calcium in the diet of pregnant and nursing mothers to prevent early childhood 
dental caries.  
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In the odontogenesis phase, every tooth goes through three developmental processes 
which are categorized into growth, calcification and eruption periods. Figure 4.6 schematically 
shows the odontogenesis process [80] [83] [84]: 
1) Growth: dental development usually begins in the fifth or sixth week of prenatal life. By the 
seventh week, skin cells of the mouth (epithelium) thicken along the ridge of the developing jaws 
creating the dental lamina. The tooth begins to take shape (morphodifferentiation process), and 
the enamel forming cells (ameloblast) and dentin forming cells (odontoblast) line up on a 
boundary line called dentino-enamel junction. At the end of morphodifferentiation, cells deposit 
the organic matrix along the boundary line (apposition process). 
2) Calcification: process by which the organic tissue becomes hardened by the deposition of 
calcium phosphate components. Next, the tooth crown receives layers of enamel that start at the 
top of the crown and go downward over its sides to the cemento-enamel junction. 
3) Eruption: after the crown of the tooth has been formed, the root begins to develop. Finally, the 
tooth erupts (movement of the tooth into its proper position in the mouth), process which takes 
about 3 years for permanent teeth. When primary teeth get ready to fall out and make way for the 
eruption of permanent teeth, they go through a process called exfoliation. The root of the primary 
tooth resorbs as the permanent tooth erupts from beneath. The primary teeth act as guides for the 
developing permanent teeth. 
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Figure 4.6. Stages in the development of a tooth [84]). 
 
Enamel formation, or amelogenesis, is a highly regulated process involving precise genetic 
control as well as protein-protein interactions, protein-mineral interactions and interactions 
involving the cell membrane. At some point before the tooth erupts into the mouth, the 
ameloblasts (enamel forming cells) are broken down. Consequently, enamel has no way to 
regenerate itself because there is no biological process that repairs degraded or damaged enamel. 
Nevertheless, enamel is sufficiently porous to allow the diffusion of ions through this material and 
also chemical reactions can occur within its structure, producing a passive mineralization from 
saliva. However, the porosity of enamel also permits acidic dissolution to occur, due to caries or 
the injection of acidic food [79]. 
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4.3.3 Dental pulp  
Special emphasis to the dental pulp and its function will be given, since in case that the 
dental pulp is amputated or extracted after a bad infection, the root canal could potentially be 
filled with the materials developed in this part of the Thesis.  
4.3.3.1 Anatomy of the pulp cavity  
Pulp space is divided into the coronal and radicular regions. The pulp cavity consists of a 
pulp chamber (coronal), pulp horns (cornua), pulp canals (root canals, radicular pulp), lateral 
canals, apical foramen and accessory foramina, as displayed in Figure 4.7. In general, the shape and 
the size of the tooth determine the shape and the size of the pulp space [80]. Anatomy of the root 
canal can vary not only between tooth types but also within tooth types. Although at least one 
canal must be present in each root, some roots have multiple canals [81]. 
 
Figure 4.7. Anatomic regions of the root canal system highlighting the pulp horn, pulp chamber, root 
canal, lateral canal and apical foremen (from [81]). 
 
4.3.3.2 Types of cells 
The dental pulp contains different types of cells: odontoblasts, stem cells 
(preodontoblasts), fibroblasts and cells from the immune system [81]. Figure 4.8 shows a schema 
of the organization of the peripheral pulp that includes each cell type. 
 The odontoblasts are the most distinctive cells of the dental pulp. They form a single layer at its 
periphery, synthesize the matrix and control the mineralization of dentin. 
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 The stem cells (preodontoblasts) are cells that have only been partly differentiated along the 
odontoblast line and can be totally differentiated into odontoblasts after an injury that results in a 
loss of the existing ones. 
 The fibroblasts produce and maintain the collagen and ground substance of the pulp and alter 
the structure of the pulp in case of disease. 
 The most prominent cells of the immune system in the dental pulp are dendritic cells. They 
recognize a wide range of foreign antigens and initiate the immune response. Other immune cells 
found in the dental pulp are macrophages and neutrophils. 
 
Figure 4.8. Diagram of the organization of the peripheral pulp (modified from [81]).  
 
4.3.3.3 Extracellular components, blood vessels and innervations 
The dental pulp is also made by extracellular components such as fibers, ground substance 
and calcifications, and also contains blood vessels and innervations [81]. 
The three main extracellular components in the dental pulp are: i) type I collagen, as the 
predominant fiber; ii) pulp ground substance, composed principally of glycosaminoglycans, 
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glycoproteins and water in the form of a sol-gel that supports the cells and acts as a medium for 
transport of nutrients and metabolites; and iii) calcifications [81]. 
The dental pulp has an extensive and unique vascular pattern and is also richly innervated 
by trigeminal afferent axons. Accordingly, they respond to stimuli that induce or threaten to induce 
injury to the pulp tissue and their activation may induce defensive, withdrawal-type reflexes in the 
masticatory muscles. The pain responses induced by external stimuli can be extremely intense.  
4.3.3.4 Functions 
The pulp performs five main functions, some formative and others supportive [81].  
i) Induction: pulp participates in the initiation and development of dentin, which, when formed, 
leads to the formation of enamel. These events are interdependent: enamel epithelium induces 
the differentiation of odontoblasts, and odontoblasts and dentin induce the formation of enamel. 
ii) Formation: odontoblasts participate in dentin formation in three ways: a) by synthesizing and 
secreting inorganic matrix; b) by initially transporting inorganic components to the newly formed 
matrix; and c) by creating an environment that permits mineralization of matrix. During early tooth 
development, dentinogenesis is generally a rapid process that forms primary dentin. After tooth 
maturation, dentin formation continues at a much slower rate, forming secondary dentin. 
Odontoblasts can also form a dentin in response to injury, i.e. the original dentin thickness is 
reduced due to caries, attrition, trauma or restorative procedures. This occurs through the 
induction, differentiation and migration of new odontoblasts or odontoblast-like cells to the 
exposure site. The so formed dentin (called tertiary dentin) is less organized than primary and 
secondary dentin and it is mostly localized in the site of the injury.  
iii) Nutrition: pulp supplies nutrients that are essential for the initial formation of dentin and, 
afterwards, for dentin health, via dentinal tubules. 
iv) Defense: odontoblasts form tertiary dentin in response to an injury. However, the structure of 
tertiary dentin may not afford the same degree of protection to the underlying pulp tissue than 
that of primary or secondary dentin. Dental pulp has also the ability to process and to identify 
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foreign substances and to elicit an immune response to their presence. This is a typical response of 
the pulp to dentinal caries. 
v) Sensation: pulp transmits neural sensations mediated through enamel or dentin to the higher 
nerve centers. These stimuli are clinically expressed as pain, usually initiated by an inflammatory 
disease. The dense innervations of the pulp and dentin (Figure 4.9) give a morphological basis for 
the high sensitivity of these tissues [82].  
 
Figure 4.9. a) Schematic drawing that shows the innervations of the dental pulp and b) the interface 
zone between dentin and pulp (from[82]). 
 
4.3.3.5 Preservation of the apex 
A healthy pulp is protected by both the structure of the hard tissue and the intact 
periodontium [82]. However, these barriers may be damaged or reduced due to processes such as 
trauma, minor cracks in enamel and dentin, gaps in the cementum, root resorption, marginal gaps 
within restorations or root caries. [82]. Specifically, the 60-90% of school children worldwide have 
dental cavities [85]. The microorganisms take advantage of these imperfections, entering the tooth 
and going along the dentinal tubules (Figure 4.10).  
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Figure 4.10. Schema of a healthy tooth versus a damaged one, which present imperfections such as 
cracks, caries or trauma (modified from [81]). 
 
4.3.3.6 Microorganisms found in an infected pulp 
Microorganisms colonizing a body site such as the root canal space may be either free-
floating as single cells (planktonic form) or microbial biofilms. The term microbial biofilm is used 
when bacterial cells become densely packed and embedded in an extracellular matrix of polymers 
of host and microbial origin. Biofilms, most often composed of several morphotypes, grow in 
multilayers or as aggregates on the dentin walls of the root canal [82]. 
The many genera and species currently identified in root canal samples comprise obligate 
anaerobic and facultative anaerobic oral bacteria. Figure 4.11 shows a schema of the bacteria 
commonly found in endodontic infections. 
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Figure 4.11. Overview of several important bacteria in endodontic infections and images of some of the 
them (scale bar indicates 1 µm): a) 
Neisseria veillonella, d) Capnocytophaga eikenella
 
After microorganisms reach the dental pulp, an inflammatory reaction arises with the aim 
to neutralize and to eliminate any harmful agent, and also to repair the damaged tissue 
However, in certain occasion the natural mechanisms are not able to reduce the bacteria and pulp
therapies have to be conducted to ensure the total disinfection and heal
4.4 Pulp therapies 
Pulp therapy and subsequent restorative procedures
restore the mechanical integrity and appearance of the tooth but also 
and to protect it from further damage. 
any access of bacterial organisms from the oral cavity through it.
antimicrobial properties, such as calcium oxide
Streptococcus enterococcus, b) Actinomyces lactobacillus
 (modified from [86] and [82]). 
ing of the tooth.
 should be designed not only to 
to allow the pulp to recover 
Therefore, the dental pulp should seal tightly 
 Thus, a material that provides 
-based pastes, is desirable in many cases. 
 
, c) 
[82]. 
 
 
to prevent 
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Nevertheless, it is generally accepted that the materials with antimicrobial properties also 
have certain cytotoxicity [87]. When applying this type of materials in a vital pulp, they produce an 
initial cauterization and a superficial necrosis of the tissue. However, as a side effect, the alkaline 
pH also stimulates the odontoblasts differentiation, which mineralizes hard tissue to form tertiary 
dentin and close the exposition of the pulp. In conventional clinical cases, the healing process takes 
about one week [82,88]. 
For extensive pulp lesions, the injured portion of the pulp should be removed and replaced 
by a temporary restoration at an early stage, allowing the recovery of the remaining pulp (the pulp 
is still inflamed after the infection) prior to the incorporation of a permanent restoration [81]. 
Sometimes the pulp is able to keep its functional state but, in other cases, in which severe lesions 
have persisted for a long time, the inflammatory response is so destructive that can induce the 
death of the tissue [82]. 
The endodontic treatments are distinguished in two groups, those in which the dental pulp 
is still vital and those in which necrosis of the pulp occurred [81,82]. When the dental pulp is vital 
but injured, the exposure of the pulp is closed with a restoration material, having previously 
partially extracted, if necessary, the injured tissue.  
Depending on the grade of injury of the tissue, and thus on the extension of the treatment, 
the clinical procedures are named differently. The vital exposed pulp may be protected 
immediately by covering it and placing a restoration (pulp capping). If the exposure is large or 
seriously infected, it may be possible to remove the diseased part of the pulp, to cap the remaining 
pulp and, finally, to place a restoration (pulpotomy) [81]. In the case that the pulp is irreversibly 
injured or necrotic, a pulpectomy is performed, in which the totality of the dental pulp has to be 
extracted [82]. Several possibilities for pulpal protection are displayed in Table 4.5, together with a 
schema of the degree of injury of the tooth and a definition of the treatment.  
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Table 4.5. Definitions of the principal terms used in pulpal protection and vital pulp therapy, classified 
in function of the degree of injury of the tissue (images from [82]).   
Term Schema 
Vital or 
necrotic pulp? 
Definition 
Direct pulp cap 
 
Vital 
A dental material placed directly on a mechanical or 
traumatic vital pulp exposure. 
Pulp cap 
 
Vital 
The pulpal wound is sealed with a dental material (i.e. 
calcium hydroxide or MTA) to facilitate the formation of 
reparative dentin and maintenance of a vital pulp. 
Step-wise 
caries 
excavation 
 
Vital 
A material is placed on a thin partition of remaining 
carious dentin that if removed might accidentally expose 
the pulp (for immature permanent teeth). 
Partial 
pulpotomy 
 
Vital 
Surgical removal of a small diseased portion of vital pulp 
as a means of preserving the remaining coronal and 
radicular pulp tissues. 
Pulpotomy 
(pulp 
amputation) 
 
Vital 
Surgical removal of the coronal portion of a vital pulp as a 
means of preserving vitality of the remaining radicular 
portion. It is usually performed as an emergency 
procedure for temporary relief of symptoms or 
therapeutic measure. 
Pulpectomy 
(pulp 
extirpation) 
 
Irreversible 
damaged or 
necrotic 
Complete surgical removal of the vital pulp 
 
 The pulpectomy, which requires the extirpation of the pulp, is the most extreme case. This 
is an endodontic treatment, also known as non-surgical root canal therapy. The followed 
procedure to perform a root canal therapy is detailed below. 
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4.4.1 Root canal therapy 
The root canal therapy or pulpectomy is a treatment performed to cure an infection of the 
dental pulp and to save the tooth (although not the pulp tissue) in a situation that the pulp is 
irreversibly damaged or necrotic. 
A perennial problem in root canal therapy is the likelihood of recurrent infections, which 
are triggered by bacteria that reach the apex region of the tooth [87]. Therefore, in a root canal 
therapy, an essential step after removing the damaged pulp tissue is to disinfect the root canal 
and, subsequently, to obturate it with a sealing material to avoid another infection (reinfection or 
secondary infection). The disinfection process, carried out by means of mechanical 
instrumentation and irrigation of antimicrobial solutions, removes between 50 and 80% of the 
bacteria found in the root canal. Thus, if the root canal would be sealed like that and the bacteria 
would receive nutrients and have some room, they would quickly grow back and would cause 
again an infection [82]. In fact, secondary infection is the main cause of endodontic failure [89]. 
In order to avoid a secondary infection, two consecutive processes are usually performed 
to totally eliminate any remaining bacteria after the mechanical and chemical treatment: i) the 
root canal is obturated with a temporary disinfectant material (inter-appointment dressing) until 
the next follow-up appointment (after 7-10 days), and ii) the temporary filling is afterwards 
removed and any remaining bacteria are buried by a permanent filler of the root canal, expecting 
that the byproducts released by the material will kill the microorganisms and/or they will die for 
the lack of nutrients or space to grow up. Nevertheless, this only occurs in the case that the 
conducts to the periapical tissue are totally blocked and sealed by the root canal filler [82].  
Therefore, the root canal therapy is usually done in more than one appointment [90]. In a 
first visit the root canal is chemically and mechanically cleaned and disinfected and an antibacterial 
inter-appointment dressing, such as calcium hydroxide, is incorporated into the root canal. In a 
follow-up appointment, a permanent root canal filler is introduced only if clinical signs of ongoing 
infection have disappeared [82]. Finally, if necessary, a coronal restoration is performed after the 
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root canal filler has set [91]. After an endodontic therapy, a tooth must be restored to functional 
and esthetic demands.  
A general and simplified overview of the whole treatment is schematically indicated in 
Figure 4.12. However, it is important to keep in mind that every root canal therapy is slightly 
different depending on the clinical situation, mainly resulting in different timings of obturation. 
 
Figure 4.12. Schema of the main steps in an endodontic process (individual images modified from [82]). 
 
4.4.2 Timing of root canal obturations 
To determine how long it takes to complete a root canal treatment, the number of 
appointments necessary or the adequate timing, factors such as i) the patients’ symptoms, ii) the 
pulp and periapical status and iii) the difficulty of the procedure should be considered. [81]. 
i) Patients’ symptoms: obturation is contraindicated if the patient presents severe symptoms. 
Since these are emergency situations, it is preferable to manage the immediate problem and delay 
the definitive treatment [81].  
ii) Pulp and periapical status:  
 Vital pulp: the procedure may be completed in a single visit regardless of the inflammatory 
status of the pulp [81].  
 Necrotic pulp without significant symptoms: canal preparation and obturation may be 
completed during the same appointment. However, multiple appointments are 
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advantageous in front of one-single appointment regarding to the healing of apical disease 
[81]. 
 Necrotic pulp with persistence of exudation in the canal during preparation: several visits 
are required. An inter-appointment dressing is introduced into the canal and the permanent 
sealing is not placed until the exudation stops [81]. 
iii) Difficulty of the procedure: those complex cases, which are time consuming, are better 
managed in multiple appointments [81]. 
4.4.3 General requirements for root canal filling materials 
The aim of a root filling material is to provide a combination of an antibacterial agent that 
at the same time seals against the further ingress of bacteria, thus removing the pulpal antagonists 
and allowing the pulp to heal [87].  
Briefly, the requirements for root canal materials are those that allow the dentist, first, to 
work comfortably with it (easy to apply and appropriate setting time), and second, to follow-up the 
treatment (radiopacity). Once implanted, the material should remain in the root canal 
permanently, sealing properly against bacteria (avoid reinfection) and, therefore, it should be 
stable with time (no degradation in physiological fluids), and should adhere and adapt to the 
dentin. The material may provide antimicrobial properties, further ensuring the bacterial death. As 
a side effect, the root canal filling should stimulate the periapical healing process. Finally, the 
material has to be biocompatible [82,89] and should not irritate local tissues or create general 
health problems such as allergies to patients and dental personnel [82]. Table 4.6 shows the 
general requirements that a root filling material has to fulfill regarding its technical, biological and 
handling properties. 
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Table 4.6. General requirements for a root canal filling material (modified from [82]). 
Technical properties Biological properties Handling 
 No shrinkage 
 No general health problems or 
allergies for patients and dental 
personnel 
 Setting in an adequate time, 
allowing sufficient time for 
obturation and radiographic 
control 
 No solubilization in physiological 
fluids 
 No irritation of local tissues  Easy to apply 
 Setting in vivo, no altered by the 
environmental humidity 
 Sterile 
 Easy to extract using solvent, 
heat or mechanical 
instrumentation 
 Good adhesion and adaptation 
to dentin or combining materials 
(cones, sealers) 
 Antimicrobial properties   
 Low porosity and water 
adsorption 
 Stimulation of the periapical 
healing process 
 
 No tooth discoloration   
 Radiopacity   
 
 There is still no commercial material that fulfills all the requirements indicated in Table 4.6, 
as reported in the literature [82,86]. This is the reason why a combination of endodontic materials 
to fill the root canal is usually employed [86]. 
The root canals are usually obturated using a combination of two or more materials in 
order to improve the performance of a single root canal filler. The primary obturating material, 
known as core, acts as a piston and a paste known as sealer, can be spread onto it, filling voids and 
attaching the core material to the dentin wall. The core comprises the bulk of material that fills the 
canal space and can be solid or semisolid (paste). The sealer is in paste form and, in fact, it is the 
material that comes into contact with the tissues of the root canal (i.e. dentin) [89]. 
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4.5 Properties required for root canal filling materials and 
assessment of these properties 
4.5.1 Radiopacity  
Root canal sealers should have sufficient radiopacity to allow a clear distinction between 
the implanted material and the surrounding anatomic structures [82,92,93]. In fact, during an 
endodontic treatment, the evaluation of the quality of the root fillings can only be controlled by 
radiographic examination. 
The X-ray is an electromagnetic radiation exhibiting wave-like behavior as it travels through 
the space. It has both electric and magnetic field components, which oscillate in phase 
perpendicular to each other and perpendicular to the direction of energy propagation. When an X-
ray photon collides with an atom, the atom may absorb the energy of the photon and boost an 
electron to a higher orbital level or, if the photon is very energetic, it may knock an electron from 
the atom altogether, causing the atom to ionize. Generally, a larger atom (with higher atomic 
number) is more likely to absorb an X-ray photon, since larger atoms have greater energy 
differences among orbital electrons. Therefore, the materials made of larger atoms (e.g. lead) 
absorb the electromagnetic radiation, thus having a high stopping power in front of X-rays.  
X-ray equipments are specifically designed to take advantage of the absorption difference 
between hard tissues (bones or teeth) and soft tissues, allowing physicians to examine different 
structures in the human body. Soft tissues are composed by atoms smaller than calcium and 
phosphorus, which are the most predominant atoms making up hard tissues; hence X-rays reveal 
the contrast differences among those chemically different structures.  
Bismuth oxide (Bi2O3) has been widely used as radiopaque agent for intraoral dental 
materials, such as root canal fillers. For instance, Bi2O3 is the radiopacifying agent added to the 
mineral trioxide aggregate (MTA), a commercial root canal filler: the white MTA (WMTA) contains 
16.13 wt% Bi2O3 and the grey MTA (GMTA) contains 15.90 wt % Bi2O3 [94]. Bi2O3 is insoluble in 
water [95] and exhibits low toxicity although it contains a heavy metal atom such as bismuth 
(atomic number 83).  
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Assessment of the radiopacity 
In scientific literature, several methodologies to measure the radiopacity of a material for 
endodontic applications have been reported. However, most of the studies have been based in the 
protocol explained in the UNE-EN ISO 6876 standard (Dental root canal sealing materials) [92] and 
in the UNE-EN ISO 9917-1 standard (Dentistry. Water-based cements, part I) [96]. In these two 
standards for dental cements, the radiopacity of a sample is compared to that of an aluminum 
stepwedge. On one hand, the UNE-EN ISO 6876 standard establishes that a disk of 1 mm thickness 
has an adequate radiopacity if its optical density is higher than that of an aluminum piece of 3 mm 
thickness. On the other hand, the UNE-EN 9917-1 ISO standard establishes that a disk of 1 mm 
thickness has an adequate radiopacity if its optical density is higher than that of an aluminum piece 
of the same thickness. The optical density can be transformed in equivalent millimeters of 
aluminum thickness by means of a calibration curve of the aluminum stepwedge. 
Different experimental conditions employed in the characterization of dental materials are 
summarized in Table 4.7.  
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Table 4.7. Compendium of different experimental conditions used to assess the radiopacity of dental materials. Some abbreviations are used: MTA: mineral trioxide aggregate; 
CPC: calcium phosphate cements; BSB: bismuth salicylite basic; AH Plus is the commercial name of a resin-type sealer. “eq. mm Al” stands for equivalent millimeters of aluminum 
thickness. 
Material of study 
Thickness 
of disks 
(mm) 
Radiopacity (mean eq. mm Al) Equipment 
Distance between 
sample and the 
radiation source 
Voltage (kV) 
Intensity 
(mA) 
Exposition 
time (s) 
Reference 
MTA 1 6.03 
General Electric, 
Milwaukee 
33.5 cm 50 10 18 pulses/s [97] 
MTA 2 
4 mm (equivalent to addition 
17.65 wt% Bi2O3) 
Gendex 765 DC 40 cm 65 7 0.25 [98] 
Pure CPC 
SrCO3/CPC 
3 
2.5 
5 
Gendex Oralix 
AC generator 
− 75 7.5 0.26 [99] 
Bi-doped CPC: CPC        
+ x wt% BSB 
CPC 
5 
Image contrast values: 
BSB = 5: 0.85 ± 0.003 
BSB = 25: 0.89 ± 0.008 
BSB = 0 (CPC): 0.55 ± 0.027 
MXR-160A, 
Shenzhen 
1 cm 60 10 0.7 [100] 
Gutta-percha 
AH Plus 
1 
9.8 ± 0.3 
11.2 ± 0.3 
Spectro 70 X 30 cm 70 8 0.2 [101] 
CaCO3-calcium 
phosphate 
CaCO3: 9.2 wt% or       
8.2 wt% if milled 
4 4  
Philips MG 
103/2.5 
70 cm 65 10 
− [102] 
202 Chapter 4  
 
4.5.2 Material stability  
The stability of a material aimed to be used as root canal filler is an essential requirement 
to guarantee that the sealing provided by the filler will endure. Moreover, those materials with 
antibacterial properties should not compromise the stability of the material due to the release of 
antibacterial substances [82]. 
Assessment of the stability of a material 
The stability of the materials has been studied in a wide range of conditions. Fridland et al. 
evaluated the degradation of MTA, a commercial root canal filling, following the UNE-EN ISO 6876 
standard (“Materials for Dental Root Canal Sealing”). Interestingly, although the material fulfilled 
the requirement for root canal filling materials established in the UNE-EN ISO 6876 standard (the 
degradation was lower than 3 wt% after 24 h, following the protocol indicated [92,103]), it showed 
a great degradation in a longer period of 78 days [104]. Therefore, Fridland’s studies showed the 
importance of performing assays for long periods of time. 
There are also some studies that evaluated the degradation of materials such as calcium 
phosphate cements, magnesium phosphate cements or a mixture of both [59–62]. In general, the 
materials showing a high biodegradation rate were pointed out to be used for bone regeneration 
applications.  
Table 4.8 schematically shows different protocols used to evaluate the degradation of 
different inorganic cements with time. 
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Table 4.8. Compendium of experimental conditions used to evaluate the stability of several materials with time. Some abbreviations are used: CPC: calcium phosphate 
cement; CMPC: calcium magnesium phosphate cement; MPC: magnesium calcium phosphate cement.  
Material 
Material/medium ratio. Medium. 
Static or dynamic conditions 
Time points of study (medium refreshed) Characterization of the degradation Weight loss (%) References 
MTA 
1 disk (∅ = 20 mm, h = 2mm)/50ml. 
Distilled water. Static 
24 h (medium not refreshed) 
Weight of material dissolved in medium was 
evaluated after evaporation of medium (study 
follows ISO 6876 standard) 
1.8−2.8 wt% 
(depending of L/P 
ratio) 
[103] 
MTA 
1 disk (∅ = 20 mm, h = 2mm)/50ml. 
Distilled water. Static 
1, 2, 5, 9, 14, 21, 30, 50, and 78 days 
(medium was not refreshed) 
Weight of material dissolved in medium was 
evaluated after evaporation of medium (study 
follows ISO 6876 standard) 
16−24 wt% 
(depending of L/P 
ratio), after 78 days 
[104] 
CPC and CMPC 
0,2 g/ml (∅ = 10 mm, h = 3 mm). SBF. 
Dynamic (100 rpm) 
90 days (medium refreshed every 2 days) 
  Weight loss (specimens dried at 60°C) 
 SEM 
CPC ∼ 3 wt%; CMPC 
∼ 60 wt% 
[59,62] 
CMPC 
0,2 g/ml (10x10x10mm). Tris HCl, pH = 
7.4. Dynamic (100 rpm) 
Every 7 days (and medium also refreshed), 
up to 90 days 
  Weight loss (specimens dried at 60°C) 
  [Ca], [Mg], [P] by ICP 
CPC ∼ 30 wt%; 
MCPC ∼ 85 wt% 
[61] 
CPC and MCPD 0,5 g/g. Tris HCl, pH = 7.4. Static. 
Every 7 days (medium refreshed every 3 
days), up to 90 days 
  Weight loss (dried, temperature not specified) 
  [Ca], [Mg], [P] by ICP 
  pH 
CPC ∼ 10 wt%; 
MCPC ∼ 85 wt% 
[60] 
Magnesium 
doped apatite 
0,2 g/ml (∅ = 10 mm h = 3 mm). Tris 
HCl, pH = 7.4. Dynamic (100 rpm) 
Every 7 days for 28 days, and every 14 days 
until day 84 (medium refreshed at every 
time point) 
  Weight loss (dried at 60°C) 8−50 wt% [63] 
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4.5.3 Dentin-cement bonding strength  
The root canal filling material should adapt and adhere to the dentin, thus decreasing the 
risk of interfacial bacterial leakage [82], and also increasing the changes of the material to remain 
in place under dislocation forces [105].  
Adhesive cements have been tested as root canal filling materials in an attempt to improve 
the sealing quality of sealers. Materials such as cyanoacrylate, calcium phosphate, polycarboxylate 
and glass ionomer cements have been explored. Although appearing favorable in biocompatibility 
tests and in long-term clinical follow-up studies, the materials have never gained great popularity. 
Likely reasons are their short setting time and difficulty of removal for retreatment [82]. 
Assessment of the dentin-cement bonding strength 
The bonding strength between a root canal filling material and dentin has commonly been 
evaluated by means of a push-out test. Although the experimental conditions among different 
works change slightly, the rationale of the assay consists on pressing the surface of a material 
placed in a sliced root canal and quantifying the strength necessary to displace the cement from its 
initial position. Reyes-Carmona et al. evaluated the bonding strength of different cements after 
storing the obturated roots for 72 h at 37°C [106]. 
4.5.4 Sealing ability 
Many studies (about 25% of the current endodontic literature) are devoted to leakage or 
sealability [82]. The term bacterial leakage, also commonly referred as microleakage, is used to 
imply the bacterial elements penetrating the margins of dental restorations. Materials that do not 
seal tight may allow bacteria to enter along the margins of the restoration. Microleakage can 
seriously affect the health condition of the apical zone and, in fact, the main cause of failure of 
endodontic treatments is the lack of seal of the root canal filling [82].  
Leakage mainly occurs between the root canal filling and the root canal wall, although 
there are some reports also showing leakage between the sealer and the core material or 
Theoretical framework 205 
 
throughout the sealer [82]. Leakage is influenced by the root canal filling material itself and by a 
number of other factors, such as [82]: 
i) Root canal anatomy and preparation. Unsuitable cleaning and shaping impede the correct 
application of the root canal filling material. 
ii) Coronal leakage. Bacteria may penetrate an obturated root canal within few days/weeks if the 
access cavity is not sufficiently sealed. 
iii) Smear layer. Removal of the smear layer (layer of microcrystalline and organic particle debris 
that covers the root canal walls), using citric acid (10–50%) or ethylenediaminetetraacetic acid 
(EDTA, 17%), may influence leakage. Although controversial results have been reported, most 
authors indicate that the leakage is decreased if the smear layer is removed, since the sealer can 
penetrate better into the dentinal tubules. 
iv) Hemostasis/dryness of the root canal. The wall of the root canal must be clean and dry for tight 
adaptation of the sealer to the wall. 
v) Root canal filling material: the material has to be stable, adhere to dentin and should have lack 
of pores. 
vi) Sealer thickness and obturation technique. Thick layers of root canal sealers showed more 
leakage than a thin one, which indicated that the sealer is more responsible for microleakage than 
the core material, probably due to the fact that most sealers contain pores and dissolve faster than 
the core material.  
Assessment of the sealing ability 
Nowadays, there is no commercial root canal filling material that can totally prevent 
leakage. Therefore, a bacteria-tight coronal restoration is of critical importance to ensure the 
success of root canal treatment [82]. 
Results reported in the literature regarding microleakage of root canal filling materials 
depend greatly upon the methods being used. Therefore, data should be regarded with caution. 
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The in vitro tests that have been more often performed include dye penetration, with additional 
pressure, centrifugation or vacuum. Bacterial penetration and fluid transport have also been used 
[82]. A widely used technique nowadays is the liquid pressure method, proposed by Derkson et al. 
for restorative materials [107], which allows quantifying root canal filling microleakage through a 
non-destructive testing. Table 4.9 shows a summary of leakage tests carried out with different root 
canal fillers, reported in literature.  
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Table 4.9. Compendium of different studies to evaluate the leakage of root canal filling materials. All tests were performed using single-root human teeth, otherwise it is 
indicated. Some abbreviations are used: GP: gutta-percha, MTA: mineral trioxide aggregate; WMTA: white MTA; GMTA: grey MTA; PCS: pulp canal sealer. Several 
endodontic materials were tested: GuttaFlow is a powdered gutta-percha with nanosilver particles, Epiphany is a resin cement, Resilon is a polymer-based material, AH Plus 
is a resin, Coltosol, pulp canal sealer (PCS) and Kerr Canal Sealer are zinc oxide cements, and TC are experimental accelerated Tetrasilicate Cement. 
Material under 
study 
Control material Use of gutta-percha? Times of study 
Method to evaluate 
leakage 
Leakage of the materials studied References 
MTA 
FMTA 
AH Plus Yes, warm 
24 h, 48 h; 1 and 2 weeks; 
1, 3 and 6 months 
Fluid filtration 
SEM/EDX 
24 h: 0.26 ± 0.20 µl/min 
48 h: 0.21 ± 0.17 µl/min 
[108] 
GuttaFlow using 
different obturation 
methods 
AH Plus 
Control yes; 
experimental groups: 
half of the groups 
1 week; 1.5 and 3 months Fluid filtration 
1 week: 
With GP: 0.07 ± 0.048 µl/min 
Only cement: 0.018 ± 0.009 µl/min 
[109] 
Epiphany/Resilon 
Coltosol 
AH Plus/GP Yes, Resilon and GP 
Immediately and 6 
months 
Fluid filtration 
Immediately: 
Epiphany/Resilon: 0.075 ± 0.075 µl/min 
AH Plus/GP: 0.05 ± 0.025 µl/min 
[110] 
MTA 
Pulp Canal Sealer 
(PCS) 
GP and PCS, apex 
sealed off with 
bonding agent and 
varnish 
Yes, warm 24 h and 28 days 
Fluid filtration 
Leaching (ICP-AAS 
and SEM) 
24 h: MTA:0.075 ± 0.075;  
24 h: PCS: 0.05 ± 0.075 
28 days: MTA: 0.09 ± 0.075;  
28 days: PCS: 0.08 ± 0.075 
[111] 
GMTA 
WMTA 
Kerr Canal Sealer 
GP and Kerr Canal 
sealer, coated with 
varnish 
Only Kerr Canal Sealer From 0 to 42 days 
Turbidity test 
(bacteria, %) 
42 days: GMTA 10% 
WMTA: 38%; Gutta+Kerr: 82% 
[112] 
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Material under 
study 
Control material Use of gutta-percha? Times of study 
Method to evaluate 
leakage 
Leakage of the materials studied References 
MTA (bovine 
incisors) 
Lateral GP 
Warm GP 
Yes, control 1 week 1% methylene blue 
GP lateral: 0.59 ± 0.63 µl/min 
Warm GP: 0.76 ± 0.86 µl/min 
MTA: 8.65 ± 4.24 µl/min 
[113] 
As a retrogradate 
material 
TC-1 
TC-2 
WMTA Yes 
4, 24 and 48 h; 1 and 2 
weeks; 3 months 
Fluid filtration 
pH 
XRD 
3h: 0.9 ± 0.2; 24h: 0.8 ± 0.5; 48h: 0.4 ± 
0.3; 1 week: 0.1 ± 0.2; 2 weeks: 0.1 ± 0.6; 
12 weeks: 0.0 ± 0.0 µl/min 
[114] 
Apical part: GP + AH 
Plus sealer or 
unfilled 
Root-end: gMTA 
(filled or 3mm) 
Completely covered 
with 2 layers of nail 
varnish 
Half of the groups 
Up to 75 days (until 
bacteria penetrate) 
Bacterial 
penetration 
Roots obturated with GP and AH plus 
sealer showed a lower average time for 
bacterial leakage 
[115] 
GP and AH Plus 
sealer, different 
post space 
preparation 
Cyanocrylate cement Half of the groups 1 month Fluid filtration 
Intrinsic permeability of system: 0.029 ± 
0.04 
Immediate removal GP: 1.26 ± 0.45 
Delayed removal GP: 1.11 ± 0.29 
MTA apical filling: 0.61 ± 0.33 
(units: µl·cmH2O-1·min-1) 
[116] 
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4.5.5 Biocompatibility  
It has to be taken into account that root canal sealers and filling materials are exposed to 
the periradicular tissue at the apical and lateral foraminae, so superior tissue tolerance to sealer is 
required to minimize local and systemic side effects [117]. Therefore, in vitro and in vivo assays are 
recommended to evaluate the material biocompatibility.  
Many works inaccurately obviate the importance of the biocompatibility of the materials 
aimed to endodontic applications, probably because they are not aimed at bone regeneration. For 
example, there are several studies regarding alkaline calcium phosphate cements intended for root 
canal filling or pulp capping that do not mention a word regarding the material biocompatibility 
[76–78,99]. However, the successful commercialization of MTA has recently encouraged the 
evaluation of its cytotoxicity and, nowadays, there are many works regarding this aspect of MTA. 
These results, which are controversial because they are highly dependent on the experimental 
conditions used, will be discussed in the Discussion section of Chapter 6. 
4.6 Materials commonly used to fill the root canals 
As previously explained, the root canals are usually obturated using a combination of the 
core, which acts as a piston, and the sealer, a paste that can be spread onto the core material, 
filling voids and attaching it to the dentin wall [89]. Figure 4.13 shows a schema of different types 
of root canal fillings, divided as core obturating materials or as sealers [81]. 
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Figure 4.13. Schema of the types of root canal filling ma
 
4.6.1 Core obturating materials
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4.6.2 Sealers 
The concept of using a sealer is that it fills the irregularities between the prepared canal 
and the core material, thus providing a fluid-tight sealing [81,89]. Generally, the major types of 
sealers are zinc-oxide-eugenol-based, resin-based (mainly made with epoxy), glass ionomer, 
calcium hydroxide-based, silicone paste and mineral trioxide aggregate (MTA) cement [81].  
Nevertheless, none of the mentioned sealers have ideal properties. On one hand, the main 
drawback of both zinc-oxide-eugenol and resin-based sealers is their toxicity [81,89]. On the other 
hand, both glass-ionomer and calcium hydroxide-based sealers degrade with time, threatening the 
sealing of the obturation [81,89]. Therefore, the two later sealers are only recommended for 
temporary restoration. In fact, calcium hydroxide has commonly been used as inter-appointment 
dressing due to its antimicrobial properties [81]. Regarding silicone pastes, their main disadvantage 
is that they do not display any antibacterial activity. Finally, mineral trioxide aggregate (MTA) has 
proved to support hard-tissue repair at root-ends and root exposures, and it is therefore a good 
sealing candidate.  
4.6.3 Gold standard for root canal filling 
Nowadays, the gold standard for root canal filling is a combination of a few gutta-percha 
points with a sealer. 
4.7 Dough core obturating materials with intrinsic antimicrobial 
properties 
Cements with antimicrobial properties have been pointed out as good candidates for 
preventing or treating certain infections. In the endodontic context, they could be applied to treat 
infections occurring in the dental pulp or to remove remaining bacteria in the root canal in a root 
canal treatment.  
In fact, endodontic fillers have been provided with a permanent antiseptic effect to ensure 
the total disinfection of the root canal and microcanals. With this aim, materials containing 
formaldehyde or iodoform have been used. Nevertheless, these materials are unacceptable for 
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their high toxicity, even causing chronic inflammation in some cases, in spite of their good physical 
properties [86]. Also, some additives such as silver oxide have been added to root canal filling 
materials to potentiate their antimicrobial properties [81]. 
Alkaline materials have also been used as root canal fillers due to their biological and 
pharmacological advantages, such as disinfecting the dentinal tubules and rendering a therapeutic 
environment surrounding the roots. Calcium oxide-based pastes have intrinsic antimicrobial 
properties due to their high pH [82]. Two of the main calcium oxide-based pastes that have been 
used as core obturating materials, calcium hydroxide and mineral trioxide aggregate (MTA), are 
described below.  
4.7.1 Calcium hydroxide 
 Calcium hydroxide-based materials (pH ∼ 12.5) have been used since 1930s as inter-
appointment dressing in pulpectomy treatments, in some apexification techniques and as a 
component of several root canal sealers [117]. These materials are commonly used as temporal 
dressing due to their low mechanical properties [88] and their high solubility.  
The two main reasons for using calcium hydroxide as a root-filling material are, on one 
hand, the stimulation of the periapical tissues, which maintains the health or promotes healing 
and, on the other hand, its antimicrobial potential. The very high pH of calcium hydroxide causes 
an initial degenerative response in the immediate vicinity to the material, this necrosis being 
rapidly followed by a mineralization and ossification response because calcium hydroxide 
encourages both reparation and active calcification, stimulating the periapical tissues to recover 
[117] [118]. 
 Several studies have compared the cytotoxic effects of calcium hydroxide with that of 
other root canal sealers [117]. Cell culture tests using either human periodontal ligament cells or 
monolayer or multilayer mouse cells have shown calcium hydroxide-based materials to be less 
toxic compared with zinc oxide eugenol and resin-based sealers [119–122].  
Theoretical framework 213 
 
4.7.2 Mineral trioxide aggregate (MTA) 
 The mineral trioxide aggregate (MTA) is a commercial cement mainly composed by CaO (∼ 
60 − 67 wt%) and SiO2 (19 – 25 wt%) that derives from the Portland cement. It was developed in 
the Loma Linda University (California, United States) in 1993 [123] and since then it has been 
proved to have a good performance in endodontic applications [124].  
 Nowadays, MTA is used as pulp capping, end-root canal filling or core obturating material 
and it has antimicrobial properties due to its high alkalinity (pH ∼ 12.5) [82]. Moreover, it has been 
reported that the MTA also shows high compressive strength, lower dissolution with time than 
calcium hydroxide [82], good sealing ability and adequate biocompatibility [104,125]. 
Even though the MTA is commercialized and widely used in clinics, it still shows significant 
drawbacks:  
 Low stability with time due to its high content in calcium oxide [94,126,127], which transforms 
into calcium hydroxide after hydration. The high solubility of calcium hydroxide (0.160 g/100 g H2O 
at 20°C, Ksp = 5.3 at 25°C [95]) allows predicting that MTA will dissolve with time [103]. In fact, a 
long-time stability study showed that 24% of MTA was dissolved after 78 days when using the 
liquid to powder ratio recommended by the manufacturer [104]; 
 Long setting time, between 3 and 4 hours [126,128], which forces to postpone the final 
restoration of the tooth in a later follow-up appointment (period during which a moist cotton 
pellet is temporarily placed in direct contact with the material [94]). Moreover, there is the risk 
that saliva removes MTA from the tooth cavity or that MTA irritates the surrounding tissues [129]; 
 Bad handling properties [124,128,130]: MTA paste may lose its consistency if an excessive 
amount of water is added, even when using the liquid to powder ratio recommended by the 
manufacturers [103]; 
 High cost [130]. 
Although this cement has been the aim of a large number of works, it still presents several 
problems. Therefore, several studies indicated strategies to reduce its setting time [131], to 
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improve its handling properties [132], to increase its antimicrobial properties [133] or to enhance 
its purity [134]. 
 
The lack of root canal filling materials with excellent properties opens a door to the 
development of new materials with enhanced performance as root canal fillers.  
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5.1 Introduction 
Magnesium-phosphate-based cements (MPC) were first discovered during 1939–1940 by 
Prosen [1,2] as refractory materials for use in casting dental alloys. They consisted of a mixture of 
magnesium oxide and phosphoric acid, and formed water-soluble magnesium dihydrogen 
phosphate [Mg(H2PO4)2·nH2O] as a reaction product. Later, ceramics with very low solubility were 
formed by replacing the phosphoric acid for a salt such as ammonium dihydrogen phosphate. 
Several magnesium-phosphate-based cements (MPC) were developed for use as structural 
materials during the second half of the last century.  
MPCs are essentially acid-base cements and can react at room temperature. Dead-burned 
magnesia is used as the alkaline component, whereas ammonium phosphates are the preferred 
acid components, either as diammonium hydrogen phosphates ((NH4)2HPO4) [3] or ammonium 
dihydrogen phosphate (NH4H2PO4) [4–7]. Their fast setting and early strength attainment and also 
their adhesive properties were some of the most relevant features of these cements, which are 
used in civil engineering for rapid repair of roads, industrial floors and airport runways [4,6,8]. The 
main problem with ammonium magnesium phosphate cements is that, during setting and even 
after, they tend to release ammonia [9–11].  
Despite the unique benefits provided by these systems, they have not been exploited in 
clinical applications up to date. Only recently, the use of ammonium-magnesium phosphate 
cements (ammonium-MPCs) in combination with calcium phosphate cements (CPCs) has been 
proposed for bone regeneration applications [12–15]. The combined CPC-ammonium-MPCs were 
shown to be biocompatible and osteogenic in vivo [13,15]. Additionally, a recent study reported 
that both mutagenicity and potential carcinogenicity were negative for ammonium MPC extracts 
[16]. In a different context, the growing interest in biodegradable magnesium alloys for medical 
application has fostered numerous studies on the effect of the release of magnesium ions in vivo. It 
has been shown that local magnesium release in bone not only has not any adverse effect [17] but 
also enhances osteoclast and osteoblast activity [18,19], thus reinforcing the hypothesis that Mg
2+
 
ions play a key role in bone metabolism [20,21].  
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Nevertheless, the use of the ammonium magnesium phosphate cements may present 
some problems in clinical applications. On one hand, the use of an ammonium salt may 
compromise the biocompatibility of the cement. In fact, ammonia released during processing and 
storage is one of the problems associated with these mortars [9–11], which leads to container 
corrosion and creates an unpleasant environmental odor, restricting their use to outdoor 
applications. On the other hand, the fast acid-base reaction leads to an exothermic process [4,9] 
that should be strictly controlled to avoid tissue necrosis. 
In this context, this Chapter aims at the development of novel formulations of MPCs that 
do not compromise the cement biocompatibility due to the ammonium release or the exothermy.  
 
5.2 Objectives 
This Chapter aims at the development of a novel family of inorganic cements, the 
magnesium phosphate cements (MPCs), with enhanced properties for clinical applications. In order 
to fulfill this purpose, the specific objectives are the following: 
1. To prepare MPCs with a low amount or without ammonium-compounds in order to reduce or 
avoid the release of ammonia or ammonium ions to the surrounding tissues. 
2. To control the exothermy of the setting reaction by the adjustment of the granulometry, the 
reactivity of MgO and/or the addition of a retarding agent. 
3. To characterize the paste of the MPC formulations by assessing the setting times and the 
injectability. 
4. To evaluate the phase composition, microstructure, mechanical properties, specific surface area, 
skeletal density and pore size distribution of the MPC formulations. 
Figure 5.1 schematically shows the structure of this Chapter. 
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Figure 5.1. Schema of the studies evaluated in Chapter 5. 
 
5.3 Materials and methods 
5.3.1 Powder phase 
The powder phase of the cement consisted of a mixture of heavy magnesium oxide (MgO, 
Merck, ref n. 105867), as the basic component, and an acid component that was either ammonium 
dihydrogen phosphate (NH4H2PO4, Panreac ref n. 131126.1210), sodium dihydrogen phosphate 
(NaH2PO4, Fluka ref n. 71496) or an equimolar mixture of both. 
Since the reaction between MgO and the phosphate salt is an acid-base one, an 
exothermic process takes place [4,9]. In order to control the exothermy of this process and to 
protect the tissues that would surround the cement in vivo, three different strategies were 
employed: i) the MgO was calcined in order to decrease its reactivity, ii) a retardant was added to 
the powder phase, and iii) the particle size of all reactants was controlled by milling.  
The MgO was calcined at 1475°C for 6 h to decrease its reactivity [22,23]. After the thermal 
treatment, 50 g of the MgO powder were milled in a planetary ball mill (Fritsch, Pulverisette 6), 
using an agate jar and 4 agate balls (φ = 30 mm) at 150 rpm for 15 min. The ammonium and sodium 
phosphate salts were also milled (50 g), following two different milling protocols in order to obtain 
coarse and fine powders for each salt. Sodium tetraborate decahydrate (Na2B4O7·10H2O, Fluka, ref 
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n. 72000), known also as borax, was added to the powder phase as a retardant of the reaction [24–
28]. Previously, 50 g of borax were milled at 150 rpm during 15 min. 
The particle size distribution was characterized by laser diffraction (Beckman Coulter LS 13 
320), after sonicating the powder in ethanol in order to avoid particle agglomeration. Table 5.1 
shows the particle size of the reactants after applying the different milling protocols, and also after 
being calcined for different time periods in the case of MgO. 
Table 5.1. Milling protocols and particle size distribution of the magnesium oxide, the two phosphate salts and the 
retardant used as reactants for the MPCs. Di (D10, D50 and D90) stands for the average particle size where i% of the sample 
volume is smaller than Di.  
 
Powder 
size 
Milling protocol D10 (µm) D50(µm) D90(µm) 
Magnesium source      
MgO (1475°C 6 h) Coarse 150 rpm−15 min 0.55 ± 0.44 4.75 ± 0.68 27.49 ± 6.65 
Phosphate source      
NH4H2PO4 
Coarse 150 rpm−15 min 16.99 ± 5.58 274.97 ± 13.70 550.4 ± 23.3 
Fine 350 rpm−60 min 1.97 ± 0.52 14.15 ± 6.32 35.89 ± 8.20 
NaH2PO4 
Coarse 150 rpm−15 min 11.89 ± 7.24 185.51 ± 97.99 446.7 ± 111.98 
Fine 350 rpm−30 min 1.59 ± 0.18 7.07 ± 0.83 29.21 ± 4.38 
Retardant      
Borax Coarse 150 rpm−15 min 13.48 ±4.77 66.77 ± 15.82 214.47 ± 55.76 
 
5.3.2 Cement preparation 
Three series of MPC were prepared by combining MgO with either ammonium dihydrogen 
phosphate, sodium dihydrogen phosphate or an equimolar mixture of both. A MgO/phosphate salt 
molar ratio of 3.8/1 was employed, since it is known that, in the case of ammonium magnesium 
phosphate cements, an excess of magnesia ensures reaction completion and enhances strength 
development [5,25,29]. The powder was mixed with distilled water at a liquid to powder ratio of 
0.13 ml/g, forming a cement paste that resulted in a solid body after hardening, as schematically 
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shown in Figure 5.2. The formulations were named as NH4-MPC, Na-MPC and NH4+Na-MPC, 
respectively, accounting for the type of phosphate salt used. 
 
Figure 5.2. Schematic representation of the reactants included in the powder phase, which when 
mixed with water, give place to the cement paste that resulted in a solid body after hardening. The 
three MPC formulations are indicated, as well as the phosphate salts that originated them.  
 
5.3.3 Optimization of the MPC formulation  
The cement exothermy while setting was a crucial parameter to control in order to avoid 
high levels of heat causing irreversible damages to the surrounding tissues [30]. The exothermy of 
the cements was evaluated at room temperature. The temperature evolution of the cements 
during the setting reaction was followed by introducing a type K thermocouple (Thermometer RS 
1313) into 1.5 g of cement paste placed in a plastic container. When monitoring the temperature 
evolution, time zero was the moment in which the liquid phase was added to the powder. 
The exothermy of the cement was adjusted gradually. Firstly, the effect of the phosphate 
salts granulometry on the exothermy was evaluated, being selected the milling protocol that 
produced a lower exothermy. Secondly, the amount of borax required was assessed (Figure 5.3).  
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Figure 5.3. Processing of the reactants to establish an appropriate exothermy
 
The MPC formulations with an adequate exothermy for 
for subsequent characterization. 
5.3.4 Physico-chemical characterization studies
Both the cement paste and the 
characterized. Except for the evaluation of the 
characterized after stopping the setting reaction by introducing the cements in acetone for 1 h and 
afterwards drying them at 37°C for 24 h. 
were used to characterize both the cement paste and the set cement. 
briefly explained beyond. 
Figure 5.4. Schema of the cement preparation and of the characterization of both the cement paste 
and the solid body. 
.  
clinical requirements were selected 
 
cement set at different time points of immersion
mechanical properties, the set cement
Figure 5.4 schematically indicates the techniques that 
The techniques used are 
 
 
 were 
s were 
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5.3.4.1 Setting and cohesion time 
The setting times of the cement paste were determined with the Gillmore needles, as 
explained in Chapter 3 (Section 3.3.2.1). The cohesion time was measured by virtual inspection of 
the cement, as explained in Chapter 3 (Section 3.3.2.2). 
5.3.4.2 In situ setting evolution by FTIR 
The fresh cements (0.5 − 1 min after the liquid phase was added to the powder) were 
analyzed using a Fourier-transform infrared spectroscopy (FTIR, Spectrum GX, Perkin Elmer). The 
three MPC formulations were prepared without the addition of borax in order to simplify the 
system. In other words, to only evaluate the reactions between the main reactants and thus avoid 
any interference of borax, which is known to interact with MgO [24,31]. A small amount of paste 
was deposited on the surface of a cell that consisted of two Hastelloy plates containing a pair of 
diamond windows that enabled samples to be compressed to an ideal thickness for transmission 
measurements. This means that pre-preparation was minimal and the fresh cement was ready for 
direct analysis on an FTIR microscope stage. The analysis was performed in situ at regular intervals 
of time for a period of 60 min. 
5.3.4.3 Mechanical properties 
Cylindrical Teflon molds (6 mm in diameter and 12 mm in height) were filled with the 
cement paste and were immersed in Ringer’s solution at 37°C to simulate physiological conditions. 
After different periods of time (1 h, 2 h, 1 day and 7 days) the specimens were removed from the 
molds and the compressive strength was measured in wet conditions using a Universal testing 
machine (Adamel Lhomargy DY 32/34) equipped with a load cell of 10 kN at a crosshead speed of 1 
mm/min. Ten specimens were tested for each time point.  
5.3.4.4 Crystalline phases 
The phase composition of the MPCs at different time points (1 h, 2 h, 1 and 7 days) was 
assessed by X-ray powder diffraction (XRD, PANalytical, X’Pert PRO Alpha-1). The samples used to 
test the mechanical properties were introduced in acetone for 1 h to stop the reaction and 
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afterwards were dried at 37°C for 24 h. The cements were pulverized by crushing them in an agate 
mortar.  
The XRD measurements were done using Bragg Brentano geometry using a Cu Kα radiation. 
The step-scanning was performed with an integration time of 50 s using a 2θ scan step of 0.017° 
between 4 and 50°. Indexing of the peaks was carried out by means of cards JCPDS #79-0612 for 
MgO; JCPDS #85-0881 for NH4H2PO4; JCPDS #84-0112 for NaH2PO4; JCPDS #12-0258 for 
Na2B4O7·10H2O; JCPDS #77-2303 for struvite, MgNH4PO4·6H2O; and JCPDS # 16-0353 for schertelite, 
Mg(NH4·HPO4)2·4H2O [32]. 
5.3.4.5 Morphology 
The microstructure of both the reactants and fracture surfaces of the cements (set in 
Ringer’s solution for 1 h and 7 days) was observed by Field Emission Scanning Electron Microscopy 
(FESEM, JEOL JSM-7001F). The samples were placed on a carbon fiber stuck on a copper layer. For 
the cements, colloidal silver was used to paint a line from the top of the cement to the holder. 
5.3.4.6 Specific surface area 
The specific surface area of MPCs set for 7 days in Ringer’s solution was analyzed by N2 
adsorption (Micromeritics ASAP 2020) following the BET (Brunnauer – Emmet – Teller) theory. Two 
replicates were performed for each formulation.  
5.3.4.7 Skeletal density 
The skeletal density of MPCs set for 7 days in Ringer’s solution was measured by helium 
pycnometry (Micromeritics AccuPyc 1330). Three replicates were performed for each formulation. 
5.3.4.8 Porosimetry 
The total porosity and the pore size distribution of MPCs set for 7 days in Ringer’s solution 
were evaluated by mercury intrusion porosimetry (MIP, Micromeritics AutoPore IV 9500). 
Cylindrical specimens (6 mm diameter and 12 mm height) set in Ringer’s solution for 7 days were 
evaluated. One assay was performed for each formulation. 
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5.3.5. Statistical analysis of the results 
A Student’s t-test was used to determine the statistically significant differences between 
the mean values of the different experimental groups. A difference between groups was 
considered to be significant at p < 0.05. 
 
5.4. Results 
5.4.1 Optimization of the MPC formulations  
a) Effect of phosphate salt type and granulometry 
The effect of both the type of phosphate salt and the powder granulometry on the 
exothermy of the three MPCs to which 3 wt% borax was added is shown in Figure 5.5. The cements 
prepared with sodium dihydrogen phosphate presented lower exothermy. Moreover, the 
maximum temperature appeared at shorter times, around 5 min, suggesting a faster reaction. In 
the cements prepared with ammonium dihydrogen phosphate, the maximum temperature was 
reached after 12 min, and the MPC prepared with an equimolar mixture of both phosphate salts, 
reached the maximum temperature at an intermediate time. Moreover, in all cases, a clear effect 
of the powder fineness was observed, the use of coarse powder reducing the exothermy of the 
reaction, as expected. Therefore, the coarse powder was selected for the continuation of the 
studies. 
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Figure 5.5. Temperature evolution
granulometry for the phosphate salt. 
 
The particle size distribution of the reactants
Figure 5.6. 
Figure 5.6. Particle size distribution of the reactants of MPCs
at 150 rpm for 15min, coarse NH4H
 
b) Effect of borax 
Figure 5.7 shows the effect of the amount of borax in the temperature evolution. In all 
cases, an increasing amount of borax resulted in a decrease of the maximum temperature reached 
 for NH4-MPC, Na-MPC and NH4+Na-MPC using different powder 
 
 used for the preparation of MPCs 
: MgO calcined at 1475°C for 6h and milled 
2PO4 and NaH2PO4, and borax.  
 
is shown in 
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and, simultaneously, in a delay of the time at which th
retarding the setting reaction. It is interesting to note that borax was more effective in reducing 
the exothermy of the reaction in the case of NH
NH4-MPC the maximum temperature was reduced from 110
whereas in the Na-MPC this temperature was reduced from 61 to 42
from 67 to 44°C.  
Figure 5.7. Temperature evolution of: a) NH
amounts of coarse borax (wt%). 
 
For the succeeding studies, a concentration of 
considered that the exothermy was low enough to be compatible with clinical applications
is maximum temperature was r
4-MPC than in the other two formulations. In the 
 to 42°C when adding 3 wt% borax, 
°C and in the NH
4-MPC, b) Na-MPC and c) NH4+Na-MPC with 
 
3 wt% borax was selected 
 243 
eached, 
4+Na-MPC 
 
different 
since it was 
 [33]. 
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5.4.2 Physico-chemical characterization of MPCs 
5.4.2.1 Setting and cohesion times  
The initial (tI) and the final (tF) setting times, and the time at which the maximum 
temperature was reached (tTmax) for the three MPC formulations containing 3 wt% borax are 
displayed in Table 5.2. The initial and final setting times of a CPC are included, for comparison [34].  
Table 5.2. Initial setting time (tI), final setting time (tF), time at which the highest temperature was 
reached (tTmax) and cohesion time (tC) for the three MPC formulations The average ± standard deviation 
is shown, n = 3. The initial and final setting times of an apatitic CPC are given for comparison [34].  
MPC formulation tI  (min) tF (min) tTmax(min) tC  (min) 
NH4-MPC 15 ± 1 16 ± 1 15.0 ± 08 ≥ 20 
Na-MPC 8 ± 2 9 ± 2 8.2 ± 0.4 ≥ 10 
NH4+Na-MPC 12 ± 2 13 ± 2 10.5 ± 0.4 ≥ 15 
CPC  9 19 
− − 
 
The Na-MPC was the formulation with shortest initial and final setting times, followed by 
NH4+Na-MPC and, finally, NH4-MPC. In contrast to what happens in CPCs, the initial and final 
setting times were very close, and tTmax was very similar to tI in all MPCs. The cohesion time was 
slightly longer than the final setting time in the three formulations. 
5.4.2.2 In situ setting evolution by FTIR 
FTIR allowed evaluating in situ the setting evolution of the MPC formulations. This study 
was done without the addition of borax to the powder phase in order to simplify the system, since 
it is known that borax can react with MgO [24,31]. 
Figure 5.8 a shows the setting evolution for NH4-MPC prepared without borax, at different 
setting times. It is interesting to note that there was a quick evolution of the bands during the first 
10 min (mostly between 500 − 1500 cm
-1
), indication of the fast reaction between MgO and 
NH4H2PO4. However, after 10 min, the bands were not significantly modified, showing that most of 
the end-products were already formed.  
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Figure 5.8 b shows the spectrum of the NH
position of most of the bands w
the phosphate groups matched with those reported for CDHA. Table 5.3 displays the experimental 
values and the wavenumbers reported in the literature
Figure 5.8. FTIR spectra of NH
reaction.  
 
 
4-MPC after 60 min of setting reaction. The 
as in accordance with that of struvite and MgO, and the position of 
.  
4-MPC (without borax): a) at different setting times and b) after 60
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Table 5.3. Band assignments for NH4-MPC (without borax) after 60 min of setting. The experimental 
values are compared with those reported in literature. Some abbreviations are used: sh: shoulder; s: 
strong band; vs: very strong; m: medium; w: weak; wd: wide.  
Band assignment 
Experimental values 
(cm
-1
) 
Compound, frequency (cm
-1
) 
according to literature 
Refs. 
Water of 
crystallization 
OH, NH stretching 3355 (wd) Struvite, 3276.9 (wd) [35] 
OH, bending 2364 (wd) Struvite, 2400 (wd) [36] 
δ(HOH) 1684 (wd) Struvite, 1680 [36] 
H2O 1438 (s) Mg3(PO4)2+Ca3(PO4)2, 1432.2 [37] 
NH4
+
 units 
ν1, NH 2820 (wd) Struvite, 2800 − 3000 [35] 
ν4, NH 1454 (sh) Struvite, 1451 [36] 
NH 1288 (m) Struvite, 1263 [36] 
NH, librational 754 (m) Struvite, 754 [36] 
NH, librational 685 (m) Struvite, 690.9 [35] 
PO4
3-
 units 
PO4
3-
, ν3 1167 (w) CDHA, 1136 (sh) [38] 
PO4
3-
, ν3 1093 (w) CDHA, 1085 (sh) [39] 
PO4
3-
, ν3 1066 (w) Struvite, 1064.7 [35] 
PO4
3-
, ν3 1033 (sh) CDHA, 1045 (vs) [38] 
PO4
3-
, ν1 970 (s) CDHA, 960 (m), 965 (w),  [38,39] 
PO4
3-
, ν4 566 (m) CDHA, 562 (w) [38] 
HPO4
2-
, ν5 871 (m) CDHA, 870 (w) [39] 
Metal-oxygen 
bonds 
MgO 526 (m) Struvite, 510.4 [35] 
 
The setting evolution of Na-MPC (prepared without borax) by FTIR showed a fast 
modification of the bands during the first 20 min (Figure 5.9 a), indication that a reaction between 
MgO and NaH2PO4 was taking place. After this time, when probably the major part of the end-
product was already formed, the position and shape of the bands remained similar until the end of 
the study. 
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Figure 5.9 b indicates the bands
The position of the bands was associated to 
were linked to that of CDHA. Table 5.4 compiles the experimental values and compares them with 
those reported in literature. 
Figure 5.9. FTIR spectra of Na
setting.  
 
Table 5.4. Band assignments for Na
values are compared with those reported in literature. So
strong band; vs: very strong; m: medium; w: weak; wd
Band assignment 
Water of 
crystallization 
OH stretching
OH
OH water-adsorbed 
bending
OH libration
PO4
3-
 units 
PO4
3-
, 
PO4
3-
, 
δOH of HPO
HPO4
2
Metal-oxygen 
bonds 
MgO
 present in the spectrum of Na-MPC after 60 min of setting
that of struvite and MgO, and the phosphate groups 
-MPC (without borax): a) at different setting times, and b) after 60 min of 
-MPC (without borax) after 60 min of setting. The experimental 
me abbreviations are used: sh: 
: wide.  
Experimental 
values (cm
-1
) 
Compound, frequenc
according to literature
 3230 (wd) Struvite, 3276.9 (w)
 2375 (wd) Struvite, 2400 (broad)
 
1651 (wd,s) CDHA, 1640 (w)
 670 (w) CDHA, 632 (sh, vw)
ν3 1066 (m) Struvite, 1064.7
ν1 984 (m) CDHA, 960 (m), 
4
2-
 1267 (sh) CDHA, 1215 (sh, w)
-
, ν5 862 (m) CDHA, 870 (w)
 516 (s) Struvite, 510
 247 
. 
 
shoulder; s: 
y (cm
-1
) 
 
Refs. 
 [35] 
 [36] 
 [39] 
 [39] 
 [35] 
965 (w) [38,39] 
 [39] 
 [39] 
.4 [35] 
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Figure 5.10 a shows the spectra of NH
times. A fast evolution of the bands
1500 cm
-1
), indication that the reactants were transforming into the end
spectra evolved slightly. Figure 5.10
reaction. The position of the bands
phosphate groups were linked to that of CDHA. Table 5.5 displays the experimental values and 
wavenumbers reported in the literature.
Figure 5.10. FTIR spectra of NH4+Na
min of setting. 
 
  
4+Na-MPC (without borax) at different reaction 
 was observed for the first 10 min (mainly between 500 and 
-products. Afterwards, 
 b shows the spectrum of NH4+Na-MPC after 60 min of 
 was associated with that of struvite and MgO, and the 
 
-MPC (without borax): a) at different setting times and b) after 60 
the 
the 
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Table 5.5. Band assignments for the NH4+Na-MPC (without borax) after 60 min of setting. Some 
abbreviations are used: sh: shoulder; s: strong band; vs: very strong; m: medium; w: weak; wd: wide  
Band assignment 
Experimental values 
(cm
-1
) 
Compound, frequency (cm
-1
) 
according to literature 
Refs. 
Water of 
crystallization 
OH 3030 (wd) Struvite, 3276.9 [35] 
OH 2360 (wd) Struvite, 2400 (broad) [36] 
OH water-adsorbed 
bending 
1647 (m) CDHA, 1640 (w) [39] 
OH libration 670 (w) CDHA, 632 (sh, vw) [39] 
NH4
+
 units 
ν4, NH 1448 (m) Mg3(PO4)2+Ca3(PO4)2, 1432.2 [37] 
NH
 -
 1271 (m) Struvite, 1263 [36] 
PO4
3-
 units 
PO4
3-
, ν3 1058 (s) Struvite, 1064.7 [35] 
PO4
3-
, ν1 984 (s) CDHA, 960 (m), 965 (w) [38,39] 
HPO4
2-
, ν5 862 (m) CDHA, 870 (w) [39] 
Metal-oxygen 
bonds 
MgO 512 (s) Struvite, 510.4 [35] 
MgO 529 (s) Struvite, 522.4 [35] 
 
5.4.2.3 Mechanical properties 
Figure 5.11 shows the compressive strength of MPC formulations at different reaction 
times. The strength evolution of an apatitic calcium phosphate cement (CPC) is included for 
comparison [39]. After 1 h, the three MPC formulations showed compressive strength values close 
to 30 MPa, in contrast to the apatitic CPC that achieved only 1 MPa. After 2 h, the compressive 
strength of all MPC formulations ranged between 30 and 50 MPa, whereas the CPC attained only 5 
MPa. After 1 day, all MPCs reached a compressive strength close to 50 MPa, which was maintained 
after 7 days except for the NH4+Na-MPC, in which case a decrease to less than 20 MPa was 
observed. The maximum compressive strength of the CPC was around 35 MPa. 
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Figure 5.11. Compressive strength for the three MPC
(7d) immersion in Ringer’s solution at 37
strength evolution of a CPC is included for comparison 
 
5.4.2.4 Crystalline phases 
The XRD patterns obtained for the different formulations after
and 7 days of immersion in Ringer’s solution
presence of MgO in excess was still detected after 7 days. In contrast, the phosphate salts used as 
reactants were not detected either in
rapid dissolution. Only small amounts o
The compounds formed after cement hardening depended on
starting reactant. Thus, in the case of NH
amount of struvite (MgNH4PO4·6H2O) appeared after 1 h setting. After 1 and 7 days the cement 
mainly consisted of struvite, although some schertelite was still
MgO. In NH4+Na-MPC a similar phase evolution was obs
detected after 1 h and a progressive increase in the intensity of the peaks corresponding to struvite 
with reaction time. After 7 days the main product was struvite, coexisting with unreacted MgO and 
a small quantity of schertelite. Finally, in Na
detected, and only a very small and wide shoulder 
the XRD pattern, indicating that the reaction product was an amorphous phase.
 formulations after 1 h, 2 h, 1 day (1d) and 7 days 
°C. Error bars indicate the standard deviation, n = 10. The 
[39].  
 0 h (initial powder), 1 h, 1 
 are shown in Figure 5.12. In all formulations the 
 Na-MPC or in NH4+Na-MPC, even at short times, suggesting 
f NH4H2PO4 were observed in NH4-MPC up to 1 day.
 the phosphate salt used as 
4-MPC, schertelite (Mg(NH4·HPO4)2·4H2O) and a small
 present, coexisting with unre
erved, with schertelite and struvite 
-MPC no crystalline phases apart from MgO were 
around 2θ ∼ 31° was observed in the baseline of 
 
 
 
 
acted 
being 
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Figure 5.12. XRD of set MPC for 0 h, 1 h, 1 day and 7 days in Ringer’s solution at 37
Na-MPC, c) NH4+Na-MPC. A.U. stands for arbitrary units. 
 
5.4.2.5 Morphology of reactants and end
The morphology of the initial reactants 
°C: a) NH
 
-products 
is shown in Figure 5.13.  
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4-MPC, b) 
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Figure 5.13. Morphology of the main reactants, milled at 150 rpm for 15 min: a) MgO, b) NH
NaH2PO4 and d) borax.  
 
Figure 5.14 shows the microstructure corresponding to fractured surfaces of the three 
MPCs after 1 h and 7 days of reaction. 
of a vitreous-like matrix covering elongated particles
Ringer’s solution (Figure 5.14 b), 
appearance. The Na-MPC after 1 h of reaction (Fig
morphology, with a few particles being distinguished underneath a
Numerous cracks were observed, which
hydrated gel-like phase. After 7 days (Figure
matrix were clearly distinguished, which could correspond to the unreacted MgO in the sodium 
magnesium phosphate matrix. The morphology of the NH
intermediate between the two previous ones
in agreement with its composition
phosphate.  
 
4H2PO
After 1 h of reaction, the NH4-MPC microstructure consisted 
 (Figure 5.14 a). After 7 days of immersion in 
the morphology was more homogenous, with a rough 
ure 5.14 c) showed a vitreous gel
 smooth glassy phase. 
 could presumably be created during the drying of the 
 5.14 d), some particles embedded in a continuous 
4+Na-MPC (Figure 5.14 e 
, with some features typical of each of them
, that contains both sodium and ammonium dihydrogen 
4, c) 
-like 
and f) was 
, which is 
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Figure 5.14. Microstructure of the fracture surface of MPC after 1 h: a) NH4-MPC, c) Na-MPC and e) 
NH4+Na-MPC, and 7 days: b) NH4-MPC, d) Na-MPC and f) NH4+Na-MPC. The cements were immersed in 
Ringer’s solution at 37°C.  
 
5.4.2.6 Specific surface area, skeletal density and porosimetry 
Table 5.6 shows the specific surface area (SSA) and the skeletal density for the MPC 
formulations after immersion in Ringer’s solution for 7 days. The lowest value of SSA was obtained 
for the Na-MPC series, whereas both NH4-MPC and NH4+Na-MPC had similar SSA values. The trend 
for the SSA was the following: Na-MPC < NH4-MPC < NH4+Na-MPC, and the values of skeletal 
density were very similar for the three formulations. 
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Table 5.6. Specific surface area (SSA
after 7 days of immersion in Ringer
and n = 3 for skeletal density.  
 
NH4-MPC 
Na-MPC 
NH4+Na-MPC 
 
The entrance pore diameter
porosimetry, is shown in Figure 5.15
distribution, with a band around 0.03 
pores around 10 µm or higher did not match with the morphology of the cement (Figure 5.1
could be attributed to some cracks formed during the drying process.
Figure 5.15. Distribution of the entrance 
Ringer’s solution for 7 days.  
 
Table 5.7 shows the results of total open porosity 
days. It should be mentioned that the total open 
, m
2
/g) and skeletal density (g/cm
3
) of the three MPC formulations 
’s solution. The average ± standard deviation is shown, n = 2 for SSA 
SSA (m
2
/g) Skeletal density (g/cm
3
) 
7.63 ± 0.82 2.46 ± 0.06 
3.95 ± 0.31 2.53 ± 0.04 
7.83 ± 0.93 2.49 ± 0.01 
 distribution, measured by means of mercury intrusion 
. In general, all the specimens presented a bimodal pore size 
µm (30 nm) and another one close to 10 µm. However, the 
 
pore diameter of MPC formulations after being immersed in 
of the three MPC formulations set for 7 
porosity might be overestimated 
4) and 
 
due to the 
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formation of some cracks during the drying process of the material, as previously explained. The 
trend of total open porosity was Na-MPC < NH4+Na-MPC < NH4-MPC.  
Table 5.7. Total open porosity (%) of the three MPC formulations after being immersed in Ringer’s 
solution for 7 days.  
NH4-MPC Na-MPC NH4+Na-MPC 
28.16 17.13 25.50 
 
5.5 Discussion 
The MPC formulations all consist on a mixture of MgO, which is sparsely soluble [9,40], 
with highly soluble acid phosphates. It is known that in this type of cements, the setting reaction 
involves three steps: i) first, the acid phosphate dissolves, releasing phosphate anions and forming 
an acid phosphate solution of low pH; ii) MgO dissolves gradually in the low pH solution and 
releases cations; iii) the phosphate anions react with the newly released cations in an acid-base 
reaction, and form a coordinated network that consolidates around the unreacted MgO (which is 
present in excess), resulting in a hardened ceramic body [9,29,31,41,42]. The mechanism of setting 
resembles the hydratation of Portland cement but it is faster in the case of MPC [25]. 
5.5.1 Exothermy 
The results obtained in this study show that, as expected, the reaction kinetics and 
exothermy of the reaction (Figures 5.5 and 5.7) strongly depend on the solubility of the phosphate 
salt used. Interestingly, Na-MPC exhibited setting kinetics faster than those of NH4-MPC, which was 
evident from both the temperature evolution and the setting times, which were in fact in close 
agreement, as shown in Table 5.2. According to these results the speed of reaction was: Na-MPC > 
NH4+Na-MPC > NH4-MPC. This correlates well with the higher solubility in water of sodium 
dihydrogen phosphate (94.5 wt%) compared with ammonium dihydrogen phosphate (40.5 wt%) 
[40]. Moreover, according to Figures 5.5 and 5.7 the maximum temperature reached during the 
cement reaction was lower when the MPC was prepared with sodium dihydrogen phosphate.  
The fineness of the phosphate salt powder and the amount of borax were two processing 
parameters that were shown to be efficient for controlling the reaction kinetics and the heat 
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evolved during the setting reaction (Figures 5.5 and 5.7). As shown in Figure 5.7, the addition of 
borax effectively reduced the maximum temperature reached during the setting reaction, 
simultaneously increasing the time needed to reach the maximum temperature. In previous 
studies the mechanism of retardation by borax was associated with the adsorption of B4O7
2-
 ions 
on the surface of MgO particles and to the subsequent formation of amorphous magnesium borate 
compounds covering the MgO grains, which would hinder their subsequent reaction [9,24,31]. 
Figure 5.16 schematically shows a possible mechanism of action of borax in an ammonium 
magnesium phosphate cement. In this respect it is interesting to note that, according to our 
results, the retarding effect of borax was more significant for NH4-MPC, followed by NH4+Na-MPC 
and, finally, Na-MPC. This can be related to the fact that the dissolution of borax, a sodium 
tetraborate decahydrate, could be hindered in the formulations containing sodium phosphate, by 
the presence of sodium ions in solution.  
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Figure 5.16. Schematic representation of the effect of borax as retarding agent in the reaction between 
MgO and phosphate salts in an ammonium magnesium phosphate cement
 
In this Chapter three cement formulations were selected with the
setting MPC which could be used in clinical applications, with a moderately exothermic reaction in
order to avoid protein denaturation and ti
phosphate salts and 3 wt% borax were selected as meeting these criteria. It ha
however, that there are specific clinical situat
reaction could be of interest. This would be the case, for instance, for the treatment of vertebral 
.  
 aim of obtaining a fast 
ssue necrosis [33]. The formulations with 
s to be mentioned, 
ions where a cement with an exo
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bone tumors, where implantation of an exothermic cement would allow the application of local 
hyperthermia at the tumor site at the same time as biomechanical stabilization was achieved.  
5.5.2 Setting and cohesion times 
The consistency of the three selected MPC formulations and also their setting times were 
acceptable for clinical applications, with setting times between 8 and 15 min (Table 5.2) [43]. The 
in situ setting evolution by FTIR confirmed the fast evolution of the cement paste, the main 
reactions occurring during the initial 10 or 20 min (Figures 5.8, 5.9 and 5.10). 
A characteristic feature of the three MPCs studied was that in all cases the final setting 
time was very close to the initial setting time (Table 5.2). The setting process was very fast, their 
transition from a plastic paste to a solid body taking place in about 1 min once the initial setting 
time had been reached. 
5.5.3 Crystalline phases 
With respect to the chemical reaction responsible for setting of the different MPCs, the 
XRD studies revealed that the reaction of MgO with either NH4H2PO4 or NaH2PO4 resulted in 
different compounds. Both NH4-MPC and NH4+Na-MPC were developed by step-reactions: first it 
was formed an intermediate phase of low stability until the formation of a more stable phase [9]. 
After only 1 h, schertelite was formed, which was partially transformed into struvite after 1 day 
(Figure 5.12 a and c). The initial formation of schertelite, a tetrahydrate magnesium ammonium 
dihydrogen phosphate with Mg/P molar ratio of 0.5, could be associated to the low availability of 
magnesium ions at the beginning of the reaction. The appearance of schertelite as an intermediate 
product of the reaction was also previously reported [7,44–46]. After 7 days, when MgO was 
further dissolved, the initial compound was almost completely transformed into struvite (Figure 
5.12 a), a magnesium ammonium phosphate hexahydrated with a Mg/P molar ratio of 1, which is 
in agreement with previous studies [5,12,29,42].  
Apart from the higher Mg/P ratio required for the formation of struvite than for 
schertelite, struvite also requires a higher amount of molecules of water than schertelite (Reaction 
5.1 and 5.2).  
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Reaction 5.1  3.8 MgO  +  NH4H2PO4  +  3 H2O  →  Mg(NH4·HPO4)2·4H2O 
        Schertelite 
 
Reaction 5.2  3.8 MgO  +  NH4H2PO4  +  5 H2O  →  MgNH4PO4·6H2O 
        Struvite 
 
The liquid to powder ratio used for the preparation of NH4-MPC (L/P = 0.13 ml/g) did not 
provide enough amount of water for the formation of struvite or schertelite (0.010 mols of H2O 
were added for 0.006 mols of NH4H2PO4, being required 0.018 mols of H2O to form schertelite and 
0.030 mols of H2O to form struvite). In the case that no extra water would be available, dittmarite, 
a magnesium ammonium phosphate monohydrated (MgNH4PO4·H2O), would be formed. However, 
if the cements absorb water from the environment, they gradually transform in a compound 
thermodynamically more stable, at the end being formed struvite. This indicates that factors such 
as the availability of Mg ions and of water governs the composition of the final product of MPCs 
[25,47]. Figure 5.17 schematically shows the step-reactions developed for NH4-MPC.  
 
Figure 5.17. Step-reactions occurring between MgO and NH4H2PO4 in a humid or dry environment. 
 
Regarding the Na-MPC, XRD was not a useful technique to determine the phase 
composition of the end-product due to its amorphous nature. The presence of a broad hump 
around 2θ ∼ 31° (Figure 5.12 b) was compatible with the formation of an amorphous magnesium 
sodium phosphate. The fact that several magnesium sodium phosphate salts have their main 
diffraction peaks in the range of 31−33° makes difficult to hypothesize if a specific poorly 
crystalline sodium magnesium salt was formed. It could be speculated that both the fast 
dissolution of NaH2PO4 in water and the poor solubility of borax in the matrix (which was hindered 
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by the presence of Na ions) enhanced the fast setting reaction of the cement, leading to the 
formation of a precipitate with amorphous nature instead of the ceramic with organized structure 
formed in NH4-MPC [9]. However, since the NH4-MPC also reacted very fast, the most plausible 
hypothesis was that the magnesium sodium phosphate inherently formed a low organized 
crystalline or quasi-amorphous structure. 
NH4+Na-MPC, which was constituted by an equimolar amount of NH4H2PO4 and NaH2PO4, 
might also form the amorphous sodium magnesium phosphate phase, although the hump around 
2θ ∼ 31° was probably masked by the crystalline peaks of struvite. 
In all cases, unreacted MgO was detected in the hardened paste (Figure 5.12), which was 
expected for two reasons. On one hand, because there was a 3.8 M excess of this compound over 
the phosphate salts; on the other hand, due to the low solubility of MgO in water [40]. As 
anticipated, the dissolution of the acid phosphates was much faster. In fact they were not detected 
in the sodium containing MPCs even after 1 h, whereas in the NH4-MPC only a small amount of 
ammonium dihydrogen phosphate remained after 1 day (Figure 5.12). This can be correlated to the 
higher solubility of the sodium dihydrogen phosphate (94.5 wt%) as compared to the ammonium 
dihydrogen phosphate (40.5 wt%) [40].  
5.5.4 In situ setting evolution by FTIR 
The bands observed by FTIR for NH4-MPC and NH4+Na-MPC after 60 min of reaction 
(Figure 8 b and 10 b) were associated to vibration of groups such as PO4
3-
, NH4
+
 and MgO, and were 
in accordance with the formation of struvite (MgNH4PO4·6H2O) [35,47] and the presence of MgO in 
excess. Moreover, the presence of a band close to 870 cm
-1
, associated to HPO4
2-
 groups, could 
indicate the formation of schertelite (Mg(NH4·HPO4)2·4H2O). Therefore, FTIR results showed a good 
accordance with the phases determined by means of XRD. 
Fewer bands were observed in Na-MPC after 60 min of reaction (Figure 9 b). The detected 
bands indicated that the end-product contained covalent bonds such as MgO, PO4
3-
 and HPO4
2-
, 
which also matched with the formation of an amorphous sodium magnesium phosphate 
compound. 
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5.5.5 Mechanical properties 
It is worth noting that the early compressive strength of all MPC formulations was much 
higher than that of CPCs (Figure 5.11), which are the hydraulic cements most used as synthetic 
bone grafts in bone regeneration applications. In these cements, brushite or hydroxyapatite is 
formed through dissolution and reprecipitation of one or more calcium phosphates when in 
contact with water. The apatitic cements, which are more resistant than brushite ones, reach 
compressive strengths of typically 35–40 MPa after several days reaction [39], as reported in Figure 
5.11. The three MPC formulations showed compressive strengths around 30 times higher than a 
CPC after 1 h, and 6–10 times higher after 2 h. At longer reaction times, although the differences 
were smaller, the MPCs continued to show higher compressive strengths, except for NH4+Na-MPC 
at 7 days, which showed a strong drop in strength. Similar maximum strengths were reached 
irrespective of the crystalline or amorphous nature of the final products. Interestingly, the 
hardening mechanism also appeared to be different from that reported in apatitic CPCs, where 
complexation between plate- or needle-like apatite crystals is responsible for progressive stiffening 
of the paste [39]. In MPCs no needle- or plate-like crystals were found, but a continuous matrix 
with polyhedral phases was observed. The early strength acquisition by the MPC formulations is an 
advantage for several clinical applications, where the cement can be subjected to moderate 
loading situations, allowing for mobility of the patient early after cement implantation. 
The hardening kinetics of MPC formulations followed the trend Na-MPC < NH4+Na-MPC < 
NH4-MPC (Figure 5.11). Surprisingly, this trend was opposed to the kinetics determined by the 
setting time and the exothermy. In other words, although the Na-MPC was the formulation that set 
faster, it was also the one needing longer immersion time in order to reach its maximum 
compressive strength. And vice versa for the NH4-MPC. Regarding the chemical composition, the 
Na ions contained in the Na-MPC may hinder the dissolution of the retardant. This would permit a 
faster reaction between the MgO and the phosphate salt, thus accelerating the setting of the 
cement. However, the Na-MPC would require longer times to reach its maximum strength, since 
the whole process of hardening would be delayed.  
The longer time required by Na-MPC to reach its maximum compressive strength (Figure 
5.11) was in accordance with the slow formation of end-products, which provided the strength to 
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the material, since a hump around 2θ ∼ 31° was not clearly observed by XRD until 1 day (Figure 
5.12). In contrast, the faster formation of struvite and schertelite in NH4-MPC and NH4+Na-MPC, 
enhanced the attainment of high early compressive strength for these formulations. 
5.5.6 Morphology, SSA, skeletal density and porosity 
The microsctructure of NH4-MPC suggested the coexistence of an amorphous matrix 
among the elongated particles after 1 h of reaction (Figure 5.14 a), although no background 
directly attributable to an amorphous phase was observed in the XRD patterns. This glassy-like 
structure was assigned to the formation of an amorphous borate compound coating, as previously 
reported [9,24,31].  
The skeletal density of NH4-MPC (Table 5.6) was higher than the expected value for 
struvite, which skeletal density is 1.71 g/cm
3
 [40]. This could be associated to a high amount of 
unreacted MgO (skeletal density of 3.6 g/cm
3
 [40]), since 50.8 wt% MgO was added and only 25.9 
wt% MgO would react (1 mol MgO should stoichiometrically react with 1 mol of NH4H2PO4). For the 
NH4-MPC, a skeletal density of 2.46 g/cm
3
 indicated that 39.7 wt% MgO remained unreacted and 
60.3 wt% struvite was formed. 
The formation of an amorphous hydrated gel in the Na-MPC observed by XRD (Figure 5.12 
b), was consistent with the SEM images obtained after 1 h of reaction (Figure 5.14 c), where a 
glassy morphology was observed. In fact, the amorphous phase observed could be a mixture of 
both the sodium magnesium phosphate formed and the borate compound. Finally, the cracks on 
the surface (Figure 5.14 c) were compatible with the cracking produced during the drying process 
of a highly hydrated gel.  
The Na-MPC, which was the only formulation that gave place to an amorphous compound, 
had a lower SSA than the other two formulations (Table 5.6). The lower SSA of Na-MPC was related 
with its flat surface (Fig. 5.14 c and d), and matched with the higher skeletal density (Table 5.6) and 
the lower porosity of the composition (Table 5.7).  
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5.6 Conclusions 
The conclusions of this Chapter can be summarized as follows: 
1. A novel family of magnesium phosphate cements (MPC), including formulations with different 
compositions, was developed. The MPC reactants consisted of sintered MgO and a phosphate salt, 
either NH4H2PO4, NaH2PO4 or a mixture of both. The three different formulations were prepared, 
namely NH4-MPC, Na-MPC and NH4+Na-MPC. 
2. The exothermy of the reaction was adjusted lower than 45°C by sintering the MgO at 1475°C for 
6 h, by using phosphate salts with a coarse particle size and by adding sodium tetraborate 
decahydrate (borax) as retardant.  
3. The setting times were adequate for clinical applications, with very similar initial and final setting 
times due to the fast cement setting. 
4. The main product of the ammonium-containing cements was struvite (MgNH4PO4·6H2O), and 
schertelite (Mg(NH4·HPO4)2·4H2O) was an intermediate product of the reaction. The Na-MPC 
formed an amorphous sodium magnesium phosphate phase. Unreacted MgO was found in all 
formulations due to the addition in excess of this reactant. 
5. The novel MPCs exhibited high early compressive strength (30 − 50 MPa after 1 – 2 h), which 
was significantly superior to a CPC (1 – 5 MPa after the same time). After 1 day, the three MPC 
formulations had a compressive strength about 50 MPa. 
6. The morphology of NH4-MPC and NH4+Na-MPC showed elongated particles covered by a glassy 
layer, which was associated to the precipitation of a borate compound on the surface of MgO 
particles, thus retarding the reaction between the MgO and the phosphate salts. The amorphous 
product of Na-MPC resulted in a glassy-like microstructure. 
7. The skeletal density of NH4-MPC set for 7 days in Ringer’s solution was higher to that of struvite 
due to the presence of unreacted MgO. Na-MPC had a higher skeletal density, lower specific 
surface area and lower total porosity than the other formulations. 
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6.1 Introduction 
The use of materials in clinical applications is conditioned by their biocompatibility. In the 
case of acid-base cements such as magnesium phosphate cements (MPCs), a first step to 
guarantee an adequate biocompatibility is to control the exothermy of the cements in order that 
the surrounding tissues can tolerate the released heat. The knowledge gained in Chapter 5, 
regarding the role of the processing parameters in the exothermy of MPCs, is applied in this 
Chapter to further reduce the exothermy of MPCs when assessing this property in conditions closer 
to a real situation. 
A second step to evaluate the biocompatibility of a material is to determine the viability of 
cells when they are in contact with it. Furthermore, microbiological studies can also inform about 
the interaction of the material with prokaryotic cells that can lead to an infection. The overall 
results should permit to speculate a potential application for the material.  
 
6.2 Objectives 
The objectives of this Chapter are the following: 
1. To optimize the MPC formulations in order to ensure that mild or no damage of the surrounding 
tissues would occur when implanting the material. 
2. To evaluate the antimicrobial properties of the formulations of MPC and to determine the 
influence of the cement aging. 
3. To evaluate the cell cytotoxicity of the MPC formulations using preosteoblast-like cells, and to 
determine if the cytotoxicity depends on the cement aging. 
Figure 6.1 schematically shows the studies performed in this Chapter. 
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Figure 6.1. Schema of the studies explained in Chapter 6. 
 
6.3 Materials and methods 
6.3.1 Powder phase  
The reactants constituting the powder phase were the same that have been reported in 
Chapter 5 (Section 5.3.1). However, they were differently processed in order to ensure that the 
exothermy would not injure the surrounding tissues. 
Briefly, the powder phase of the cement consisted of a mixture of heavy magnesium oxide 
(MgO, Merck, ref n. 105867) and a phosphate salt that was either ammonium dihydrogen 
phosphate (NH4H2PO4, Panreac ref n. 131126.1210), sodium dihydrogen phosphate (NaH2PO4, 
Fluka ref n. 71496), or an equimolar mixture of both. Sodium borate decahydrated 
(Na2B4O7·10H2O, Fluka, ref n. 72000), known also as borax, was added to the powder phase as a 
retardant of the reaction [1–5]. 
The MgO was sintered at 1475°C for 6 or 12 h, in order to reduce its reactivity [6,7]. 
Afterwards, 50 g of the calcined MgO was milled in a planetary ball mill (Fritsch, Pulverisette 6), 
using an agate jar and 4 agate balls (φ = 30 mm) at 150 rpm during 15 min. The ammonium and 
sodium phosphate salts were milled at 150 rpm during 15 min, producing coarse powders, which 
resulted in a moderate exothermy when used as reactants of the cement, as shown in Chapter 5 
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(Section 5.4.1). Fifty g of borax were milled following two different protocols, in order to produce 
fine (350 rpm during 30 min) and coarse (150 rpm during 15 min) powders. 
The particle size distribution was characterized by laser diffraction (Beckman Coulter LS 13 
320), after sonicating the powder in ethanol in order to avoid particle agglomeration. Table 6.1 
shows the particle size of the reactants after applying the mentioned processing parameters. 
Table 6.1. Milling protocols and particle size distribution of the magnesium oxide, the two phosphate salts and the 
retardant, used as reactants for the MPCs. Di (D10, D50 and D90) stands for the average particle size where i% of the 
sample volume is smaller than Di.  
 
Powder 
size 
Milling protocol D10 (µm) D50(µm) D90(µm) 
Magnesium source      
MgO (1475°C 6 h) 
Coarse 150 rpm-15 min 
0.55 ± 0.44 4.75 ± 0.68 27.49 ± 6.65 
MgO (1475°C 12 h) 0.34 ± 0.02 5.20 ± 0.31 27.2 ± 1.27 
Phosphate source      
NH4H2PO4 
Coarse 150 rpm-15 min 
16.99 ± 5.58 274.97 ± 13.70 550.4 ± 23.3 
NaH2PO4 11.89 ± 7.24 185.51 ± 97.99 446.7 ± 111.98 
Retardant      
Borax 
Coarse 150 rpm-15 min 13.48 ±4.77 66.77 ± 15.82 214.47 ± 55.76 
Fine 350 rpm - 30 min 2.36 ± 0.14 16.17 ± 1.00 35.98 ± 2.10 
 
6.3.2 Cement preparation 
The same formulations described in Chapter 5 (Section 5.3.2) were used. Briefly, each MPC 
formulation was constituted by MgO and a phosphate salt, NH4H2PO4, NaH2PO4 or a mixture of 
both. The MgO/phosphate salt ratio was 3.8. Therefore, each formulation was named as NH4-MPC, 
Na-MPC and NH4+Na-MPC, respectively, accounting for the type of phosphate salt used. The 
cement was prepared with a liquid to powder ratio of 0.13 ml/g. 
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6.3.3 Assessment of the exothermy
The exothermy of the MPCs 
could cause irreversible damages to the surrounding tissues 
was adjusted gradually. Firstly, the effect of the fineness of borax and, afterwards, of the 
calcination time of MgO was assessed, selecting at each step the process that reduced 
exothermy. Finally, the amount of borax needed was determined, as indicated in Figure 6.2.
Figure 6.2. Processing of the reactants to reduce the exothermy
 
The temperature evolution of the cements during the setting reaction was followed by 
introducing a type K thermocouple (Thermometer RS 1313) in
plastic container, immersed into an 
small hole made on the container’s seal, which was placed to avoid heat dissipation. When 
monitoring the temperature evolution, 
powder was considered as time zero.
Dunne et al. determined the maximum exothermy that the tissues surrounding a material 
can bear without suffering any harmful effect 
the curing process of the acrylic cements was evaluated, and the authors
exothermy using a thermal coefficient that took into account the period of time 
temperature remained constant. Therefore, the thermal coefficient
of the potential biomaterial and allowed predicting if the surrounding tissues would be severely 
 
was controlled in order to avoid high levels of heat
[8]. The exothermy of the cement
 of the cement down to safety levels. 
 1.5 g of cement paste placed in a 
isostatic bath at 37°C. The thermocouple passed
the moment at which the liquid phase was added to the 
  
[8]. In the mentioned study, the exothermy during 
 proposed to quantify the 
at which
 evaluated the thermal histo
, which 
s 
more the 
 
 
 
 through a 
 each 
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damaged or if, otherwise, the suffered injury would be mild or inexistent. The experimental curve 
of Figure 6.3 shows the period of time in which a temperature ranging from 40 to 75°C could be 
tolerated by the body (bottom left of Figure 6.3). On the contrary, when a temperature higher than 
40°C was maintained for a longer period of time or when the reached temperature was higher 
than 70°C, the tissue might suffer an irreversible damage (top right of Figure 6.3). A temperature 
between 37 and 44°C caused a minimal damage to the tissue and thus the thermal coefficient was 
calculated considering that this range of temperature would cause an irreversible damage only if 
the exposition time was longer than 10.000 s.  
 
Figure 6.3. Experimental curve that indicates the periods of time during which a determined 
temperature would only cause a mild damage to the surrounding tissue (bottom left) or an irreversible 
one (top right) (modified from [8], which extracted the data from [9]). 
 
The thermal coefficient was calculated by integrating a function f(T) between the initial 
temperature and the final temperature of the exothermy curve (Equation 6.1), in which f(T) 
function (Equation 6.2) was the fraction between the period of time in which a cement stayed at a 
determined temperature range divided by the maximum time that tissues could bear this 
temperature without suffering any irreversible damage (see Appendix A.2 for further details). 
Equation 6.1  Thermal coeficient =  	 f 
TdT

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Equation 6.2  
f 
T =  time spent at temperature T
maximum time at which no tissue damage occurs at temperature T
 
Dunne et al. considered that when the f(T) value was higher than 1, the exothermy could 
produce an irreversible damage to the surrounding tissues, whether a f(T) value lower than 1 
would only produce mild or no damages [8], as summarized in Table 6.2. 
Table 6.2. Expected effect that the exothermy will have to the tissues in function of the f(T) value.  
f(T) Effect of the exothermy to the tissue 
> 1 May produce irreversible damages 
< 1 Only produces mild or no damages 
 
6.3.4 Assessment of the physico-chemical properties of the optimized 
MPCs 
6.3.4.1 Characterization of the cement paste 
The paste was evaluated in terms of setting and cohesion times using the Gillmore needles 
or by visual inspection, respectively, as explained in Chapter 3 (Section 3.3.2.1). In this Chapter, the 
setting times and cohesion times were evaluated while maintaining the cements at 37°C.  
The injectability of a cement paste is defined as the percentage of cement that can be 
extruded through a syringe when a similar force to the one that could be done by hand is applied. 
In general, it is considered that a human hand can apply a force between 100 and 200 N [10]. The 
most restrictive force (100 N) was selected and thus the assay ended when the force applied to the 
cell load reached 100 N [11–13]. Figure 6.4 shows a schematic representation of the used 
experimental setup. 
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Figure 6.4. Schematic representation of the experimental setup used to quantify the injectability, 
before and during the injection process (modified from [14]). 
 
The cement paste (prepared with 2.2 g of powder to have a volume around 2 ml) was 
transferred into a 5 ml syringe (BD Discardit
TM
 II) with 2 mm-aperture. The paste was extruded 
using a mechanical testing machine (Bionix® MTS 370) with a load cell of 1 kN. Two min 30 s after 
the liquid contacted the cement powder, the syringe piston started being displaced at a cross-head 
speed of 15 mm/min (Figure 6.5).  
 
Figure 6.5. a) Universal testing machine performing an injectability test by displacing the syringe piston, 
and b) extrusion of the cement paste during the injectatility test. 
 
The injectability of the paste was calculated by weighting the syringe before the assay, 
empty (wsyringe) and containing the cement paste (winitial), and by weighting it again with the 
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remaining paste after the assay (wafter). The % of injectability was calculated as indicated in the 
Equation 6.3. Three replicates of each formulation were tested. 
Equation 6.3.    
Injectability 
% = (1 −  w − w	

w	
		 − w	

) ∗  100 
A load/displacement curve was obtained for each paste. These curves inform about the 
load profile along paste injection and thus give information about the injectability of the paste.  
6.3.4.2 Characterization of the set cements 
 The cement was introduced in Teflon molds (∅ = 6 mm, h = 12 mm) and were set in 
Ringer’s solution for different time points (1 h, 2 h, 1 day and 7 days). The compressive strength 
was measured with the set specimens following the protocol detailed in Section 5.3.4.3.  
Afterwards, the set cements were characterized after stopping the setting reaction by 
introducing the cements in acetone for 1 h and drying them at 37°C for 24 h. The experimental 
procedures described in Chapter 5 were followed to evaluate the crystalline phases (Section 
5.3.4.4), the morphology of the fracture surfaces (Section 5.3.4.5), the specific surface area (SSA, 
Section 5.3.4.6), the skeletal density (Section 5.3.4.7) and the porosimetry (Section 5.3.4.8). 
 The morphology of the fracture surfaces was evaluated with the optimized formulations 
and also with cements free of borax in order to determine the influence of the retardant in the 
microstructure of the cements. 
6.3.5 Antimicrobial assays and anti-biofilm activity 
Doses of 1.5 g of the cement powders were prepared in plastic containers, were 
individually sealed in plastic bags and were sterilized by gamma rays (25 kGy) (Aragogamma, 
Barcelona, Spain). The cements were prepared in a sterile environment right before their use. 
6.3.5.1 Bacterial culture conditions 
The antimicrobial properties of the MPCs were tested against Escherichia coli, strain DH5α 
(Invitrogen, Carlsbad, CA), Pseudomonas aeruginosa, strain PAO1, and Aggregatibacter 
Magnesium phosphate cements for clinical applications: optimization of the formulations 
and biological properties 
283 
 
actinomycetemcomitans, strain JP2. The latter two strains were kind gifts from Dr. Donald Demuth, 
University of Louisville (Kentucky, USA). The bacterial strains were selected for their presence in 
caries or endodontic infections (E. coli and P. aeruginosa) [15–17] or in periodontitis infections (A. 
actinomycetemcomitans) [18]. 
E. coli and P. aeruginosa were grown in Luria Bertani broth (LB, Difco, ref. n. 244620) and 
A. actinomycetemcomitans in Brain Heart Infusion broth (BHI, Bacto, ref. n. 237500). The bacterial 
growth conditions either in liquid (broth media) or in solid (agar plates) are shown in Table 6.3. The 
density of bacterial cultures was quantitated by spectroscopy at 600 nm and converted to 
approximate colony forming units per volume (CFU/ml), as indicated in Table 6.3.  
Table 6.3. Conditions of the bacterial growth in liquid and solid media for the three bacterial species. 
 
6.3.5.2 Preparation of cement extracts  
To test the antimicrobial effect of the cements, MPCs was prepared as explained above 
with a liquid to powder ratio of 0.13 ml/g. The cement was either allowed to set for 1 h at room 
temperature (fresh-cement), or was set for 1 h at room temperature and then further incubated in 
Ringer’s solution for 24 h (aged-cement). This allows for the complete transformation of the 
cements to their reaction products. The fresh- and aged-cements were then incubated in broth (LB 
or BHI) or in phosphate buffered saline solution (PBS, Gibco, ref. n. 18912-014) for 72 h, using a 
cement mass versus medium volume ratio of 0.85 g/ml. The resulting solutions (cement extracts) 
were centrifuged at 3000 rpm for 5 min to remove particulates prior to use. The extracts prepared 
 E. coli P. aeruginosa A. actinomycetemcomitans 
Broth media Luria Bertani (LB) Luria Bertani (LB) Brain Heart Infusion (BHI) 
Liquid culture 
conditions 
200 rpm, 37°C, 
overnight 
200 rpm, 37°C, 
overnight 
Static, 35°C, 2 days 
Oxygen conditions Aerobic Aerobic 
Semi-anaerobic (sealed plastic 
box with a candle inside) 
OD600  CFU/ml 1  1·10
9
 CFU/ml 1  1·10
10
 CFU/ml 0.3  1·10
9
 CFU/ml 
Agar plate culture 
conditions 
35°C, 24 h 35°C, 24 h 35°C, 48 h 
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from fresh-cements were termed as fresh-cement extracts and the extracts prepared from aged-
cements were termed as aged-cement extracts. The preparation of the fresh- and aged-cements, 
as well as the preparation of their extracts, is schematically shown in Figure 6.6. 
 
Figure 6.6. Schema of the followed steps to prepare fresh- and aged-cements, as well as fresh- and 
aged-cement extracts. RT stands for room temperature. 
 
 The osmolarity of the PBS-extracts was quantified by means of an Osmometer (Roebling 
1313 DR), which quantifies the amount of ionic species in a solution by evaluating their freezing 
point. This technique is based on the reduction of the freezing point of a solution by the presence 
of electrolyte particles, which is called freezing point depression [19]. 
In order to have a more specific information regarding the ionic species dissolved in the 
extracts, the concentration of Mg, P and Na (from now on [Mg], [P] and [Na]) in the PBS-extracts 
was quantified by means of inductively coupled plasma-optical emission spectrometry (ICP-OES, 
Perkin Elmer Optima 3200 RL) after diluting each extract 50-fold with HNO3 1%. However, it should 
be considered that the contribution of the NH4
+
 released by the ammonium-containing cements 
could not be obtained, since this technique does not permit to quantify nitrogen. Four replicates of 
each extract were analyzed by both the Osmometer and the ICP-OES. The pH of the extracts was 
measured in triplicate using a pH-meter (Beckman Coulter, A51705). 
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6.3.5.3 Antibacterial assays 
6.3.5.3.1 Agar diffusion test 
One approach to determine the antibacterial activity of cement formulations was the agar 
diffusion test (ADT). Bacteria (10
7
 CFU) were cultured on agar plates. Three cavities (12 mm 
diameter) were punched in the agar and filled with the cements. The Na-MPC and NH4+Na-MPC 
were injected with 5-ml syringes with a 2 mm-aperture, and the NH4-MPC was applied with a 
spatula due to its low injectability. After 48 h of incubation at 35°C, inhibition of bacterial growth 
around the cement plugs was measured using a 1 mm-precision ruler. The inhibition zone was 
calculated from the diameter of the inhibition zone (∅iz) and the diameter of the cement-filled 
cavity (∅c), according to Equation 6.4 [20]. Images of the plates were taken with a Kodak Image 
Station 4000R. The study was performed in duplicate. 
Equation 6.4.   Inhibition zone size 
mm =  ∅∅

   
 
6.3.5.3.2 Growth curves 
Bacterial growth curves were obtained by inoculating 10
6
 CFU/ml in broth (control) or in 
broth-cement extracts. The samples were kept on an orbital shaker (Stovall Belly Dance Shaker) for 
24 h at 35°C in order to favor the bacterial growth. At different time points, the viable bacteria 
were quantified by plating 100 µl of diluted aliquots in duplicate on agar plates. CFUs were 
enumerated on the plates after incubation for 24 h (E. coli and P. aeruginosa) or 48 h (A. 
actinomycetemcomitans) at 35°C (Table 6.3). Growth curve assays were carried out in duplicate. 
6.3.5.3.3 Bactericidal activity 
Bactericidal activity of the extracts was evaluated by incubating 10
6
 CFU/ml in PBS (control) 
or in PBS-cement extracts. PBS was the chosen medium because although it has a similar 
osmolarity than bacteria’s cytoplasm, not causing osmotic pressure to bacteria, it inhibits the 
bacterial growth because it is free of nutrients, and thus the bacterial death was not masked by the 
bacterial growth. After 2 h at 35°C, 100 µl of diluted aliquots were plated in duplicate on agar 
plates. CFUs were determined after 24 h (E. coli and P. aeruginosa) or 48 h (A. 
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actinomycetemcomitans) of incubation at 35°C. The % of surviving bacteria was calculated 
according to Equation 6.5, where CFUsample is the number of colonies enumerated in the cement 
extract or PBS (control) and CFUPBS is the number of colonies enumerated in the PBS (control).  
Equation 6.5.  Viable bacteria (%) =  
	


∗ 100  
To evaluate whether the antimicrobial effects of the extracts were related to their pH, 
bactericidal assays were performed using an alkaline buffer prepared with 0.2 M glycine (Sigma 
Aldrich, ref. n. 410225) and 0.2 M NaOH (Fischer Scientific, ref. n. BP359) brought to a final pH 
between 9-11. Bacteria (10
6
 CFU/ml) were incubated in the alkaline buffer for 2 h at 35°C. 
Afterwards, 100 µl of diluted aliquots were plated in duplicate on agar plates to determine the % of 
viable bacteria, as described above. Bactericidal activity assays were carried out in duplicate. 
6.3.5.3.4 Anti-biofilm activity 
Bacterial biofilms were formed by incubating 2·10
7
 CFU/ml of P. aeruginosa in 96-well 
plates for 24 h at 35°C. Following incubation, the plates were washed twice with PBS to remove 
unattached bacteria. 125 µl of broth (control) or of broth-fresh-cement extracts were added to 
each well in order to evaluate the bacterial growth in each extract. The samples were kept on the 
orbital shaker for 24 h at 35°C and then washed twice with PBS to remove detached bacteria. 
Surviving bacteria were quantified by a chemiluminiscent assay for ATP quantitation using the 
manufacturers’ protocol (BacTiter Glo; Promega, ref n. G8231). Every sample was quantitated in 
triplicate by luminescence in a multi-mode plate reader (Biotek, Synergy HT) using a sensitivity of 
125.  
The % of surviving bacteria living in the biofilm was calculated according to Equation 6.6, 
where Isample is the intensity of the luminescence signal of the extract or PBS (control) and IPBS is the 
intensity of the luminescence signal of the PBS (control).  
Equation 6.6.  Viable bacteria in bioilm (%) =  	


∗ 100 
The anti-biofilm activity study was run twice. 
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6.3.6 Studies with eukaryotic cells: cell viability 
6.3.6.1 Cells and culture conditions 
Rat preosteoblast-like MC3T3-M1 cells were used as a cell model to test the cytotoxicity of 
the cement extracts. The cells were maintained in complete medium (MEM Alpha medium, GIBCO, 
ref. n. 12571) supplemented with 10 v/v% fetal bovine serum (Hyclone ref. n. SH30071-03) and 1 
v/v% of penicillin/streptomycin (GIBCO, ref. n. 15140) at 37°C in a humid atmosphere with 5% CO2. 
The culture medium was renewed every third day. Upon confluence, cells were detached with 5 ml 
of trypsin-EDTA (GIBCO, ref. n. 25300) that was inactivated with complete medium after 10 min. 
The cells were then centrifuged at 1000 rpm for 10 min and the pellet was resuspended in 
complete medium. Finally, the cells were re-cultured or used for the experiment. 
6.3.6.2 Preparation of cement extracts  
Cement extracts were prepared to test the cytotoxicity of the cement. For this purpose, 
the cements were either allowed to set for 1 h at room temperature (fresh-cement), or allowed to 
set for 1 h at room temperature and then further incubated in Ringer’s solution for 24 h (aged-
cement). The fresh- and aged-cements were then incubated in complete medium either for 5 or 72 
h (5h-extract or 72h-extract, respectively), using a cement mass versus medium volume ratio of 
0.85 g/ml. The resulting solutions (cement extracts) were centrifuged at 3000 rpm for 5 min to 
remove particulates prior to use. The extracts prepared from fresh-cements were termed as fresh-
cement extracts and the extracts prepared from aged-cements were termed as aged-cement 
extracts. The preparation of the fresh- and aged-cements, as well as the preparation of their 
extracts, is schematically shown in Figure 6.7. 
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Figure 6.7. Schema of the followed steps to prepare the 5h and 72h-extracts, using the corresponding 
fresh- and aged-cements. RT stands for room temperature. 
 
6.3.6.3 Experimental study 
Cells (10
4
 cells/well) were seeded in 96-well plates and incubated for 20 ± 3 h. After this 
period, cells were adhered on the plastic surface and unattached cells were removed by washing 
each well twice with PBS. Finally, cells were incubated with 100 µl of cement extract prepared with 
fresh- or aged-cement for a period of 5 h or 72 h (5h-fresh-cement extract, 72h-fresh-cement 
extract, 5h-aged-cement extract or 72h-aged-cement extract). Every extract was used undiluted (1-
1), with a 2-fold (1-2) or a 10-fold (1-10) dilution. Control samples consisted on incubating cells 
with complete medium (negative control) or with complete medium supplemented with 1 v/v% 
triton X-100 (Sigma Aldrich, T9284) (positive control). Complete medium was added in wells free of 
cells as blank. Every sample was tested in triplicate and the whole experiment was repeated twice 
(n = 6).  
After 24 h of incubation, each well was washed twice with PBS to remove the unattached 
cells and cell viability was determined using CellTiter-Glo reagent (Promega, ref. n. G7571), as 
described by the manufacturer. The reagent extracted the ATP from the cells and then supported a 
luminescent reaction. The luminescence signal was directly proportional to the ATP present, thus 
being directly related to the number of metabolically active cells. A calibration curve with 
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decreasing concentration of cells was created to convert the results to cell numbers. The 
luminescence was read in a plate reader (Biotek, Synergy HT) with a sensitivity of 125. 
6.3.7 Statistical analysis of the results 
A Student’s t-test was used to determine the statistically significant differences between 
the mean values of the different experimental groups. A difference between groups was 
considered to be significant at p < 0.05. 
 
6.4 Results  
6.4.1 Exothermy 
a) Effect of the environmental temperature 
The exothermy of MPCs, which powder contained MgO sintered at 1475°C for 6 h, coarse 
phosphate salts and 5 wt% of coarse borax, was evaluated. Figure 6.8 compares the temperature 
evolution of MPCs when the plastic flask that contained the cement was maintained either at room 
temperature (RT) or at 37°C. The maximum temperature attained was substantially higher when 
the cements set at 37°C than at RT, the temperatures increasing from 31 to 57°C for NH4-MPC and 
from 40 to 62°C for Na-MPC. Moreover, the maximum temperature was reached at a shorter time 
when the cement set at 37°C, the time being reduced from 18 to 6 min for NH4-MPC and from 9 to 
3 min for Na-MPC, respectively.  
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Figure 6.8. Temperature evolution of: a) NH
(RT) and at 37°C. The cements were prepared with MgO calcined at 1475
for 15 min), with coarse phosphate salts 
 
The significant increase of exothermy when 
indicated that the reactants had to be further processed in order to optimize the exothermy at this 
temperature. The exothermy of the cement
proved to be efficient in Chapter 5. 
fineness of borax and, secondly, the calcination time of MgO. 
b) Effect of the borax fineness 
Figure 6.9 compares the exothermy of the MPCs containing 5 wt% of borax 
particles size, coarse and fine. When the fine borax was used
decreased about 10°C in NH4-MPC and about 3
temperature was approximately the same
following studies due to its more efficient reduction of the exothermy than the coarse one.
  
4-MPC and b) Na-MPC, while setting at room temperature 
°C for 6 h (milled at 150 rpm 
and 5 wt% of coarse borax was added.  
the cements were in an environment at 37
s was adjusted gradually, following the directions 
The effect of the exothermy was assessed for, f
 
of two different 
, the maximum reached temperature 
°C in Na-MPC. The time to reach the maximum 
 in both cements. The fine borax was selected for the 
 
°C 
irstly, the 
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Figure 6.9. Temperature evolution of: a) NH
borax, while setting at 37°C. 
at 150 rpm for 15 min) and with coarse phosphate salts. 
 
c) Effect of the calcination time of MgO
Figure 6.10 shows the temperature evolution of NH
fine borax in function of the calcination time of MgO. The cements that were prepared with MgO 
calcined for 12 h where slightly le
maximum temperature decreasing about 5
temperature was significantly increased for Na
to 4.5 min, and was unmodified 
with MgO calcined for 12 h. 
Figure 6.10. Temperature evolution of: a) NH
h (milled 150 rpm 15min), while setting at 37
fine borax was added.  
and biological properties
4-MPC and b) Na-MPC, with 5 wt% of either coarse or fine 
The cements were prepared with MgO calcined at 1475°C for 6 h 
 
 
4-MPC and Na-MPC containing 5 wt% of 
ss exothermic than those containing MgO calcined for 6 h, the 
°C in both cements. The time to reach the maximum 
-MPC prepared with MgO calcined for 12 h, from 3 
for NH4-MPC. Therefore, from now on, the cements were prepared 
4-MPC and b) Na-MPC, prepared with MgO calcined at 1475
°C. The cements were prepared with coarse phosphate salt and
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The studies explained above indicated that the exothermy could be efficiently reduced 
using fine borax and calcining the MgO at 1475°C for 12 h. Figure 6.11 shows the particle size 
distribution of the processed reactants. 
 
Figure 6.11. Particle size distribution of the MPC reactants: MgO calcined at 1475°C for 12 h (milled at 
150 rpm for 15min), coarse NH4H2PO4 and NaH2PO4, and fine borax.  
 
d) Effect of the amount of borax 
Finally, the amount of borax required to ensure the safety of the surrounding tissues was 
determined. Figure 6.12 shows the temperature evolution of the three formulations of MPC with 
different amounts of borax. 
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Figure 6.12. Temperature evolution of: a) NH4-MPC, b) Na-MPC and c) NH4+Na-MPC, with different 
amounts of fine borax, while setting at 37°C. All cements were prepared with MgO calcined at 1475°C 
for 12 h (milled at 150 rpm for 15min) and with coarse phosphate salts.  
 
The amount of borax necessary to get cements with innocuous exothermy for the 
surrounding tissues was determined with the thermal coefficient of every temperature evolution 
(Figure 6.13). The amount of borax selected to prepare the MPCs was 6 wt%, since this was the 
lowest amount that resulted in a thermal coefficient lower than 1 for the three formulations, 
although the NH4-MPC and NH4+Na-MPC already had a thermal coefficient lower than 1 when 5 
wt% of borax was added. 
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Figure 6.13. Thermal coefficient of the NH4-MPC, Na-MPC and NH4+Na-MPC prepared with different 
amounts of fine borax. All cements were prepared with MgO calcined at 1475°C for 12 h (milled at 150 
rpm for 15min) and with coarse phosphate salts. 
 
6.4.2 Physico-chemical characterization of MPCs 
6.4.2.1 Setting and cohesion time  
The final setting and the cohesion time of the three MPC formulations are shown in Table 
6.4. The initial setting times are not shown since they were very similar to the final setting times, 
being just about one minute apart in every case. The cohesion time was slightly shorter than the 
final setting time in the case of Na-MPC and NH4+Na-MPC, and it was halved in the case of NH4-
MPC. 
Table 6.4. Final setting times (tF) and cohesion times (tC) of the MPCs. The average ± standard deviation 
is shown, n = 3. 
MPC formulation tF (min) tC (min) 
NH4-MPC 14± 2 ≤ 6 
Na-MPC 7 ± 1 ≤ 6 
NH4+Na-MPC 8.5 ± 1 ≤ 7 
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6.4.2.2 Injectability 
 The load/displacement curves displayed for the three MPC formulations showed the three 
typical stages of an injectable material (Figure 6.14). The first stage was an initial transient regime 
in which the applied load increased rapidly until it reached the yield load corresponding to the 
force needed for the paste starting to flow. In the second stage, pastes flowed in steady state 
conditions at a constant load that is referred to as injection load. In the final stage, the load 
increased again either because the syringe was empty or because the paste was not injectable 
anymore.  
The yield load was between 14 and 16 N for the three formulations, with no significant 
differences among them (p > 0.05). However, the displacement of the piston was different for each 
MPC formulation, following the trend NH4+Na-MPC > Na-MPC > NH4-MPC, which was consistent 
with the amount of paste injected for each formulation (Table 6.5). 
 
Figure 6.14. Load/displacement curves (displacement of the MTS piston and, therefore, of the syringe 
plunger) for the MPC formulations.  
 
 Table 6.5 shows the injectability for each formulation. NH4+Na-MPC was the most 
injectable formulation, followed by Na-MPC, and both formulations had a significantly higher 
injectability than NH4-MPC (p < 0.05).  
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Table 6.5. Injectability (%) of the MPC formulations. The average ± standard deviation is shown, n = 3.  
NH4-MPC Na-MPC NH4+Na-MPC 
41.4 ± 14.0 74.4 ± 13.0 86.4 ± 3.4 
 
6.4.2.3 Mechanical properties 
The compressive strength after 7 days of immersion in Ringer’s solution is shown in Table 
6.6. NH4-MPC and NH4+Na-MPC had similar compressive strengths, with values higher than 40 
MPa. However, the compressive strength of Na-MPC was about 31 MPa, significantly lower (p < 
0.05) than that of the other two formulations. For NH4-MPC, the compressive strength was also 
tested after 2 h, which showed a value of 16.0 ± 4.0 MPa (Table 6.6).  
Table 6.6. Compressive strength of the MPC formulations immersed in Ringer’s solution for 7 days at 
37°C. The compressive strength of NH4-MPC after 2 h of immersion in Ringer’s solution is also shown. 
The average ± standard deviation is shown, n = 10.  
Time points NH4-MPC Na-MPC NH4+Na-MPC 
2 h 43.4 ± 11.1 30.8 ± 3.0 46.1 ± 6.2 
7 d 16.0 ± 4.0 − − 
 
6.4.2.4 Crystalline phases 
Figure 6.15 shows the XRD of the cement powder (0 h) and of the cement immersed in 
Ringer’s solution for 7 days. The phases formed for each MPC formulation were the same than 
those observed in Chapter 5 (Section 5.4.2.4). Briefly, NH4-MPC and NH4+Na-MPC transformed into 
struvite and schertelite, and Na-MPC gave place to an amorphous compound. Unreacted MgO was 
found in all formulations. 
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Figure 6.15. XRD of MPC formulations set for 0 h and 7 days in Ringer’s solution at 
b) Na-MPC and c) NH4+Na-MPC. A.U. stands for arbitrary units. 
 
6.4.2.5 Morphology  
The microstructures of surface fractures of MPCs set i
displayed in Figure 6.16. The microstructure
phase are also included, in order to evaluate t
cements. 
Interesting differences were observed between those MPC containing borax and those 
without borax. For instance, NH
particles. In contrast, an amorphous layer 
prepared with borax (Figure 6.1
layer (Figure 6.16 c), the morphology of the same formulation without borax showed some 
particles between 20 and 60 µm embedded into 
fracture surface of NH4+Na-MPC 
and biological properties
37°C: a) NH
 
n Ringer’s solution for 7 days are
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he influence of borax on the morphology of 
4-MPC without borax (Figure 6.16 b) was composed of 
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layer, whereas the NH4+Na-MPC that did not contain borax had a more heterogeneous 
microstructure (Figure 6.16 f).  
 
Figure 6.16. Microstructure of the MPC prepared with 6 wt% of borax: a) NH4-MPC, c) Na-MPC and e) 
NH4+Na-MPC, and without borax: b) NH4-MPC, d) Na-MPC and f) NH4+Na-MPC. The cements were 
immersed for 7 days in Ringer’s solution at 37°C.  
 
6.4.2.6 Specific surface area, skeletal density and porosimetry 
Table 6.7 shows the specific surface area (SSA) and the skeletal density for MPC 
formulations after immersion in Ringer’s solution for 7 days. The trend for the SSA was Na-MPC < 
NH4-MPC < NH4+Na-MPC and for the skeletal density it was NH4-MPC < NH4+Na-MPC < Na-MPC. 
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Table 6.7. Specific surface area (SSA, 
MPC after 7 days of immersion in Ringer’s solution
n = 2 for SSA and n = 3 for skeletal density. 
 
NH4-MPC
Na-MPC
NH4+Na-MPC
 
 Figure 6.17 shows the entrance pore diameter distribution, measured by means of mercury 
intrusion porosimetry. In general, the three MPC formulations showed a peak around 0.01
µm, and NH4-MPC and NH4+Na-
formulations showed a peak of entrance pore diameter 
the presence of cracks on the surface of the cements
process of the samples.  
Figure 6.17. Distribution of th
Ringer’s solution for 7 days.  
 
Table 6.8 shows the results of total open porosity of the three MPC formulations set for 7 
days. Na-MPC was the formulation exhibiting a lower total open porosity, followed by NH
and NH4+Na-MPC.  
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m
2
/g) and skeletal density (g/cm
3
) of the three formulations of 
 at 37°C. The average ± standard deviation is shown, 
 
SSA (m
2
/g) Skeletal density (g/cm
3
) 
 1.85 ± 0.19 2.43 ± 0.02 
 1.76 ± 0.26 2.64 ± 0.02 
 2.43 ± 0.40 2.59 ± 0.02 
MPC also showed a wide peak around 1 µm. Finally, the three
around 10 µm that could be associated to 
 (Figure 6.16), occurring during the drying 
e entrance pore diameter of MPC formulations after being immersed in 
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Table 6.8. Total open porosity (%) of
solution for 7 days.  
NH4-MPC
30.84
 
6.4.3 Antimicrobial assays 
6.4.3.1 Agar diffusion test 
Every MPC formulation caused growth inhibition of the Gram negative bacteria 
aeruginosa and A. actinomycetemcomitans
samples inserted into an agar plate seeded with bacteria (Figure 
Figure 6.18. Agar diffusion test of the three fresh
A. actinomycetemcomitans (A.a.).  
 
The inhibition zone for each bacterial strain and MPC
Although no statistically significant diffe
0.05), NH4+Na-MPC was the formulation that caused the largest inhibition zone. 
zones were greater for P. aeruginosa
significantly larger than that for E. coli
  
 the three MPC formulations after being immersed in Ringer’s 
 Na-MPC NH4+Na-MPC 
 28.80 35.08 
, which was observed as a clear ring around the 
6.18).  
-cement formulations in: a) E. coli, b) P. aeruginosa
 formulation is shown in Table 6.9
rences were observed between MPC formulations 
The 
 than for A. actinomycetemcomitans, and both were 
 (p < 0.05). 
E. coli, P. 
cement 
 
; c) 
. 
(p > 
inhibition 
Magnesium phosphate cements for clinical applications: optimization of the formulations 
and biological properties 
301 
 
Table 6.9. Inhibition zone size that appeared around the fresh NH4-MPC, Na-MPC and NH4+Na-MPC 
formulations after the incubation time of the three bacterial strains studied: E. coli, P. aeruginosa and 
A. actinomycetemcomitans. The data indicate mean ± standard deviation, n = 2.  
Inhibition zone size (mm) 
 
E. coli P. aeruginosa A. actinomycetemcomitans 
NH4-MPC 4.2 ± 1.6 10.5 ± 1.0 9.6 ± 3.0 
Na-MPC 3.3 ± 1.2 7.1 ± 1.3 8.6 ± 0.1 
NH4+Na-MPC 4.5 ± 1.0 11.4 ± 0.8 9.8 ± 2.1 
 
6.4.3.2 Growth curves 
Bacterial growth curves were obtained for the fresh- and aged-cement extracts for the 
three bacterial species. 
a) Fresh-cement extracts 
The growth curves of the three bacterial species inoculated in broth (control) or in broth-
fresh-cement extracts are shown in Figure 6.19. E. coli grew exponentially in broth, whereas no 
growth was evident when bacteria were incubated with the fresh-NH4-MPC or NH4+Na-MPC 
extracts (Figure 6.19 a). Fresh-Na-MPC extract caused a decline in CFU suggesting that this extract 
had bactericidal activity. Similar results were obtained with P. aeruginosa, with a sharper decrease 
in CFU for Na-MPC (Figure 6.19 b). Finally, all three fresh-MPC extracts caused the killing of A. 
actinomycetemcomitans, as evidenced by a decline of CFU over time (Figure 6.19 c). 
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Figure 6.19. Growth curve of a) E. coli, b) P. aeruginosa and c) A. actinomycetemcomitans, inoculated in 
broth (control) or in broth-fresh-cement extracts. The absence of bacteria on the plates (no surviving 
CFUs) is indicated with the corresponding symbol at 10
-1
 CFU/ml. Error bars indicate the standard 
deviation, n = 4. Since it is difficult to appreciate the error bars, which are smaller than the symbols, the 
mean and standard deviation values are displayed in Appendix A.3. 
 
b) Aged-cement extracts 
The retention of the antibacterial properties after cement setting was studied in the aged-
cement extracts. The growth curves of the three bacterial species inoculated in broth (control) or 
in broth-aged-cement extracts are shown in Figure 6.20. Whereas all three species exhibited 
exponential growth in broth, bacterial counts (CFU/ml) were drastically reduced in 2-4 h in aged-
Na-MPC extract. In contrast, E. coli (Figure 6.20 a) and P. aeruginosa (Figure 6.20 b) had similar 
behaviors when incubated in aged-NH4-MPC or NH4+Na-MPC extracts, with an exponential growth 
with time, the amount of bacteria after 24 h not being significantly different than that in control (p 
> 0.05). Differently, viable A. actinomycetemcomitans decreased with time (Figure 6.20 c), with 
none surviving bacteria neither in aged-NH4-MPC nor in NH4+Na-MPC extracts after 8 h. 
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Figure 6.20. Growth curve of a) E. coli, b) P. aeruginosa and c) A. actinomycetemcomitans, inoculated in 
broth (control) or in broth-aged-cement extracts. The absence of bacteria on the plates (no surviving 
CFUs) is indicated with the corresponding symbol at 10
-1
 CFU/ml. Error bars indicate the standard 
deviation, n = 4. Since it is difficult to appreciate the error bars, which are smaller than the symbols, the 
mean and standard deviation values are displayed in Appendix A.3. 
 
The pHs of the broth-fresh-cement and of the broth-aged-cement extracts are summarized 
in Table 6.10. The fresh-Na-MPC extract was alkaline (pH 10.1 ± 0.6), whereas the NH4-MPC and 
NH4+Na-MPC extracts were slightly acidic. All the aged-cement extracts were alkaline, the Na-MPC 
having the higher pH. 
Table 6.10. pH of the broth-cement extracts, prepared by immersing fresh- or aged-cements in broth 
(LB or BHI) during 72 h. The ratio between the cement paste and the immersion media was 0.85 g/ml. 
The data indicate mean ± standard deviation, n = 3.  
Cement formulation Broth-fresh-cement extract Broth-aged-cement extract 
NH4-MPC 5.8 ± 0.5 9.1 ± 0.4 
Na-MPC 10.1 ± 0.6 11.9 ± 0.3 
NH4+Na-MPC 6.5 ± 0.3 10.4 ± 0.2 
Control (pristine broth) 7.3 ± 0.2 
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6.4.3.3 Bactericidal activity of the cement extracts 
The results of the growth curves suggested that the three fresh-MPC formulations had a 
bacteriostatic or, in some cases, bactericidal activity. To verify this assertion, bacteria were 
incubated for 2 h in PBS (control), in PBS-fresh-cement or in PBS-aged-cement extracts. 
Subsequently, the CFUs were enumerated and the % of viable bacteria was calculated. The results 
are displayed in Figure 6.21.  
The viability of the bacteria in contact with the PBS-fresh-cement extracts from all MPC 
formulations significantly decreased when compared with that of the control (p < 0.05) (Figure 
6.21 a), especially for the Na-MPC extracts, where only 1.3 ± 1.1 % of P. aeruginosa survived, while 
no viable bacteria of either E. coli or A. actinomycetemcomitans were found. 
Regarding the bactericidal activity of the PBS-aged-cement extracts, the Na-MPC was the 
most bactericidal extract, as displayed in Figure 6.21 b, exhibiting 100% bactericidal activity against 
E. coli and A. actinomycetemcomitans, whereas 9.2 ± 1.4 % of P. aeruginosa survived under these 
conditions. NH4+Na-MPC extract also exhibited 100% bactericidal activity against E. coli and A. 
actinomycetemcomitans, and NH4-MPC significantly reduced (p < 0.05) the amount of viable 
bacteria in comparison with that in the control. P. aeruginosa was the most resistant strain, the 
amount of viable bacteria being similar than that in control (p > 0.05) after incubation in NH4-MPC 
or NH4+Na-MPC extracts. 
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Figure 6.21. Bactericidal activity of the 
extracts and b) aged-cement extracts. Bacteria were incubated in
plated on agar to determine surviving CFUs. Results presented as percentage of bacterial viability. Error 
bars indicate the standard deviation, n = 4
 
In order to determine if the bactericidal effect found in the extrac
their pH, the three bacterial species were incubated for 2 h in an alkaline buffer with different pH 
values (Figure 6.22). The viability of 
surviving bacteria at pH 11.0. The 
with 11.3 ± 8.6% surviving bacteria detected at pH 11.0. 
a decreasing viability with the 
higher. 
and biological properties
PBS-cement extracts, using PBS as control: a) fresh
 the PBS extracts for 2 h at 35
. * indicates statistically significant differences (p <
ts could be related to 
E. coli was reduced at pHs higher than 10.0, remaining no 
viability of P. aeruginosa gradually decreased with increasing pH, 
A. actinomycetemcomitans
increasing pH, with no surviving bacteria detected at pH 10.5 or 
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-cement 
°C, and 
 0.05).   
 also exhibited 
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Figure 6.22. Bactericidal activity of buffer solutions set at pHs between 9 and 11. Bacteria were 
incubated in the buffer for 2 h at 35
presented as percentage of bacterial viability. Error bars indicate the standard deviation, n = 4
indicates statistically significant differen
 
The pHs of the PBS-fresh-cement 
Table 6.11.  
Table 6.11. pH of the PBS-cement 
during 72 h. The ratio between the cement paste
indicate mean ± standard deviation, n = 3. 
Cement formulation PBS
NH4-MPC 
Na-MPC 
NH4+Na-MPC 
Control (pristine broth) 
 
The osmolarity of the PBS-extracts as well as the [Mg], [P] and [Na] is shown in Figure 6.2
where the values of pristine PBS are indicated as a dashed line. 
indicates the total amount of ionic species dissolved in the solution. 
[Mg], [P] and [Na], thus informing about
°C and plated on agar to determine surviving CFUs. Results are 
ces (p < 0.05).  
and of the PBS-aged-cement extracts are summarized in 
extracts, prepared by immersing fresh- or aged-cements in PBS 
 and the immersion media was 0.85 g/ml. The data 
 
-fresh-cement extract PBS-aged-cement extract 
6.3 ± 0.4 9.1 ± 0.6 
9.7 ± 0.1 11.4 ± 0.6 
6.5 ± 0.2 9.9 ± 0.5 
7.0 ± 0.2 
The osmolarity of the extracts 
The ICP analysis indicated the 
 which was the ionic contribution in the osmolarity of the 
 
. * 
3, 
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extract. However, ICP did not permit to quantify the [N] resulting from the NH
ammonium-containing cements
complete picture of the total amount of ionic species dissolved in the extract
Both osmolarity and [Mg], [P] and [Na]
formulation were significantly higher (p < 0.05) than that of PBS
were significantly higher (p < 0.05)
except for the osmolarity of Na-
osmolarity observed for the fresh
NH4+Na-MPC extracts had both osmolarity and 
that of NH4-MPC and Na-MPC extracts. 
Regarding the fresh-cement, it should be noted that the ionic concentration of Mg 
(between 1.5 and 6.5 mM) was much lower than that of the P (between 400 and 725 mM
(between 750 and 1100 mM, excluding NH
Figure 6.23. Osmolarity and i
immersing fresh- or aged-cements in PBS 
quantified by means of an o
[Na]. The ratio between the cement paste
indicates the ionic concentration of PBS
statistically significant differences (p 
and biological properties
4
+
 
, and thus the osmolarity was the technique providing 
. 
 of fresh- and aged-cement 
 and, interestingly, 
 for the fresh-cement extracts than that for
MPC, which difference was not statistically significant
-cements was NH4-MPC > NH4+Na-MPC > Na
ionic concentration ([Mg], [P] and [Na]
 
4-MPC).  
onic concentration of the three MPC formulations extracts, prepared by 
for 72 h. The osmolarity and ionic concentration
smometer or ICP-OES, respectively: a) Osmolarity, b) [Mg], c
 and the immersion media was 0.85 g/ml. The dashed
. Error bars indicate the standard deviation, n = 4. * indicates 
< 0.05).  
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 the aged-ones, 
. The trend of 
-MPC. Finally, 
) between 
) or Na 
 
 were 
) [P] and d) 
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6.4.3.4 Anti-biofilm activity 
The incubation of P. aeruginosa biofilm for 24 h with broth-fresh-cement extracts (Figure 
6.24) resulted in a reduction of the amount of metabolically active bacteria in the biofilms by 99.93 
± 0.11% for the Na-MPC aged-cement extracts. In contrast, NH4-MPC and NH4+Na-MPC reduced 
92.65 ± 1.60% and 77.02 ± 10.96%, respectively, the amount of metabolically active bacteria. 
 
Figure 6.24. Bactericidal activity of broth-fresh-cement extracts against P. aeruginosa biofilm after 24 h 
of incubation at 35°C. Error bars indicate the standard deviation, n = 6. * indicates statistically 
significant differences (p < 0.05).    
 
6.4.4 Cell viability 
Figure 6.25 shows the cell viability after MC3T3-M1 cells were for 24 h with fresh- or aged-
cement extracts, prepared immersing the cements for 5 or 72 h in complete medium. In general 
terms, it can be noted that, on one hand, the aged-cement extracts (both 5 and 72h-extracts) 
resulted in higher cell viability than their fresh-cement counterparts. On the other hand, the cell 
viability trends regarding the formulations were NH4+Na-MPC > Na-MPC > NH4-MPC for the fresh-
cements and NH4-MPC > NH4+Na-MPC > Na-MPC for the aged-cements, regardless of the 
preparation time of the extract. Nevertheless, all 5h-extracts showed higher cell viability than 72h-
extracts. As expected, the cell viability was increased by diluting more the cement extracts. 
The 5h-fresh-cement extracts (Figure 25 a) prepared with Na-MPC and NH4+Na-MPC had a 
cell viability higher than 90 % when were 10-fold diluted, whereas their NH4-MPC counterparts 
extracts had a viability of 10 % with the same dilution. In contrast, the undiluted 5h-aged-cement 
extracts prepared with NH4-MPC had a cell viability of about 90% and when prepared with NH4+Na-
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MPC of about 70%, and the Na-
fold diluted.  
The 72h-fresh-cement extracts
viability of 70% when 10-fold diluted,
viability for the other two formulations. 
and NH4+Na-MPC reached a cell viability of about 70% when 2
10-fold diluted to produce a cell
Figure 6.25. Cell viability after 
for a period of 24 h. The extracts were prepared immersing the 
medium for: a) 5h (5h-cement 
undiluted, 2-fold dilution and 10
medium) and T stands for positive control
Triton the complete medium. 
 
Table 6.12 displays the pH of the fresh
medium. While fresh NH4-MPC and NH
either for 5 h and 72h, fresh-Na
0.05) the extracts prepared for 72 h
mediums, the pH trend being NH
prepared for 72 h had a significantly higher alkalinity (p < 0.05) than those prepared for 5 h.
and biological properties
MPC counterparts had a viability of 60 % when the extract was
 (Figure 25 b) prepared with NH4+Na-MPC resulted in a 
 being necessary a higher dilution to obtain values of similar 
The 72h-aged-cement extracts prepared with 
-fold diluted, and Na
 viability of about 90 %.  
cells were in contact with NH4-MPC, Na-MPC and NH4+Na-MPC extracts
fresh- or aged-cement in 
extract) or b) 72 h (72h-cement extract). 1-1, 1-2 and 1-10 stands for 
-fold dilution, respectively. C stands for negative control 
 (1 wt% triton), which was prepared supplementing 
Error bars indicate standard deviation, n = 6.  
- and aged-cement extracts prepared with complete 
4+Na-MPC led to slightly acidic extracts 
-MPC led to alkaline extracts, being significantly more alkaline 
. The three formulations of aged-cements produced alkaline 
4-MPC < NH4+Na-MPC < Na-MPC. The aged-cement extracts 
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Table 6.12. pH of the three MPC formulation extracts, prepared by immersing fresh- or aged-cements 
in complete medium either for 5 or 72 h. The ratio between the cement paste and the immersion 
media was 0.85 g/ml. The data indicate mean ± standard deviation, n = 2.  
Cement formulation 
5h-extract 72h-extract 
Fresh-cement Aged-cement Fresh-cement Aged-cement 
NH4-MPC 6.0 ± 0.2 7.7 ± 0.4 6.1 ± 0.1 9.0 ± 0.3 
Na-MPC 7.8 ± 0.2 9.9 ± 0.3 10.4 ± 0.1 11.6 ± 0.2 
NH4+Na-MPC 6.5 ± 0.1 9.0 ± 0.4 6.9 ± 0.1 10.6 ± 0.3 
Control (pristine medium) 7.3 ± 0.2 
 
6.5 Discussion 
6.5.1 Exothermy 
The effect of the environmental temperature was shown to be a determinant factor for the 
cement exothermy during the setting reaction. The exothermy was significantly higher when the 
cement was in an environment at 37°C than in one at RT (Figure 6.8), fact that can be explained in 
two different ways. On one hand, the initial temperature of the cement was already about 13°C 
higher when the cement was maintained at 37°C than at RT (around 24°C). On the other hand, the 
higher temperature favored the dissolution of the reactants and thus their reaction was faster. 
Moreover, the faster reaction in the cements maintained at 37°C also permitted a lower 
dissipation of the heat, the temperature increasing even more. Moreover, the cements prepared at 
37°C reached the maximum temperature in a third of the time than the ones prepared at RT due to 
their faster reaction. 
 Three parameters were shown to be relevant to reduce the exothermy of the MPCs. On 
one hand, since Chapter 5 showed that the particle size of the reactants (i.e. phosphate salts) was 
an important parameter to control the exothermy of the cement, in this Chapter it was chosen to 
decrease the particle size of borax in order to further reduce the exothermy. Indeed, the finer were 
the particles of borax (Figure 6.9), the lower was the maximum temperature reached for the 
cement. This observation was associated with the higher specific surface area of the borax, being 
increased its contact with MgO and thus being potentiated its efficiency. On the other hand, the 
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longer the calcinations of the MgO, the lower the exothermy of the MPC formulations (Figure 
6.10). This result was associated with the sintering of the MgO particles, decreasing its reactivity 
and thus slowing down the reaction between MgO and the phosphate salts. Finally, the addition of 
borax effectively reduced the maximum temperature reached during the setting reaction, 
increasing simultaneously the time needed to reach it, as shown in Figure 6.12.  
 The overall results indicated that an adequate exothermy at 37°C could be obtained by 
sintering the MgO at 1475°C for 12 h, using coarse phosphate salts and adding 6 wt% of fine borax. 
6.5.2 Physico-chemical characterizations 
6.5.2.1 Setting times 
The setting times of the MPCs evaluated at 37°C (Table 6.4) were shorter than those of the 
MPCs evaluated at room temperature (Table 5.2). However, these results have to be evaluated 
carefully, discerning three simultaneous effects: i) for the MPCs evaluated at 37°C, the reactants 
were processed in order to further reduce the exothermy of the cements, intrinsically increasing 
the setting time; ii) a higher evaporation of the liquid phase occurs at 37°C than at room 
temperature, thus decreasing the setting times; and iii) the reactants dissolve faster at 37°C than at 
room temperature, thus allowing a faster reaction between them. Since the setting times of the 
MPCs were shorter when evaluated at 37°C than at room temperature, the environmental 
temperature was shown to be a more determinant factor for the setting time than any of the 
processing performed to the reactants. 
6.5.2.2 Injectability 
The load/displacement curves of Na-MPC and NH4+Na-MPC indicated that the paste was 
injected at a constant load (Figure 6.14). However, a small part of the paste remained in the 
syringe, indication that filter pressing might have taken place. Filter pressing, which is a 
phenomenon occurring simultaneously to the paste flow, occurs when the pressure required to 
filter the liquid through the cement particles is lower than the pressure required to inject the 
paste, causing phase separation [10]. The filter pressing causes that the paste initially injected has 
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a higher L/P ratio and, consequently, the paste in the bottom of the syringe has a lower L/P ratio 
than the nominal one, its viscosity being higher and thus being more difficult to inject.  
The load/displacement curve of NH4-MPC showed an early increment of the load needed 
for the continuous flow of the paste (Figure 6.14). This could indicate that clogging of the syringe 
aperture occurs, reducing the injectability of the paste. The clogging of the syringe could be 
attributed to the large particle size of the NH4H2PO4 (Figure 6.11). 
The displacement reached by the syringe plugger when the force started to increase in 
third stage of the load/displacement curve (Figure 6.14) matched with the injectability of each 
material: NH4+Na-MPC > Na-MPC >> NH4-MPC (Table 6.5). 
It should be mentioned that most surgeons complain that bone cements (e.g. calcium 
phosphate cements, CPCs), are poorly injectable [21]. In contrast, scientists consider CPCs as 
injectable materials. This discrepancy comes from the fact that the injectability of cements is not 
clearly defined. In principle, any cement paste can be claimed to be injectable. The question is how 
injectable it really is [10]. The results of injectability are linked to the experimental setup 
parameters. The variables that have a higher effect on injectability of the pastes are: the aperture 
of the syringe, the amount of paste used to start the extrusion and the force limit of the 
experiment. For instance, if a force limit of 200 N would have been used in this study, which other 
studies assure that is the normal force that a hand can apply to a syringe [10], the injectability of 
the MPC formulations would have been higher.  
6.5.2.3 Crystalline phases 
The end-products after 7 days of immersion in Ringer’s solution (Figure 6.15) were the 
same than those observed in Section 5.4.2.4 and discussed in Section 5.5.3, as expected, since the 
same initial compounds were used. Briefly, NH4-MPC and NH4+Na-MPC formed struvite and a 
smaller amount of schertelite, and Na-MPC formed an amorphous phase. Unreacted MgO was 
detected in the three formulations. Borax was not detected by XRD and no phase related with this 
compound (e.g. luneburgite) was observed.  
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6.5.2.4 Compressive strength 
The compressive strength of the MPC formulations (containing 6 wt% borax) after 7 days of 
immersion in Ringer’s solution (Table 6.6) were similar to the values displayed in Figure 5.11, 
where MPCs were prepared with 3 wt% borax. Nevertheless, the scenario was quite different if 
comparing the compressive strength of NH4-MPC after 2 h (Table 6.6). After 2 h, NH4-MPC 
containing 6 wt% borax reached a third of the compressive strength (16.0 ± 4.0) that was reached 
for the NH4-MPC prepared with 3 wt% borax (48.7 ± 5.6 MPa). The delay on hardening of the MPCs 
optimized to ensure adequate exothermy at 37°C was associated to the addition of a higher 
amount of borax, with a finer particle size, and to the longer sinterization time of MgO. 
6.5.2.5 Morphology, SSA, skeletal density and porosity 
 The microstructure of the fracture surfaces of MPCs containing 6 wt% borax (Figure 6.16) 
were similar to those of the MPCs prepared with 3 wt% borax developed (Figure 5.14). This 
indicated that the extra addition of borax had no influence in the morphology of the cements.  
In contrast, comparing the microstructures of those MPCs containing borax with those 
prepared without borax, interesting differences were revealed, especially for NH4-MPC. In NH4-
MPC prepared without borax (Figure 6.16 b), elongated particles were displayed, instead of the 
glassy phase observed when the samples contained borax (Figure 6.16 a). The morphology of NH4-
MPC without borax was in accordance with that previously reported for schertelite, described as 
either cuboids or thick plates [22]. The morphology of Na-MPC prepared without borax (Figure 
6.16 d) showed an amorphous matrix with some incrusted particles which were probably covered 
by a glassy layer when borax was included in the powder phase (Figure 6.16 c). Finally, the NH4+Na-
MPC containing borax had a more homogeneous microstructure (Figure 6.16 e) than those 
containing no borax (Figure 6.16 f).  
The glassy layer observed when the MPCs contained borax was associated to the dissolved 
borax forming an amorphous magnesium borate compound on the surface of the MgO particles, as 
explained in Chapter 5 (Section 5.5.6).  
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The skeletal density of NH4-MPC (Table 6.7) was higher than the expected value for struvite 
(skeletal density of 1.71 g/cm
3
 [23]). This could be associated to a high amount of unreacted MgO 
(skeletal density of 3.6 g/cm
3
 [23]), since 50.8 wt% MgO was added and only 25.9 wt% MgO should 
react (1 mol MgO should stoichiometrically react with 1 mol of NH4H2PO4). A skeletal density of 
2.43 g/cm
3
 for NH4-MPC indicated that, theoretically, it contained 61.9 wt% struvite and 38.1 wt% 
MgO.  
The total open porosity of the three MPC formulations was about 30% or lower (Table 6.8), 
being mainly formed by nanometric pores intrinsically present in the microstructures of cements. 
However, the total open porosity could be overestimated due to the contribution of superficial 
cracks (Figure 6.16) −that appeared during the drying process of the samples−, producing pore 
entrance diameter peaks around 10 µm (Figure 6.17). In fact, no pores of this size were present in 
the microstructure of the cements. 
6.5.3 Antimicrobial assays and anti-biofilm activity  
The potential antimicrobial properties of the MPCs were envisaged due to the addition of 
MgO in excess, a basic compound that could provide the cements with an effect analogous to 
calcium oxide or alkaline compounds [24–26].  
6.5.3.1 Agar diffusion test 
The bacterial inhibition of the three formulations was evaluated by the agar diffusion test 
(Figure 6.18). NH4+Na-MPC was the formulation that presented the largest inhibition area, 
followed by NH4-MPC and, finally, Na-MPC. The size of the inhibition zone is indicative of the 
pathogen’s susceptibility to grow close to the material and, in fact, it is dependent on the diffusion 
of the solubilized ionic species from the cement through the agar gel [27,28]. In this regard, it must 
be pointed out that NH4+Na-MPC, which was the formulation with lower viscosity, was the one 
that favored more the diffusion of solubilized ions from the cement paste. It is important to note, 
therefore, that the outcome of this test can be considerably affected by the liquid to powder ratio 
of the cement paste [27].  
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6.5.3.2 Growth curves 
The antibacterial properties of the fresh- and aged-MPCs were also evidenced by bacterial 
growth curves performed with broth-cement extracts. While the three bacterial strains incubated 
in broth grew exponentially with time, their growth remained inhibited or the number of viable 
bacterial colonies decreased when incubated with fresh-cement extracts (Figure 6.19).  
For the fresh-cement extracts, it could be speculated that the antimicrobial properties of 
the extracts were directly correlated with their pH (Table 6.10), the slightly acidic pH of NH4-MPC 
and NH4+Na-MPC (pH 6.3 ± 0.4 and 6.5 ± 0.2, respectively) inhibiting the growth of E. coli and P. 
aeruginosa, while the alkaline Na-MPC extract (pH 10.1 ± 0.6) slowly killing these bacterial strains 
(Figure 6.19). However, since the pH of the NH4-MPC and NH4+Na-MPC was very close to 
neutrality, it was questioned whether there could be another factor involved in the antimicrobial 
properties of the cement extracts.  
When bacteria were immersed in aged-cement extracts (Figure 6.20), only the Na-MPC 
formulation (pH 11.9 ± 0.3) reduced the viable bacteria, even though the NH4-MPC and NH4+Na-
MPC also produced alkaline extracts (pH 9.1 ± 0.4 and 10.4 ± 0.2, respectively). This result suggests 
that there could be a pH threshold over which the medium turns to be a toxic solution for the 
three bacterial strains. However, the lack of antibacterial properties of the aged-NH4+Na-MPC 
extract, whose pH (pH 10.4 ± 0.2) was even higher than that of the fresh-Na-MPC extract (pH 10.1 
± 0.6) that reduced to zero the viable bacteria, reinforced the hypothesis that in some cases (there 
was another factor influencing the bactericidal activity of the extracts in addition to the pH. 
The fact that the number of viable A. actinomycetemcomitans was reduced with time 
when it was immersed in any of the cement extracts (cements of any formulation, used as either 
fresh or aged) was associated with a higher sensibility of this strain to slightly alkaline or acidic pHs 
in comparison with that of the other strains tested.  
6.5.3.3 Bactericidal activity 
The bactericidal activity test consisted on the quantification of the viable bacteria 
remaining after their immersion in media free of nutrients for a short period of time (i.e. 2 h). The 
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media used in this assay were free of nutrients (buffer medium ranging between 9 and 11, PBS-
extracts and pristine PBS as control) in order to avoid bacterial growth and thus directly associate 
the reduction of viable bacteria with the bactericidal effect of the extract. 
a) pH and osmolarity of the MPCs extracts  
The pH values of the extracts (Table 6.11) can be explained by the chemical composition of 
MPCs. On one hand, MgO is alkaline, although sparsely soluble in water [23,29]. On the other 
hand, the phosphate salts are acidic and very soluble in water [23]. When the cements were 
immersed in an aqueous medium, the phosphate salts were dissolved first, thus decreasing the pH 
of the medium. This explains the lower pH of the fresh-cement extracts than that of the aged-ones. 
The higher pH of Na-MPC extracts in comparison with that of the ammonium-containing cements 
could be associated to a faster dissolution of the MgO or of the formed amorphous sodium 
magnesium phosphate compound, releasing alkaline groups that would increase the pH of the 
medium. 
Both fresh- and aged-cement extracts had statistically significant higher values (p < 0.05) of 
both osmolarity and ionic concentration ([Mg], [P] and [Na]) than that of the pristine PBS (Figure 
6.23), showing that the cement released ionic species probably until the saturation of the extract. 
Moreover, within the extracts, the fresh-cement extracts had a higher osmolarity and also a 
significantly higher [Mg], [P] and [Na] (p < 0.05) than the analogous aged-ones, suggesting that 
most ions were released during the first 24 h due to the higher solubility of the phosphate salts. 
This result was in accordance with the lower pH of the fresh-cement extracts than of the aged-ones 
(Table 6.11).  
The high [P] and [Na] found in fresh-cement extracts was associated with the high 
dissolution of the phosphate salts and the low [Mg] could be attributed to the low solubility of 
MgO [23], which as long as it was dissolved reacted with the phosphate salts, producing the end-
products. It should be noted that the fresh-NH4-MPC extracts also had a statistically significantly 
higher (p < 0.05) [Na] than the pristine PBS due to the dissolution of the retardant, a sodium 
tetraborate decahydrate. Interestingly, the osmolarity of the fresh-cement extracts followed the 
trend NH4-MPC > NH4+Na-MPC > Na-MPC, which showed the amount of ionic species that were 
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released from the cements. In other words, this trend indicated that in the present conditions NH4-
MPC was the most soluble formulation, followed by NH4+Na-MPC and, finally, Na-MPC. 
b) Bactericidal activity of cement extracts 
In order to interpret the bactericidal activity of the extracts, it should be considered that 
the cements modified both the pH and the osmolarity of the extract. In general, three different 
situations were found: a) highly alkaline extracts with moderate osmolarity (e.g. aged-Na-MPC), b) 
almost neutral pH extracts with very high osmolarity (e.g. fresh-NH4-MPC and NH4+Na-MPC), or c) 
alkaline extracts with moderate osmolarity (e.g. aged-NH4+Na-MPC). The osmolarity was 
considered to be moderate when it was significantly higher than that of the pristine PBS (285 ± 1 
mOs/Kg).  
The bactericidal effects of different pH buffers were evaluated to understand the effect of 
pH on the bacterial strains under study. In general, the higher was the pH of the extract, the higher 
was the reduction of viable bacteria for the three bacterial species (Figure 6.22). However, the 
intensity of this effect differed for each bacterial strain. Specifically, 100 % of E. coli was killed at pH 
11, 11.3 ± 8.6% of P. aeruginosa survived at the same pH and no A. actinomycetemcomitans 
survived at pH 10.5 or higher. It is interesting to note that A. actinomycetemcomitans was the most 
sensitive strain to pH changes, whilst P. aeruginosa was the most robust one [30]. These results 
were associated with the fact that every microorganism has a definite pH range and a pH optimum 
for growth, and that although they often grow over wider ranges of pH and far from their optimal 
one, they have tolerance limits since drastic variations in cytoplasmic pH can harm 
microorganism’s enzymes and membrane transport proteins [27].  
Nevertheless, the fact that a buffer solution with pH 10 only killed around 30% of E. coli 
(Figure 6.22), whilst a cement extract with similar pH (i.e. fresh-Na-MPC extract, pH = 9.7 ± 0.1) 
had 100% bactericidal activity against this bacterial strain (Figure 6.21 a), showed that at certain 
ranges of pH, the bactericidal effect was not only due to the alkalinity of the medium but that 
other factors, such as the osmolarity of the medium, could be involved. It is known that bacteria 
immersed in high osmolarity media may suffer hyperosmotic stress, which stimulates the synthesis 
of several proteins to maintain the internal osmotic conditions, whilst decreases the synthesis of 
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several others, as bacteria adjust to the new external environment [31]. Bacteria that cannot adapt 
to the osmotic changes usually die when their membranes are ruptured due to osmotic pressure. 
Moreover, it should be highlighted that although single parameters such as pH modification and 
moderate osmotic conditions might have relatively minor effects to bacteria, their combination can 
have a profound synergistic effect [32], as reported by Schwan et al. for the transcription of 
specific bacterial genes. 
The bactericidal activity tests indicated that the fresh-Na-MPC extracts reduced the 
number of viable bacteria between 98.5 and 100 % of the three bacterial strains (Figure 6.21 a), 
and the aged-Na-MPC ones reduced 100% viable E. coli and A. actinomycetemcomitans, and 90.8 ± 
1.4 % P. aeruginosa (Figure 6.21 b). On one hand, the high bactericidal effect of the fresh-Na-MPC 
extract against the three bacterial strains could be associated to the synergistic effect of both its 
alkaline pH (9.7 ± 0.1) and its moderate osmolarity (755 ± 36 mOs/Kg), which was 2.5-fold times 
higher than that of pristine PBS (286 ± 0.6 mOs/Kg). On the other hand, the high bactericidal effect 
of the aged-Na-MPC extract against E. coli and A. actinomycetemcomitans could be mainly related 
to its very high pH (11.4 ± 0.6), which probably was over the pH threshold that turned the solution 
into a toxic one for the bacteria under evaluation, by irreversibly damaging the enzymes and the 
membrane transport proteins of bacteria.  
Surprisingly, the fresh-Na-MPC extract killed more efficiently the P. aeruginosa than the 
analogous aged-one. This could indicate that, particularly for this bacterial strain that is robust to 
pH changes of the medium (Figure 6.22) [30], the synergistic effect caused by the high osmolarity 
and the alkalinity of the extract could be specially potentiated from the side of osmolarity. 
Therefore, the fresh-cement extract (osmolarity 755 ± 36 mOs/Kg and pH 9.7 ± 0.1) would 
accentuate the osmotic stress conditions in front to the aged-cement extract (osmolarity 619 ± 96 
mOs/Kg and pH 11.4 ± 0.6), reducing the viable bacteria more effectively. 
Both fresh-NH4-MPC and fresh-NH4+Na-MPC extracts significantly reduced (p < 0.05) the 
population of viable bacteria of the three bacterial strains in comparison the control (Figure 6.21 
a), which could be mainly attributed to the very high osmolarity of the extracts (1703 ± 155 and 
1171 ± 73 mOs/Kg, respectively), which were 6-fold and 4-fold times that of the pristine PBS. 
Moreover, the slightly acidic pH (pH 6.3 ± 0.4 and 6.5 ± 0.2, respectively) could also contribute to 
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the bactericidal potential of the extracts by creating a synergistic effect. The bactericidal activity 
was even more pronounced for the aged-NH4-MPC and aged-NH4+Na-MPC for E. coli and A. 
actinomycetemcomitans (Figure 6.21 b). This antimicrobial activity was probably due to the 
synergistic effect of the alkaline pH (9.1 ± 0.4 and 9.9 ± 0.5, respectively) and the moderate 
osmolarity (553 ± 29 mOs/Kg and 495 ± 46 mOs/Kg, respectively). The higher efficiency for the 
aged-NH4+Na-MPC could be associated to the higher alkalinity of this extract (9.9 ± 0.5), which in 
the present synergistic conditions could be over the pH threshold of both strains, causing 
irreversible damages to some of their enzymes and proteins. The number of viable P. aeruginosa 
after incubation with aged-NH4-MPC and aged-NH4+Na-MPC did not change significantly (p > 0.05), 
since this strain is robust to pH changes [30] and the osmolarity of the extracts was moderate. 
6.5.3.4 Bacterial growth curve versus bactericidal activity 
The growth curve assays (Figure 6.19 and 6.20) and the bactericidal activity tests (Figure 
6.21) showed a good correlation regarding the effectiveness of each MPC formulation on the 
reduction of viable bacteria. It should be highlighted that the growth curve study was performed 
with broth-extracts and shows a balance between the growth and the death of bacteria, whilst the 
bactericidal activity test was conducted with PBS-extracts and only reveals the reduction of 
bacteria, since a medium free of nutrients inhibits bacterial growth. 
In general, two different situations were found. In the first situation, the bactericidal 
efficiency of the cement extracts was about 100% and caused no bacterial growth. This was the 
case of fresh- and aged-Na-MPC in all bacterial strains and also of fresh- and aged-NH4-MPC and 
NH4+Na-MPC for A. actinomycetemcomitans. In the second situation, the cement extracts 
significantly reduced the viable bacteria and the bacterial growth was delayed or inhibited. This 
was the case of fresh- and aged-NH4-MPC for E. coli and of fresh-NH4-MPC for P. aeruginosa. 
However, E. coli immersed in aged-NH4+Na-MPC extract showed an inconsistent result since its 
bactericidal effect was 100% but bacteria grew exponentially with time.  
For both groups of tests it was observed that the bacterial viability in MPC extracts 
depended, on one hand, on the pH (Table 6.10 and 6.11) and, on the other hand, on the osmolarity 
(Figure 6.23) of each extract. The osmolarity and the pH was different for each cement formulation 
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(osmolarity: NH4-MPC > NH4+Na-MPC > Na-MPC; pH: Na-MPC > NH4-MPC ∼ NH4+Na-MPC) and also 
depended on the aging time of the cement (osmolarity: fresh > aged; pH: aged > fresh). In most 
cases, the pH modification and the moderate osmolarity of the extract produced a synergistic 
effect which efficiently reduced the viable bacteria. In other cases, the pH of the extract was over a 
pH threshold, killing the totality of bacteria due to the harmful effect for certain enzymes and 
proteins of bacteria. It should be noted that the pH threshold seemed to be slightly higher for the 
extracts prepared in broth than for those prepared in PBS, since the bacteria would be able to 
adapt better in the broth extract.  
Moreover, each bacterial strain was differently affected by the mentioned parameters. For 
instance, P. aeruginosa seemed to be more affected by a high ionic concentration than by a high 
pH, since a higher efficiency to inhibit bacterial growth in broth (growth curve assay) or to kill this 
strain in PBS (bactericidal activity assay) was observed for the fresh-cement extracts. This could be 
explained for the robusticity of P. aeruginosa to alkaline pHs [30]. In contrast, A. 
actinomycetemcomitans was more sensitive to the modifications of the media than the other two 
strains, being observed a reduction of viable bacteria with time and also 100% of bacterial death in 
the bactericidal activity test in any cement extract. 
In conclusion, the growth curve and the bactericidal activity assays allowed predicting that, 
in vivo, the alkalinity of Na-MPC would provide the implantation site with bactericidal properties 
against E. coli, P. aeruginosa and A. actinomycetemcomitans, whilst the NH4-MPC and NH4+Na-
MPC would provide it with a bacteriostatic effect against the same bacterial strains.  
6.5.3.5 Anti-biofilm activity 
The anti-biofilm activity showed that the fresh-Na-MPC-extracts reduced the viable 
biofilm-P. aeruginosa almost in their totality, whether fresh-NH4-MPC and fresh-NH4+Na-MPC 
extracts left 8 and 22 % of biofilm-bacteria alive, respectively (Figure 6.24). This data could be 
correlated with the results after 24 h of the growth curve performed with planktonic P. aeruginosa 
(Figure 6.19 b), where no viable bacteria were found in the Na-MPC extract, and the viable bacteria 
in fresh-NH4-MPC and in NH4+Na-MPC extracts represented about 0.003-0.004 % of the viable 
bacteria present in pristine broth. However, the population of viable biofilm-bacteria was higher 
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than that of the planktonic bacteria due to the higher resistance of bacterial communities to 
antimicrobial substances [33,34]. 
As previously explained (Section 6.5.3.3), the Na-MPC reduced the population of viable 
bacteria more effectively than NH4-MPC and NH4+Na-MPC. Briefly, the bactericidal activity of this 
extract was caused by the synergistic effect of both its alkalinity and moderate osmolarity. 
6.5.4 Cell viability 
The antimicrobial properties observed for the MPCs could consequently compromise the 
viability of eukaryotic cells. Therefore, cell viability tests were performed in order to evaluate the 
cytotoxicity of the material to preosteoblastic cells. The cell viability of the extracts (Figure 6.25) 
allowed evaluating the effect of several factors: the cement formulation (NH4-MPC, Na-MPC or 
NH4+Na-MPC), the cement aging (fresh or aged), the preparation time of the extract (5h or 72h-
extract) and the dilution of the extract (1-1, 1-2 or 1-10).  
Even though the osmolarity of the extracts prepared with complete medium was not 
evaluated, it was assumed to be similar to the values found with the PBS-extracts (Figure 6.23). 
Table 6.13 summarizes the results of cell viability in the undiluted 72 h-cement extracts, which are 
the most harmful extracts for cells, together with their pH values and their osmolarity. 
Table 6.13. Cell viability, pH and osmolarity for the undiluted 72 h-cement extracts prepared in complete 
medium (except for the osmolarity, which values are from PBS-extracts). 
 NH4-MPC Na-MPC NH4+Na-MPC Pristine 
medium  Fresh Aged Fresh Aged Fresh Aged 
Cell viability 
(%) 
0 43.5 ± 7.0 0 0 0 1 ± 0.7 100 % 
pH 6.1 ± 0.1 9.0 ± 0.3 10.4 ± 0.1 11.6 ± 0.2 6.9 ± 0.1 10.6 ± 0.3 7.3 ± 0.2 
Osmolarity 
(mOs/Kg) 
∼ 1700 ∼ 550 ∼ 750 ∼ 620 ∼ 1170 ∼ 500 ∼ 285 
 
As observed in Table 6.13, except for aged-NH4-MPC extracts, the cell viability was close to 
zero. This could be ascribed either to the high osmolarity of the extract (1170 – 1700 mOs/Kg) or to 
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its high alkalinity (pH 10.4 – 11.6), the former case occurring in fresh-cement extracts and the latter 
in the aged-ones. However, in both cases, the synergistic effect caused by the osmolarity and the 
pH modification of the extracts would be specifically harmful for the cells. In contrast, the aged-
NH4-MPC extract showed a cell viability over 40 % due to the moderate osmolarity of the extract (∼ 
550 mOs/Kg) and its slight alkalinity (pH 9.0 ± 0.3).  
Looking to the whole cell viability study (Figure 6.25), aged-cement extracts had higher cell 
viability than the fresh-cement ones. These results suggested that the high osmolarity of the media 
was a more detrimental factor than their alkalinity, since aged-cement extracts had a higher pH 
and a lower osmolarity than fresh-ones. However, the cell viability results showed that around 
40−70% of cells survived at pH around 9 (e.g. aged-5h-NH4+Na-MPC-extract and aged-72h-NH4-
MPC-extract), but that they did not survive at a pH close to 10 (e.g. aged-5h-Na-MPC-extract). 
These results verified that cells, like bacteria, have a pH threshold over which an irreversible 
damage is caused to certain enzymes and proteins of cells. 
The higher viability of cells in aged-cement extracts than in their fresh-counterparts 
allowed speculating that, in vivo, their cytotoxicity would be reduced with time. This result was 
also in agreement with a study performed by Ghoddusi et al. [35], which showed that the fresh-
MTA (cement for endodontic applications) was more cytotoxic than the aged-one.  
Cytotoxicity studies performed with MTA have been reported. However, the lack of 
normalization of these studies makes difficult to compare the results between different works. On 
one hand, Ko et al. [36] showed that the cell viability of MTA extracts (prepared in a 
surface/volume ratio of 6.3 cm
2
/ml) was 25% for MTA set for 1 h or 30% for MTA set for 24 h, and 
that the cell viability of MTA increased by placing the cement disks in 100% humidity at 37°C for 48 
h or more. On the other hand, Ribeiro et al. [37] reported only a slight cytotoxicity of MTA, 
probably due to the low cement/volume ratio of 1000 µg/ml (1 mg/ml) used. This concentration 
was 850 times lower than the one used in the current study (0.85 g/ml = 850 mg/ml). Ghoddusi et 
al. [35] evaluated the cytotoxicity of MTA with the L929 cell line by preparing extracts of 1 g 
cement/5 g medium ratio. These extracts, which were evaluated neat and diluted up to 1/100, 
showed a good biocompatibility of the cement. Nevertheless, it has to be pointed out that the neat 
extract was already 3.5 times more diluted than the one used in the current study. Finally, it is 
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important to remark that even though an alkaline root canal filler such as MTA may lead to cell 
toxicity in vitro, successful results in clinical studies have been repeatedly reported [38]. 
There are also several studies regarding the cytotoxicity studies performed with Ca(OH)2, 
which has been conventionally used as an inter-appointment dressing material. Cell culture tests 
using either human periodontal ligament cells, monolayer or multilayer mouse cells have shown 
calcium hydroxide-based materials to be less toxic compared with zinc oxide eugenol and resin-
based sealers [39–43].  
6.5.5 Antimicrobial properties versus cell viability 
It is generally accepted that materials showing antimicrobial properties induce some 
inflammatory response in the local tissues, while those that do not elicit an inflammatory response 
are, at best, bacteriostatic. In other words, it is difficult to reconcile both the biocompatibility and 
the antimicrobial properties of a material, since this would require a high degree of selectivity in 
the biological response [17]. However, it is essential to avoid a chronic inflammation, which could 
lead to the loss of the tooth, the opposite of the intended outcome [44]. Therefore, it is important 
to evaluate the cytotoxicity level of the MPCs and also to determine whether this cytotoxicity 
decreases with time.  
For the purposes of this work, the antimicrobial properties and the cell viability of fresh- 
and aged-cement extracts were evaluated. The bacteriological assays showed that the extracts of 
the three fresh- and aged-cement formulations reduced the viable bacteria, Na-MPC doing so in its 
totality. In general, this antimicrobial effect was fostered by the synergistic effect of the alkalinity 
and the moderate osmolarity of the extract. As it could be expected, the eukaryotic cells were 
similarly affected by the cement extracts. However, interestingly, the cell viability was significantly 
increased for the aged-cement extracts, showing that the cells were more robust to slight alkaline 
pH (i.e. pH ∼ 9) than to high osmolarity. The importance of this result relies on the lower 
cytotoxicity that the cements would have after aging.  
Extrapolating these results to a hypothetic situation in which MPCs would be used to 
obturate an infected cavity, such as a root canal during an endodontic treatment, it could be 
expected that the cement would kill any remaining microorganism contaminating the wound site 
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(root canals and microtubules) from the very beginning. Consequently, as a side effect, the tissue 
in contact with the alkaline cement (apical part) would suffer superficial necrosis that could trigger 
an inflammatory response. However, after a few days, the material would reduce its cytotoxicity 
against eukaryotic cells, the inflammation response would decrease, new eukaryotic cells would be 
able to grow back and, finally, the surrounding tissue would recover. Indeed, commercialized 
alkaline root canal fillers such as MTA, which led to cell toxicity in vitro [36], have shown successful 
results in clinics [38].  
Similarly, epoxy resin sealers guarantee the balance between both antimicrobial properties 
and biocompatibility due to their short period of antimicrobial activity. These materials are 
supposed to be toxic only for a short period of time during which the material is reacting, although 
long enough to kill residual bacteria. After setting, they should not be harmful anymore, leaving 
time for the surrounding tissues to heal [44].  
 
6.6 Conclusions 
 The conclusions that can be extracted from this Chapter are the following: 
1. MPCs were optimized to avoid tissue-damaging exothermy in physiological conditions by adding 
6 wt% of borax and calcining the MgO for 12 h at 1475°C. These modifications performed to the 
cements did not significantly modify their physico-chemical properties regarding to their crystalline 
phases, microstructure, mechanical properties, specific surface area, skeletal density and 
porosimetry after 7 days of immersion in Ringer’s solution. 
2. The agar diffusion test showed that the three MPC formulations inhibited bacterial growth of E. 
coli, P. aeruginosa and A. actinomycetemcomitans. However, the obtained results had to be 
considered as qualitative and dependent on the cement diffusion through the agar. 
3. Both fresh- and aged-Na-MPC extracts showed bactericidal properties against E. coli, P. 
aeruginosa (as free floating single bacteria or as biofilm) and A. actinomycetemcomitans. The 
antimicrobial potency of this formulation was fostered by the synergistic effect of the elevated pH 
and the moderate or high osmolarity of the extract. 
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4. Both fresh-NH4-MPC and NH4+Na-MPC extracts showed bacteriostatic properties against E. coli, 
P. aeruginosa and A. actinomycetemcomitans, which was associated to the synergistic effect of a 
high osmolarity and the slight pH modification.  
5. Fresh-MPC extracts reduced osteoblastic-like cells viability. However, the cell viability increased 
by aging the cements, probably due to the lower osmolarity of the resulting extracts. 
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7.1 Introduction 
Any material intended to be used as root canal filling material, apart from being 
biocompatible, should fulfill other requirements. One of the most essential requirements is to seal 
tightly against bacteria, in other words, to avoid the penetration of bacteria through the material 
or through the interface between the filling material and the dentin [1]. In order to ensure the 
sealing, the material has to remain stable with time [1–3]. Moreover, the material should have a 
high bonding strength, reducing the risk of bacterial leakage in the interface between the filling 
material and the root canal. A good bonding strength also ensures the mechanical stability of the 
root canal filler material during basic functions such as mastication [4].  
In summary, the aim of a root filling material is to act as an effective and permanent 
antibacterial barrier [5]. However, there is still no commercial material that fulfills all the 
requirements for root canal filling and, for this reason, a combination of two endodontic materials 
is usually employed [1,6]. Therefore, the concept of using a paste as a unique filling material makes 
it more appealing since it would be a simple method to fill and seal the root canal. 
The magnesium phosphate cements (MPCs), which have been used in civil engineering, are 
proposed in this Thesis as novel materials for clinical applications. With this aim, the physico-
chemical properties of the MPCs have been tailored and their biological properties have been 
evaluated (Chapter 6). The antimicrobial properties of the MPCs (Chapter 6) allowed pointing them 
out as potential candidates for endodontic treatments and, specifically, for root canal filling. 
However, the MPCs should be provided with radiopacity in order to be used in the mentioned 
applications. 
 
7.2 Objectives 
The objectives of this Chapter are the following: 
1. To modify the MPC formulations (optimized in Chapter 6) in order to provide them with 
radiopacity (cements coded as RAD-MPC). 
2. To characterize the physico-chemical properties of the RAD-MPC. 
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3. To evaluate some specific properties relevant for endodontic applications:  
i) Stability;  
ii) Dentin-cement bonding strength; 
iii) Sealing ability. 
 
The following schema shows the studies performed in this Chapter. 
 
Figure 7.1. Schema of the parts composing Chapter 7. 
 
7.3 Materials and methods 
7.3.1 Powder phase 
The three magnesium phosphate cement (MPC) formulations optimized in Chapter 6 were 
further modified to provide the cements with radiopacity. This novel family of cements is coded as 
RAD-MPC. Briefly, MPC formulations consisted of a combination of magnesium oxide (MgO, Merck, 
ref. n. 105867) and either ammonium dihydrogen phosphate (NH4H2PO4, Panreac, ref. n. 
131126.1210), sodium dihydrogen phosphate (NaH2PO4, Fluka ref. n. 71496) or an equimolar 
mixture of the two phosphate salts. A sodium borate decahydrated, Na2B4O7·10H2O, known also as 
borax (Fluka, ref n. 72000), was added as a retardant of the reaction, and bismuth oxide (Bi2O3, 
Sigma Aldrich ref. n. 223891) was included as a radiopacifying agent.  
The processing parameters performed to the reactants and their particle size distribution 
were described in Chapter 6 (Table 6.1). However, the NH4H2PO4 was milled more energetically in 
this Chapter in order to improve its moldeability and its injectability. Fifty g of NH4H2PO4 was milled 
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in a planetary ball mill (Fritsch, Pulverisette 6), using an agate jar and 4 agate balls (φ = 30 mm) at 
350 rpm during 30 min. The particle size distribution was characterized by laser diffraction 
(Beckman Coulter LS 13 320) after sonicating the powder in ethanol in order to avoid particle 
agglomeration. The D10, D50 and D90 (µm) of the milled powder was 1.97 ± 0.52, 14.15 ± 6.32 and 
35.89 ± 8.20, respectively, Di accounting for the average particle size where i% of the sample 
volume is smaller than Di. Figure 7.2 shows the particle size distribution of the main reactants of 
RAD-MPC. 
 
Figure 7.2. Particle size distribution of the processed reactants: MgO sintered at 1475°C for 12 h 
(milled at 150 rpm for 15 min), NH4H2PO4 milled at 350 rpm for 30 min (fine), NaH2PO4 milled at 150 
rpm for 15 min (coarse) and borax milled at 350 rpm for 30 min (fine).  
 
The Bi2O3 was characterized in terms of crystalline phases by X-ray powder diffraction 
(XRD, PANalytical, X’Pert PRO Alpha-1), of morphology by Field Emission Scanning Electron 
Microscopy (FESEM, JEOL JSM-7001F) and of particle size distribution by laser diffraction (Figure 
7.3). The specific surface area of this compound, which was analyzed by N2 adsorption 
(Micromeritics ASAP 2020) following the BET (Brunnauer – Emmet – Teller) theory, was 0.37 ± 0.15 
m2/g. 
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Figure 7.3. a) Characterization of Bi2O3: a) XRD, the theoretical position of Bi2O3 are indicated, b) 
morphology and c) particle size distribution.  
 
7.3.2 Cement preparation 
The cement was prepared as explained in section 5.3.2, with the difference that Bi2O3, 
which is yellow, was added to the cement powder that after being manually homogenized with a 
spatula became a matt yellow powder (Figure 7.4 a). Magnesium phosphate cements were 
prepared by mixing the powder phase with distilled water in a L/P ratio of 0.13 ml/g. The mixture 
of the powder and the liquid phase gave place to a paste that set within minutes into a solid body 
(Figure 7.4 b). The resulting cements were named NH4-MPC, Na-MPC and NH4+Na-MPC, 
respectively, accounting for the type of phosphate salt used. 
 Figure 7.4. a) Appearance of:
powder phase, and Na-MPC paste
powder and the process until the harde
 
The experimental methodology to 
modifying the MPCs (optimized in Chapter 6)
in Figure 7.5. Firstly, the amount of 
and, secondly, the amount of borax required 
tolerable levels for the surrounding tis
Figure 7.5. Experimental procedu
MPC cements with appropriate radiopacity and exothermy, 
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; b) schema in which are shown the reactants that constitute the 
ning of the cement.  
tune the RAD-MPC formulations consisted on further 
 through a two-steps process, as schematically shown 
Bi2O3 needed to produce radiopaque cements 
in order to maintain the cements’ exothermy
sues was evaluated.  
re to determine the amount of Bi2O3 and borax required to produce 
respectively. 
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3 with the 
was determined 
 within 
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7.3.3 Radiopacity assessment
The amount of radiopacifying agent (Bi
determined following the radiopacity criterion established in 
(“Dental root canal sealing materials”) 
7.3.3.1 Sample preparation  
Disks of RAD-MPC formulations
the commercial MTA contains about 16 wt% 
lower and higher amounts of Bi2O3
thickness = 2 mm) were prepared including 0, 10, 15, 20, 30, 40 wt% Bi
the samples thickness is a determinant factor to evaluate the radiopacity, abrasive paper
to reduce the thickness of each disk to exactly 2 mm
7.3.3.2 Aluminum standard 
The radiopacity of the cement 
that served as an internal standard for each radiographic exposure
by the UNE-EN ISO 6876 standard [7]
of each sample in terms of equivalent 
Figure 7.6. Schema in which is represented a X
2 mm-thickness disk.  
 
  
  
2O3) that had to be included in RAD
the UNE-EN ISO 6876
[7]. 
 containing different amounts of Bi2O3 were prepared. 
Bi2O3 [8], samples of RAD-MPC were prepared 
 than that in MTA. Therefore, RAD-MPC disks (∅
2O3, and 0 wt% borax
.  
disks was compared with that of an aluminum step
 (Figure 7.6), as recommended 
. The use of a step-wedge allowed calculating the radio
millimeters of aluminum thickness [9].  
 
-ray going through a) an aluminum step-wedge and b) 
-MPC was 
 standard 
Since 
with 
 = 15 mm, 
. Since 
 was used 
-wedge 
pacity 
a 
 The aluminum step-wedge
Figure 7.7. Aluminum step-wedge used as a standard of the radiopacity tests.
Mechanical Workshop of the Department of Material Science and Metallurgy of the Technical University of 
Catalonia. 
 
An aluminum alloy #6082
in this alloy are indicated in Table 
Table 7.1. Impurities of the aluminum alloy #6082 (
Al Cr Cu 
95.2−98.3 < 0.25 < 0.10 
 
7.3.3.3 Radiopacity quantification
According to UNE-EN ISO 6876 standard
root canal sealing materials [7,9]
density on X-ray imaging is that of 
The image processing software Adobe Photoshop (CS4 portable) was used to determine 
the grey scale values (optical density) 
[10]. Five regions of the disk were 
region was averaged over an area of 11 x 11 pixels
of grey levels, which lower value (
(R = G = B = 255) matched with the white one. 
deviation of R = G = B. 
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 had the dimensions indicated in Figure 7.7.  
 
 The step-wedge was 
 was used to make up the step-wedge. The impurities contained 
7.1.  
wt %). 
Fe Mg Mn Si Ti
< 0.50 0.60−1.20 0.40−1.0 0.70−1.30 < 0.10
 
, which reports the required radiopacity 
, a 1 mm-thickness material is 100 % radiopaque when
an aluminum piece of 3 mm-thickness.  
of the sample regions, as reported by Carvalho
randomly selected to measure their grey scale values. Each 
. The radiopacity was quantified from the range 
R = G = B = 0) represented the black color and their higher value 
The level of grey was expressed as means ± standard 
 341 
made at the 
 Zn 
Other 
(total) 
 < 0.20 < 0.15 
for dental 
 its optical 
-Junior et al. 
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A calibration curve of the grey scale values 
wedge (thickness from 1 to 8 mm) was created to convert the 
samples to equivalent millimeters of aluminum thickness (
Figure 7.8. Calibration curve of the aluminum standard, and interpolation of the level of grey of a 
sample to determine the equivalent millimeters of aluminum
 
7.3.3.4 X-ray equipment 
A portable X-ray unit was used 
small (4 x 2.2 cm), the images of the disks 
V = 70 kV, I = 8 mA, exposition time: 0.250 s and
samples of 37 cm. Figure 7.9 shows
radiopacity of a cement disk. 
Figure 7.9. a) Portable X-ray unit and
vertical position in order that the X
(0 < R = G = B < 255) of the aluminum step
grey scale (optical density
Figure 7.8).  
 
 thickness.  
(SATALEC X Mind). Since the size of the radiographies
had to be taken one by one. The parameters 
 focal distance between the X-ray source 
 the X-ray cannon in the working position to analyze the 
 b) X-ray cannon 37 cm far from the disk, which was kept in a
-rays go through its thickness. 
-
) of the 
 is 
used were: 
and the 
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7.3.4 Physico-chemical characterizations of RAD-MPC 
After selecting the optimal amount of Bi2O3 to have an adequate radiopacity, samples 
including 0, 1 and 3 wt% borax were prepared and their exothermy and setting times were 
evaluated, as described in Sections 6.3.3 and 3.3.2.1, respectively. The thermal coefficient was 
calculated (Section 6.3.3), indicating that only those formulations with a coefficient value lower 
than 1 were eligible for clinical applications. Both the exothermy and the setting times assays were 
used to determine the adequate amount of borax that should be added to comply with the clinical 
requirements. The resulting formulations were coded as RAD-MPC.  
The three formulations of RAD-MPC were physico-chemically characterized with the 
techniques detailed in Chapter 5 and 6. The injectability of the pastes was characterized using a 
mechanical testing machine (Bionix® MTS 370) until the cell load reached 100 N (Section 6.3.4.1). 
The RAD-MPC formulations were also characterized after different times of immersion in Ringer’s 
solution (0.9 wt% NaCl), in terms of mechanical properties (Section 5.3.4.3), crystalline phases 
(XRD) including also the card JCPDS # 710465 for Bi2O3 [11] (Section 5.3.4.4), morphology and 
chemical analysis by energy dispersive X-ray spectrometry (Section 5.3.4.5 and 3.3.4.3.4, 
respectively), specific surface area (Section 5.3.4.6), skeletal density (Section 5.3.4.7) and 
porosimetry (Section 5.3.4.8).  
7.3.5 Specific characterizations for endodontic cements 
7.3.5.1 Material stability 
The stability of the RAD-MPCs was evaluated in static conditions. Cement disks (Ø = 15 
mm, h = 2 mm), which were set in air for 20 min, were soaked in 50 ml of a phosphate buffer 
solution (PBS, Gibco, ref. n. 18912-014). After 2 h of soaking, the cement disks were weighted, 
these values accounting for the initial weight (w0). The disks were maintained immersed in PBS at 
37°C for a total period of 60 days, during which the solution was refreshed every 3.5 days. At every 
time point, the cement was weighted immersed into a fresh PBS solution using an analytical 
balance (Sartorius BP 211 D). The weight change (%) at every time point was calculated as 
indicated in Equation 7.1, where w0 is the specimen’s weight after 2 h and wt is the specimen’s 
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weight at time t. A positive weight change indicated a weight gain, while a negative weight change 
indicated a weight loss. The study was performed with five specimens for each formulation. 
Equation 7.1.    Weight change (%) =


  
 It is important to highlight that this study was done under more drastic conditions than the 
actual ones in the root canal (the disk was soaked in a high amount of liquid that was frequently 
refreshed to avoid the ionic saturation of the medium), with the aim to accelerate the 
solubilization process of the material.  
The pH of the degradation medium was monitored with a pH-meter (Crison MM 41). The 
pH was evaluated with 5 replicates. The magnesium, phosphorus and sodium concentration, from 
now on [Mg], [P] and [Na], were quantified using different analytical methods. 
a) Quantification of the [Mg] 
The [Mg] of the medium was quantified by a complexometric titration [12], specifically a 
back titration, which is a method commonly used to determine the total hardness of fresh water 
(combined concentration of Mg
2+
 and Ca
2+
). Briefly, the Mg ions in the sample were complexed 
with ethylenediaminetetraacetic acid (EDTA, Panreac, ref. n. 131669). Then, Eriochrome Black T 
(EBT, Fluka, ref. n. 32751) was added as dye indicator and magnesium chloride hexahydrated 
(MgCl2·6H2O, Panreac, ref. n. 131356) was used as titrating agent. To ensure an alkaline pH, 
NH4Cl/NH3 buffer was also added. The dye–metal ion complex is less stable than the EDTA–metal 
ion complex. Therefore, the Mg ions from MgCl2·6H2O complexed the EBT dye only when all EDTA 
molecules were already complexed, the dye changing color from blue to pink in the process. The 
[Mg] were evaluated with 5 replicates. The titration process is schematically shown in Figure 7.10 
and the reactants concentration and volumes used are indicated in Table 7.2.  
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Figure 7.10. a) Schema of the titration process, where the reactants used are indicated, and b) color 
changes observed during the titration process, the formation of molecular complexes responsible of 
them are indicated. EBT stands for Eriochrome Black T. 
 
Table 7.2. Concentration and volume of the reactants used for the titration.  
Reactant Concentration, [  ] (mM) Volume, V (ml) 
Sample Unknown 25 
MgCl2·6 H2O 0.3125 − 0.625 10 − 40 
EDTA 5 3 − 9 
EBT 28.9 2 − 3 drops 
NH4Cl/NH3 1300/7330 10 
 
The [Mg] of the sample was calculated knowing that both the Mg ions of the sample and 
the added Mg ions (as MgCl2·6H2O) reacted with the totality of molecules of EDTA, at this moment 
the dye changing its color. The [Mg] of the sample was calculated as shown in Equation 7.2, where 
[EDTA] and [Mg] is the concentration of EDTA and Mg, respectively, and V is the volume of the 
compound displayed as a subscript.  
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Equation 7.2.  mols Mg + mols Mg			 = mols EDTA  
mols Mg  = mols EDTA −  mols Mg			 
[Mg] · V =  EDTA · V
 −  [Mg]			 · V 			 
[Mg]  =
EDTA · V
 −  [Mg]			 · V 			
V
 
 
b) Quantification of [P] 
The [P] was quantified by a colorimetric method reported by Chen et al. [13]. The 
experimental procedure consisted on mixing 300 µl of sample with 300 µl of a reagent recently 
prepared in a 48 well plate. The reagent contained 1 volume of sulfuric acid 6 N, 1 volume of 
ammonium orthomolybdate 2.5 %, 1 volume ascorbic acid 10% and 2 volumes of distilled water. 
Briefly, the phosphate groups of the sample reacted with the ammonium orthomolybdate in the 
acidic solution, and the formed phosphomolybdic acid was reduced with ascorbic acid converting 
the solutions to blue color (Figure 7.11). The optical density of the colored solution was recorded 
using a plate spectrophotometer (Biotek, Synergy HT). This optical density was linearly 
proportional to the concentration of phosphates in the sample. A calibration curve with different 
concentrations of NaH2PO4, which [P] ranged between 10
-4
 and 10
-6
 M, was obtained. The [P] was 
calculated with 3 replicates of each cement formulation, each of them being quantified in triplicate 
(n = 9).  
 Figure 7.11. Step-reaction in which the ammonium orthomolybdate reacts with phosphate
result in a colored phosphomolybdate complex.
 
c) Quantification of [Na] 
The [Na] was measured by means of a selective
Instrumentation Laboratory. 
7.3.5.2 Dentin-cement bonding strength 
The bonding strength between the 
push-out test. This study was performed 
under study. Briefly, the test consisted o
canal and quantifying the needed 
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(push-out test) 
cements and the dentin was evaluated 
obturating single-root human teeth with the cements 
n pressing the surface of a cement placed in 
stress to displace the cement from its original position
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 groups to 
2+
, K
+
, Na
+
, pH, 
by means of a 
a sliced root 
.  
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It should be underlined that the dentin-cement bonding strength assays are displayed 
together with the specific characterization for endodontic cements, although this test was not 
performed with the RAD-MPC formulation, but with the MPCs optimized in Chapter 6. Grey MTA 
(Dentsply, Pro-root) was used as control. 
Human extracted teeth were obtained as clinical waste specimens without identifying data. 
The project was exempt (exemption #4) from IRB review (University of Minnesota, Minnesota, 
USA). Before use, every tooth was placed in 5% sodium hypochlorite solution (NaClO) for 1 h for 
surface disinfection and periodontal ligament removal, followed by storage in 1% NaClO solution at 
4°C for a period no longer than 1 month. Every tooth was individually measured with the aim to 
perform the tests using the coronal third of the root canal (Figure 7.12 a). Then, the teeth were 
fixed perpendicularly to a glass surface with wax (Figure 7.12 b) and were embedded in resin 
(Figure 7.12 c). The resin containing the teeth were cut with a low speed diamond saw (Buehler 
Isomet) through the apical and coronal areas marked previously (Figure 7.12 d).  
The root canals were enlarged using Gates Glidden burs mounted using a slow-speed 
dental handpiece, progressively increasing their diameter until reaching 1.1 mm (Figure 7.12 e). 
The root canals were irrigated with 17% EDTA solution (a calcium chelating agent) for 2 min to 
remove the smear layer [14], followed by rinsing with sterile normal saline solution (0.9 wt% NaCl 
in water) and, finally, root canals were dried with paper points. Each cement was placed into the 
root canal using a lentulo spiral and was laterally compacted with endodontic pluggers (Figure 7.12 
f). A single operator conducted all procedures. 
After storing the obturated roots embedded in resin for 24 h in 100% relative humidity, 
they were sectioned horizontally into 2-mm slices, using a low-speed diamond saw (Figure 7.12 g).  
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Figure 7.12. Process to prepare the teeth to finally obtain cemented root slices: a) single-root canal 
teeth with marks for cutting, b) tooth perpendicularly fixed in a glass surface with wax, c) tooth 
perpendicular to a glass surface and inside a circular mold, prepared for the addition of resin, d) teeth 
embedded inside resin with their coronal and apical parts cut, e) shaping the root canal to a diameter 
of 1.1 mm, f) cement obturation into the root canal and g) 2 mm-thickness slices containing the 
cemented root embedded in resin. 
 
 The push-out test was performed in a universal testing machine (Material Test System, TS 
810) (Figure 7.13 a). The resin layer containing the cemented tooth was stuck on a steel holder 
(Figure 7.13 b), the apical part of the root facing up (to avoid blockage due to the root conical 
morphology) and matching the hole of the holder (∅ = 2 mm) with the root canal (∅ = 1.1 mm). 
The steel holder was fixed in the universal testing machine and, finally, a 1-mm diameter pin was 
used to push the cement perpendicularly at a speed rate of 0.5 mm/min, until the pin was 
displaced 1 mm (Figure 7.13 c). Figure 7.13 d schematically summarizes the parameters used for 
the push-out test. 
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Figure 7.13. a) Universal testing machine to perform the push-out test, b) layer of cemented teeth 
sticked in the steel holder, c) pin perpendicular to the root slice, pressing into the surface of cement 
and d) schema of the push-out test where the conditions used are indicated.  
 
The bonding strength (MPa) between the cement and the dentin was determined by a 
quotient between maximum load (N) and bonding surface (mm
2
), as indicated in Equation 7.3. The 
bonding surface between cement and dentin (Figure 7.14) was calculated as displayed in Equation 
7.4, where r is the radius of the cement (mm) and h is the height of the root slice (mm). Twelve 
specimens were assayed for each formulation.  
Equation 7.3.   Bonding strength MPa =
 	 ()
	  ()
 
Equation 7.4.  Bonding surface (mm) = 2 · π · r · h 
 
 
Figure 7.14. Schema that represents a tooth slice which root canal was obturated with cement. The 
height of the slice was 2 mm and the diameter of the root was 1.1 mm. 
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7.3.5.3 Sealing ability (microleakage test) 
A microleakage test was carried out in order to evaluate the sealing ability of the RAD-
MPC. The preparation of the samples and the technique employed in this study are described 
below. 
7.3.5.3.1 Root canal filling 
The study was performed with 86 single-rooted human premolar teeth extracted for 
surgical or periodontal reasons. The selected teeth had similar root length (13.5 ± 2.0 mm) and 
similar root canal diameter. Teeth with root fractures, root caries or multiple canals were excluded. 
The teeth were stored in 0.5 % chloramines T (Sigma-Aldrich) at 4°C for preventing bacterial 
growth, for no longer than one month. Human specimens were obtained with a protocol that was 
reviewed and approved by the Institutional Ethics Committee (University of Granada, Granada, 
Spain). 
The teeth were decoronated using a low speed diamond saw (Struers, Minitorm) and the 
root length was standarized to approximately 12 mm. The cleaning and shaping of the root canal 
was performed as described below. Firstly, Gates Glidden drills (Dentsply International Inc.) size #2 
and #3 were used to open the upper third of the root canal system. Secondly, canal patency was 
achieved with Flex-o-file (Dentsply International Inc.) size #15. Working length was measured and 
established 0.5 mm shorter than apical foramen. Finally, instrumentation was performed with a 
crown-down technique using endodontic rotatory nickel-titanium file instruments (Dentsply 
International Inc.) mounted on a low-speed hand-piece to a size #30. At each instrument change, 
the intracanals were irrigated with 5.25 % sodium hypochlorite (NaOCl, Panreac) by means of a 27-
gauge needle supported in a syringe (Microlance ref. n. 300635). At the end of canal 
instrumentation, every root canal was irrigated with 17 % EDTA for 3 min (MD-Cleanser, Meta 
Biomed), a calcium chelating agent that removes the smear layer [14]. A final irrigation with 5.25 % 
NaOCl, followed with distilled water, was performed. Finally, every tooth was dried with paper 
points (Dentsply International Inc.). A single operator conducted all procedures. 
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Teeth were obturated with four different cements: experimental NH4-MPC, Na-MPC and 
NH4+Na-MPC, and grey MTA (ProRoot, Dentsply International Inc.) was used for comparison. MTA 
cement was prepared with a liquid to powder ratio of 0.33 ml/g, as indicated by the manufacturer 
[8]. The teeth were randomly divided in 8 groups of 10 teeth each, since the four cement types 
were applied either as root canal sealers together with gutta-percha, or as root canal fillers without 
gutta-percha. The cements were introduced into the root using a lentulo spiral [15] [16]. When the 
cements were applied as sealers, a few gutta-perchas point size #30 were slightly coated with the 
cement and placed into the canal to working length. Lateral compaction was achieved using 
endodontic pluggers [17]. When using cements as fillers, the cement was also placed into the canal 
using a lentulo spiral and was laterally compacted with endodontic pluggers. In both cases, excess 
of gutta-percha and/or cement was removed from the coronal portion of the root canal and a 3 
mm coronally space was created to insert the fluid filtration device. The space was filled with Cavit 
(3M ESPE) as a provisional restoration [18].  
Positive and negative controls were prepared using three teeth for each group. Positive 
controls were prepared introducing a cotton pellet into the root canals, and negative controls by 
obturating the teeth with resin AHPlus [19] and gutta-percha. The roots of the negative control 
were entirely covered with a double layer of varnish in order to ensure their perfect sealing.  
X-ray images of each tooth were taken to assess the correct placement of the material 
along the root canal, as well as to detect the presence of any void in the filling material. Finally, 
teeth were stored in PBS solution at 37°C for 24h.  
7.3.5.3.2 Fluid filtration system 
After storing the obturated root canals in PBS for 24 h, the teeth were covered with 2 
layers of varnish up to 2 mm of the apical site, in order to seal off any microcrack that they could 
have. The provisional restoration was removed and the coronal part was fixed on a Plexiglass 
support (2.12 x 0.6 cm) with cyanocrylate adhesive (Rocket, Corona). Previously, the Plexiglass 
support was pierced and penetrated by an 18-gauge needle (Figure 7.15 a), which was introduced 
 2 mm into the root coronal portion
roots, the other side of the 18-gauge needle was introduced into an 18
(Tygon R-3603) of the fluid filtration system. 
Figure 7.15. Preparation of the fluid filtration system: a) 18
support, b) coronal part of the tooth fixed
the root canal. 
 
The fluid flow of the 
(Sensirion, ASL 1600), which was connected between the source of hydraulic pressure and the root 
specimen. A constant hydraulic pressure of 6.86 kPa was generated 
with 60 ml of deionized water 70 cm above the sensor. Figure
filtration system and Figure 7.16 b
Figure 7.16. a) Schema of the fluid filtration system, b) p
actually used. 
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 (Figure 7.15 b). To measure the microfiltration of the obturated 
-gauge polyethylene tubing 
 
 
-gauge needle pierced in the Plexiglass 
 on the Plexiglass support, 2 mm of the needle penetrating 
obturated root canal was measured using a liquid flow sensor 
by suspending a syringe filled 
 7.16 a shows a schema of th
 displays the pictures of the system that was actually used.
ictures of the fluid filtration system that was 
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The fluid flow rate of every specimen
30s and repeated 10 times in succession, after 5 mi
fluid flow through the root canal of the specimens was measured at different time peri
48 h, 1 and 2 weeks, and 1, 3 and 6 months. 
37°C in PBS and the medium was refreshed every 2 weeks. 
7.3.6 Statistical analysis of the results
A Student’s t-test was used to determine 
the mean values of the experimental groups. A difference between 
be significant at p < 0.05. 
 
7.4 Results 
7.4.1 Radiographic assessment
Figure 7.17 a displays the radiographic image of the 
observed that the thicker was the step
level of grey (optical density) of each
wedge (Figure 17 b). 
Figure 7.17. a) X-ray image of the aluminum
indicated, b) calibration curve of the aluminum
standard deviation, n = 5.  
 (out of 10 for each formulation) was measured for 
n of fluid stabilization. Therefore, n = 100. The 
ods: 24 and 
During the whole study, the specimens were stored 
 
 
the statistically significant differences 
two groups was considered to 
 
aluminum step-wedge, where 
, the more radiopaque (whiter) was the X-ray image
 step was used to draw the calibration curve of the step
 step-wedge, where the level of grey for each step is
 step-wedge. The data and error bars indicate mean 
at 
between 
it can be 
. The 
-
 
 
± 
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A linear regression of the calibration curve resulted in Equation 7.5, which was used to 
determine the equivalent millimeters of aluminum thickness of each sample. 
Equation 7.5.   Level of grey = 25.045 · Al thickness −  16.879 
Al thickness =  
Level of grey + 16.879
25.045
 
 
Figure 7.18 shows the X-ray images of the cement disks of the three RAD-MPC 
formulations prepared with different amounts of Bi2O3. It should be noted that the X-ray images of 
the RAD-MPC disks prepared with 10 − 20 wt% Bi2O3 showed several white dots, which were 
attributed to conglomerates of the radiopacifying agent.  
 
Figure 7.18. a) X-ray images of the specimens prepared with NH4-MPC, Na-MPC and NH4+Na-MPC to 
which different amounts of Bi2O3 were added. The amounts of Bi2O3 added are indicated on the top 
right corner of each image in wt%.  
 
The level of grey of each sample was used in Equation 7.5 to determine its equivalent 
millimeters of aluminum thickness. Figure 7.19 shows the equivalent millimeters of aluminum 
thickness for each MPC formulation prepared with different amounts of Bi2O3. The cement itself, 
without the addition of Bi2O3, had between 1.3 and 1.7 equivalent millimeters of aluminum. The 
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radiopacity also depended on the formulation and the following trend was observed: Na-MPC > 
NH4+Na-MPC > NH4-MPC. The radiopacity rose to values between 5.7 and 6.5 equivalent 
millimeters of aluminum when 10 wt% of Bi2O3 was added and a maximum radiopacity of about 11 
equivalent millimeters of aluminum was reached with 30 – 40 wt% Bi2O3. 
 
Figure 7.19. Equivalent millimeters of aluminum thickness versus amount of Bi2O3 (wt %) added to the 
cement powder. Error bars indicate the standard deviation, n = 5.  
 
It is important to keep in mind that the equivalent millimeters of aluminum thickness were 
interpolated from the linear regression done with the aluminum step-wedge, which ranged from 1 
to 8 mm. Thereafter, any value of radiopacity higher than 8 equivalent millimeters of aluminum 
thickness was out of the scale and should be considered as an approximation. 
According to UNE-EN ISO 6876 standard [7], a root canal filling material of 1 mm thickness 
should have a radiopacity of 3 equivalent millimeters of aluminum thickness. Therefore, in the 
current situation, a disk of 2 mm thickness should have a radiopacity of 6 equivalent millimeters of 
aluminum. Equation 7.5 was used to calculate the minimal amount of Bi2O3 required for each 
formulation to comply with the ISO standard. The results indicated that a minimal amount of 11.2, 
9.7 and 9.9 wt% should be added to NH4-MPC, Na-MPC and NH4+Na-MPC, respectively. Therefore, 
an amount of Bi2O3 of 10 wt% was selected since the radiopacity of the ammonium-free and the 
ammonium-reduced formulations complied with the ISO standard, ensuring that the cement would 
 be distinguished from hard tissues such as 
root canal filling, MTA, contains 
 10 wt% Bi2O3 was selected. 
7.4.2 Assessment of the exothermy
The addition of the radiopacifying agent modified physical properties of the cement: 
exothermy diminished and the setting time
decreasing the amount of borax (
with the MPCs without Bi2O3. 
In order to determine the amount of borax that had to be added to the RAD
cements were prepared with different 
were evaluated. Figure 7.20 show
prepared with 0, 1 and 3 wt% of 
Figure 7.20. Temperature evolution 
wt% Bi2O3, and to which 0, 1 and 3 wt% borax 
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dentin. For comparison, a commercially used cement 
around 16 wt % Bi2O3 [8].  
 and the setting times 
s increased. This reduction of the exother
retardant) that had to be added in the RAD-MPCs, in comparison 
amounts of borax, and the exothermy and the 
s the temperature evolution of the three RAD-MPC formulations 
borax. 
of: a) NH4-MPC, b) Na-MPC and c) NH4+Na-MPC prepared with 
was added.  
 357 
for 
the 
my allowed 
-MPCs, the 
setting times 
 
10 
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Table 7.3 shows the thermal coefficient
different amounts of borax. A thermal coefficient 
material would cause mild or no damages
of borax had to be added to the cements, since NH
coefficient higher than 1. 
Table 7.3. Calculated thermal coefficients 
Bi2O3 when 0, 1 and 3 wt% borax wa
Added borax (wt%)
0  
1 
3 
  
The initial and final setting times of t
Bi2O3 and 0, 1 and 3 wt% of borax are shown in 
Figure 7.21. a) Initial setting times and b) final setting times 
containing 10 wt% Bi2O3 when 0, 1 and 3 wt% borax was
borax, the error bars indicate the standard deviation, n = 3
 
When no borax was added, 
the times were short for the three cement
min). The addition of 1 wt% of borax increased 
formulations (initial setting time values between 6 and 9 min). 
< NH4+Na-MPC when 1 wt% borax was added. 
time of NH4-MPC, which then had an
s of the three cement formulations prepared with 
lower than 1 was required to ensure that the 
 to the surrounding tissues [20]. Therefore, at least 1 wt% 
4-MPC prepared without borax had a thermal 
of NH4-MPC, Na-MPC and NH4+Na-MPC containing 10 wt% 
s added.  
 NH4-MPC Na-MPC NH4+Na-MPC 
> 1 < 1 < 1 
< 1 < 1 < 1 
< 1 < 1 < 1 
he three cement formulations containing 
Figure 7.21. 
of NH4-MPC, Na-MPC and NH4+Na
 added to the cement powder. For 1 wt% of 
. 
both the initial and final setting times were very similar,
 formulations (initial setting times were between 4 and 8 
slightly the setting time of the three 
The trend was Na-MPC 
A 3 wt% of borax increased substantially
 initial setting time of 22.5 min and a final setting time of 35 
10 wt% of 
 
-MPC 
 and 
cement 
< NH4-MPC 
 the setting 
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min. In contrast, the setting times of the other two formulations increased moderately, that of 
NH4+Na-MPC more than that of Na-MPC.  
An amount of borax of 1 wt% was selected for the continuation of the study because the 
exothermy of the three cement formulations would not cause any damage to the surrounding 
tissues and the setting times were adequate for dental applications [21].  
 1 wt% of borax was selected. 
From now on, 10 wt% of Bi2O3 and 1 wt% of borax were included to the powder phase of 
the MPC formulations, which were coded as RAD-MPC. 
7.4.3 Physico-chemical characterizations of the RAD-MPC 
7.4.3.1 Injectability 
Figure 7.22 shows the load/displacement curves during extrusion of the RAD-MPC pastes 
through a 2 mm-aperture syringe. Na-MPC and NH4+Na-MPC showed the typical 
load/displacement curves of the injectability tests, which contain three relevant stages, as 
explained in Section 6.4.2.2.  
The yield force of Na-MPC was 18 N and that of NH4+Na-MPC was 13 N. Afterwards, the 
paste was continuously injected when a constant load was applied to the syringe plugger. 
However, when a small portion of the paste was left inside the syringe, after the piston had been 
displaced about 7.5 mm for Na-MPC and about 8.0 mm for NH4+Na-MPC, the load start increasing 
linearly until 100 N was reached, which was the limit load used for this assay. The injectability 
curve of NH4-MPC had a different pattern than the curve of the other two formulations. After the 
piston was displaced about 1.0 mm, the load started increasing, until the maximum load was 
reached. The displacement of the piston when the load started to increase, which was similar for 
Na-MPC and NH4+Na-MPC and much lower for NH4-MPC, indicated the injectability of the pastes. 
The lower injectability of NH4-MPC was associated to a major filter pressing occurring for this 
formulation. 
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Figure 7.22. Load/displacement curves 
 
Table 7.4 shows the injectability of the three 
and that of NH4+Na-MPC were injected almost total
contrast, only about 36 % of NH4-MPC paste was inject
Table 7.4. Injectability of the three 
deviation, n = 3.  
NH4-MPC
35.8 ± 1.0
 
7.4.3.2 Compressive strength  
Figure 7.23 shows the compressive strength of
solution for 1 h, 2 h, 1 day and 7 days
comparison [22]. After 1 h of immersion, the RAD
between 12.3 and 17.2 MPa, in contrast with the 1.2 
higher disparity in the compressive strength of the three formulations, with 
MPC (33.8 ± 3.0 MPa), followed by NH
MPa). The compressive strength of CPC 
MPC formulations reached their maximum strength. At this time, there were not significant 
differences (p > 0.05) in the compressive strength of the three formulations, which ranged 
for the RAD-MPC formulations.  
RAD-MPC formulations. The paste of Na
ly, with injectability values around 90
ed.  
RAD-MPC formulations. The data indicate mean ± standard 
 Na-MPC NH4+Na-MPC 
 88.9 ± 0.6 90.3 ± 0.2 
 the cements after immersion in Ringer
. The strength evolution of an apatitic CPC is included for 
-MPC exhibited compressive strength values 
± 0.1 MPa of the CPC. After 2 h, there was 
a higher value
4+Na-MPC (23.9 ± 2.4 MPa) and, finally, Na-MPC (
after 2 h was 4.9 ± 0.2 MPa. After 1 day the three RAD
 
-MPC 
 %. In 
’s 
 for NH4-
17.3 ± 2.1 
-
 between 39.6 ± 3.6 MPa (Na-MPC) and 46.0 
of CPC after 1 day was 32.7 ±
formulation that showed a significant change on
31.5 ± 4.4 MPa. 
Figure 7.23. Compressive strength of the three RAD
immersion in Ringer’s solution at 37
comparison [22]. The error bars 
 
7.4.3.3 Phase composition  
Figure 7.24 shows the evolution of the 
formulations, at time zero (initial powder) 
solution. The spectrum of the cement powder (
formulation, except for borax, which was added in 
solution, both NH4-MPC and NH
also coexisted after 1 day and 7 days, with a gradual increase of the amount of struvite with time. 
In contrast, Na-MPC spectra showed a hump centered at 
amorphous phase and slightly increased with time. 
not clear for the NH4+Na-MPC, probably
hump. The radiopacifying agent (
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± 6.5 MPa (NH4+Na-MPC). The compressive strength 
 1.8 MPa, slightly lower than that of MPCs. At 7 days the only 
 strength was NH4+Na-MPC, which dropped to 
-MPC formulations after 1 h, 2 h, 1 and 7 days of 
°C. The strength evolution of a CPC has been included for 
indicate the standard deviation, n = 10.  
phase composition of the three 
and after 1 h, 1 day and 7 days of immersion in Ringer
0 h) showed all the reactants present in
only 1 wt%. After 1 h of immersion in Ringer’s 
4+Na-MPC formulations resulted in struvite and sche
2θ ∼ 31° that was associated to an 
The observation of an amorphous pha
 because crystalline peaks masked the presence of the 
Bi2O3) was unaltered with time. 
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Figure 7.24. XRD of RAD-MPC formulations set for 0 h (initial powder), 1 h, 1 day and 7 days in Ringer’s 
solution at 37°C: a) NH4-MPC, b) Na-MPC, c) NH4+Na-MPC. A.U. stands for arbitrary units. 
 
7.4.3.4 Morphology  
Figure 7.25 shows the morphologies at low magnification (40x) of fracture surface of the 
cements after 7 days of immersion and Figure 7.26 shows the same samples at high magnification 
(2000x). Some pores of 10–50 µm of entrance size were distributed heterogeneously on the 
fracture surface of NH4-MPC (Figure 7.25 a). Figure 7.25 b displays some large cracked particles 
embedded in the matrix of Na-MPC. Finally, NH4+Na-MPC showed a few pores without the 
presence of embedded particles (Figure 7.25 c). 
 Figure 7.25. Microstructure at 40x 
Ringer’s solution for 7 days at 37
particles (P) and the matrix (M) are indicated.
 
Figure 7.26 shows the microstructure of
1 h and 7 days. The microstructures
glass-like morphology with some cracks
elongated particles of different sizes embedded in a glassy
the particles observed in NH4+Na
The presence of Bi2O3 (morphology of Bi
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of fracture surfaces of the RAD-MPC formulations after immersion i
°C: a) NH4-MPC, b) Na-MPC and c) NH4+Na-MPC. For Na-
  
 RAD-MPC after immersion in Ringer’s solution for 
 of the three formulations after 1 h were similar
. After 7 days, NH4-MPC and NH4+Na
-like matrix, being significantly smaller 
-MPC. The morphology of Na-MPC was a flat and cracked surface
2O3 is shown in Figure 7.3) was not clearly distinguished
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Figure 7.26. Microstructure at 2000x 
immersion in Ringer’s solution for 
days: b) NH4-MPC, d) Na-MPC and f) NH
 
Table 7.5 shows the chemical anal
after 1 h and 7 days. For Na-MPC (Figure 7.25 b)
separately on the particles (coded as P) and on the matrix (coded as M). 
consideration the particles found in Na
MPC formulations had 34−42 wt% Mg
had 8−18 wt% N, and Na-MPC and NH
embedded in Na-MPC contained a lower amount
than the matrix.  
of fracture surfaces of the RAD-MPC formulations 
1 h at 37°C: a) NH4-MPC, c) Na-MPC and e) NH4+Na-MPC, and 
4+Na-MPC.  
ysis of fracture surfaces of the RAD-MPC formulations
, the chemical analysis was performed focusing
Without 
-MPC, it can be generalized that the matrix of 
, 26−41 wt% P and 7−13 wt% Bi. NH4-MPC and NH
4+Na-MPC had 4−15 wt% Na. In contrast, the particles 
 of Mg and Bi, and higher amount of P and Na 
 
after 
for 7 
 
 
taking into 
three RAD-
4+Na-MPC 
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Table 7.5. Chemical analysis (EDS) of the fracture surfaces of the three RAD-MPC formulations after 1 h 
and 7 days in Ringer’s solution. M stands for matrix and P for particle, which is indicated in Figure 7.25 
b. The chemical composition of the initial powder of each formulation is included for comparison. The 
standard deviation associated to the technique is ± 2%. 
Formulation Time 
Elements (wt%) 
Mg P N Na Bi 
NH4-MPC 
Powder 61.2 20.5 9.3 
− 9.0 
1 h 38.5 36.0 15.6 
− 9.9 
7 d 33.7 41.2 18.0 
− 7.1 
 Powder 57.7 19.3 
− 14.4 8.6 
 1 h (M) 42.2 25.6 
− 18.8 13.4 
Na-MPC 1 h (P) 13.6 45.2 − 33.0 8.2 
 7 d (M) 37.9 31.0 − 23.1 8.0 
 7 d (P) 28.9 40.8 − 29.1 1.2 
NH4+Na-MPC 
Powder 59.4 19.9 4.6 7.2 8.8 
1 h 36.3 30.8 9.0 11.9 12.0 
7 d 39.1 36.6 7.6 8.3 8.3 
 
 
7.4.3.5 Specific surface area, skeletal density and porosimetry 
Table 7.6 shows the specific surface area (SSA) and the skeletal density of the three RAD-
MPC formulations immersed in Ringer’s solution for 7 days. The trend of the MPC formulations for 
SSA (NH4-MPC > NH4+Na-MPC > Na-MPC) was the opposite than for the skeletal density (Na-MPC > 
NH4+Na-MPC > NH4-MPC). 
Table 7.6. Specific surface area (SSA, m
2
/g) and skeletal density (g/cm
3
) of the three formulations of 
MPC after 7 days of immersion in Ringer’s solution. The average ± standard deviation is shown, n = 2. 
 SSA (m
2
/g) Skeletal density (g/cm
3
) 
NH4-MPC 30.37 ± 0.09 2.65 ± 0.07 
Na-MPC 1.38 ± 0.01 2.77 ± 0.01 
NH4+Na-MPC 13.68 ± 0.04 2.71 ± 0.02 
 
Figure 7.27 shows the distribution of the entrance pore size diameter for the three RAD-
MPC formulations immersed in Ringer’s solution for 7 days. NH4-MPC had a bimodal distribution, 
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with a wide peak around 6.5 µm and a very sharp one centered at 32 µm. Both Na-MPC and 
NH4+Na-MPC formulations had a unique peak around 7 µm. NH4+Na-MPC showed another peak 
around 250 µm that was associated to the cracks appearing in the material during the drying 
process, as observed in Figure 7.26 f.  
 
Figure 7.27. Distribution of the entrance pore size diameter of NH4-MPC, Na-MPC and NH4+Na-MPC 
after being immersed in Ringer’s solution for 7 days at 37°C.  
 
Table 7.7 shows the total open porosity of the three RAD-MPC formulations after 7 days of 
immersion in Ringer’s solution. The total open porosity of the three formulations was lower than 
11.0 %, following the trend NH4-MPC > Na-MPC > NH4+Na-MPC. 
Table 7.7. Total open porosity of the three RAD-MPC formulations after 7 days of immersion in Ringer’s 
solution.  
NH4-MPC Na-MPC NH4+Na-MPC 
11.0 5.0 4.2 
 
7.4.4 Specific characterizations for endodontic cements 
 In the following section, the results of the characterizations performed to the RAD-MPC 
with the aim to determine if these cements could be applied in endodontic applications are 
 described. Specifically, the stability with time, the bonding strength to dentin and the se
ability of the cements were evaluated.
7.4.4.1 Material stability 
In the degradation study, the weight of each specim
the weight change was calculated (Figure 
increased their weight about 0.8, 1.8 and 3.3 wt%, respectively. However, after this time, the 
weight of NH4-MPC and Na-MPC started decreasing continuously. The weight remained constant 
between 14 and 35 days for NH
formulations dropped their weight slightly and, finally, they remained again stable with time until 
the end of the study. NH4+Na-MPC maintained the 
21 days and, afterwards, it decreased slightly wit
0.6, 5.2 ± 0.8 and 2.4 ± 1.6 wt% for NH
differences were only found between the Na
Figure 7.28. Weight change of the three MPC formulations immersed in PBS solution for 60 days at 
37°C, the medium being refreshed every 3.5 days. Error bars indicate the standard deviation, n = 5. 
 
Tailoring magnesium phosphate cements for endodontic applications
 
en was monitored every 3.5 days
7.28). After 1 day, NH4-MPC, Na-MPC and NH
4-MPC and between 14 and 42 days for Na-MPC. Afterward
reached weight after 1 day stable for the initial 
h time. After 60 days, the weight loss was 4.3 
4-MPC, Na-MPC and NH4+Na-MPC, respectively. 
-MPC and the NH4+Na-MPC. 
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aling 
 and 
4+Na-MPC 
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Significant 
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The three MPC formulations released Mg ions continuously with time (Figure 7.29 a). For 
the initial 24 days, the trend of [Mg] was NH4-MPC > NH4+Na-MPC > Na-MPC, although the fast 
increasing release of Mg ions of NH4+Na-MPC led to a similar [Mg] than that of NH4-MPC after 24 
days. After 28 days, the continuous release of Mg ions by both Na-MPC and NH4+Na-MPC 
formulations produced a constant [Mg] with time and, in contrast, NH4-MPC tended to decrease 
the [Mg] with time.  
After 3.5 days, the three MPC formulations released phosphate ions, causing a [P] of 21.3 ± 
2.1, 30.2 ± 2.7 and 14.7 ± 0.9 mM for NH4-MPC, Na-MPC and NH4+Na-MPC, respectively (Figure 
7.29 b). However, after 7 days, whilst NH4-MPC still released P ions causing a slightly higher [P] 
than that of PBS, Na-MPC and NH4+Na-MPC did not significantly modify the [P] of PBS (Figure 7.29 
b). At longer times, no significant release of P ions was detected. 
For the initial 31 days, both Na-MPC and NH4+Na-MPC released Na ions producing a [Na] 
slightly higher than that in PBS (Figure 7.29 c). Afterwards, the [Na] of media remained similar to 
that in PBS, showing that the cements did not release Na ions anymore.  
Finally, during the whole period of study, the three MPC formulations increased the pH of 
PBS medium from 7.4 to around 8.5 (Figure 7.29 d). The general trend observed was that Na-MPC 
increased the pH slightly less than the other two formulations and, after 35 days, NH4-MPC was the 
formulation that most increased the pH.  
 Figure 7.29. Degradation study in which the three 
solution for 60 days at 37°C, the medium being refreshed every 3.5 days: a) 
pH. The dash lines indicate the concentrations or pH of pristine PBS. 
deviation, n = 5 for a, c and d, and
 
7.4.4.2 Dentin-cement bonding strength
 First of all, it should be highlighted that this study has been included in this Chapter 
because the dentin-cement bonding strength is a c
be used for endodontic applications. Nevertheless, the family of MPCs 
used, which contained 6 wt% borax and 0 wt% Bi
Figure 7.30 shows the surface of tooth slices after the root canal was obturated with Na
MPC, observed with an optical microscope (
Tailoring magnesium phosphate cements for endodontic applications
RAD-MPC formulations were immersed in PBS 
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haracterization specific for material
optimized in Chapter 
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Figure 7.30. Images of root slices with the root canal cemented with Na-MPC, observed with an optical 
microscope (the magnifications applied are indicated in every picture). 
 
Figure 7.31 shows the images of the three MPC formulations and the control (grey MTA) 
filling the root canal, viewed with the optical microscope.  
 
Figure 7.31. Images of root slices, the root canal cemented with NH4-MPC, Na-MPC, NH4+Na-MPC and 
MTA (control), observed with an optical microscope at a magnification of 10x. 
 
 The bonding strength between the cements under study (3 formulations of MPC and grey 
MTA as control) and the dentin of the root canal is shown in Figure 7.32. NH4-MPC, Na-MPC and 
NH4+Na-MPC had a bonding strength between 20.5 and 22.0 MPa, which was significantly higher 
(p < 0.05) than that of MTA (13.8 ± 5.3 MPa). Samples that fractured during the test (4.2 % of total) 
were not included in the analysis. 
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Figure 7.32. Dentin-cement bonding strength, evaluated with the push-out test, between the cement 
formulations (NH4-MPC, Na-MPC, NH4+Na-MPC and MTA) and the dentin. Error bars indicate standard 
deviation, n = 12. * indicates statistical significant differences between MTA and the other formulations 
(p < 0.05).  
 
7.4.4.3 Sealing ability (microleakage test) 
 Figure 7.33 shows the X-ray images of the root canals obturated with the three 
formulations of RAD-MPC and with grey MTA (used as control). For each cement formulation and 
procedure of obturation (with or without gutta-percha) the cement was clearly distinguished from 
the anatomic structure of the root, which demonstrates that the amount of radiopacifying agent 
was adequate. However, the contrast of some of the X-ray images is low. 
Figure 7.33. X-ray images of the root canal obturated with NH4-MPC, Na-MPC, NH4+Na-MPC and grey 
MTA, with gutta-percha (cement used as sealer) or without gutta-percha (cement used as filler). GP 
stands for gutta-percha. 
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 In this study, the microleakage of the root canal fillings was evaluated in function of several 
parameters:  
a) Time: 24 h, 48 h, 72 h, 1 week, 2 weeks, 1 month, 3 months and 6 months; 
b) Formulation of cements: three experimental ones within the family of RAD-MPC (NH4-MPC, Na-
MPC, NH4+Na-MPC) and a control (grey MTA); 
c) Procedure of obturation, using the cements as sealers (together with gutta-percha) or as fillers 
(without gutta-percha). 
 The results are summarized in Figure 7.34 and in Table 7.8, where the statistically 
significant differences are included. 
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Figure 7.34. a) Microleakage of different cement formulations
months and 6 months, h stands for hour, w stands for week and m stands for month), ii) 
stands for NH4+Na-MPC) and iii) the obturation 
bars indicate the standard deviation, n = 100. 
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 in function of three parameters: i) the time of immersion in PBS (24 h, 48 h, 1 week, 2 weeks, 1 month and 3 
the cement formulation (NH4-MPC,Na
procedure of the root canal, which was either with cement and gutta-percha (with GP) or 
 
-MPC, NH4+Na-MPC and MTA; N+N-MPC 
only with cement (w/o GP). Error 
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Table 7.8. Microleakage of different cement formulations represented in Figure 7.34. Statistical analyses were carried out among each parameter, fixing the other 
conditions: i) the time of immersion in PBS (numbers 1-5), ii) the cement formulation (letters A-C) and iii) obturation of the root canal using either cement and gutta-percha 
(with GP) or only cement (w/o GP) (symbols ψ, *, $,and χ). For (i) and (ii), groups marked with the same letter or with the same number were not statistically different, for 
(iii) groups marked with the same number of symbols (one or two) were not statistically different.   
  24 hours 48 hours 1 week 2 weeks 1 month 3 months 6 months 
With GP 
NH4-MPC 
0,074±0.047 
1-A-ψ 
0,076±0.057 
1-A-ψ 
0,080±0.033 
1-A-ψ 
0,089±0.039 
1-A-ψ 
0,082±0.035 
1-B-ψ 
0,097±0.035 
2-A-ψ 
0.195±0.046 
3-B-ψ 
Na-MPC 
0,059±0.046 
1-B-* 
0,075±0.049 
2-A-* 
0,106±0.048 
3-B-* 
0,120±0.044 
3-B-* 
0,119±0.030 
3-A-* 
0.113±0.042 
3-A-* 
0.144±0.056 
4-C-* 
NH4+Na-MPC 
0,037±0.030 
1-C-$ 
0,078±0.060 
2-A-$ 
0,070±0.047 
2-A-$ 
0,093±0.035 
3-A-$ 
0,097±0.037 
3-C-$ 
0,100±0.043 
3-A-$ 
0.171±0.074 
4-A-$ 
MTA 
0,063±0.050 
1-A,B-χ 
0,077±0.049± 
2-A-χ 
0.115±0.041 
3-B-χ 
0,114±0.028 
3-C-χ 
0,115±0.041 
3-A-χ 
0,147±0.076 
4-B-χ 
0.205±0.077 
5-A-χ 
w/o GP 
NH4-MPC 
0,022±0,034 
1-A-ψψ 
0,058±0,043 
2-A,B-ψψ 
0.063±0.038 
2-A-ψψ 
0,068±0,035 
2-B-ψψ 
0,059±0,050 
2-B-ψψ 
0,097 ±0,035 
3-A-ψ 
0.168±0.097 
4-A- ψ 
Na-MPC 
0,014±0,043 
1-A-** 
0,046±0,029 
2-B,C-** 
0,089±0,058 
3-B-* 
0,097±0,046 
3-A-** 
0.100±0.047 
3-A-** 
0,096 ±0,038 
3-A-** 
0.165±0.079 
4-A-* 
NH4+Na-MPC 
0,019±0,026 
1-A-$$ 
0,065±0,040 
2-A-$ 
0,055±0,040 
2-A-$ 
0,099±0,049 
3-A-$ 
0.099±0.052 
3-A-$ 
0,096±0,044 
3-A-$ 
0.157±0.058 
4-A-$$ 
MTA 
0,013±0,052 
1-A-χχ 
0,042±0,054 
2-C-χχ 
0,105±0,057 
3-B-χ 
0.103±0.048 
3-A-χ 
0,111±0,061 
3-A-χ 
0,117 ±0,049 
3-B-χχ 
0.213±0.077 
4-B-χ 
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In order to analyze more easily the effect of each parameter, the results are represented in 
three separate graphs, one for each variable to evaluate. Figures 7.35, 7.36 and 7.37 show the 
microleakage of the three RAD-MPC formulations and the MTA used to obturate the root canal of 
human teeth in function of the immersion time, the tested formulation and whether gutta-percha 
was used or not, respectively. 
a) Microleakage versus time 
Figure 7.35 shows the root canal microleakage in function of the immersion time. The 
general trend for both the roots obturated with cement and gutta-percha and those obturated 
only with cement shown a moderate increase of the microleakage with time, being more relevant 
between 24 h and 1 week and, afterwards, between 3 and 6 months. The microleakage monitored 
was between 0.05 to 0.2 µl/min for all formulations and times, either when gutta-percha was used 
or not for the root obturation.  
Specifically for those roots obturated with cement and gutta-percha (Figure 7.35 a), NH4-
MPC was the formulation that maintained the initial value of microleakage constant for a longer 
period of time, from 24 h to 1 month. In contrast, the other three formulations had lower 
microleakage values than those of NH4-MPC after 24 h, but their microleakage increased 
significantly (p < 0.05) after 48 h, reaching a similar microleakage than that of NH4-MPC. The 
microleakage of Na-MPC and MTA significantly increased (p < 0.05) between 48 h and 1 week, 
whilst that of NH4+Na-MPC suffered a similar increase between 1 and 2 weeks. The four 
formulations reached a stable value of microleakage (p > 0.05) for a period of time, NH4-MPC 
between 24 h and 1 month, Na-MPC between 1 week and 3 months, NH4+Na-MPC between 2 
weeks and 3 months, and MTA between 1 week and 1 month. Finally, the four formulations viewed 
a significant increase (p < 0.05) between 3 and 6 months.  
The microleakage of the teeth obturated without gutta-percha (Figure 7.35 b) significantly 
increased (p < 0.05) between 24 and 48 h for the four formulations. Afterwards, the four 
formulations maintained a constant value of microleakage (p > 0.05) for a period of time that was 
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between 48 h and 1 month for NH4-
weeks and 3 months for NH4+Na-MPC, and between 1 week and 3 months for MTA. Finally, the 
microleakage significantly raised (p < 0.05) for all of them between 3 and 6 months.
Figure 7.35. a) Microleakage of root canals 
gutta-percha (with GP), b) root canal
the standard deviation, n = 100. The significant differences have been evaluated within consecutive 
times, groups identified by the same superscript letters are not significantly different (p > 0.05).
 
b) Microleakage versus formulation 
Figure 7.36 shows the micro
immersion times. Regarding the teeth obturated with cement and gutta
there were significant differences between formulations after 24
significantly lower microleakage than the other three formulations (p < 0.05). However, there were 
no significant differences between formulations (p 
month, in general, two differentiated
microleakage (p < 0.05) than NH4-MPC and NH
was significantly higher (p < 0.05) than that of the
values were not statistically different 
months was significantly higher (p < 0.05) for NH
MPC had a significantly lower microleakage
The microleakage trends of the root
different than those observed for roots obturated with gutta
differences (p < 0.05) between formulations appeared after
Na-MPC and MTA had a significantly higher micro
MPC, between 1 week and 3 months for Na-MPC, between 2 
 
versus time: a) root canals obturated with cements and 
s obturated only with cements (without GP). Error bars indicate 
  
leakage in function of the cement formulation at fixed 
-percha (Figure 
 h, the NH4+Na-MPC having a 
> 0.05) after 48 h. Between 1 week and 1 
 groups appeared, Na-MPC and MTA had a significantly higher 
4+Na-MPC. After 3 months, the microleakage of MTA 
 other three formulations, whose microleakage 
(p > 0.05) between them. Finally, the microleakage after 6 
4+Na-MPC and MTA than for NH4-MPC, and Na
 (p < 0.05) than the other three formulations
 canals filled only with cement (Figure 7.36 
-percha and cement. Significant 
 48 h and at longer times. After 1 week, 
leakage (p < 0.05) than those of NH
 
7.36 a), 
-
. 
b) were 
4-MPC and 
 NH4+Na-MPC. After 2 weeks and 1 month, NH
0.05) than the other three formu
higher microleakage (p < 0.05) than the other three formulations.
Figure 7.36. Microleakage v
gutta-percha (with GP), b) root canal
the standard deviation, n = 10
different (p > 0.05).  
 
c) Microleakage versus use or not of gutta
Figure 7.37 shows the microleakage of e
gutta-percha was used to obturate the root
note that when differences appeared for different form
cement and gutta-percha had a significantly higher (p < 0.05) microleakage than those obturated 
only with cement. The differences were more pronounced at short times, mainly at 24 h and 48 h, 
which were indistinctive of the formulation.
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Figure 7.37. Microleakage versus use of gutta
GP” stands for without gutta-percha, n
indicate the standard deviation, n = 100.
samples of the same formulation that were immersed in PBS for the same time
significant differences (p < 0.05).  
 
7.5 Discussion 
7.5.1 Radiographic assessment
Interestingly, the MPCs had ce
elements making up the MPC powder, sorted in ascending atomic number. Regardless
Mg and P (Z = 12 and 15, respectively) 
number. The radiopacity of the MPC formulations showed the trend: Na
NH4-MPC. The higher radiopacity of 
have higher atomic number than N (Z = 7
to that of the other two formulations
equimolar ratio of NH4H2PO4 and NaH
respectively. 
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 The significant differences have been evaluated within 
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rtain radiopacity by themselves. Table 7.9 
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-MPC > NH4+Na
Na-MPC was due to the presence of Na ions (Z = 11)
). The radiopacity of NH4+Na-MPC, which was in
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2PO4, used for the preparation of NH4-MPC and Na
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Table 7.9. Atoms making up the RAD-MPC formulations sorted by ascending atomic number (Z). 
Atom B N O Na Mg P Bi 
Atomic number (Z) 5 7 8 11 12 15 83 
 
Bi2O3, which had a high absorption capacity, was added as a radiopacifying agent. The 
addition of Bi2O3 to the cement powder increased the radiopacity of the cements linearly in the 
range between 0 and 20 wt % (Figure 7.19). When 30 wt% Bi2O3 was added, the cement 
radiopacity reached the maximum level of grey (R = G = B = 255) that, with the used quantification 
method, was assimilated to the maximum optical density. Therefore, it could not be distinguished 
any increase on the radiopacity of the cement when adding more Bi2O3. 
When 10 wt% Bi2O3 was added to the cement powder and 2 mm-thickness cement disks 
were prepared, the sodium-containing MPCs had a radiopacity higher than 6 equivalent 
millimeters of aluminum thickness. Since this radiopacity satisfied the UNE-EN ISO 6876 standard 
for dental root canal filling materials (1 mm-thickness disk should have a minimum radiopacity of 3 
equivalent millimeters of aluminum thickness) [7], 10 wt% Bi2O3 was the selected amount. It 
should be mentioned that only NH4-MPC did not strictly fulfill the ISO standard. Nevertheless, it 
was selected 10 wt% Bi2O3 because the two novel formulations developed in this Thesis, which 
were free of ammonium ions (Na-MPC) or contained a reduced amount (NH4+Na-MPC), did meet 
the standard. Moreover, the selected amount of Bi2O3 was enough to easily distinguish the three 
MPC formulations from the surrounding anatomical structures, as observed by the X-ray images of 
the root canals obturated with RAD-MPCs (Figure 7.33).  
The amount of raciopacifying agent added to the RAD-MPCs was lower than that in the 
commercial root canal sealer MTA, which contains 16 wt% Bi2O3 [8]. In this work, the addition of 
Bi2O3 was minimized on purpose because even though it has been proved that compound is not 
harmful to the human body, since it is insoluble in water, this compound could decrease the 
material biocompatibility if it is leached out when the cement is degraded [23].  
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7.5.2 Assessment of the exothermy and the setting times 
The factors influencing the exothermy and the setting times of the three MPC formulations 
have been extensively discussed in Chapter 5 (Section 5.5.1 and 5.5.2, respectively). Therefore, 
these topics will only be briefly discussed in this section, and Chapter 5 should be addressed for 
further details. 
When the MPCs were provided with 10 wt% Bi2O3 and 0 wt% borax was added, the 
maximum temperature reached by NH4-MPC (62°C) was significantly higher than that of Na-MPC 
(46°C) (Figure 7.20). The higher exothermy of NH4-MPC was associated to the higher acidity of 
NH4H2PO4 in comparison to its analogous phosphate salt, NaH2PO4, used for the preparation of Na-
MPC. However, Na-MPC reached the maximum temperature earlier (3 min) than NH4-MPC (3.5 
min), due to the higher solubility of NaH2PO4 (94.5 wt%) than that of NH4H2PO4 (40.5wt%) [24]. 
Nevertheless, the difference was rather small, since NH4H2PO4 had a smaller particle size 
distribution than NaH2PO4 (Figure 7.2), favoring the solubilization of the former salt.  
Interestingly, the addition of 1 wt% borax reduced significantly the exothermy of NH4-MPC 
and, in contrast, Na-MPC was almost not affected by the addition of the retardant (Figure 7.20). 
This was attributed to the better solubilization of borax, a sodium tetraborate decahydrate, into 
NH4-MPC, since Na-MPC contains sodium ions that may hinder the process. In fact, this behavior 
was more accentuated when 3 wt% borax was added. Whereas the setting times of Na-MPC only 
increased slightly, NH4-MPC triplicated its setting time (Figure 7.21).  
When MPCs contained 10 wt% Bi2O3 and 1 wt% borax, the setting time of the cements 
followed the trend Na-MPC < NH4-MPC < NH4+Na-MPC (Figure 7.21). This correlated well with the 
evolution of temperature observed for the three formulations. As already stated, the faster setting 
of Na-MPC in comparison with that of NH4-MPC could be related to two complementary factors: i) 
the higher solubility in water of NaH2PO4 (94.5 wt%) with respect to that of NH4H2PO4 (40.5wt%) 
[25] [24] accelerated the reaction; and ii) the sodium ions present in Na-MPC hindered the 
dissolution of borax, the retardant was less effective and thus the cement set faster. Surprisingly, 
even though it would be expected that NH4+Na-MPC would have setting times between the ones 
of the other two formulations, it showed the longest values.  
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The addition of 10 wt% Bi2O3 decreased the exothermy and increased the setting times of 
the MPCs. Thus, only 1 wt% borax was needed in order to have a cement with appropriate 
exothermy (thermal coefficient lower than 1, Table 7.3) and an adequate setting time (final setting 
times between 7.4 and 11.4 min, Figure 7.21), in comparison with the 6 wt% added to the MPCs 
optimized in Chapter 6. 
7.5.3 Physico-chemical characterization of the RAD-MPC 
The factors that determine the physico-chemical properties of the MPC formulations have 
been extensively explained in Chapters 5 and 6. Thus, this section is mainly focused on discussing 
the differences brought by the incorporation of the radiopacifying agent. 
7.5.3.1 Injectability 
The load/displacement curves (Figure 7.22) correlated well with the total amount of 
injected paste: the longer the displacement of the piston, the higher amount of paste injected 
(Table 7.4). The NH4-MPC was hardly injectable, whereas Na-MPC and NH4+Na-MPC showed a 
good injectability. These results matched with the better moldeability of both Na-MPC and 
NH4+Na-MPC. 
The addition of 10 wt% Bi2O3 slightly increased the injectability of Na-MPC and NH4+Na-
MPC in comparison with the MPCs optimized in Chapter 6 (comparison shown at Table 7.10). This 
was attributed to the unreactivity of the radiopacifying agent, which did not set with time. Another 
parameter that could have an effect on the different injectability between the MPCs and the RAD-
MPCs is the fineness of the NH4H2PO4, being finer in the RAD-MPC. The finer NH4H2PO4 would have 
a higher specific surface area, thus increasing the viscosity of the cement. 
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Table 7.10. Injectability of the three formulations of RAD-MPC and MPC. The data indicate mean ± 
standard deviation, n = 3. 
Family of MPC NH4-MPC Na-MPC NH4+Na-MPC 
MPCs (Chapter 6) 41.4 ± 14.0 74.4 ± 13.0 86.4 ± 3.4 
RAD-MPCs (Chapter 7) 35.8 ± 1.0 88.9 ± 0.6 90.3 ± 0.2 
 
7.5.3.2 Phase composition 
In comparison with the MPCs optimized in Chapter 6, the addition of Bi2O3 only affected 
the phases composition by the presence of Bi2O3 as an extra crystalline phase. Briefly, NH4-MPC 
and NH4+Na-MPC formulations formed schertelite and struvite, which evolved with time (Figure 
7.24), the amount of struvite (MgNH4PO4·6H2O) increasing in detriment to schertelite 
(Mg(NH4·HPO)2·4H2O). As explained in Section 5.5.3, the initial formation of schertelite was 
associated to a kinetic limitation, since struvite can only be formed when enough Mg atoms and 
molecules of water are available [26] [27]. Therefore, at longer times, the higher amount of MgO 
dissolved and the higher amount of molecules of water available, which permeated through the 
cement, favored the reorganization of the crystalline structure giving place to struvite, a phase 
thermodynamically more stable than schertelite [26] [27].  
The end-product formed by Na-MPC was amorphous, and although the hump centered at 
2θ ∼ 31° was consistent with the formation of an amorphous magnesium sodium phosphate phase, 
it was difficult to specify which one was it by means of XRD. The observation of an amorphous 
phase was not clear for the NH4+Na-MPC because peaks of struvite masked the presence of the 
hump. However, since NH4+Na-MPC had an equimolar content of NH4H2PO4 and NaH2PO4, it was 
assumed that the amorphous phase coexisted with the crystalline one. 
While the phosphate salts were dissolved quickly with time, the intensity of the XRD peaks 
of MgO decreased very slightly with time (Figure 7.24). This can be attributed to the low solubility 
of this compound in water [24] and to its addition in excess in order to have a core material that 
enhances the strength development [28] [26] [29]. The radiopacifying agent, Bi2O3, remained 
unaltered with time since it is insoluble in water [24]. 
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7.5.3.3 Reaction kinetics: compressive strength and setting times 
 The hardening kinetics was NH4-MPC > NH4+Na-MPC > Na-MPC, although the three 
formulations reached their higher compressive strength after 1 day (Figure 7.23). The longer period 
of time required by Na-MPC to reach its maximum compressive strength was associated to the 
slow formation of end-products, which provided the strength to the material. In fact, the formation 
of an amorphous phase was almost negligible after 1 h by XRD and a hump around 2θ ∼ 31° did not 
clearly appear until 1 day (Figure 7.24), which indicated the slow reaction kinetics of Na-MPC. As 
previously explained, it could be hypothesized that the dissolution of the retardant, a sodium 
borate decahydrate, was hindered in the Na-MPC matrix due to the presence of sodium ions, being 
thus less effective at short times (fast setting times) (Figure 7.21) and delaying the reaction at 
longer times, as well as the attainment of compressive strength (Figure 7.23). In contrast, NH4-MPC 
had longer setting times due both to the slower dissolution of NH4H2PO4 in water and the higher 
efficiency of borax. Nevertheless, the faster formation of struvite and schertelite end-products 
(Figure 7.24), which enhanced the attainment of higher compressive strength after 1 and 2 h for 
NH4-MPC (Figure 7.23). Surprisingly, NH4+Na-MPC was the formulation with longer setting times. 
However, its speed to increase the compressive strength was in between to that of NH4-MPC and 
Na-MPC, and the formation of struvite and schertelite after 1 h could be assimilated to that of NH4-
MPC.  
Regarding the compressive strength, it is worth noting that the maximum values attained 
by the different MPC formulations were not significantly (p > 0.05) different after 1 day (Figure 
7.23), regardless of the crystalline or amorphous nature of the end-product. 
7.5.3.4 Morphology, chemical analysis, specific surface area, skeletal density and 
porosity 
a) Morphology and porosity 
The three RAD-MPC formulations showed a glassy-like morphology, probably due to the 
formation of a borate compound layer on the surface of the material (Figure 7.26), as explained in 
Chapter 5 (Section 5.5.6). The elongated particles observed after 7 days in Figure 7.26 b and f could 
384 Chapter 7 
 
be associated with the formation of struvite and schertelite. It was difficult to discern between the 
MPC matrix and the added Bi2O3. 
At a low magnification, it was observed that NH4-MPC had pores around 50 µm distributed 
along the surface fracture, which were not observed on Na-MPC and were present in a much lower 
quantity on NH4+Na-MPC (Figure 7.25). The pores observed on the NH4-MPC surface were in 
accordance with the pore size distribution of this formulation (Figure 7.27), which showed a peak 
centered at 32 µm. The mentioned pores could correspond to the voids left after the dissolution of 
NH4H2PO4, particles embedded in the matrix of the set cement. This hypothesis was also in 
agreement with the broad particle size distribution of NH4H2PO4, between 1 and 300 µm, with the 
highest amount of particles with a size around 43 µm (Figure 7.2). In contrast, no pores were 
observed in the morphology of Na-MPC. The fact that only NH4H2PO4 particles resulted in pores 
within a matrix was attributed to the lower solubility of this salt (40.5 wt%) than that of NaH2PO4 
(94.5 wt%) [24]. The higher solubility of NaH2PO4 allowed the total dissolution of the salts prior to 
the cement setting, and thus the spaces left for the salt were filled by the cement paste. The 
morphology of NH4+Na-MPC showed only the presence of few pores that could also be associated 
to the dissolution of NH4H2PO4, whose amount was half than that of Na-MPC. 
The low liquid to powder ratio needed to produce MPC with adequate viscosity (L/P = 0.13 
ml/g) leaded to set cement with a low total open porosity, between 4 and 11 wt% (Table 7.7). This 
is a good property for cements aimed to be used for endodontic applications, where leakage 
through the material and its degradation has to be minimized. For comparison, the MTA cements 
used for endodontic applications have a porosity comprised between 30.2 and 38.4% for a liquid to 
powder ratio comprised between 0.26 and 0.33 ml/g, respectively [30]. The higher porosity of MTA 
could be mainly associated to the higher liquid to powder ratio needed to have workable cements. 
It should be highlighted that the porosity was significantly lower for the RAD-MPC 
formulations than for the MPCs optimized in Chapter 6 (comparison shown at Table 7.11). This was 
associated to the addition of Bi2O3 that could fill voids between particles, allowing a better 
compaction of the end-products. Nevertheless, these results differed from the work of Lumley et 
al. [31] that showed that the incorporation of 20 wt% Bi2O3 increased the porosity of the material. 
However, the amount of Bi2O3 used in the current work was half of the one used by Lumley et al. 
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and, moreover, the porosity is known to be a parameter highly dependent on the particle size of 
the reactants and the liquid to powder ratio, among several other variables, being therefore not 
possible to directly compare the results of porosity with other works. 
Table 7.11. Total open porosity (%) for the MPC formulations optimized in Chapter 6 and for the RAD-
MPC formulations. 
Family of MPC NH4-MPC Na-MPC NH4+Na-MPC 
MPC (Chapter 6) 30.8 28.8 35.1 
RAD-MPC (Chapter 7) 11.0 5.0 4.2 
 
b) Morphology and chemical analysis 
The atomic ratio obtained from the punctual chemical analysis of NH4-MPC after 7 days 
was MgP0.96N0.93 (excluding Bi), which indicated the presence of struvite (MgNH4PO4·6H2O). 
However, it should be stressed that NH4-MPC is a multiphasic material, constituted by a mixture of 
struvite (end-product), MgO (reactant in excess) and Bi2O3 (insoluble radiopacifying agent).  
The morphology of Na-MPC showed the presence of some particles (Figure 7.25 b). The 
fracture surfaces of the cements was analyzed by EDS, which allowed determining that the 
particles found in Na-MPC had a higher ratio of Na and P atoms, and a lower ratio of Mg and Bi 
atoms than the matrix (Table 7.5).  
The chemical analysis showed a high dispersion in the amount of Bi2O3 for each sample, 
between 8.0 and 13.4 wt% after 1 h (Table 7.5), which indicated that this compound was not 
homogeneously distributed along the matrix. In fact, agglomerates of the radiopaque agent were 
also observed in the X-ray images of cement disks as white dots (Figure 7.18). The same problem 
was reported by Tadier et al. [9], which showed that similar agglomerates of their radiopaque 
agent (SrCO3) appeared in a cement, and reported that this agent could be homogeneously 
distributed by milling together all the reactants composing the powder. This procedure could be 
also applied for the RAD-MPC powders, although some time should be invested to find a milling 
protocol that would not alter the physical properties of cements, and the borax amount should be 
readjusted to maintain the exothermy and setting times within adequate ranges.  
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c) Specific surface area, skeletal density and porosity 
The specific surface area (SSA) followed the trend NH4-MPC > NH4+Na-MPC > Na-MPC 
(Table 7.6). The higher SSA of NH4-MPC was associated to the elongated particles of struvite and 
schertelite, which also produced a higher porosity of the material (Table 7.7), in contrast with the 
flat surface and glassy-like morphology of Na-MPC, which produced very low SSA and porosity. The 
NH4+Na-MPC, which had a morphology with characteristics of both NH4-MPC and Na-MPC, had as 
well a value of SSA between the other two formulations. However, the NH4+Na-MPC had a porosity 
slightly lower than Na-MPC. Surprisingly, the NH4-MPC and NH4+Na-MPC exhibited values of SSA 
significantly high, even though their porosity was low. 
The trend of the skeletal density values were the opposite than those of the SSA: Na-MPC 
> NH4+Na-MPC > NH4-MPC (Table 7.6). The amorphous phase formed in Na-MPC resulted to be 
denser than struvite and schertelite phases formed in NH4-MPC. Again, NH4+Na-MPC had values of 
skeletal density between the other two formulations. The skeletal density for the of NH4-MPC was 
higher than the expected value for struvite (skeletal density of 1.71 g/cm
3
 [24]. This could be 
associated to the addition of 10 wt% Bi2O3 (skeletal density 8.9 g/cm
3
 [24]) and to the potentially 
high amount of unreacted MgO (skeletal density of 3.6 g/cm
3
 [24]), since 50.8 wt% MgO was added 
and only 25.9 wt% MgO should react (1 mol MgO should stoichiometrically react with 1 mol of 
NH4H2PO4). Indeed, the skeletal values of the RAD-MPC formulations were higher than those of the 
MPCs optimized in Chapter 6 (Table 7.12) due to the presence of the radiopacifying agent. 
Table 7.12. Skeletal density (g/cm
3
) for the MPC formulations optimized in Chapter 6 and for the RAD-
MPC formulations. 
Family of MPC NH4-MPC Na-MPC NH4+Na-MPC 
MPC (Chapter 6) 2.43 ± 0.02 2.64 ± 0.02 2.59 ± 0.02 
RAD-MPC (Chapter 7) 2.65 ± 0.07 2.77 ± 0.01 2.71 ± 0.02 
 
7.5.4 Specific characterization for endodontic cements 
 The aim of a root filling material is to seal the access of microorganisms through the root 
canal, since otherwise a secondary infection could occur. In order to ensure this permanent 
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sealing, the material has to intrinsically be a good sealer and it must be stable with time. In other 
words, it must not dissolve or disintegrate as a result of the contact with physiological fluids. 
Moreover, the root canal filling material should adapt to the dentin’s shape, thus reducing the risk 
of leakage. Furthermore, the root canal filling material should remain fixed in its original position, 
enduring to mechanical charges present during the normal activities of a patient [32].  
The root canal filling material should also be biocompatible and produce minimal irritation 
to the apical tissues, and it cannot be toxic or carcinogenic. Moreover, a material with 
antimicrobial properties is desired, to kill any bacteria remaining in the root canal after the 
disinfection process done by mechanical and chemical procedures. Chapter 6 has dealt with the 
evaluation of some of these biological properties. Finally, for practical reasons, the material should 
be easy to manipulate and radiopaque to allow its control by means of X-rays [1–3,6]. 
In this section, the stability with time, the bonding strength to dentin and the sealing ability 
of the three MPC formulations are discussed.  
7.5.4.1 Material stability 
The degradation assay was performed in order to evaluate the stability of cements with 
time when immersed in an aqueous solution. It is important to note that the conditions of this 
assay were not the actual ones in the root canal, but more drastic due to the high volume of liquid 
used, which was periodically refreshed in order to accelerate the degradation pattern of the 
materials.  
The total weight loss was 4.3 ± 0.6, 5.2 ± 0.8 and 2.4 ± 1.6 wt% for NH4-MPC, Na-MPC and 
NH4+Na-MPC, respectively (Figure 7.28). However, if the weight loss was calculated considering as 
initial weight the maximum value reached for each formulation (i.e. after 1 day), the total weight 
loss would be 5.1 ± 1.0, 7.1 ± 0.8 and 5.7 ± 0.4 wt% for NH4-MPC, Na-MPC and NH4+Na-MPC, 
respectively, although no significant differences were found between formulations (p > 0.05). The 
weight loss was associated with the solubilization of the cements in PBS. The solubilization of the 
set cements started from the surface and also from the micropores and canals containing trapped 
water, which diffused out when the medium was refreshed [30,33]. 
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The key parameters involved in the solubility of a material are the temperature (in this 
case, 37°C), the pH (7.4 for pristine PBS) and the ionic concentration of the medium (pristine PBS 
contains [P] ∼ 9 mM and [Na] ∼ 151 mM). The small degradation of NH4-MPC and NH4+Na-MPC, 
which are mainly formed by struvite and MgO in excess, could be explained by the solubility of 
these two compounds at the exposed conditions. The solubility product (pKs) of struvite is between 
9.41 and 13.36 [34–41], and of magnesium hydroxide (the compound that forms MgO in water) is 
11.25 [24]. The solubility of struvite can be considered to be very low [34] or relatively high [42], in 
function of the application given to this compound. However, both struvite and magnesium 
hydroxide are more soluble than α-TCP (pKs = 25.5) and much more soluble than calcium deficient 
hydroxyapatite (pKs = 85.1). The solubility of Na-MPC, which contained an amorphous magnesium 
sodium phosphate product and unreacted MgO, is unknown. 
The weight changes observed for the three MPC formulations in the first day (Figure 7.28) 
were the balance of two processes occurring at the same time. On one hand, the formation of 
hydrated phases such as struvite, schertelite or a magnesium sodium phosphate phase increased 
the weight. On the other hand, the release of ions such as Mg, P and Na (Figure 7.29), 
counteracted this effect. In fact, the formulations that released a higher amount of P after 3.5 
days, namely NH4-MPC and Na-MPC, matched to be the ones that also gained a lower amount of 
weight in the same period of time. And vice versa for NH4+Na-MPC. The high [P] produced at the 
very beginning could be partially due to the dissolution of the phosphate salts, which occurred in a 
few hours (Figure 7.24). The fast dissolution of the phosphate salts was in accordance with the high 
solubility of the phosphate salts in water, the NaH2PO4 (94.5 wt%) being more soluble than the 
NH4H2PO4 (40.5 wt%) [24].  
The continuous weight loss observed after 1 day for NH4-MPC and Na-MPC, and after 21 
days for NH4+Na-MPC, was associated to the degradation of the end-products (i.e. schertelite, 
struvite or amorphous phase) or the remaining reactants (i.e. MgO). The dissolution of these 
compounds with time produced a [Mg] between 0.3 and 0.8 mM (Figure 7.29 a) and contributed to 
the decrease of weight. The ions released to the medium, for instance, the hydroxyl ions formed 
during the dissociation of MgO increased the pH of the medium to about 8.5 during the entire 
study (Figure 7.29 d). In general, NH4-MPC was the formulation that released the highest amount 
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of Mg ions with time, consequently increasing more the pH of the medium, whilst Na-MPC 
released the lowest amount of Mg ions and also caused the minor increase of pH. The release of 
Na ions by Na-MPC and NH4+Na-MPC, which occurred for a period of 31 days (Figure 7.29 c), also 
might decrease the samples weight. The period of time during which Na ions were released was 
not limited to the initial stages, associated to the dissolution of NaH2PO4. Therefore, the release of 
Na ions could be associated to the dissolution of the amorphous magnesium sodium phosphate 
phase. It is interesting to note that whilst the [Na] of the PBS medium was increased in about 1 − 5 
mM at each time point, the [Mg] was increased in only 0.3 − 0.8 mM. Thus, the Na ions probably 
had a higher influence on the weight loss than the Mg ones, which was in accordance with the 
higher weight loss observed for Na-MPC, although it was the formulation that released a lower 
amount of Mg ions.  
Similar degradation studies have been published for MTA. Vivan et al. [43] reported that 
disks of MTA (20 mm diameter and 1.5 mm height) immersed in 50 ml of distilled water for a time 
period of 7 days experienced a weight loss of 3.5 wt%. Another study that used the same 
experimental conditions determined that the degradation of the MTA after 7 days was between 
1.8 and 2.8 wt% when a liquid to powder ratio between 0.26 and 0.33 ml/g was used, respectively 
[30]. For comparison, in the current work, the degradation observed after 7 days showed that NH4-
MPC decreased about 1.8 wt%, whereas NH4+Na-MPC increased 3.3 wt% and Na-MPC remained 
with the same weight. However, it should be considered that the study carried out by Vivan et al. 
was conducted in distilled water, whereas our studies were performed in PBS. Other degradation 
studies, conducted for a longer period of time, reported that when disks of MTA were immersed in 
distilled water for 78 days the weight loss was 16 and 24 wt% for liquid to powder ratios between 
0.28 and 0.33 ml/g, respectively [44].  
The low solubility found for the MPCs is quite in contradiction with other works conducted 
with similar procedures, immersing ammonium-magnesium phosphate cements disks in SBF or in 
Tris/HCl (pH = 7.4) and showed a weight loss between 50 and 80 wt% after 90 days of immersion 
[45–49]. These differences could be ascribed mainly to the phase composition of the materials, the 
mentioned works using farrangstonite (Mg3(PO4)2 and ammonium phosphate as reactants of the 
cement [47–49] or not using any retardant of the reaction [45–47]. 
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7.5.4.2 Dentin-cement bonding strength (push-out test) 
It should be highlighted that the bonding strength characterization was performed with the 
MPCs optimized in Chapter 6, which contained 6 wt% borax, instead of the 10 wt% Bi2O3 and 1 wt% 
borax present in RAD-MPC. However, since the amount of reactants aimed to the formation of the 
magnesium phosphate matrix was 94 wt% for MPCs and 89 wt% for the RAD-MPCs, it was 
expected that both families of cements would have very similar adhesive properties. Nevertheless, 
this assay should be validated with RAD-MPC in a future study.  
The bonding strength between the three formulations of MPC and dentin was significantly 
higher than that of MTA and dentin (Figure 7.32). The bonding between the cements and the 
dentin was most probable mechanical, without the establishment of chemical bonds. Probably, the 
cement paste was introduced into microporosities of the dentin before setting, producing a strong 
mechanical anchorage [50].  
Reyes-Carmona et al. performed a push-out test study with MTA [51] by introducing the 
cement into root canals of 1.3 mm of diameter. They evaluated the dentin-cement bonding 
strength after storing the obturated roots in different conditions: a) covering the cement with a 
wet cotton pellet for 72 h at 37°C or b) immersing the teeth in PBS for 2 months at 37°C. Reyes-
Carmona et al. reported values of dentin-cement bonding strength of 4.67 ± 1.35 MPa after 72 h 
and of 7.14 ± 0.42 after 2 months. The differences between their results and the results reported 
in this Chapter for MTA (13.8 ± 5.3 MPa) could be mainly attributed to the different experimental 
conditions such as storage of the samples, diameter of the roots or speed rate during the test. 
The adhesion between the material and the dentin is important in order to ensure the 
success of an endodontic treatment, since the anchorage allows the material to keep fixed to its 
original position even though the presence of dislocation forces, such as mechanical stress [4]. 
Furthermore, a high bonding strength to dentin also allows to expect a lower risk of interfacial 
bacterial leakage [6].  
7.5.4.3 Sealing ability (microleakage test) 
Although several methodologies have been described to evaluate the microleakage of 
materials, in this work, the liquid pressure method proposed by Derkson et al. for restorative 
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materials [52] was selected since it is a quantitative and non-destructive method. Moreover, this 
method has a higher reliability than others such as dye penetration, bacterial penetration or fluid 
transport [6]. 
The microleakage of the three formulations of RAD-MPC and MTA was evaluated by 
obturating the root canal of human teeth, using the cement either as root canal filler or as root 
canal sealer together with gutta-percha. The microleakage was monitored at different times for a 
period of 6 month, during which the teeth were soaked in a PBS solution. The study aimed at 
evaluating the microleakage of MPCs and the influence that the immersion time, the cement 
formulation and the use of gutta-percha had on the microleakage.  
The microleakage was mainly influenced by the period of time that the teeth had been 
immersed in PBS (Figure 7.35). Although the microleakage of all formulations remained stable for a 
considerable period of time, afterwards, all of them suffered a significant increase (p < 0.05) 
between 3 and 6 months. The fact that the microleakage increased with time was associated with 
the degradation of the cement, which probably increased its total porosity making an easier path 
for water to go through it. For the teeth obturated with cement and gutta-percha, the degradation 
of the cement could make some voids between the gutta-perchas, also creating a kind of 
microcanals through which water could leak.  
The four tested formulations had a value of microleakage of the same order (Figure 7.36). 
However, whilst NH4-MPC was one of the MPC formulations that, in general, had a lower 
microleakage for a longer period of time, MTA could be pointed as the tested cement with the 
highest microleakage, especially at long times (3 and 6 months). This result would indicate that the 
MTA had a higher degradation rate that the MPCs.  
Finally, the effect that the use of gutta-percha had on the microleakage was assessed 
(Figure 7.37). At short times (24 h and 48 h) it was very clear that the use of gutta-percha had a 
negative influence on the teeth obturation, since the microleakage was significantly higher in those 
formulations sealed with gutta-percha and cement than in their counterparts sealed only with 
cement. This may indicate that the cement alone was more effectively compacted into the root 
canal than the combination of gutta-percha and cement. Nevertheless, this effect was reduced 
with the immersion time, the microleakage for those root canals obturated only with cement 
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increasing between 24 h and 48 h, probably due to the changes in microstructure of the 
transforming cement or its partial degradation, and after 6 months differences due to the gutta-
percha were only observed for NH4+Na-MPC. In contrast, whilst the root canals obturated with 
gutta-percha initially had a higher microleakage, the lower amount of present degradable material, 
in other words, the lower amount of cement added in the root canals maintained the initial 
microleakage stable for a longer period of with time. 
After 6 months, the microleakage of the three formulations of RAD-MPC was significantly 
lower than that of MTA, applying the cements into the root canal with and without gutta-percha 
(except for NH4+Na-MPC used with gutta-percha). Since MTA is a commercially used sealer for 
endodontic applications, the three RAD-MPC formulations could be considered as potentially good 
candidates as root canal filler or sealer. 
The results reported in literature regarding microleakage of root canal filling materials 
depend greatly upon the method being used. Therefore, data should be regarded with caution. 
Nevertheless, the microleakage values obtained in the current work were in the order of other 
studies. For instance, Gandolfi et al. [53] found that when root canals were filled with warm 
vertical compaction of gutta-percha and sealer, which was either an experimental MTA (cement) or 
AH plus (resin), the microleakage was between 0.13 and 0.26 µl/min for a period of time between 
24 h and 6 months, although the values did not follow any clear trend. Interestingly, Brackett et al. 
[54] found that the microleakage of root canals filled with GuttaFlow (powdered gutta-percha with 
nanosilver particles) increased with time (evaluated after 1, 6 and 12 weeks), as observed in the 
current study. In contrast, Gandolfi et al. [55] reported that when retrograde filling of the root-end 
canal was performed using white-MTA (ProRoot), the microleakage diminished with time for a 
period comprised between 4 h and 12 weeks, which was associated with the formation of 
hydroxyapatite that would obliterate voids, pores and capillary channels. 
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7.6 Conclusions 
In this Chapter, the MPCs formulations optimized in Chapter 6 were modified with the aim 
to make them suitable for endodontic applications such as root canal filling (coded as RAD-MPC). 
Both physico-chemical characterizations and studies focused on evaluating the potential 
performance of the cement for endodontic applications have been carried out. The main 
conclusions extracted from this work are indicated below.  
1. The addition of 10 wt% Bi2O3 to the MPC powder resulted in cements that fulfilled the 
radiopacity requirement established in UNE-EN ISO 6876 standard, the anatomic structure of the 
root being visible in X-ray images. The addition of 1 wt% borax allowed tailoring the exothermy of 
the reaction to physiological requirements. 
2. The three RAD-MPC formulations had adequate setting times, and NH4-MPC and NH4+Na-MPC 
were almost completely injectable using a syringe of 2 mm-aperture and a maximum load of 100 N.  
3. NH4-MPC and NH4+Na-MPC resulted into a mixture of struvite and schertelite compounds, whilst 
Na-MPC resulted in an amorphous magnesium sodium phosphate. MgO remained in excess and 
Bi2O3 was unaltered with time. 
4. The three RAD-MPC formulations attained their maximum compressive strength after 1 day, 
regardless of the nature of the end-products. The compressive strength was reached significantly 
faster than in calcium phosphate cements. 
5. The total porosity of the three RAD-MPC formulations was low, between 4 and 11 %. 
6. Cements were quite stable with time in the experimental conditions used, which could be 
attributed to their composition, as well as to their low porosity. 
7. The bonding strength between the cements and the dentin was significantly higher for the three 
MPCs than for MTA.  
8. The microleakage of the three RAD-MPCs suffered a moderate increase with time when the root 
canal was obturated with or without gutta-percha. After 3 and 6 months, the microleakage was 
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significantly lower for the three RAD-MPC formulations than for MTA when the root canal was 
obturated with or without gutta-percha. The gutta-percha increased the microleakage of the root 
canal at short times, but the root canals obturated with gutta-percha suffered a lower increase in 
microleakage with time. 
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I. General conclusions  
This Thesis addresses the development of two novel families of inorganic cements for hard 
tissue regeneration or substitution: silicon-doped calcium phosphate cements and magnesium 
phosphate cements. Below are summarized the main findings for each of them. 
 
 Regarding the silicon-doped calcium phosphate cements:  
1. A new method to stabilize α-tricalcium phosphate with silicon was developed and optimized. 
The high temperature polymorph α-tricalcium phosphate was stabilized by the presence of silicon, 
which inhibited the reversion of the β→α transformation. This was achieved by the addition of 
2.54 wt% colloidal silicon oxide to a calcium deficient hydroxyapatite and subsequent sintering at 
1250°C for 2 h, followed by slow cooling. In the Si-free sample α-tricalcium phosphate completely 
reverted to the β-polymorph. The addition of Si did not modify the β→α transformation 
temperature, which took place between 1148 and 1150°C. Fourier Transform Infrared analysis 
suggested the formation of Si2O7
6-
 groups within the α-TCP structure, following an oxygen-vacancy 
formation mechanism. 
2. The Si-stabilized α-tricalcium phosphate was a suitable reactant for the preparation of silicon-
containing calcium phosphate cements with adequate setting and cohesion times for clinical 
applications. Si-stabilized α-tricalcium phosphate was completely hydrolyzed to a calcium deficient 
hydroxyapatite, showing faster reaction kinetics than its Si-free counterpart, as proved by its 
shorter setting and cohesion times, as well as by its higher earlier compressive strength. Upon 
complete reaction, the crystalline phases, morphology and mechanical properties of both cements 
were similar.  
3. The in vitro bioactivity of the calcium phosphate cements was enhanced by the addition of Si. 
The formation of an apatite layer when immersed in simulated body fluid was accelerated in the Si-
containing calcium phosphate cements as compared to the Si-free calcium phosphate cements. 
This formed apatite layer had a higher Ca/P ratio and a higher Si content than the core material. 
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4. An in vitro cell culture study, in which osteoblastic-like cells were exposed to the medium 
modified by the Si-containing calcium phosphate cement and the undoped calcium phosphate 
cement, showed a delay in cell proliferation and stimulation of cell differentiation in both cases, 
the latter effect being more marked for the Si-containing cement. These results can be attributed 
to a strong modification of the ionic concentrations of the culture medium by both materials. Ca 
depletion from the medium was similarly observed for both cements, whereas continuous Si 
release was detected for the Si-containing cement. 
 
 Regarding the magnesium phosphate cements: 
1. A novel family of magnesium phosphate cements with different compositions was developed. 
The MPC reactants consisted of magnesium oxide and a phosphate salt, either NH4H2PO4 or 
NaH2PO4 or a mixture of both.  
2. The exothermy and setting times of the three magnesium phosphate cements were tailored for 
clinical applications by sintering the magnesium oxide, adjusting the particle size of the reactants 
and adding sodium tetraborate decahydrate (borax) as retardant. The cements exhibited very 
similar initial and by final setting times due to their fast setting. The sodium-containing 
formulations were injectable using a 2 mm-aperture syringe and a maximum load of 100 N. 
3. The main product of the ammonium-containing cements was struvite (MgNH4PO4·6H2O), 
schertelite (Mg(NH4·HPO4)2·4H2O) being an intermediate product of the reaction. An amorphous 
phase was formed in the magnesium phosphate cements prepared with NaH2PO4. Unreacted MgO 
was found in all formulations due to the addition of this reactant in excess. 
4. The MPCs displayed high early compressive strength, reaching 30 – 50 MPa after 1 – 2 h, 
whereas conventional calcium phosphate cements only reached 1 – 5 MPa at the same time. After 
1 day, the magnesium phosphate cements reached their maximum compressive strength, which 
was close to 50 MPa.  
5. The morphology of ammonium-containing cements showed elongated particles covered by a 
glassy layer, which was associated to the precipitation of a borate compound on the surface of 
magnesium oxide particles, thus retarding the reaction between the magnesium oxide and the 
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phosphate salts. The amorphous product of the magnesium phosphate cements prepared with 
NaH2PO4 resulted in a glassy-like microstructure. 
6. In general, extracts of fresh magnesium phosphate cement prepared with NaH2PO4 had 
bactericidal properties against Escherichia coli, Pseudomonas aeruginosa (as free floating bacteria 
or as biofilm) and Aggregatibacter actinomycetemcomitans, whilst extracts of fresh magnesium 
phosphate cement prepared with NH4H2PO4 or with an equimolar mixture of NH4H2PO4 and 
NaH2PO4 had bacteriostatic properties against the same bacterial strains. The antimicrobial 
potency of these extracts was associated to the synergic effect of the high osmolarity and the pH 
modification. 
7. Fresh magnesium phosphate cement extracts reduced osteoblastic-like cell viability. However, 
the cell viability increased by aging the cements, probably due to the lower osmolarity of these 
extracts. 
8. The magnesium phosphate cement formulations were also optimized for endodontic 
applications. Radiopaque magnesium phosphate cements were developed, their physico-chemical 
properties not being substantially modified in comparison to magnesium phosphate cements. The 
cements showed to be quite stable with time, with a high cement-dentin bonding strength and a 
low microleakage up to 6 months, similar to that of commercial cements used for endodontic 
applications.  
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II. Future perspectives 
This Thesis represents a step forward in the development of novel inorganic phosphate 
cements which have shown to present interesting outstanding properties for clinical applications. 
However, some of the studies should be continued by providing a more in depth characterization 
and other potential applications should be explored.  
 
 Regarding silicon-doped calcium phosphate cements: 
The physico-chemical modifications that silicon may induce upon incorporation into the α-
tricalcium phosphate structure should be investigated through further characterization. Similar 
analysis should also be performed on the silicon-doped calcium deficient hydroxyapatite to prove 
introduction of Si into the structure.  
Moreover, different strategies should be undertaken in order to be able to suggest possible 
mechanisms by which silicon increases the bioactivity of the doped-calcium phosphate cement and 
also stimulates the cell differentiation. 
An additional study of potential interest would be to develop porous scaffolds of silicon-
containing calcium deficient hydroxyapatite in order to improve cell colonization in bone 
regeneration applications. Cell seeding on these materials should be performed to evaluate cell 
colonization, proliferation and differentiation in these porous samples.  
Finally, in vivo studies should be carried out to evaluate the real performance of these 
materials. In order to study the stimulation of new bone growth by the ceramic scaffolds, these 
scaffolds could be introduced in a previously drilled cavity in the femur of a small animal model like 
rabbit. 
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 Regarding magnesium phosphate cements: 
 Despite the great potential of the family of magnesium phosphate cements and its 
interesting properties, there are several aspects that should be addressed in view to their 
application in endodontic treatments. On the one hand, the paste should be optimized in order to 
guarantee its injectability by means of cannulae typically used in these applications. On the other 
hand, a more homogeneous radiopacity of the material should be achieved. From a more 
fundamental perspective, further studies should be performed to deeply understand the setting 
reaction mechanism of these cement formulations at short times. Further in vitro studies should be 
carried out to know in more detail the effect of cement aging on the cell response. Finally, in vivo 
studies should be performed using big animal models like dogs. In this study, root canals with vital 
pulp should be instrumented and obturated in a single session with the magnesium phosphate 
cements, which could be used as filler or as sealer materials.  
The magnesium phosphate cements could also be considered for other clinical 
applications. On the one hand, the intrinsic high exothermy of the magnesium phosphate cements 
could be exploited in vertebroplasty, after removing a tumor confined in the vertebral column. 
Ideally, the cements would restore the mechanical properties of the injured site, at the same time 
that would destroy any remaining malign tissue. On the other hand, the magnesium phosphate 
cements as dense or porous structures could be used for bone regeneration applications after 
ensuring a good biocompatibility of the cements, which might restrict the use of only aged 
cements. It should be pointed out that these potential future applications are, by now, only ideas 
that require further studies at different levels to corroborate their feasibility.  
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A1. Acronyms 
α-TCP  alpha-tricalcium phosphate  
ALP alkaline phosphatase 
β-TCP  beta-tricalcium phosphate  
BET Brunnauer – Emmet – Teller theory 
CDHA  calcium deficient hydroxyapatite 
CPC calcium phosphate cement 
DTA differential thermal analysis 
FTIR fourier transform infrared spectra 
FWHM full width at half maximum 
HA hydroxyapatite  
ICP-OES     inductively coupled plasma-optical 
emission spectrometry 
ICP-MS     inductively coupled plasma-mass 
spectrometry 
ICSD inorganic crystal structure database 
JCPDS  joint committee on powder 
diffraction standards 
L/P  liquid to powder ratio 
LDH lactate dehydrogenase  
MIP mercury intrusion porosimetry 
MPC magnesium phosphate cement 
MTA  mineral trioxide aggregate 
PBS phosphate buffers solution  
SBF simulated body fluid 
SEM scanning electron microscope 
Si-α-TCP     silicon-doped-alpha-tricalcium 
phosphate 
SSA specific surface area 
TEM transmission electron microscope 
XRD X-ray diffraction 
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A.2. Data used to calculate the time-temperature damage threshold 
Dunne et al. determined the maximum exothermy that the tissues surrounding a material 
can bear without suffering any harmful effect 
1
. Figure A.1 was used to determine the maximum 
time that tissues could bear a determined temperature without suffering any irreversible damage. 
 
Figure A.1. Experimental curve that indicates the periods of time during which a determined 
temperature can be maintained causing just a mild damage to the surrounding tissue (left bottom) or 
an irreversible one (right top) (modified from 
1
, which extracted the data from 
2
). 
The data to calculate the time-temperature damage threshold was extracted from Figure 
A.1, and it is displayed in Table A.1. Thus, Table A.1 shows the exposition time that a tissue can 
bear a temperature without suffering irreversible damages. 
  
                                                            
1
 Dunne NJ, Orr J. Thermal characteristics of curing acrylic bone cement. ITBM-RBM 2001; 22: 88–97. 
2
 Moritz AR, Henriques FC Jr. Studies of thermal injury, II: the relative importance of time and surface temperature in the 
causation of cutaneous burns. The American Journal of Pathology 1947; 23: 695–720. 
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Table A2.1. Exposition time that a tissue can bear a temperature without suffering irreversible 
damages (extracted from Figure A.1). 
Exposition temperature (°C) Exposition time (s) 
46 10,000 
1,000 48 
50 100 
55 10 
60 2 
65 0.8 
70 0.6 
75 0.5 
 
 Afterwards, a more extended Table (Table A.2) was done from the information extracted 
from Figure A.1. However, it has to be considered that the values of exposition times were 
approximated. Moreover, it was considered that temperature between 37 and 46°C would only 
cause irreversible damage if they were maintained for times longer than 10,000 s and that 
temperature between room temperature and 37°C would not cause any damage regardless the 
exposition time. 
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Table A2.2. Detailed values of the exposition time that a tissue can bear a temperature without 
suffering irreversible damages (approximated from Figure A.1). 
  
Exposition 
temperature (°C) 
Exposition time (s) 
Exposition 
temperature (°C) 
Exposition time (s) 
45 1000 58.5 3 
46 1000 59 2.3 
47 1000 59.5 2.1 
48 1000 60 2 
48.5 500 60.5 1.8 
49 210 61 1.5 
49.5 120 61.5 1.2 
50 100 62 1.1 
50.5 70 62.5 1 
51 52 63 1 
51.5 40 63.5 1 
52 32 64 1 
52.5 28 64.5 1 
53 20.5 65 1 
53.5 18 65.5 1 
54 12 66 1 
54.5 10.8 66.5 1 
55 10 67 1 
55.5 8 67.5 1 
56 7 68 1 
56.5 6 68.5 1 
57 5 69 1 
57.5 4 69.5 1 
58 3.2 70 1 
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A3. Growth curve values  
A3.1. Fresh-cement extract 
Table A3.3. Data of the growth curve of E. coli incubated in fresh-NH4-MPC, Na-MPC and NH4+Na-
MPC broth-extract or in broth (control). The mean and standard deviation are indicated, n = 4. 
Time (h) NH4-MPC-extract Na-MPC-extract NH4+Na-MPC-extract Broth (control) 
0 2.2·10
5
 ± 2.6·104 2.4·105 ± 2.5·104 2.0·105 ± 2.3·104 2.3·105 ± 2.5·104 
1 1.7·10
5
 ± 5.7·103 1.3·105 ± 1.1·103 1.1·105 ± 1.2·104 1.8·105 ± 2.5·104 
2 1.5·10
5
 ± 2.9·104 7.6·104 ± 9.9·103 1.5·105 ± 1.4·104 4.4·105 ± 7.7·104 
4 2.0·10
5
 ± 4.8·104 9.6·104 ± 1.7·104 1.8·105 ± 1.6·105 1.4·106 ± 5.9·105 
8 2.4·10
5
 ± 1.9·104 1.0·104 ± 9.9·103 1.7·105 ± 1.8·104 6.0·107 ± 6.4·105 
24 1.4·10
5
 ± 4.2·104 0 ± 0 2.4·105 ± 2.8·103 1.0·109 ± 3.2·108 
 
Table A3.4. Data of the growth curve of P. aeruginosa incubated in fresh-NH4-MPC, Na-MPC and 
NH4+Na-MPC broth-extract or in broth (control). The mean and standard deviation are indicated, n = 
4. 
Time (h) NH4-MPC-extract Na-MPC-extract NH4+Na-MPC-extract Broth (control) 
0 1.4·10
5
 ± 5.3·104 1.3·105 ± 5.3·104 1.5·105 ± 5.3·104 1.1·105 ± 5.3·104 
1 1.1·10
5
 ± 5.1·104 6.5·103 ± 7·102 1.6·105 ± 1.5·104 7.5·104 ± 3.4·104 
2 1.2·10
5
 ± 4.1·104 2.0·103 ± 1.4·103 8.9·104 ± 4.9·103 2.6·105 ± 8.5·104 
4 1.5·10
5
 ± 4.9·103 0 ± 0 9.1·104 ± 1.4·103 1.3·107 ± 6.1·106 
8 1.2·10
5
 ± 1.5·104 0 ± 0 9.5·104 ± 3.2·104 2.0·108 ± 3.7·107 
24 8.6·10
4
 ± 6.4·103 0 ± 0 6.9·104 ± 1.7·104 2.2·109 ± 4.2·108 
 
Table A3.5. Data of the growth curve of A. actinomycetemcomitans incubated in fresh-NH4-MPC, Na-
MPC and NH4+Na-MPC broth-extract or in broth (control). The mean and standard deviation are 
indicated, n = 4. 
Time (h) NH4-MPC-extract Na-MPC-extract NH4+Na-MPC-extract Broth (control) 
0 8.7·10
5
 ± 1.4·105 8.9·105 ± 1.2·104 8.6·105 ± 1.8·105 9.2·105 ± 2.0·105 
2 3.3·10
4
 ± 3.5·103 0± 0 1.5·106 ± 2.1·103 1.4·106 ± 1.6·105 
4 0 ± 0 0 ± 0 0 ± 0 2.3·106 ± 3.7·105 
8 0 ± 0 0 ± 0 0 ± 0 7.2·106 ± 4.2·106 
24 0 ± 0 0 ± 0 0 ± 0 2.8·108 ± 5,6·107 
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A3.2 Aged-cement extract 
Table A3.6. Data of the growth curve of E. coli incubated in aged-NH4-MPC, Na-MPC and NH4+Na-
MPC broth-extract or in broth (control). The mean and standard deviation are indicated, n = 4. 
Time (h) NH4-MPC-extract Na-MPC-extract NH4+Na-MPC-extract Broth (control) 
0 2.4·10
5
 ± 4·104 2.8·105 ± 6.0·104 2.6·105 ± 5.0·104 2.7·105 ± 2.8·104 
1 2.6·10
5
 ± 3.6·104 5.0·102 ± 7.1·102 2.8·105 ± 1.5·104 2.7·105 ± 4.2·103 
2 1.6·10
5
 ± 2.1·104 0 ± 0 3.0·105 ± 3.2·104 3.9·105 ± 1.1·104 
4 2.5·10
5
 ± 6.3·104 0 ± 0 9.9·105 ± 8.4·104 2.7·106 ± 1.8·105 
8 1.4·10
6
 ± 5.2·105 0 ± 0 2.8·107 ± 5.7·105 5.1·107 ± 3.5·106 
24 1.4·10
8
 ± 1.7·107 0 ± 0 5.4·108 ± 8.5·107 4.3·108 ± 5.7·107 
 
Table A3.7. Data of the growth curve of P. aeruginosa incubated in aged-NH4-MPC, Na-MPC and 
NH4+Na-MPC broth-extract or in broth (control). The mean and standard deviation are indicated, n = 
4. 
Time (h) NH4-MPC-extract Na-MPC-extract NH4+Na-MPC-extract Broth (control) 
0 7.9·10
4
 ± 3.0·104 7.7·104 ± 4.0·104 7.6·104 ± 4.0·104 7.3·104 ± 3.0·104 
1 7.9·10
4
 ± 9.9·103 1.9·104 ± 2.8·103 9.3·104 ± 2.9·104 2.1·105 ± 1.3·105 
2 9.3·10
4
 ± 3.5·103 4.0·103 ± 1.4·103 2.7·105 ± 2.1·105 1.8·105 ± 2.0·104 
4 3.3·10
5
 ± 1.8·105 0 ± 0 9.9·105 ± 2.0·104 1.5·106 ± 8.8·105 
8 1.0·10
6
 ± 1.2·105 0 ± 0 3.6·107 ± 4.5·106 6.1·107 ± 3.8·106 
24 3.0·10
8 ± 1.2·107 0 ± 0 1.5·109 ± 1.7·108 2.5·109 ± 4.2·108 
 
Table A3.8. Data of the growth curve of A. actinomycetemcomitans incubated in aged-NH4-MPC, Na-
MPC and NH4+Na-MPC broth-extract or in broth (control). The mean and standard deviation are 
indicated, n = 4. 
Time (h) NH4-MPC-extract Na-MPC-extract NH4+Na-MPC-extract Broth (control) 
0 1.3·10
6
 ± 5.4·105 1.5·106 ± 7.7·104 1.4·106 ± 6.2·105 1.3·106 ± 4.5·105 
2 4.5·10
5
 ± 8.6·104 0 ± 0 5.7·105 ± 6.0·104 1.3·106 ± 6.4·104 
4 3.5·10
4
 ± 1.7·104 0 ± 0 1.4·105 ± 7·103 2.2·106 ± 8.8·104 
8 0 ± 0 0 ± 0 0 ± 0 1.1·107 ± 8,8·106 
24 0 ± 0 0 ± 0 0 ± 0 2.0·108 ± 2.8·107 
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Biomaterialia 6 (2010) 2863–2873. 
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A5. Participation in congresses  
The conference communications are shown in inverse chronological order. The presenting 
author is underlined. 
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Antimicrobial sodium magnesium phosphate cement: resorbability, bonding strength and 
sealability study. 24
th
 European Conference on Biomaterials (ESB 2011). Dublin (Ireland), 
2011. Oral presentation. 
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MP. Magnesium phosphate cements for bone regeneration. 23
rd
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7. Mestres G, Ginebra
 
MP. Novel magnesium phosphate cements for endodontic treatment. 
International Association for Dental Research & American Association for Dental Research 
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